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Background 
Type 2 diabetes is a condition of chronic hyperglycaemia and insulin resistance. 
Currently it is estimated that 1-2 million Australians have type 2 diabetes with this 
predicted to increase by 47% over the next 20 years. Treatment of type 2 diabetes is 
complicated through diabetes related conditions of retinopathy, neuropathy and 
cardiovascular disease. Exercise has been recommended to be the first line of treatment, 
followed by oral hypoglycaemic medications and reverting to exogenous insulin 
injections if the prior treatment modalities fail to control blood glucose levels. With this 
in mind, expert authorities have made recommendations about the type and volume of 
exercise that people with type 2 diabetes should complete. These recommendations 
however are hampered by limitations within the available literature, particularly around 
resistance training for individuals with type 2 diabetes, where the initial exercise 
guidelines from the American College of Sports Medicine cited only two randomised 
control studies investigating the efficacy of exercise in this population. While the volume 
of evidence available has increased, from which the most recent guidelines are based, 
there is still a genuine lack of understanding of how each mode of exercise contributes to 
metabolic health improvements and what the most efficient and effective prescription is. 
Previously, these recommendations have primarily centred around aerobic type exercise, 
however it has been theorised that this particular form of training, requiring extended 
durations at moderate-high intensities is not well tolerated by individuals with type 2 
diabetes and that resistance training may be a modality that, with its short work periods 
followed by frequent rest periods, is an attractive alternative that provides similar 
benefits to aerobic type exercise. 
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Purpose 
This PhD thesis set out to explore the acute and chronic effects of resistance exercise, 
prescribed in accordance with guidelines produced by expert authorities. An initial 
observation is that resistance exercise guidelines vary between authorities and appear to 
have little supporting scientific evidence derived from populations with type 2 diabetes.  
The aims of the series of closely linked studies presented in this thesis were to determine 
the effects of resistance exercise on insulin sensitivity and glucose control, and to 
generate data that may inform a more precise resistance exercise prescription for this 
population.  
 
Assessment of reliability and validity of methods 
A preliminary study investigated blood analysis techniques of cytometric bead array and 
the commonly used ELISA methods for the analysis of markers of diabetes 
pathophysiology. Blood samples from 18 individuals were analysed pre- and post-
resistance exercise using both methods, with cytometric bead array not detecting tumour 
necrosis factor-alpha or interleukin-6 in any sample. However, these cytokines were 
detected using ELISA. Leptin was detected in samples using both techniques, with values 
from cytometric bead array correlating strongly with those from ELISA (r = 0.93, p < 
0.001) despite overestimating the value by 115% (p < 0.001). This suggests that the 
cytometric bead array provides different concentration values to ELISA and may not be 
sufficiently sensitive to measure some adipose derived cytokines involved in the 
pathophysiology of type 2 diabetes, and which are thought to respond to exercise. Based 
on these findings, ELISA was the technique chosen to evaluate insulin and adipose 
derived cytokines throughout this PhD thesis.  
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Another preliminary study investigated the reproducibility of the oral glucose tolerance 
test (OGTT) to provide a consistent estimate of insulin sensitivity across four consecutive 
days in 10 apparently healthy individuals. Individual coefficients of variation for the oral 
glucose insulin sensitivity index (OGIS) and the Stumvoll insulin sensitivity index were 
7.8% and 14.4% with no statistically significant difference between days, however 
individuals with impaired glucose metabolism showed greater variability. Therefore, the 
OGTT was deemed to be a suitable technique for assessing insulin sensitivity in the 
subsequent intervention study involving apparently healthy individuals, but not so for 
studies involving individuals with type 2 diabetes. Given this finding, other methods of 
estimating insulin sensitivity (homeostasis assessment modelling [HOMA] and 
adipocytokine markers of inflammation) and glucose tolerance (continuous glucose 
monitoring) were employed when investigating the exercise response in people with type 
2 diabetes. 
 
Acute resistance exercise intervention in apparently healthy individuals 
Given the equivocal evidence surrounding the impact of a single session of resistance 
exercise on insulin sensitivity, the specific aim of this study was to investigate whether a 
single session of resistance-exercise modulated insulin sensitivity and how long any 
changes were present. Oral glucose tolerance test derived mathematical equations (OGIS) 
shown to correlate with the euglycaemic-hyperinsulinaemic clamp were used to estimate 
insulin sensitivity. The OGTT was performed prior to exercise and on four consecutive 
days following exercise to track the insulin sensitivity response over 96 hours in 10 
apparently healthy individuals. This study found a clinically meaningful impairment of 
insulin sensitivity (increase in OGIS ≥ 52.7 ml·min-1·m-2) over four days in people 
unaccustomed to resistance exercise. Thereby indicating that, a single session of 
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resistance exercise in apparently healthy individuals may impair insulin sensitivity for up 
to four days. If a similar response is not evident in people who regularly undertake 
resistance exercise, it leads to the possibility that frequent, regular sessions of resistance 
exercise are required to overcome the potentially adverse short-term effects of a single 
session of resistance exercise. Additionally, novice exercisers and their advisors should 
be aware of this when undertaking an exercise regimen. 
 
Acute resistance exercise intervention in individuals with type 2 diabetes 
The data investigating the acute effects of resistance exercise in people with type 2 
diabetes have typically used OGTTs to estimate insulin sensitivity. Given the earlier 
finding from this thesis that OGTTs are probably inappropriate to use in this population, 
the specific aim of this study was to investigate whether individuals with type 2 diabetes 
responded in a similar way to a single session of resistance exercise as apparently healthy 
individuals. This study used indices of insulin sensitivity from fasting glucose and insulin 
concentrations (HOMA2) in 10 individuals with type 2 diabetes and 10 apparently 
healthy individuals, and found no group by time interactions (p > 0.05) for fasting 
glucose, fasting insulin, insulin resistance or insulin sensitivity. Although significant 
differences between individuals with and without type 2 diabetes for insulin sensitivity 
and insulin resistance were present at baseline (p < 0.05), these disappeared at 72 hours 
following the session. Additionally, adipocytokine markers of inflammation were not 
significantly altered 24 hours after the session (p > 0.05). This suggests that individuals 
with type 2 diabetes don’t experience any improvement or impairment to insulin 
sensitivity between 24 hours and 72 hours following a single session of resistance 
exercise. It is possible however, that by using these ‘snapshot’ methods to investigate 
insulin sensitivity, any transient response, occurring within the first 24 hours was missed. 
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Therefore, methodologies that give a more complete picture by sampling more frequently 
or continuously would be very useful. 
 
Resistance and aerobic exercise response in individuals with insulin treated type 2 
diabetes  
Continuous glucose monitoring has been used recently to indicate that individuals with 
type 2 diabetes can spend up to 40% of a 24-hour period in a state of hyperglycaemia 
(blood glucose ≥ 10 mmol·L-1). This randomised cross-over study compared the 
continuous blood glucose response to a single session of resistance exercise with a single 
session of aerobic exercise in eight males with type 2 diabetes requiring insulin 
treatment. Continuous glucose monitoring was performed for one day prior to exercise 
and for three days following a single session of exercise. This indicated an increased (p = 
0.006) area under the 24-hour glucose curve in the initial 24 hours following both 
resistance and aerobic exercise that then returned to pre exercise levels in the 48-72 hour 
time period. However, there was no statistically significant change in the amount of time 
spent in hyperglycaemia following either exercise intervention (p = 0.11). So, whilst 
chronic exercise participation has been shown to improve glucose tolerance and control, 
an acute bout of unfamiliar exercise appears to adversely impair glycaemic control, and 
regular sessions of exercise may be required to overcome the apparent transient 
impairment to glycaemic control. 
 
Insulin sensitivity response to an eight week exercise intervention 
With the earlier findings from this thesis indicating a potential impairment of insulin 
sensitivity and glucose tolerance from a single session of resistance exercise, the aim of 
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this randomised controlled trial was to investigate whether a period of eight weeks of, 
thrice weekly, exercise training resulted in any initial or lasting improvements to insulin 
sensitivity. The indicators used were: indices from fasting glucose and insulin 
concentrations (HOMA2) and adipocytokine markers of inflammation. Thirty-eight 
individuals with type 2 diabetes treated with oral hypoglycaemic medications were 
randomised to complete either resistance exercise, aerobic exercise or flexibility exercise 
(control condition) and completed follow-up measures at two, four and seven days after 
the final exercise session. Repeated measures ANOVA revealed no group by time 
interaction, but did identify a significant time effect (p = 0.04) in response to eight weeks 
of exercise for fasting glucose, where the glucose level seven days after the final session 
was significantly higher than the glucose level two days after the final session. 
Interestingly, although not statistically significant, glucose was lower than baseline at 48 
hours after the final session for those completing both aerobic and resistance exercise, 
before increasing in the aerobic group and being maintained in the resistance group. A 
significant group by time interaction was found for concentrations of adiponectin (p = 
0.04) and a time effect for leptin where concentrations were reduced two days after the 
final session but increased significantly from there at seven days after the final session. 
Therefore, following the exercise prescription guidelines for eight weeks does not appear 
to provide any lasting improvement to insulin sensitivity. It appears possible though, that 
the exercise prescription guidelines are inadequate for improving metabolic health in 
individuals with type 2 diabetes, or that exercise needs to be performed on an ongoing 
basis with any changes being due to an acute response to the last exercise session, and 
that this may be lost within 48 hours (i.e. before the first post-intervention sampling time 
point in this study). 
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Overall conclusions 
The results of these closely linked studies suggest that resistance exercise is safe to 
perform in individuals with type 2 diabetes as there were no significant adverse events or 
lasting impairments to any diabetes related outcomes. It appears however, that 
individuals with type 2 diabetes may respond differently to a single session of resistance 
exercise than apparently healthy individuals. It is also evident that unfamiliar resistance 
exercise leads to short-term impairments in insulin sensitivity and glucose tolerance in a 
similar way to a single session of aerobic exercise. While not being statistically 
significant, the difference in the trends of the glucose and insulin response to eight weeks 
of exercise between resistance and aerobic exercise, indicate that the mechanisms of 
regulating glucose tolerance are likely to be different, however this thesis does not shed 
any further light on the mechanisms involved. Given the overall conclusion from this 
series of studies is that no metabolic improvements are evident from either a single 
session or eight weeks of exercise training three times a week, future research should 
investigate the frequency, intensity and duration of resistance exercise that is required to 
induce metabolic benefits in individuals with type 2 diabetes. 
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1. Introduction 
1.1. Type 2 Diabetes 
Type 2 diabetes encompasses a group of metabolic conditions characterised by high 
concentrations of blood glucose, termed hyperglycaemia. Hyperglycaemia occurs as a 
direct result of defects in insulin secretion or insulin action alone, or a combination of 
both [1]. Symptoms of hyperglycaemia include passing large amounts of urine over a 
short period of time (polyuria), feelings of excessive thirst (polydipsia), marked weight 
loss, being excessively hungry (polyphagia) and also having blurred vision [2]. All of 
these symptoms may indicate the presence of diabetes mellitus and the need for further 
investigations. From a health perspective, it is important to note that a degree of 
hyperglycaemia sufficient to cause pathological and functional changes in target tissues 
may be present for an extended duration of time before being detected as diabetes 
mellitus [1] and hence, responding to and addressing early indications is imperative. 
 
There are several classifications of diabetes mellitus and further classifications of 
impaired glucose regulation. Insulin dependent diabetes mellitus (IDDM), or more 
commonly known as type 1 diabetes or juvenile-onset diabetes is resultant from a 
cellular-mediated autoimmune destruction of the β-cells of the pancreas [3-5]. 
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that 
first occurs or is recognised during pregnancy [3-5]. Non-insulin dependent diabetes 
mellitus (NIDDM), or more commonly type 2 diabetes (T2D) encompasses individuals 
who are resistant to insulin and usually have some form of relative (rather than absolute) 
insulin deficiency and do not require exogenous insulin to survive but may require it as a 
treatment method [3-5]. Further to these classifications, individuals who have mild 
hyperglycaemia that does not meet criteria for the diagnosis of diabetes mellitus can be 
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classified as having either impaired glucose tolerance (IGT) or impaired fasting glucose 
depending on their fasting blood glucose concentration. These individuals are often 
referred to as having pre-diabetes and are at significantly increased risk of developing 
T2D [3-5]. 
 
Type 2 diabetes and IGT are defined by varying degrees of glucose intolerance and 
insulin resistance with diagnosis criteria traditionally based on plasma glucose and serum 
insulin response to an oral glucose challenge through an oral glucose tolerance test 
(OGTT) [3-5]. The specifics of glucose tolerance will be discussed in depth later, 
however essentially IGT is caused through either a lack of insulin secretion, or an inferior 
capacity to respond to insulin and transport glucose into the muscle for use as a fuel at 
the peripheries. It is recommended to complete an OGTT when fasting plasma glucose is 
in the borderline range, as it is the most sensitive test to detect a mild disturbance of 
glucose metabolism [6]. However, despite the sensitivity of the OGTT, there has been a 
recent shift towards using glycated haemoglobin (HbA1c) levels to diagnose diabetes [7]. 
 
Diabetes mellitus is associated with a number of long-term complications including 
retinopathy with potential loss of vision, nephropathy leading to renal failure, peripheral 
neuropathy with risk of foot ulcers, and amputations through gangrene [6]. People with 
diabetes are also at increased and accelerated risk of developing atherosclerotic 
cardiovascular, peripheral arterial and cerebrovascular disease [8]. Furthermore, 
hypertension and abnormal lipid metabolism are also regularly found in this population 
[9]. Consequently a reduced life expectancy, significant morbidity due to specific 
diabetes related micro-vascular complications and also the increased risk of macro-
vascular complications listed above, along with a decreased quality of life have all been 
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associated with diabetes mellitus [10-12]. This has been substantiated in a recent 
Australian study which evaluated the chronic complexity of diabetes mellitus in terms of 
quality of life and found that as the degree of glucose tolerance worsened, the physical 
health and functional abilities of the affected person became steadily worse [13].  
 
This also has great economic cost to the individual with T2D, the government and the 
overall population. Apart from the other health issues associated with T2D mentioned 
above, males and females have 3.1 and 0.6 more lost work days respectively per year 
while bed days are increased by 7.9 and 8.1 in males and females respectively with T2D 
compared to those without T2D [14]. The financial cost of incurring a lost workday was 
estimated in 2002 to be an average of $168 with the cost of a bed day estimated to be 
40% of the cost of a lost work day [14]. Given these estimates, the cost of lost 
productivity to the individual with T2D was approximately $1500 in 2002 and given the 
increases in wages and cost of living over the last decade, this is likely to be more now. 
Further, in the USA alone in 2002, the direct costs of treating T2D (including hospital 
admissions, doctors fees, emergency services fess and medication costs) and the indirect 
costs through lost productivity were estimated to be 131,672 million dollars and this was 
predicted to increase to 156 billion dollars in 2010 and to 192 billion dollars in 2020 [14]. 
In Australia, the total direct and indirect costs of having diabetes has been estimated to be 
$5360 per person per annum [15], with this cost being 2.4 times higher in people 
suffering micro-vascular and macro-vascular complications compared to those without 
complications. Additionally, the government provides annual subsidies for people with 
diabetes through the forms of pensions and sickness benefits totalling an average of 
$5540 per person [15]. Given the increasing prevalence of T2D, the total cost of care for 
this condition is likely to increase at a similar rate. Therefore, an increased focus should 
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be given to primary prevention and low cost treatments for T2D which can be achieved 
through increasing levels of physical activity.  
 
1.1.1. Epidemiology of Type 2 Diabetes 
Metabolic conditions such as T2D and IGT are currently increasing in prevalence in 
Australia and abroad [16, 17]. Global estimates in 1995 reported approximately 135 
million adults above the age of 20 years had diabetes [18]. It was also reported that the 
prevalence of diabetes would increase in developed countries (which includes Australia) 
by 27% to a total prevalence of 7.6% by the year 2025 [18]. While in themselves these 
are damning figures for population health, it may be somewhat underestimated. Looking 
closely at the figures reported for Australia in the same study, by the year 2025 it was 
estimated that the total population of Australia would be 18.374 million with a diabetes 
prevalence of 3.3% [18]. However, reports from the Australian government indicate the 
total population reached 20 million in mid 2007, well above what it was estimated to be 
by 2025. In the year 2000, the estimated number of adults with diabetes globally had 
increased from 135 million as previously reported to approximately 171 million, an 
increase of approximately 36 million and an 11% increase on the projected year 2000 
number of 154 million adults [19]. The projected prevalence for 2025 and 2030 are again 
markedly different with the first projection indicating that almost 300 million adults 
would have diabetes worldwide compared to the more recent estimate of 366 million 
adults to have diabetes by 2030 [18, 19]. The most recent update estimated global 
prevalence of diabetes by completing statistical analyses on literature previously 
published and identified from countries within the United Nations [20]. These estimates 
suggest that in 2010 the global prevalence of diabetes was 6.4% consisting of some 285 
million adults between the age of 20 and 79 years, and is predicted to increase to 7.7% of 
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the population consisting of some 439 million adults of the same age by the year 2030, 
which is considerably different to the previous estimates for the prevalence of diabetes in 
the year 2030 of 366 million adults [19]. Further estimations from the World Health 
Organisation from a systematic analysis of the literature suggest that the prevalence of 
diabetes in adult males was 9.8% and 9.2% in adult females [21]. 
 
The most recent population study carried out in Australia, reported almost 10 years ago, 
indicated that the total diabetes prevalence of known and newly diagnosed diabetes was 
7.4% [17]. This however, rose to 9.4% when considering only those aged 40-74 years, 
with a greater number of males being affected than females. A recent study of older white 
Australian residents in New South Wales (NSW) concurred with these data, reporting a 
9.3% incidence in diabetes at 10 years follow-up after entering the study without a 
diagnosis of diabetes [22]. This is much greater than the estimates of 2.7% for the year 
2000 and 3.3% for the year 2025 reported by the earlier global estimates [18]. These 
figures from NSW in Australia are very similar to those of the United States of America 
(USA) where it was reported that the total prevalence for diagnosed and undiagnosed 
diabetes in 1999-2000 was 8.3% of their total population [23]. The Australian population 
data from 1999-2000 [17] was followed up 5 years later with a response rate of 60% and 
reported an incidence of type 2 diabetes of 4.3%, with again a higher prevalence in males 
compared to females [24]. The most recent National Health Survey conducted by the 
Australian Bureau of Statistics in 2007-08 indicated a prevalence of diagnosed diabetes 
of 4%, with 88% of these cases being T2D. This estimate is likely to understate the actual 
prevalence due to not taking into account un-diagnosed cases which have been estimated 
to be at least that of diagnosed cases [25]. 
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When conditions of impaired fasting glucose and IGT are included with T2D, the total 
prevalence in the Australian population greater than 25 years of age having abnormal 
glucose tolerance was 23.7% with the prevalence reaching 53.1% for people aged 75 
years or older [17]. This figure compares unfavourably to that of the USA where they 
report a total prevalence of abnormal glucose tolerance of only 14.4% and increasing to 
33.6% by the time they reached 60 years of age [23]. This highlights potential differences 
between the American and Australian populations in terms of physical activity levels and 
dietary intake and the varied approaches taken in managing, diagnosing and reporting 
diabetes. 
 
Therefore, T2D is a significant medical condition that affects large numbers of people 
throughout the world and can have dramatic effects on other organs and an individual’s 
health status. Given this, it is important to understand the pathophysiology involved in 
glucose tolerance and T2D so that effective and efficient treatment regimens can be 
determined and prescribed. 
 
1.2. Pathophysiology of Glucose Tolerance 
Maintenance of normal glucose tolerance following a meal or ingestion of glucose is 
dependent on three events occurring in a tightly coordinated response. These events 
include stimulating the secretion of insulin from the pancreas, insulin-mediated 
suppression of endogenous glucose production via the resultant hyperinsulinaemia, and 
insulin-mediated stimulation of glucose uptake by peripheral tissues [26]. 
Hyperglycaemia is a well-established result of metabolic conditions such as T2D and 
IGT, caused through increased hepatic glucose production due to an insulin secretion 
abnormality and hepatic resistance to insulin [27]. This means that abnormal glucose 
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tolerance can be a result of either a defect in insulin secretion or insulin action or a 
combination of the two, where normal insulin action involves the suppression of hepatic 
glucose production and enhancing glucose uptake at the peripheries, especially at the 
muscle [26]. Factors known to contribute to abnormal glucose tolerance include obesity, 
physical inactivity and genetics. 
 
Decreased insulin action can also be referred to as insulin resistance, where insulin 
resistance is classically defined as a state of decreased responsiveness of target tissues to 
normal circulating levels of insulin [28]. Skeletal and cardiac muscle, adipose tissue and 
the liver are the primary targets for insulin with skeletal muscle responsible for 
approximately 80% of all glucose uptake [28, 29]. In conditions of insulin resistance the 
ability of insulin to mediate glucose uptake is impaired and hepatic glucose production is 
no longer inhibited [30]. This results in greater concentrations of glucose in the blood 
since glucose is unable to be taken up and used by the target tissues at the same rate, 
thereby resulting in a state of hyperglycaemia.  
 
In a normal state of glucose homeostasis, approximately 85% of endogenous glucose 
production is derived from the liver, while the remaining 15% is derived from the kidney 
with glycogenolysis and gluconeogenesis processes contributing equally to basal hepatic 
glucose production [29]. There is unequivocal evidence indicating hepatic resistance to 
insulin in conditions of T2D, which is substantiated by the impaired ability of insulin to 
suppress the hepatic glucose production [26]. This results in a constant flow of glucose 
entering the blood stream from the liver and producing the condition of hyperglycaemia 
in either the basal or fasting state [27]. Research indicates that insulin inhibits the hepatic 
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glucose production and release through blocking gluconeogenesis and glycogenolysis 
[28]; both of which increase in people with T2D. 
 
Skeletal muscle is the most insulin sensitive tissue in the body, however in individuals 
with T2D, muscle tissue becomes resistant to insulin [26]. This is reportedly due to 
disruptions in glucose transport leading to defective muscle glycogen synthesis [28]. 
Glucose transport through adipocytes and myocytes is increased when insulin stimulates 
the translocation of the glucose transporter 4 (GLUT4) from an intracellular pool to the 
plasma membrane [28]. This occurs when insulin binds to its receptor on the plasma 
membrane and activates the tyrosine kinase activity and autophosphorylation of specific 
tyrosine residues of the receptor, initiating the intracellular signalling cascade [30]. This 
insulin signalling cascade in relation to glucose transport is not fully understood, 
however two main pathways have been identified. These are the phosphatidylinositol 3-
kinase (PI-3K) and mitogen-activated protein (MAP) kinase pathways. 
 
The PI-3K pathway is initiated by tyrosine phosphorylation of one of the insulin receptor 
substrate family (IRS-1/2/3/4) which associates with the p85 regulatory subunit of the PI-
3K and activates the enzyme phosphatidylinositol 3,4,5-phospate (PIP3). This results in 
the activation of protein kinase B (otherwise known as Akt) and other downstream 
effector molecules, mediating the metabolic response to insulin, which includes the 
translocation of GLUT4 [30]. The MAP kinase pathway is the other main pathway which 
begins with phosphorylation of the Shc adaptor protein or insulin receptor substrate, 
which binds Grb2 and activates Ras which in turn binds and disinhibits Raf, activating 
another kinase (MEK1), which activates extracellular signal-regulated kinases ERK1 and 
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ERK2. These mediate the mitogenic and proinflammatory responses of insulin signalling 
[30]. 
 
Defects in insulin receptor function, insulin receptor-signal transduction pathway, 
glucose transport and phosphorylation, glycogen synthesis and glucose oxidation all 
contribute to a state of insulin resistance [26]. It is then reported that due to the defect in 
the insulin receptors, the PI-3K pathway is impaired from the reduced ability of the 
insulin receptor and IRS-1 to activate tyrosine phosphorylation and a decreased 
association of p85 protein [31]. This decreases the number and availability of the GLUT4 
to transport glucose from the blood stream into the muscle. The MAP kinase pathway 
however, remains intact and continues to mediate the mitogenic and proinflammatory 
responses which contribute to atherosclerosis and other associated health conditions 
including hypertension, dyslipidaemia, insulin resistance and T2D [31]. 
 
Impaired insulin secretion is a major contributor to the pathophysiology of glucose 
intolerance, with all individuals with T2D and elevated fasting plasma glucose 
concentrations having a defect in insulin secretion [26]. Initially the pancreas has the 
capacity to up-regulate the production of insulin enabling the body to mediate the 
disposal of glucose through the peripheries and inhibit hepatic glucose production so that 
a degree of normoglycaemia is maintained through being in a state of hyperinsulinaemia 
[27]. However, prolonged hyperfunction of the pancreas (hyperinsulinaemia) can lead to 
β-cell exhaustion, beginning the cascade of hyperglycaemia with a gradual progression 
towards T2D [30]. This is a result of abnormal β-cell function via a progressive loss of 
pancreatic islet β-cells resulting in insulin deficiency and a requirement to replace insulin 
exogenously [27]. Of which, the major pathological consequence is non-insulin 
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dependent diabetes mellitus and the series of complications associated with this like 
chronic kidney disease, peripheral neuropathy and retinopathy can develop. 
 
Theories of glucotoxicity and lipotoxicity have also been suggested in T2D, where 
prolonged high concentrations of glucose impair insulin gene transcription and lead to 
decreased insulin synthesis and secretion [29]. The lipotoxicity theory suggests increased 
free fatty acids within the β-cells results in the conversion of long-chain fatty acids to 
their fatty acyl-CoA derivatives, which over time causes increased nitric oxide and 
increased expression of inflammatory cytokines which actually impairs β-cell function 
and insulin secretion [29]. This indicates that a number of factors including age, genetics 
and insulin resistance are implicated in the failure of the β-cell to perform its natural 
function adequately and maintain the body in a state of normoinsulinaemia with resultant 
normoglycaemia. While the pancreas has an excellent ability to be able to adapt to 
abnormal conditions, a modest reduction in β-cell mass of 20%-40% can have major 
implications on glucose homeostasis [29]. 
 
While the pathophysiology of T2D is a complicated sequence of events, in essence, it can 
be expressed as the body’s inability to regulate glucose production efficiently with high 
circulating levels of glucose increasing the risk for other associated conditions of 
retinopathy, neuropathy and renal disease. A number of different medications can be 
prescribed to reduce blood glucose levels through either stimulating further insulin 
production or improving insulin sensitivity with the final step being exogenous insulin 
prescribed to supplement naturally produced insulin [4]. Exercise is also a well-known 
beneficial treatment for T2D as it has the ability to impact the PI-3K pathway through 
increasing the availability of GLUT4 but also impacting the MAP kinase pathway 
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through increasing the quality of the muscle and improving its ability to take up greater 
amounts of glucose [32], and modulate concentrations of adipose derived cytokines 
which indicate sub-clinical levels of inflammatory disease [33]. Additionally, exercise 
has the ability to reduce the risk of some other predicting and contributing factors for 
T2D such as overweight and obesity [34]. 
 
1.3. Predicting and Contributing Factors 
Research over the past decade has indicated that inflammation is a key feature of obesity 
and T2D [35], with reports identifying obesity as the most critical factor in the 
emergence of metabolic disease [36]. The population study of Australia carried out in 
1999-2000 indicated that the overwhelming majority of people with diabetes were 
overweight (> 25 kg·m-2), or more likely, obese (> 30 kg·m-2) according to their body 
mass index (BMI) [17]. In a smaller sub-population study of older Australians, 16% of 
those who were obese at baseline progressed to a diagnosis of diabetes within 10 years 
[22]. Data from the National Health and Nutrition Examination Survey, 1999 to 2004 
shows the increasing prevalence of diabetes with increased class of obesity up to an odds 
ratio of 5.1 for those who were class three obese [37], while in Australia, the odds ratio 
for abdominal obesity associated with diabetes is between two and five with a population 
attributable fraction of 47.4% for women and 38.0% for men [38]. However, obesity on 
its own or with a single additional trait of the metabolic syndrome is not a strong 
predictor of progression to diabetes, with only 6% of these people diagnosed with T2D 
[22]. When obesity was in addition to two or more traits of the metabolic syndrome the 
incidence of progressing to diabetes within 10 years increased to between 20-40% [22]. 
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A large population sample of Australians aged 25 years or older reported a prevalence of 
overweight of 39% and obesity of almost 21% [39]. When BMI was replaced with a 
measure of waist circumference, overweight levels (94-102cm for men & 80-88cm for 
women) were reduced to a prevalence of 25%, with obesity prevalence (> 102cm for men 
& > 88cm for women) increasing to 30% [39]. Thus indicating large levels of truncal or 
abdominal obesity, which has been reported to be more metabolically active, and 
increasing the risk of T2D, coronary artery disease, cancer and premature death. Data 
from the Diabetes Prevention Program indicated that waist circumference was a better 
predictor of diabetes than BMI [40], probably due to its sensitivity of measuring central 
adiposity, although BMI was still able to significantly predict diabetes. Throughout the 
Asia-Pacific region it is reported that Australia has the greatest levels of overweight and 
obesity of any country at a staggering 60% of the population compared to a mere 5% of 
the Indian population being classified the same way [41]. This figure compares very 
closely to those reported for the USA, where in 2003-2004 66% of their population was 
either overweight or obese [42]. Childhood and adolescent levels of overweight have 
most recently been reported to be affecting 17% of the American population which has 
risen steadily from 14% only eight years ago [42]. In Australia, the most recent estimates 
of childhood and adolescent overweight and obesity were conducted in the 2007-08 
National Health Survey [25], which reported that approximately 17% of children and 
adolescents aged 5-17 years were overweight and 8% were obese, this was up from a 
total of 20% meeting the criteria for overweight in 1995 [16]. 
 
Sedentary behaviour is also emerging as a significant contributor to T2D, with landmark 
findings of increased fasting plasma glucose and two-hour plasma glucose both being 
shown to increase significantly with every additional hour of television viewing time in 
 
 
22 
 
men and women [43]. Even in people without diagnosed T2D, increased amounts of 
sitting time have been associated with increased levels of overweight, increased 
triglycerides, increased two-hour plasma glucose and increased fasting insulin 
concentrations, while it has also been associated with reduced high-density lipoprotein 
cholesterol in women only [44]. Further, the detrimental effects of sitting time on 
components of the metabolic syndrome has also been shown to be independent of 
moderate-vigorous physical activity and all other lifestyle risk factors [45]. 
 
1.4. Exercise Recommendations 
Exercise is widely accepted and recommended as part of the treatment plan for 
individuals with T2D and those with IGT to reduce the risk of progression to T2D. 
Aerobic exercise with an emphasis on endurance training is the main feature of most 
exercise guidelines released by the major exercise and medical associations. The latest 
position statement released by the American Diabetes Association (ADA) concludes that 
physical activity is a vital component of the primary prevention as well as management 
of T2D and must be viewed as a high priority [46]. Without making any specific 
recommendations of its own, it supports the position of the American Surgeon General’s 
Report on Physical Activity and Health of completing 30 minutes of moderate intensity 
physical activity on most days of the week. The ADA report also indicates that high 
intensity resistance training may be suitable for young individuals with diabetes, but not 
for older individuals or those with long standing diabetes, and that moderate intensity 
resistance training with light weights and high repetitions can maintain or enhance upper 
body strength. This position statement reports why exercise is so beneficial for people 
with both type 1 and type 2 diabetes, but fails to enlighten on what type, volume and 
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intensity are required to achieve the benefits [46]. A summary of all the exercise 
guidelines for individuals with T2D can be found in Table 1.1. 
 
1.4.1. Primary prevention of type 2 diabetes 
The American College of Sports Medicine (ACSM) along with the American Heart 
Association (AHA) have recently updated their physical activity and public health 
recommendations [47] that were originally published with the Centers for Disease 
Control and Prevention (CDC) in 1995 [48]. This recommendation states that all healthy 
adults need to complete moderate intensity aerobic activity for a minimum of 30 minutes 
on five days each week or vigorous intensity aerobic activity for a minimum of 20 
minutes on three days each week or a combination of the two [47]. It also states that 
adults will benefit from performing resistance training exercises on a minimum of two 
days each week, completing 8-10 different exercises using a weight that allows 8-12 
repetitions of each exercise resulting in volitional fatigue. 
 
Further to these recommendations the ACSM and AHA also released updated guidelines 
for older adults or adults older than 50 years with a chronic condition or functional 
limitation [49]. The aerobic activity guidelines for older adults are the same as the 
physical activity and public health guidelines with the intensity differing slightly from 
using MET values for moderate and vigorous intensities to using values on a 10 point 
scale and changes to heart and breathing rates. Similarly for the resistance training 
guidelines, the only notable difference is how many repetitions of each exercise should 
be achieved, being 10-15 where the effort is moderate to high. Here the ACSM 
recommends moderate intensity resistance training but acknowledges high intensity 
training is an option when older adults are supervised or when they have sufficient fitness 
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and experience to complete it. It is also recommended that older adults partake in 
flexibility and balance exercises on at least two days each week. 
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Table 1.1: Summary of exercise guidelines for those with type 2 diabetes. 
Year Recommending 
Body 
Aerobic Exercise Guidelines Resistance Exercise Guidelines Notes Exercise intervention RCT 
studies in T2D cited 
2011 ESSA [50] Minimum of 150 min per week 
at a moderate intensity (40-
59% VO2R or HRR) OR a 
minimum 75 min per week of 
vigorous intensity (60-84% 
VO2R or HRR) exercise with 
no more than two consecutive 
days without exercising. 
Minimum of 60 min per week of 
moderate to vigorous multi-joint 
exercises using large muscle groups. 
8-10 exercises, 2-4 sets, 8-10 
repetitions at 70-84% 1RM with 1-2 
minute rest intervals. Complete 2 or 
more times a week. 
Aerobic and resistance 
exercises should be completed 
attaining a minimum of 210 min 
per week at a moderate intensity 
or 125 min per week at a 
vigorous intensity. 
8 
2010 ACSM / ADA [51] At least 150 min per week of 
moderate intensity (40-60% 
VO2max) on at least 3 days per 
week with no more than 2 days 
between sessions. 
5-10 exercises for upper and lower 
extremities, completing 1 set (but as 
many as 3-4) of 10-15 reps 
(progressing to 8-10) on 2 but 
ideally 3 days each week at a 
moderate (50% 1RM) or vigorous 
(75-80% 1RM) intensity. 
Complete resistance training 
along-side aerobic training. 
18 
2009 AHA [52] A minimum of 10 min on a 
minimum of 3 days a week 
accumulating 150 min of 
moderate intensity or 90 min of 
vigorous intensity a week. 
3 days per week using all muscle 
groups progressing to 3 sets of 8-10 
reps at 75-85% 1RM with 1-2 min 
rest between sets. 
Patients with T2D should 
perform both aerobic and 
resistance exercise and 
minimise sedentary behaviours. 
15 
2004 ADA (technical 
review) [53] 
At least 150 min per week of 
moderate intensity PA and/or 
90 min of vigorous aerobic 
exercise on at least 3 days a 
week with no more the 2 days 
between sessions. 
In the absence of contraindications, 
3 times a week, progressing to 3 sets 
of 8-10 reps using a weight that 
cannot be lifted more than that 
amount. Including all major muscle 
groups. 
Flexibility training is not 
recommended OR advised 
against. 
5 
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Table 1.1 (Continued) 
2004 ADA [46] At least 3-4 sessions of aerobic 
exercise per week of 30-60 min 
duration at 50-80% VO2max 
High intensity resistance training for 
younger individuals but not older or 
those with long standing diabetes. 
 0 
2003 CDA [54] At least 150 min per week of 
moderate intensity PA on at 
least 3 days a week with no 
more the 2 days between 
sessions. 
3 times a week, progressing from 1 
set of 10-15 reps to 3 sets of 8 reps. 
 2 
2000 ACSM [55] 3-5 PA sessions per week of 
10-15 min duration but ideally 
30 min at a low to moderate 
intensity (40-70% VO2max) 
8-10 resistance training exercises for 
major muscle groups completed at 
least twice week. Complete a 
minimum of 1 set containing 10-15 
reps. 
Accumulate a minimum energy 
expenditure of 1000 kcal·wk-1 
from aerobic activities with the 
addition of a well rounded 
resistance training program. 
2 
ESSA = Exercise and Sports Science Australia; ACSM = American College of Sports Medicine; CDA = Canadian Diabetes Association; ADA = American Diabetes 
Association; AHA = American Heart Association; reps = repetitions; VO2max = maximal aerobic capacity; 1RM = one repetition maximum; min = minutes; PA = physical 
activity; VO2R = VO2 reserve; HRR = heart rate reserve 
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1.4.2. Treatment of type 2 diabetes 
In a separate statement, the ACSM specifically endorse exercise as a treatment for T2D 
with recommendations to expend a minimum cumulative total of 1000 kcal·wk-1 from 
aerobic activities and in addition, complete a well-rounded resistance training program 
[55]. The resistance training program suggested, appears to be based on the previous 
public health recommendations from 1998 [56] and is very similar to the ACSM and 
AHA’s updated recommendations of completing 8-10 resistance training exercises at 
least two days a week with a minimum of one set of 10-15 repetitions. While this at least 
gives practitioners something to work from it is still very much a generalised guideline 
based on limited scientific data from populations with T2D. 
 
The Canadian Diabetes Association has also released physical activity recommendations 
for those with T2D, indicating that they should accumulate at least 150 minutes of 
moderate intensity aerobic exercise each week spread over at least three non-consecutive 
days [54]. They also suggest that if willing, individuals with T2D should be encouraged 
to accumulate greater than four hours of exercise per week and that all individuals with 
T2D should be encouraged to perform resistance exercise three times per week, 
progressing from one set of 10-15 repetitions to three sets of eight repetitions. 
 
A technical review released by the ADA [53] only nine months following its position 
statement [46] gives much more detail regarding the issues surrounding type, volume and 
intensity for those with T2D. It recommends undertaking aerobic exercise to improve 
glycaemic control, assist with weight maintenance and reduce the risk of cardiovascular 
disease for at least 150 minutes per week at a moderate intensity and/or undertake at least 
90 minutes per week of vigorous exercise. This should be distributed over a minimum of 
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three days a week with no more than two consecutive days without physical activity as 
insulin sensitivity is increased following a single bout of aerobic exercise for between 24 
and 72 hours. It is noted however, that for long-term maintenance of significant weight 
loss, larger volumes of exercise may be helpful. Since the ACSM’s (2000) resistance 
training guidelines for T2D were published, several resistance training studies have been 
published which have formed the basis of the guidelines by the ADA [53]. The ADA 
recommends resistance training be completed in the absence of contraindications, three 
times a week, progressing to three sets of 8-10 repetitions using a weight that cannot be 
lifted more than that quantity of repetitions [53]. Again this recommendation is based on 
the prescription in only a few randomised controlled trials (Table 1.1) and therefore has 
not been subjected to the same quantity of scientific investigation that the aerobic 
training guidelines have. Further research regarding the acute and chronic effects of 
resistance training specifically conducted on individuals with T2D in relation to training 
intensities and frequency is required to strengthen the basis of the guidelines, rather than 
taking a best guess developed from literature on other populations. 
 
Taking a slightly different approach, the AHA released a scientific statement looking at 
the impact on cardiovascular disease of exercise training for people with T2D [57]. They 
reported many beneficial effects of exercise and recommend that exercise training be 
completed on at least three non-consecutive days a week with each session to last a 
minimum of 10 minutes and in addition, to minimise the amount of sedentary behaviours. 
Their guidelines for aerobic exercise are moderate intensity on 3-7 days per week 
accumulating 150 minutes per week or completing vigorous exercise on three days per 
week for an accumulated total of 90 minutes. They also recommend the completion of 
resistance training for the major muscle groups at a moderate to high intensity 
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progressing to three sets of 8-10 repetitions. While they recommend exercise on non-
consecutive days, it is suggested that training five or more days a week may maximise 
the acute glucose lowering effect and the cardiovascular benefits. The authors [57] also 
state that caution should be applied to prescribing walking as it could easily be performed 
at lower intensities and therefore recommend that vigorous intensities should be targeted 
if tolerated with consideration of any contraindications, thereby suggesting the need to 
work at as high intensity as possible. This is a major point of difference from other 
guidelines. 
 
In late 2010, the ACSM and the ADA released a joint position statement for exercise and 
T2D [58]. These guidelines recommend completing aerobic exercise at a moderate 
intensity (40-60% of maximal exercise capacity) on at least three days per week with no 
more than two consecutive days between sessions to achieve a volume of at least 150 
minutes per week. They also recommend completing resistance training alongside 
aerobic training on at least two, but ideally three, non-consecutive days a week. This 
resistance training session should encompass 5-10 exercises for upper and lower 
extremities of the body, consisting of one set, but as many as 3-4 sets, of 10-15 
repetitions (progressing to 8-10) at a moderate (50% of one repetition maximum) or 
vigorous (75-80% of one repetition maximum) intensity. Although there are a few more 
randomised controlled studies of exercise cited in these guidelines, it appears that not all 
randomised controlled trials have been considered.  
 
Locally in Australia, the National Evidence Based Guideline for Blood Glucose Control 
in Type 2 Diabetes [59] suggests that lifestyle modification (diet and physical activity) is 
an integral component of diabetes care. The Royal Australian College of General 
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Practitioners along with Diabetes Australia release a diabetes management document on 
an annual basis. The latest recommendations [60] for exercise and physical activity from 
this document reflect other diabetes association’s views and the physical activity 
guidelines for Australian adults. It therefore recommends that individuals with diabetes, 
like all adults, should complete a minimum of 30 minutes of aerobic exercise which 
makes them ‘huff and puff’ on three or four days each week, or complete greater than 
150 minutes of exercise each week [60]. It also outlines the risks involved with isometric 
exercise or heavy weight lifting, such as increases in blood pressure and sudden cardiac 
events, but identifies that resistance training programs using moderate weights and high 
repetitions can be part of an exercise program for those with T2D. These guidelines with 
respect of resistance training do not reflect the scientific research findings and are very 
conservative in this area, probably due to the document being aimed specifically towards 
general practitioners who typically have limited training and knowledge in regards to 
exercise prescription.  
 
Very recently, Exercise and Sports Science Australia (ESSA) released a position 
statement relating to exercise prescription for patients with T2D [50]. Within this 
statement, ESSA recommend completing a minimum of 150 minutes of aerobic exercise 
per week along with two 30 minute sessions of whole-body resistance training, with no 
more the two consecutive days between exercise sessions. The authors also suggest that 
patient capabilities and interests be taken into consideration and state that any 
combination and volume is better than not completing exercise at all and will provide 
similar health benefits to those experienced if adhering to the guidelines, they will just 
take longer to be experienced [50]. 
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The main type of exercise traditionally prescribed and recommended for people with 
T2D continues to be aerobic type exercise. However, as can be seen from the latest 
guidelines released since 2009, resistance type exercise is starting to be recommended 
more. It is concerning however, that between the major exercise and health organisations 
around the world, that there is no clear agreement on the type, duration, intensity or 
frequency that should be completed, especially with consideration to the resistance 
training guidelines. It is therefore evident that greater research is required to identify the 
optimal duration, intensity and frequency required of each type of exercise for the 
improvement and maintenance of blood glucose levels in individuals with T2D. 
 
While resistance training is being increasingly advocated with new research reporting 
beneficial effects from this form of exercise, there are many issues that remain 
unresolved, especially in relation to individuals with T2D. Therefore, the following 
chapters of this dissertation will review the literature specifically in relation to resistance 
training and T2D followed by a series of closely linked acute and chronic investigations 
which will detail the acute metabolic responses to resistance exercise along with the 
chronic adaptations and health benefits gained from an ongoing resistance training 
program. As it is understood that resistance and aerobic exercise provide similar diabetes 
related benefits through common and different mechanisms, changes and responses from 
resistance exercise interventions will also be compared to those from aerobic type 
exercise to outline the potential differences between exercise types. 
 
1.5. Aims 
The primary aim of the research presented in this thesis was to establish the glucose, 
insulin and insulin sensitising effect from a single bout of resistance exercise and how 
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long those changes persisted. The secondary aim was then to determine if the period of 
time the changes were present for altered after a prolonged period of regular resistance 
exercise. The conflicting evidence base surrounding an acute bout of resistance exercise 
in which some [61-64] report improvements to insulin sensitivity at different time points 
in people with and without T2D compared to others who report no changes [62, 63, 65-
68] points to the lack of evidence for the frequency of exercise required to alter blood 
glucose concentrations. It is also important to note that the longest follow-up time 
following a single session of resistance exercise is 36 hours and these have only been 
looked at in terms of pre and post exercise values. Additionally, it appears that the insulin 
and glucose responses following either a single session or long–term resistance exercise 
interventions have not been tracked over a number of days. The lack of agreement of the 
time frame for acute effects to remain has seen the follow-up period for chronic 
intervention studies be anywhere between two and four days following the final exercise 
session. However, the response to resistance exercise has not been sufficiently 
investigated to see exactly how long any changes might be present for following an 
ongoing period of resistance training. 
 
Understanding the time course of the glucose and insulin responses is important to know 
as it has the ability to influence exercise training guidelines in terms of the required 
exercise frequency. The current guidelines for exercise frequency appear to be based on 
data obtained in healthy and athletic populations and then applied to clinical populations 
and therefore may not actually be the most appropriate for those with or at risk of 
developing T2D. It is also important to define the minimum efficacious exercise dose as 
currently large numbers of people with T2D do not meet the recommended exercise 
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volumes [69], so if it were possible to achieve and maintain metabolic improvements 
with less frequent exercise sessions, this would be a very important public health finding. 
 
The following hypotheses were investigated over the course of this thesis: 
i. That cytometric bead assay would be sensitive enough to accurately measure 
adipocytokines. 
ii. That oral glucose tolerance tests repeated on four consecutive days would 
produce similar estimates of insulin sensitivity. 
iii. That a single session of resistance exercise would not modulate insulin sensitivity 
in apparently healthy individuals. 
iv. That a single session of resistance exercise would improve insulin sensitivity in 
people with type 2 diabetes when compared with apparently healthy individuals. 
v. That a single session of resistance exercise would improve glucose control to a 
similar extent as that experienced following a single session of aerobic exercise. 
vi. That compared to a sham exercise (flexibility training) control group; there would 
be no difference in the change to insulin sensitivity after aerobic or resistance 
exercise training. 
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2. Resistance training improves metabolic health in type 2 diabetes: A systematic 
review 
2.1. Preface  
To accurately assess the gaps in the literature and guide future research a systematic 
review was undertaken. This chapter is based on a peer-reviewed paper published in 
Diabetes Research and Clinical Practice [70] (Appendix A). This paper has been cited 
numerous times, including in the most recent update of the exercise recommendations for 
individuals with type 2 diabetes published jointly by the American College of Sports 
Medicine [51] and the American Diabetes Association [71]. 
 
2.2. Introduction 
The world-wide prevalence of type 2 diabetes (T2D) continues to increase [19] however, 
despite exercise being promoted as a vital part of the treatment process, exercise 
guidelines do not vary between prevention and treatment. For individuals with existing 
diabetes, specific benefits of exercise include increased insulin sensitivity, improved 
glycaemic control [72, 73], improved lipid profile and lower blood pressure [73]. 
Importantly, individuals with diabetes completing exercise training using various 
exercise modes for between eight weeks and 12 months have experienced decreased 
glycated haemoglobin (HbA1c) by clinically significant levels (0.6%), improved insulin 
sensitivity and reduced serum triglycerides [74].  
 
The American College of Sports Medicine (ACSM) endorses exercise as a treatment 
method for people with T2D and recommends expending a minimum cumulative total of 
1000 kcal·wk-1 of energy from aerobic activities [55]. The American Diabetes 
Association (ADA) has similar recommendations for at least 150 minutes per week of 
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moderate intensity aerobic physical activity and/or 90 minutes per week of vigorous 
aerobic exercise [53]. Accordingly, aerobic exercise has been the major focus for 
exercise-training studies due to consistent findings of improved glucose control [46, 75], 
however long-term compliance to these recommendations remains low [76] necessitating 
the investigation of an effective strategy to improve adherence rates.  
 
Recently, resistance training has been the focus of increased research and it is suggested 
to improve glycaemic control and insulin sensitivity partially via similar mechanistic 
pathways to aerobic training [77], and partially through discrete pathways providing 
additive insulin signalling benefits. The focus on resistance training is in part due to a 
recognition that individuals with T2D, who are also likely to be obese or suffering from 
other co-morbidities, are likely to struggle to achieve the volume and intensity of aerobic 
training that’s required to be effective [77, 78], and therefore compliance to resistance 
training may be higher. Both the ACSM and the ADA had included resistance training in 
their exercise prescription guidelines for younger individuals with T2D and for older 
individuals with T2D who were free from contraindications. The recommendations were; 
one set of 10-15 repetitions for 8-10 exercises twice a week [55] and, progressing to three 
sets of 8-10 repetitions three times a week [53]. These recommendations appeared to be 
largely based on information regarding healthy individuals and the few [79-82] 
randomised controlled trials of resistance training in individuals with T2D completed at 
the time that they were published. The authors of the ADA position statement do 
acknowledge the fact that prospective cohort studies have had a large influence over the 
content of the guidelines [53]. Recently the ACSM and the ADA released a joint position 
statement recommending that individuals with T2D complete both aerobic and resistance 
exercise [51] and this has been endorsed by Exercise and Sports Science Australia 
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(ESSA) who have also recommended the completion of both types of exercise [50]. 
However, it should be noted that significant improvements to insulin sensitivity in 
healthy individuals have been reported only when resistance training was performed 
three or more days a week [83] and the responses of individuals with diabetes may differ. 
Therefore the purpose of this chapter was to systematically review the literature on the 
effects of resistance training on the diabetes markers of glycaemic control and insulin 
sensitivity in individuals with T2D.  
 
2.3. Methods 
2.3.1. Search Strategy 
Ovid MEDLINE (1950 to December 2011), and CINAHL (1982 to December 2011) 
electronic databases were searched on September 09 2011. First, three keyword and 
categorical searches were performed (i) ‘diabetes’, or ‘diabetes mellitus’, or ‘type 2 
diabetes mellitus’; (ii) ‘weight lifting’, or ‘resistance training’, or ‘strength training’, or 
‘weight training’, or ‘progressive resistance training’, or ‘circuit training’; (iii) ‘glucose 
intolerance’, or ‘blood glucose’, or ‘glucose’, or ‘glucose metabolism disorders’, or 
‘glucose tolerance test’, or ‘insulin’, or ‘insulin resistance’, or ‘diabetes complications’, 
or ‘haemoglobin A’, or ‘glycosylated haemoglobin A’, or ‘HbA1c’.  Second, categories i 
to iii were combined using ‘and’, limited to humans and reported in the English language 
with duplicates removed. In addition, reference lists of all publications meeting the 
inclusion criteria were manually searched to identify any relevant studies not found 
through electronic searching. 
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2.3.2. Inclusion and Exclusion Criteria 
Studies that met the following criteria were included in this review: (i) published in 
English (ii) cohorts were adults above the age of 18 years with T2D, (iii) a form of 
resistance training was included as an isolated intervention arm, (iv) it was an 
intervention study, (v) one diabetes marker (HbA1c, fasting glucose or insulin, insulin 
sensitivity) or an insulin signalling outcome were reported. Cross-sectional and 
observational studies, review or opinion/editorial papers were excluded along with 
studies that did not report diabetes or insulin signalling markers or studies that 
investigated only individuals without diabetes. Interventions that combined resistance 
training with another intervention (aerobic training or diet) or did not involve ongoing 
training were also excluded. 
 
2.3.3. Statistical Analyses 
To avoid misrepresentation of the presented data, a meta-analysis was not conducted due 
to the methodological differences in terms of frequency and intensity of training, along 
with the number and type of exercises completed. Clinical significance has been 
interpreted as a 0.6% improvement in HbA1c [74]. Effect sizes were not calculated as 
only eight papers included in the review provided enough information to enable effect 
size to be calculated. 
 
2.4. Results 
2.4.1. Search Results 
Thirty-five papers from 31 studies met the criteria and are included in this review. Search 
results are shown in Figure 2.1. One doctoral dissertation was excluded, but its related 
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publication was identified and also excluded [84]. A paper reporting insulin sensitivity 
data was excluded [85] as this data had been published previously [86] and another paper 
reporting HbA1c was excluded [87] as this data had been published previously [88]. A 
paper reporting phase one of a study [82] was excluded due to having a weight loss diet 
added to the resistance training, however a paper describing phase two [89] was included 
as dietary modification was ceased at the completion of phase one. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Sequence of searching & search results. 
RCT = randomised controlled trial; NRCT = non-randomised controlled trial; UCT = uncontrolled trial; RT 
= resistance training; Combined interventions = aerobic and resistance training OR diet and resistance 
training. 
  
‘diabetes’, or ‘ diabetes mellitus’, or type 2 
diabetes mellitus’ 
N = 450,622 
‘weight lifting’, or ‘ resistance training’, or 
‘strength training’, or ‘weight training’, or 
‘progressive resistance training’, or ‘circuit 
training’ 
N = 25,341 
‘glucose intolerance’, or ‘blood glucose’, or 
‘glucose’, or ‘glucose metabolism disorders’, 
or ‘glucose tolerance test’, or ‘insulin’, or 
‘insulin resistance’, or ‘diabetes 
complications’, or ‘haemoglobin A’, or 
‘glycosylated haemoglobin A’, or ‘HbA1c’ 
N = 739,407 
Combined using ‘AND’ 
N = 743 
Limited to Humans & English language 
N = 544 
Duplicates removed 
N = 502 
Articles found manually 
N = 506 
Included studies 
N = 35 
Excluded studies 
N = 471 
Review article (N = 168) 
No RT Intervention (N = 77) 
Cohort not T2DM (N = 148) 
Not Adults (N = 19) 
Meta-Analysis (N = 6) 
Doctoral Dissertation (N = 1) 
No Diabetes Markers (N = 13) 
Duplicate Diabetes Markers (N = 2), 
Combined Interventions (N = 26), 
No Ongoing Training (N = 2), 
Abstracts (N = 2) 
Opinion/Comment (N = 3) 
Not Humans (N = 4) 
RCT 
N = 21 
NRCT 
N = 10 
UCT 
N = 4 
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2.4.1.1. Study Design / Quality Assessment 
Most (18/21) of the papers based on randomised controlled trials (RCT) [80, 81, 88, 90-
104] reported eligibility criteria (Table 2.1); as did just more than half (8/14) of the trials 
that had no randomisation.  
 
Assessors were reported to be blinded in only eight papers [81, 88, 91, 99, 103-106]. In 
all studies, previous medical intervention was maintained with changes to drug regimes 
occurring only where medically required. With one exception [107], all studies were 
completed using an out-patient design with participants under free-living conditions. 
 
2.4.1.2. Baseline Characteristics 
Generally, there were no differences between intervention and control groups except 
where studies were intentionally designed to compare different cohorts [62, 63, 86, 108-
110] (Table 2.1). Baseline characteristics differed in two RCTs [93, 101] with the 
resistance training group having higher fasting blood glucose levels and lower body mass 
index and fat mass than untrained controls [93] and the aerobic group having increased 
insulin sensitivity compared to the resistance training and control groups [101]. Five 
studies did not report any analysis between groups at baseline [90, 99, 101, 103, 111]. 
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Table 2.1: Study Quality 
Reference  Design Subjects Intervention Compliance Outcome Measures 
 
Publication D
ate 
Study D
esign 
R
andom
ization 
C
oncealm
ent 
A
ssessor B
linding 
Participant B
linding 
Eligibility C
riteria 
A
nalysis betw
een groups at 
baseline 
Treatm
ent vs C
ontrol sim
ilar at 
baseline 
D
etails of R
T exercise 
prescription 
Intensity of R
T 
A
dverse Events R
eported 
Loss to Follow
-up 
A
ttendance 
Treatm
ent of m
issing data 
specified 
Statistical A
nalysis Specified 
Prim
ary &
 Secondary 
O
utcom
es Identified 
Sam
ple Size (determ
ined by 
pow
er calculations 
C
ontrol &
 Treatm
ent M
ethod 
&
 A
nalysis the sam
e 
C
V
’s Provided 
Jorge [100] 2011 RCT Y N N N Y Y Y N N N N Y N Y Y N Y N 
Plotnikoff [104] 2010 RCT Y Y Y N Y Y Y Y Y Y Y Y Y Y Y Y Y N 
Church [99] 2010 RCT Y Y Y N Y N ? Y N Y Y N N Y Y Y Y N 
Ku [101] 2010 RCT Y N N N Y N N Y Y N N N N Y N Y Y N 
Kwon [102] 2010 RCT Y N N N Y Y Y Y Y N N N N Y Y N Y N 
Ng [103] 2010 RCT Y Y Y N Y N ? Y Y Y Y Y Y Y Y Y Y Y 
Arora [97] 2009 RCT Y N N N Y Y ? Y Y Y Y N N Y Y N Y N 
Cheung [98] 2009 RCT Y N N N Y Y Y Y N N Y Y Y Y N N Y N 
Winnick [96] 2008 RCT Y N N N Y Y Y Y N N N N N Y Y N Y N 
Baum [90] 2007 RCT Y N N N Y N ? Y Y N N N N Y N N Y N 
Brooks [91] 2007 RCT Y N Y N Y Y Y Y Y N N Y Y Y Y N Y Y 
Sigal [88] 2007 RCT Y Y Y N Y Y Y Y Y Y Y Y N Y Y Y Y N 
Castaneda [105] 2006 RCT Y N Y N N Y Y Y Y N N N N Y Y N Y Y 
Dunstan [94] 2006 RCT Y N N N Y Y Y Y N Y Y Y Y Y Y N Y N 
Gordon [95] 2006 RCT Y N N N Y Y Y Y Y N Y Y N Y Y N Y Y 
Cauza [92] 2005 RCT Y N N N Y Y Y Y Y Y Y N N Y N N Y N 
Cauza [93] 2005 RCT Y N N N Y Y N Y Y Y N N N Y Y N Y N 
Dunstan [89] 2005 RCT Y N N N N Y Y Y Y Y Y Y N Y Y N Y Y 
Baldi [79] 2003 RCT Y N N N N Y Y Y Y Y Y Y N Y Y N Y Y 
Castaneda [81] 2002 RCT Y N Y N Y Y Y Y Y Y Y Y Y Y Y N Y Y 
Dunstan [80] 1998 RCT Y N N N Y Y Y Y Y N Y N Y Y Y N Y Y 
Bweir [106] 2010 NRCT N N Y N Y Y Y Y N N Y Y Y Y N N Y N 
Hazley [112] 2010 NRCT N N N N N Y Y Y Y Y N Y N Y N N Y N 
Ibanez [110] 2008 NRCT N N N N Y Y N Y Y N N Y N Y Y N Y Y 
Colberg [108] 2006 NRCT N N N N Y Y N Y Y N N N N Y Y N Y N 
Wojtaszewski [109] 2005 NRCT N N N N N Y N Y Y N N N Y N N N Y N 
Fenicchia [62] 2004 NRCT N N N N Y Y N Y Y N N N N Y Y N Y N 
Holten [86] 2004 NRCT N N N N N Y N Y Y N N N N Y Y N Y N 
Ishii [107] 1998 NRCT N N N N N Y Y Y Y N N N N Y Y N Y N 
Honkola [111] 1997 NRCT N N N N N N ? Y Y Y Y Y Y Y Y N N N 
Smutok [113] 1994 NRCT N N N N Y Y Y Y Y N N N N Y Y N Y N 
Cauza [114] 2009 UCT N N/A N N Y N/A N/A Y N N Y N Y Y Y N N/A N 
Misra [115] 2008 UCT N N/A N N Y N/A N/A Y Y N N Y N Y Y N N/A N 
Ibanez [116] 2005 UCT N N/A N N Y N/A N/A Y Y Y Y Y N Y Y N N/A Y 
Eriksson [117] 1997 UCT N N/A N N N N/A N/A Y Y Y N N N Y Y N N/A N 
RCT = Randomised controlled trial; NRCT = non-randomised controlled trial; UCT = uncontrolled trial; ? = not 
specified; Y = yes; N = no; N/A = not applicable; Adverse events reported = refers to whether the authors reported on 
adverse events, not that adverse events occurred; CV’s provided = coefficient of variation of the measure reported 
within the methodology section, indicating reliability of the measure. 
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2.4.1.3. Statistical Analysis and Power Calculations 
The purpose of the research was outlined in all studies except six [90, 93, 98, 101, 106, 
112], however one paper [109] did not report the purpose despite a previous paper [86] 
from the same study reporting this information. Additionally, few papers (11/35) reported 
how missing data were treated (Table 2.1). With the exception of one study [111], the 
intervention and control groups were subjected to the same research methodology and 
analysis. Only four studies [88, 99, 101, 104] reported determining sample size by a 
priori power calculation. Additionally, only seven RCTs reported whether an intention to 
treat or per protocol design was undertaken [81, 88, 91, 94, 99, 103, 104], with all of 
these completing an intention to treat design. 
 
2.4.2. Resistance training for type 2 diabetes 
Within the included studies, resistance training was almost always completed using 
machines, including pin-loaded machines (28/35 papers), with some studies 
incorporating the use of free-weights [62, 80, 92-94, 97, 103, 104, 106, 107, 112-114], 
however three studies used resistance bands [98, 101, 102] (Table 2.2). Three studies 
varied the delivery of resistance training using circuit-type training [80, 103, 111]. A 
whole-body training protocol, mostly progressive in nature where the weight lifted, or 
sets and repetitions completed increased at varying stages was favoured by most 
researchers (30/31 studies; Table 2.2). However, one study [86, 109] used only three 
exercises and focused solely on the lower limbs.  
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2.4.2.1. Frequency 
Resistance training protocols were commonly performed on three non-consecutive 
days·wk-1 (Table 2.2), although one non-randomised study [107] admitted their 
participants to hospital to complete low intensity resistance training five days·wk-1 and 
two RCTs performed exercises with resistance bands five days·wk-1 [98, 101]. Six studies 
[94, 97, 111, 112, 116, 117] performed resistance training on two days·wk-1, with one 
study [94] prescribing two days·wk-1 to maintain benefits achieved from previously 
training three days·wk-1. One RCT did not report the frequency of completing resistance 
training [96]. 
 
2.4.2.2. Intensity 
The intensity of each resistance training protocol varied considerably, with some studies 
giving precise information about initial intensities and progression points, while other 
studies provided vague details of increasing the weight (by an unspecified amount) when 
participants were able to complete a certain number of sets and repetitions (Table 2.2). 
Two studies [110, 116] specifically reported completing power exercises using low 
weight and high velocity movement, in addition to their normal resistance training 
program. Two studies prescribed the training weight as percentage of one repetition 
maximum (1RM) but measured strength using 3RM [86, 109], KIN-COM [107] or 
estimated 1RM from a sub-maximal load, while another study [63] prescribed resistance 
training based on percentage 10RM after conducting 1RM testing. The precise intensities 
reported for each RCT are shown in Table 2.2.  
 
 
 
44 
 
2.4.2.3. Duration 
The duration of all studies varied from 4-6 weeks to 12 months of training. One study 
[62] reported the acute effects of resistance training, before also reporting six-week 
follow-up data. An additional study reported data at six weeks [86, 109], while another 
study reported a duration of 4-6 weeks [107]. Sixteen studies had durations of 6-16 
weeks [79, 80, 96-98, 100-104, 106, 108, 110, 112, 114, 115], and another study 
examined changes over six months [88] with another over nine months [99]. 
Additionally, one paper reported a six-month follow-up period [89] after a six month RT 
and weight loss intervention [82]. One study reported a two-month supervised 
introductory phase, followed by 12 months of home-based maintenance [94]. 
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Table 2.2: Exercise intervention characteristics 
Author (year) 
Country 
N = Sample 
M/F 
Age y 
Control / 
Comparison 
condition 
Exercise mode & intervention F: Frequency 
I: Intensity 
D: Duration 
Strength 
Test 
Resistance 
Training 
equipment 
Duration Supervision 
Jorge (2011)  
Brazil [100] 
N = 48 
CT = 12 
RT = 12 
AT = 12 
C = 12 
M = 18/F = 30 
53.9 ± 9.9 y 
Control: Flexibility 
exercises 3 times a 
week 
Aerobic: 60 min 
cycling at lactate 
threshold 3 week-1 
Combined: Aerobic 
and resistance at 
same intensity of 
corresponding 
groups but half the 
volume. 
Resistance training: 
7 exercises: leg press, bench 
press, lat pull-down, seated row, 
shoulder press, abdominal curls & 
knee curls 
F: 3 week-1 
I: NR 
D: 60 min 
1RM – All 
exercises 
NR 12 weeks NR 
Plotnikoff 
(2010) 
Canada [104] 
N = 48 
RT = 27 
C = 21 
M = 32/F = 8 
54.5 ± 12 y 
Non-training control 
group, no other 
details specified 
Home-based progressive 
resistance training: 
8 exercises: squats, seated row, 
chest press, shoulder press & 4 
others from a group of 9 
complementary exercises 
F: 3 week-1 
I: 3 sets x 8-10 reps 
70-85% 1RM 
D: NR 
1RM – seated 
chest press, 
seated row & 
leg press 
Multigym & 
dumbbells 
provided to 
participant 
16 weeks Qualified exercise 
specialist for 18 
out of 48 sessions 
Church (2010) 
USA [99] 
N = 262 
CT = 76 
AT = 72 
RT = 73 
C = 41 
M = 97/F = 165 
55.8 ± 8.7 y 
Combined: 150 min 
of moderate 
intensity activity per 
week & 2 week-1 RT 
Aerobic: 150 min of 
moderate intensity 
activity per week 
Control: Weekly 
stretching & 
relaxation classes 
Resistance training: 
9 exercises: bench press, seated 
row, shoulder press, pull down, 
leg press, leg extension, leg 
flexion, abdominal crunches & 
back extensions 
F: 3 week-1 
I: 2 sets x 10-12 reps 
upper body exercises, 
& abdominal crunches, 
back extensions; 
3 sets x 10-12 reps 
lower body exercises, 
D: NR 
Biodex NR 9 months All sessions: 
unspecified 
personnel 
Ku (2010) 
Korea [101] 
N = 44 
RT = 13 
AT = 15 
C = 16 
M = 0/F = 44 
38 – 68 y 
Control: Diabetes 
education, maintain 
sedentary lifestyle 
Aerobic: walking 60 
min at moderate 
intensity 5 week-1 
Resistance training: elastic banc 
exercises 3 week-1 in hospital 
gymnasium, 2 week-1 at home. 
Biceps curl, triceps extension, 
upright row, shoulder chest press, 
trunk side-bending, seated row, 
leg press, hip flexion & leg 
extension. 
F: 5 week-1 
I: 3 sets x 15-20 reps 
40-50% max capacity 
D: NR 
1RM – chest 
and leg press 
Resistance 
bands 
12 weeks Individual 
supervision 
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Table 2.2 (continued) 
Author (year) 
Country 
N = Sample 
M/F 
Age y 
Control / 
Comparison 
condition 
Exercise mode & intervention F: Frequency 
I: Intensity 
D: Duration 
Strength 
Test 
Resistance 
Training 
equipment 
Duration Supervision 
Kwon (2010) 
Korea [102] 
N = 28 
RT = 13 
C = 15 
M = 0/F = 28 
56.4±7.1 y 
Control: no exercise Home-based resistance training: 
11 exercises: biceps curl, triceps 
extension, upright rows, shoulder 
press, chest press, seated row, leg 
press, hip flexion, leg flexion, leg 
extension, side bends. 10 minute 
warm-up and 10 minute cool-
down. 
F: 3 week-1 
I: 3 sets x 10-15 reps 
40-50% 1RM 
D: 40 min RT, 60 min 
total 
1RM – chest 
& leg press 
Resistance 
bands 
12 weeks NR 
Ng (2010) 
Singapore 
[103] 
N = 60 
RT = 30 
AT = 30 
M = 19/F = 41 
58 ± 7 y 
Aerobic: 50 min at 
65-70% of max HR, 
2-3 week-1 
Progressive resistance training:  
9 exercises - circuit: leg press, 
straight leg raise, hamstrings curl, 
biceps curl, triceps extension, 
lateral raises, front raises, hip 
abduction, hip extension 
F: 2-3 week-1 
I: 3 sets x 10 reps 
65-70% 1RM 
D: 50 min max 
Predicted 
1RM 
Machines and 
free weights 
8 weeks All sessions 
physiotherapist 
Arora (2009) 
India [97] 
N = 30 
RT = 10 
AT = 10 
C = 10 
M = 16/F = 14 
40-70 y 
Control: no training, 
maintain 
medications and 
diet. 
Aerobic: walking 30 
min 3 week-1 
Progressive resistance training: 
7 exercises for major muscle 
groups – biceps, triceps, upper 
back, abdominals, knee flexors & 
extensors 
F: 2 week-1 
I: 3 sets of 10 reps 
60% 1RM progressing 
to 100% 1RM 
D: NR 
1RM – 
exercises not 
specified 
Dumbbells, 
pulleys, lateral 
pull down, 
quadriceps 
table 
8 weeks NR 
Cheung (2009) 
Australia [98] 
N = 40 
RT = 21 
C = 19 
M = 12/ F = 25 
60.5 y 
Control: no 
intervention 
Home-based resistance training:  
7 exercises: chest press, seated 
back row, leg abduction, leg 
extension, seated leg press, triceps 
extension & biceps curl. Plus 5 
min warm-up and 5 min cool-
down. 
F: 5 week-1 
I: 2 sets x 12 reps 
D: 30 min RT, 40 min 
total 
Hand grip 
strength 
Resistance 
bands and body 
weight 
16 weeks 5 sessions by 
fitness leaders in 
collaboration with 
an exercise 
physiologist 
Winnick (2008) 
USA [96] 
N = 59 
Whites = 23 
RT = 8 
AT = 15 
African = 36 
RT = 12 
AT = 24 
M = ?/F = ? 
25-60 y 
White subjects 
Aerobic: 30-40 min 
walking on 
motorised treadmill, 
3 week-1 for first 4 
weeks expending 
~600 kcal/week, 
then 5 week-1 
expending ~1000 
kcal/week. 
Progressive resistance training: 
8 exercises: not specified, 
modified after 4 weeks in 
accordance with performance 
outcomes. 
F: NR 
I: NR 
D: NR 
10 RM 
 All exercises 
Machines 8 weeks NR 
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Table 2.2 (continued) 
Author (year) 
Country 
N = Sample 
M/F 
Age y 
Control / 
Comparison 
condition 
Exercise mode & intervention F: Frequency 
I: Intensity 
D: Duration 
Strength 
Test 
Resistance 
Training 
equipment 
Duration Supervision 
Baum (2007) 
Germany [90] 
N = 40 
RT = 13 
Flex = 13 
Vib = 14 
M = 24/F = 16 
62.9 ± 7.3 y 
Flexibility: 8 
exercises, 15 min 
Vibration: 8 
exercises, 20 min 
Resistance training 
8 whole body exercises:  leg 
extension, seated leg flexion, leg 
press, seated calf raise, lat pulley, 
horizontal chest press, butterfly & 
rowing. 
Wk 1-6 70% 1RM 
Wk 7-9 increase to 2 sets x 12 
reps, Wk 10-12, 3 sets x 10 reps, 
80% 1RM 
F: 3 week-1 
I: 1 set  x 12 reps 
D: 45 min total 
1RM,  
Max 
isometric 
torque 
(quads) 
Machine 
weights 
12 weeks All sessions: 
Unspecified 
personnel 
Brooks (2007) 
USA [91] 
N = 62 
RT = 31 
C = 31 
M = 40/F = 22 
66 ± 15.7 y 
Standard type 2 DM 
care  
Resistance training & standard 
care 
5 whole body exercises: upper 
back, chest press, leg press, knee 
extension & flexion. 
Wk 1-8 60-80% 1RM 
Wk 10-14 70-80% 1RM 
F: 3 week-1 
I: 3 sets  x 8 reps 
High intensity 
D: 45 min total, 5 min 
warm-up & cool down 
1RM  
- Upper & 
lower body 
Pneumatic 
Machine 
weights 
16 weeks NR 
Sigal (2007) 
Canada [88] 
N = 251 
RT = 64 
AT = 60 
CT = 64 
C = 63 
M = 160/F = 91 
54.7 ± 7.5 y 
Aerobic: 3 week-1 45 
min @ 75% HRmax,  
Combined: Aerobic 
& resistance 3 week-
1 
Control: No exercise 
intervention 
Resistance training: 
2 groups of 7 whole body 
exercises:  
A) Abdominal crunch, seated 
row, biceps curl, bench press, 
leg press, shoulder press & leg 
extension 
B) Abdominal crunch, lateral 
pulldown, triceps pushdown, 
chest press, leg press, upright 
row & leg curl  
Progressing from 1 set of 15 reps 
@ 15RM to 3 sets of 8 reps @ 
8RM 
F: 3 week-1 
I: 2-3 sets  x 7-9 reps 
D: NR 
2-3 min between sets 
8RM Machine 
weights 
26 weeks Weekly first 4 
weeks, then 
fortnightly: 
Unspecified 
personnel 
Castaneda 
(2006) 
Germany [105] 
N = 18 
RT = 13 
C = 5 
M = 6/F = 12 
66 ± 8 y 
Standard type 2 DM 
care  
Resistance training 
5 whole body progressive 
exercises: 2 upper body, 3 lower 
body exercises 
60-65% 1RM, increasing to 75-
80% 1RM by week 4 
F: 3 week-1 
I: 3 sets  x 8 reps 
Moderate-high intensity 
D: 45 min total, 5 min 
warm-up & cool down 
1RM 
- 2 upper & 3 
lower body 
exercises 
Pneumatic 
Machine 
weights 
16 weeks All sessions: 
Unspecified 
personnel 
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Table 2.2 (continued) 
Author (year) 
Country 
N = Sample 
M/F 
Age y 
Control / 
Comparison 
condition 
Exercise mode & intervention F: Frequency 
I: Intensity 
D: Duration 
Strength 
Test 
Resistance 
Training 
equipment 
Duration Supervision 
Dunstan (2006) 
Australia [94] 
N = 60 
I = 28 
C = 29 
M = 33/F = 27 
60.5 ± 8.2 y 
Home based 
resistance training: 
given 1 dumbbell & 
weight plates. 
Monthly phone call 
Community gym based resistance 
training 
8 whole body exercises: similar to 
program undertaken in a 
supervised setting previously. 
F: 2 week-1 
I: 3 sets x 8 reps 
Increase weight when 
able to perform 3 x 8 
D: NR 
1RM 
-Bench press 
- Leg 
extension 
Machine & free 
weights 
12 months Yes, YMCA staff 
Gordon (2006) 
USA [95] 
N = 30 
RT = 15 
C = 15 
M = 15/F = 15 
67 ± 11 y 
Standard type 2 DM 
care: no exercise, 
fortnightly telephone 
interview 
Resistance training & standard 
care 
5 whole body progressive 
exercises: knee extension, chest 
press, leg curl, upper back & leg 
press. 
60-65% 1RM, increasing to 75-
80% 1RM by week 4 
F: 3 week-1 
I: 3 sets x 8 reps 
D: 45 min total, 1-2 
min rest between sets, 5 
min warm-up 
1RM Pneumatic 
Machine 
weights 
16 weeks Yes: Unspecified 
personnel 
Cauza (2005) 
Austria [92] 
 
N = 43 
RT = 22 
AT = 17 
M = 22/F = 21 
56 ± 6.6 y 
Aerobic training: 
cycle 3 week-1, 15 
min progressing 5 
min per week to 90 
min @ 60% VO2max 
Resistance training 
10 min warm-up moderate 
cycling 
Minimal weight wk 1 & 2 to 
teach technique 
Progressive resistance from wk 3 
10 whole body exercises: bench 
press, chest cross, shoulder press, 
pull downs, biceps curls, triceps 
extensions, situps, leg press, calf 
raises, leg extensions, increasing 
to 4, 5 & 6 sets/wk 
F: 3 week-1 
I: 3 sets/wk x 10-15 
reps 
ie. 1 set x 10-15 reps 
each session 
Weight increase when 
able to complete 15 
reps 
D: NR 
1RM 
- bench press 
- rowing 
- leg press 
All seated. 
Machine & free 
weights 
4 months All sessions: 
Professional 
instructor, 
Physician 
Cauza (2005) 
Austria [93] 
N = 15 
RT = 8 
AT = 7 
M = 4/F = 11 
55 ± 7.8 y 
Aerobic training: 
cycle 3 week-1, 15 
min progressing 5 
min per week  to 90 
min @ 60% VO2max 
Resistance training 
10 min warm-up moderate 
cycling 
Minimal weight wk 1 & 2 to 
teach technique 
Progressive resistance from wk 3 
10 whole body exercises: bench 
press, chest cross, shoulder press, 
pull downs, biceps curls, triceps 
extensions, sit-ups, leg press, calf 
raises, leg extensions, increasing 
to 4, 5 & 6 sets 
F: 3 week-1 
I: 3 sets x 10-15 reps 
Weight increase when 
able to complete 15 
reps 
D: NR 
1RM 
- seated 
bench press 
Machine & free 
weights 
4 months All sessions: 
Professional 
instructor, 
Physician 
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Table 2.2 (continued) 
Author (year) 
Country 
N = Sample 
M/F 
Age y 
Control / 
Comparison 
condition 
Exercise mode & intervention F: Frequency 
I: Intensity 
D: Duration 
Strength 
Test 
Resistance 
Training 
equipment 
Duration Supervision 
Dunstan (2005) 
Australia [89] 
N = 36 
RT=14 
C = 12 
M = 21/F = 15 
60-80 y 
Home based 
flexibility training, 3 
week-1, telephoned 
fortnightly 
Home based resistance training 
9 whole body exercises: lying 
dumbbell flies, seated single-leg 
extension, dumbbell shoulder 
press, dumbbell bent-over row, 
standing leg curl, dumbbell biceps 
curls, dumbbell triceps kickback, 
abdominal curls. 
60-80% 1RM. Additional weights 
provided to facilitate progression 
F: 3 week-1 
I: 3 sets x 8-10 reps 
D: NR  
1RM Free weights 6 months No, telephone 
monitoring 
weekly first 4 
weeks, then 
fortnightly 
Baldi (2003) 
New Zealand 
[79] 
N = 18 
RT = 9 
Con = 9 
M = 18/F = 0 
47.9 y 
No exercise 
completed. 
Resistance training 
10 whole body progressive 
exercises: not specified 
1 set x 12 reps in wk 1 then 2 sets 
x 12 reps. Resistance progressed 
by 5% when able to successfully 
complete the program. 
F: 3 week-1 
I: 2 sets x 12 reps 
Max weight for 10 reps 
for upper body and 15 
reps for lower body 
exercises. 
Moderate intensity 
D: NR, 60 sec rest 
between sets 
Max 
isokinetic 
torque 
- Leg and arm 
flexion 
NR 10 weeks All sessions: 
Unspecified 
personnel 
Castaneda 
(2002) 
USA [81] 
N = 62 
RT = 31 
C = 31 
M = 22/F = 40 
66 ± 11.8 y 
Standard type 2 DM 
care: Telephone call 
fortnightly 
Resistance training 
5 whole body progressive 
exercises: chest press, leg press, 
upper back, knee extension & 
flexion. 
Wk 1-8 = 60-80% 1RM 
Wk 10-14 = 70-80% 1RM 
Wk 9 & 15 = 10% decrease 
F: 3 week-1 
I: 3 sets x 8 reps 
High intensity 
D: 45 min total, 5 min 
warm-up & cool down 
1RM 
- 2 upper & 3 
lower body 
exercises 
Pneumatic 
Machine 
weights 
16 weeks All sessions: 
Unspecified 
personnel 
Dunstan (1998) 
Australia [80] 
N = 27 
RT = 15 
C = 12 
M = 17/F = 10 
50 ± 10.4 y 
Control: no exercise 
intervention with 
medical review 
fortnightly 
Progressive circuit resistance 
training 
10 whole body exercises: leg 
extension, bench press, leg curl, 
biceps curls, behind neck pull 
down, calf raise, overhead press, 
seated rowing, triceps extension 
& abdominal curls. 
Wk 1-2 = 2 sets 
Wk 3-8 = 3 sets 
F: 3 week-1 
I: 2-3 sets x 10-15 reps 
D: 60 min total, 30 sec 
per exercise, 30 sec 
active rest including 
warm-up & cool down 
1RM 
- all 
intervention 
exercises 
performed  
Machine & free 
weights 
8 weeks All sessions: 
Instructor, 
Physician 
RT = resistance training; Flex = flexibility training; Vib = vibration training; 1RM = 1 repetition maximum; min = minutes; Max = maximum; C = control; type 2 DM / T2DM = type 2 diabetes mellitus; standard type 
2 DM care = routine medical care for type 2 diabetes mellitus; NR  not reported; AT = aerobic training; CT = combined aerobic & resistance training; HRmax = maximum heart rate; wk = week; sec = seconds; YC = 
young healthy controls; OC = age matched controls; IGT = impaired glucose tolerance; HI = hyperinsulinaemia; HRR = heart rate reserve; VO2max = maximal oxygen uptake; MVC = maximal voluntary contractions 
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2.4.2.4. Compliance 
When the interventions were completed at a specific exercise venue, eight papers 
reported compliance levels of ≥ 85% with most of the training completed under 
supervision (Table 2.2). Participants who were given weight equipment [104] or 
resistance bands [98] and asked to exercise at home achieved 71% and 90% compliance 
respectively. When direct supervision was removed during maintenance programs at 
home or at a leisure-centre, adherence dropped to 67-72% [89, 94] and 68% [94] 
respectively. 
 
2.4.2.5. Adverse Events 
Although information regarding adverse events was not reported in 10 of 21 papers 
reporting RCTs [80, 90, 91, 95, 96, 98, 100-102, 105] and only four of 14 papers 
describing non-RCTs reported information on adverse events [111, 112, 116, 117] (Table 
2.1), the interventions seemed to be well tolerated in these clinical populations with co-
morbidities. Cases of hypoglycaemia were reported in five resistance training studies, 
during training [94], immediately following training [81], during the night after 
resistance training [93], or at unspecified times, with medication decreased to counteract 
this outcome [88, 117]. Hypoglycaemic events were also reported with combined 
training, aerobic training and in the control group, with medication adjusted for this [88]. 
Additionally, hypoglycaemia occurred frequently in one individual both before and after 
aerobic training [93], while seven hypoglycaemic events were reported in a control group 
[81]. In only one case, was hypoglycaemia severe enough to warrant medical attention 
[94]. Two studies reported musculoskeletal conditions requiring the program to be 
modified [88, 104], episodes of chest pain were reported twice [81, 88] and one study 
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reported a case of hypotension [117]. One study reported cases of diverticulitis, lung 
cancer and cardiovascular events that were unrelated to the exercise programs [99]. 
 
2.4.3. Glycaemic Control 
2.4.3.1. Glycated Haemoglobin 
Glycated haemoglobin (HbA1c) is considered the optimal way of measuring long term 
(120 days) glycaemic control [118], with HbA1c values of < 7.0% accepted as 
representing good glucose control [118]. Seventeen RCTs reported HbA1c data (Table 
2.3), with two studies [81, 91, 92, 95] reporting HbA1c reduced by 1.0-1.2%, from above 
8.0% prior to 16 weeks of moderate-high intensity training. Baldi and Snowling [79] 
showed an improvement over the intervention period which approached significance (p = 
0.057) after 10 weeks of resistance training with HbA1c levels reducing from 8.9% to 
8.4%. Maintenance programs completed at home [89, 94], or at a community-gym [94] 
reported glycaemic control returned towards baseline after six months or became worse 
after 12 months, which is likely to be a result of decreased compliance to the prescribed 
training. Interestingly, resistance training appears to be as effective as aerobic training at 
improving HbA1c when compared to control groups [88] and more effective when 
compared to aerobic training [92]. This finding requires further validation though as the 
resistance training group appeared to spend a larger volume of time training than the 
aerobic training group [92]. Sigal and colleagues [88] however, concluded that combined 
training was superior at improving glycaemic control to either resistance training or 
aerobic training on their own. The results from these two studies [88, 92] require careful 
interpretation, given one is a large RCT that was well controlled and conducted over a 
long duration of six months [88] while the other was smaller and less well controlled 
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given that only two interventions were prescribed, an aerobic exercise program and a 
resistance exercise program [92]. The lack of a non-exercising control group limits the 
ability of Cauza and colleagues [92] to confidently conclude that the changes were 
absolutely as a result of the exercise interventions, while the lack of comparison between 
the different exercise interventions within the Sigal and colleagues study [88] draws into 
question the conclusion the combined training was superior to that of either resistance or 
aerobic training on their own. 
 
Ten non-RCTs reported HbA1c data, with the trials reporting different subjects (diabetes 
vs. non-diabetes) indicating significant differences, while in an RCT, both resistance and 
aerobic exercise caused an improvement to HbA1c which was significantly greater in the 
resistance training group [106]. Three studies [114, 115, 117] reported an improvement 
over time, although another [107] reported a 2% improvement in HbA1c which was not 
statistically significant. 
 
The greatest improvements to glycaemic control occurred when HbA1c was poor (> 
8.0%) at baseline however, based on current literature [74], clinically relevant 
improvements of 0.6% were generally seen with moderate-high intensity resistance 
training or where the duration of training lasted 10 weeks or longer. The exception to this 
was 4-6 weeks of low intensity resistance training five days·wk-1 resulting in a 2.0% 
improvement of HbA1c [107], although this study was not randomised and participants 
were remarkably light and had a low body mass index, reducing the generalisability of 
this study. 
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2.4.3.2. Fasting Blood Glucose 
Fasting blood glucose is less frequently used as a measure of glycaemic control but can 
be a substitute when HbA1c is not measured, for instance when the intervention duration 
is less than that required for a change in glycaemic control to be fully reflected in HbA1c 
(< 3 months). Twelve RCTs reported fasting blood glucose levels (Table 2.3), with only 
one [92] reporting a significant change when compared to the comparison group 
(aerobic). This was quite a large improvement (3.2 mmol·L-1) and included some subjects 
taking insulin, where no other study included subjects taking insulin. This study however 
was not identically matched in terms of volume, with the resistance training group 
completing up to six sets of 10-15 repetitions per week for 10 exercises (estimated to be 
120 minutes of exercise per week plus 120 minutes of rest/recovery during the sessions) 
and the aerobic training group completing up to 90 minutes per week. Again, only three 
[106, 115, 116] of eight [62, 86, 106, 108, 112, 115-117] non-RCTs reporting fasting 
blood glucose indicated an improvement over time.  
 
2.4.4. Insulin Sensitivity 
2.4.4.1. Euglycaemic-Hyperinsulinaemic Clamp 
Although considered the gold-standard for determining insulin sensitivity levels [119], 
only two studies used the euglycaemic-hyperinsulinaemic clamp [86, 107]. Holten and 
colleagues [86] reported that despite individuals with diabetes having significantly lower 
glucose disposal rates and therefore greater insulin resistance than controls, leg glucose 
clearance rates increased during the second stage of the euglycaemic-hyperinsulinaemic 
clamp, showing that improvements are achievable with resistance training despite being 
less sensitive to insulin. Ishii and colleagues [107] also used an euglycaemic-
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hyperinsulinaemic clamp, reporting a 48% (p < 0.05) increase in insulin sensitivity with 
resistance training and no change in sedentary individuals with diabetes acting as 
controls.  
 
Comparing these studies is difficult due to one [86] reporting glucose disposal rate at 
varying levels of insulin infusion, and another [107] reporting final glucose disposal rate. 
However, it is likely that resistance training for 4-6 weeks will result in increased insulin 
sensitivity. 
 
2.4.4.2. Oral Glucose Tolerance Test 
Insulin sensitivity using area under the curve (AUC) equations for glucose and insulin 
levels during an oral glucose tolerance test (OGTT) has been validated against the 
euglycaemic-hyperinsulinaemic clamp [119] with lower glucose values indicating better 
glucose tolerance and lower insulin values indicating increased insulin sensitivity. The 
OGTT was used in two RCTs [80, 90] (Table 2.3), with results indicating an 
improvement in insulin sensitivity when compared to sedentary controls [80] but not 
when compared to vibration or flexibility training [90], although the method of 
performing this analysis varied from other studies as blood was drawn from the ear lobe, 
rather than the commonly used antecubital vein and only glucose was measured, not 
insulin as well. Two non-RCTs [62, 113] completed OGTTs with AUC for glucose and 
insulin improving over time with both resistance training and aerobic training [113], 
although Fenicchia and colleagues [62] showed no change after six weeks of resistance 
training despite reporting an improvement 12-24 hours after the first resistance training 
session however, the time of completing the OGTT post training was later. The time 
utilised for each OGTT trial varied considerably between 24 and 72-96 hours post-
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training (Table 2.3). This may be a factor in whether studies reported improvements or 
not as it is still unclear precisely how long insulin sensitivity remains increased following 
resistance training, and therefore acute rather than chronic training effects could have 
been reported. The training regimes may also have contributed to the varied results as 
different protocols at different intensities were employed by each study. 
 
2.4.4.3. Homeostasis Model Assessment 
The homeostasis model assessment (HOMA) is a mathematical model of determining 
insulin resistance from fasting glucose and insulin concentrations which has been 
validated against the euglycaemic-hyperinsulinaemic clamp [119]. This was the most 
common method of determining insulin resistance and estimating insulin sensitivity, 
possibly because of its ease and speed of completion as it requires only a fasting blood 
sample, with seven papers describing six RCTs using this method [89, 91, 92, 94-96, 
100] (Table 2.3). The HOMA was originally developed in 1985 and updated in 1996 to 
estimate insulin sensitivity (HOMA2) [120] although it is unclear whether any of the 
studies using HOMA modelling utilised the updated version.  
 
A reduction in insulin resistance after four months of resistance training (p = 0.04) was 
reported in a study with 22 participants [92], while 12 months of centre-based 
maintenance following a two-month introductory period saw insulin sensitivity improve 
(p < 0.05) [94]. Comparing resistance training with the control group significantly 
improved (p < 0.05) [91] and tended to improve (p = 0.08) [95] insulin resistance, while 
resistance training compared with aerobic training also showed a trend towards (p = 0.09) 
improvement of insulin resistance [92]. Winnick and colleagues [96] reported a 
significant improvement in insulin resistance for African Americans completing 
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resistance training when compared to Whites completing resistance training. There was 
no difference between ethnicity however, when aerobic training was completed. 
 
Insulin resistance improved by 3.2 units when calculated using HOMA 72 hours after the 
final session [95], which is supported by a 9.4% improvement in insulin sensitivity when 
measured 48 hours after the final resistance training session [94]. Additionally two non-
RCTs [108, 112] reported HOMA, stating no change in insulin resistance 24 hours and 
48-72 hours following the final resistance training session. The limited number of studies 
and the variation in HOMA limits the ability to make conclusions. However, insulin 
sensitivity seemed to at least tend to improve compared to a comparison group [80, 91, 
92, 95], though how long this improvement remains is unclear. 
 
2.4.4.4. Insulin Sensitivity Index 
The insulin sensitivity index is another validated mathematical model for determining 
insulin sensitivity [119], but was used by only one RCT [79] and one uncontrolled trial 
[116] with each using a different model. Contrasting results were reported, with Baldi 
and Snowling [79] finding no evidence of change in either resistance training (10 weeks) 
or control groups, while Ibanez et al. [116] observed a 46% improvement in insulin 
sensitivity (p < 0.001) after 16 weeks of resistance training. This difference could be time 
related as the improvement was measured 24 hours after the final session [116] compared 
to 36-48 hours when no improvement was seen [79], or this could be related to intensity 
or duration of training.  
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2.4.4.5. Insulin Tolerance Test 
Two RCTs measured insulin sensitivity using an insulin tolerance test [101, 102] and did 
not report any change over the 12-week resistance training intervention with resistance 
bands compared to either aerobic or non-exercising controls. One non-RCT [115] used a 
short insulin tolerance test to measure insulin sensitivity. This test was completed 72-96 
hours after the final training session of a 12-week program completed with free weights 
in a physiotherapy clinic, and reported a significant improvement in insulin sensitivity. 
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Table 2.3: Metabolic outcomes 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
Jorge (2011) 
Brazil [100] 
CT 
 
RT 
 
AT 
 
C 
NR Pre:Post 
 
 
 
 
 
 
 
Time effect 
7.6±1.2:7.5±1.1 
 
8.5±2.5:8.2±2.1 
 
7.6±1.7:7.4±1.5 
 
6.9±0.7:7.1±0.7 
 
NS 
8.58±2.35:7.88±2.04 
 
10.78±4.41:9.22±3.36 
 
8.14±2.31:7.04±1.99 
 
8.26±2.39:6.94±1.14 
 
p < 0.05 
 HOMA-IR 3.14±2.12:2.59±1.31 
 
4.54±3.94:4.07±2.90 
 
2.45±1.31:2.24±1.52 
 
3.91±4.42:4.28±5.74 
 
NS 
Plotnikoff (2010) 
Canada [104] 
RT 
 
C 
NR Pre:Post 
 
 
 
Group effect 
6.9±1.5:7.0±1.4 
 
6.8±0.8:6.8±0.8 
 
p = 0.27 
6.9±2.1:7.1±1.7 
 
7.2±1.4:7.1±1.2 
 
p = 0.59 
92.3±50.1:90.1±46.6 
 
111.2±57.1:137.3±75.3 
 
p = 0.02 
  
Church (2010) 
USA [99] 
CT 
 
 
AT 
 
 
RT 
 
 
C 
NR Pre:Post 
Δ 
 
 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
7.6±0.1:7.4±0.1 
-0.2±NR ∆ 
 
7.6±0.1:7.4±0.1 
-0.1±NR ∆ 
 
7.6±0.1:7.5±0.1 
0.0±NR ∆ 
 
7.6±0.1:7.7±0.1 
+ 0.1±NR ∆ 
 
NR 
 
P = 0.03 CT v C 
NS RT & AT v C 
8.3±2.0:NR 
NR 
 
8.1±1.7:NR 
NR 
 
8.5±2.2:NR 
NR 
 
8.8±2.3:NR 
NR 
 
NR 
 
NR 
173.4±NR:NR 
NR 
 
111.0± NR:NR 
NR 
 
122.4±NR:NR 
NR 
 
106.2±NR:NR 
NR 
 
NR 
 
NR 
  
Ku (2010) 
Korea [101] 
RT 
 
 
AT 
 
 
C 
NR Pre:Post 
∆ 
 
 
 
 
 
 
 
Group effect 
7.3±0.9:7.0±0.9 
-0.3±0.9 ∆ 
 
7.7±1.0:7.1±0.8 
-0.6±1.2 ∆ 
 
7.3±0.7:7.2±0.9 
-0.1±0.6 ∆ 
 
NS 
6.3±0.7:7.1±2.2 
+ 0.8±2.2 ∆ 
  
7.1±1.1:6.7±1.1 
-0.4±1.2 ∆ 
 
6.9±1.1:6.7±1.3 
-0.2±1.2 ∆ 
 
NS 
 Insulin 
Tolerance Test 
– kITT (%/min) 
1.87±0.97:2.13±0.76 
+ 0.26±1.16 ∆ 
 
2.81±1.02:2.50±0.63 
-0.31±0.93 ∆ 
 
1.98±0.78:2.12±0.62 
+ 0.14±0.71 ∆ 
 
NS 
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Table 2.3 (continued) 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
Kwon (2010) 
Korea [102] 
RT 
 
C 
NR Pre:Post 
 
 
 
Time effect 
 
Group*time 
7.3±0.9:7.0±0.9 
 
7.4±0.7:7.3±0.9 
 
NS 
 
p = 0.57 
  Insulin 
Tolerance Test 
– kITT (%/min) 
1.8±1.0:2.1±0.8 
 
2.0±0.8:2.1±0.6 
 
NS 
 
p = 0.69 
Ng (2010) 
Singapore [103] 
RT 
 
 
AT 
36-48 hours Pre:Post 
∆ 
 
 
 
 
Group effect 
8.9±1.5:8.4±1.2 
-0.4±0.6 ∆ 
 
8.5±0.9:8.1±1.1 
-0.3±0.9 ∆ 
 
NS 
10.4±3.1:10.1±3.6 
-0.3±2.8 ∆ 
 
9.5±2.5:9.3±2.2 
-0.2±1.7 ∆ 
 
NS 
   
Arora (2009) 
India [97] 
RT 
 
AT 
 
C 
NR Pre:Post 
 
 
 
 
 
Time effect 
 
Group effect 
7.6±1.4:6.2±0.8 
 
8.1±0.9:6.7±0.9 
 
7.8±0.9:7.4±0.9 
 
p < 0.05 RT & AT 
 
NR 
    
Cheung (2009) 
Australia [98] 
RT 
 
 
C 
NR Pre:Post 
∆ 
 
 
 
 
Group effect 
7.2±1.6:NR 
+ 0.3±0.9 ∆ 
 
7.4±1.0:NR 
-0.1±1.2 ∆ 
 
p = 0.30 
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Table 2.3 (continued) 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
Winnick (2008) 
USA [96] 
Whites 
RT 
 
 
AT 
 
 
African 
RT 
 
 
AT 
NR  
Pre:Post 
∆ 
 
 
 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
 
7.9±2.0:NR 
 
 
7.8±1.2:NR 
 
 
 
6.5±1.0:NR 
 
 
7.6±1.5:NR 
 
 
NR 
 
NR 
 
 
 HOMA IR  
6.8±4.8:NR 
+13.2% ∆ 
 
10.6±8.5:NR 
-3.68% ∆ 
 
 
5.8±2.4:NR 
-19.15% ∆ 
 
8.6±7.4:NR 
+3.79% ∆ 
 
NR 
 
P<0.05 RT African v Whites 
P>0.05 AT African v Whites 
Baum (2007) 
Germany [90] 
RT 
 
 
Vib 
 
 
Flex 
72-96 hours Pre:Post 
Δ 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
6.8%±0.17:NR 
+0.2±0.15 ∆ 
 
7.3%±0.66:NR 
-0.3±0.22 ∆ 
 
6.7%±0.26:NR 
+0.34±0.26 ∆ 
 
NR 
 
NR 
6.99±1.28:6.66±1.22 
 
 
7.38±3.16:6.77±1.94 
 
 
6.66±1.39:6.38±1.22 
 
 
NR 
 
NR 
 OGTT – ear 
lobe 
Glucose only 
NR:NR 
-5.6% ∆ 
 
NR:NR 
-6.3% ∆ 
 
NR:NR 
0.00% ∆ 
 
P<0.05 RT & Vib 
 
NR 
Brooks (2007) 
USA [91] 
RT 
 
 
Con 
72 hours Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
8.7±10.0: 7.6±8.4 
-1.0±1.1 Δ 
 
7.8±8.9: 8.3±7.2 
+0.4±1.7 Δ 
 
NR 
 
p < 0.001 
8.8±2.8:7.9±2.2 
-0.9±2.8 Δ 
 
9.9±3.9:9.5±3.3 
-0.3±4.5 Δ 
 
NR 
 
p = 0.92 
116±690:105±390 
-16±384 Δ 
 
115±729:133±702 
+6±479 Δ 
 
NR 
 
p = 0.27 
HOMA-IR 7.1±31.7:5.3±30.6 
-0.7±20.0 Δ 
 
6.7±50.1:6.4±37.9 
+0.8±21.2 Δ 
 
NR 
 
p = 0.05 
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Table 2.3 (continued) 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
Sigal (2007) 
Canada [88] 
RT 
 
AT 
 
CT 
 
Con 
Minimum 
48 hours 
Pre:Post 
 
 
 
 
 
 
 
Time effect 
 
 
 
 
Group*time 
7.5±1.5:7.2±1.5 
 
7.4±1.5:7.0±1.5 
 
7.5±1.5:6.6±1.6 
 
7.4±1.4:7.5±1.5 
 
p = 0.018 RT 
p = 0.002 AT 
p < 0.001 CT 
p = 0.57 Con 
 
p = 0.038 RT v Con 
p = 0.007 AT v Con 
p = 0.001 CT v RT 
p = 0.014 CT v AT 
    
Dunstan (2006) 
Australia [94] 
Centre 
 
 
Home 
48 hours Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
7.8±0.9:NR 
+0.1±1.0 ∆ 
 
7.5±0.5:NR 
+0.2±1.2 ∆ 
 
p < 0.05 both grps 
 
NS 
9.0±2.0:NR 
-0.3±1.8 ∆ 
 
8.4±1.9:NR 
-0.2±2.2 ∆ 
 
NS 
 
NS 
143.7±66.1:NR 
-21±47.6 ∆ 
 
126.6±55.1:NR 
-8.5±32.8 ∆ 
 
p < 0.05 centre 
 
NS 
HOMA 46.9±26.1:NR 
+9.4±16.4 ∆ 
 
50.7±24.6:NR 
+2.4±12.4 ∆ 
 
p < 0.05 centre 
 
NS 
Gordon (2006) 
USA [95] 
RT 
 
Con 
72 hours Pre:Post 
 
 
 
Time effect 
 
Group*time 
8.7±1.9:7.7±1.6 
 
8.0±1.6:8.3±1.6 
 
NR 
 
p < 0.01 
 173±108:132±54 
 
157±101:168±139 
 
NR 
 
p < 0.05 
HOMA-IR 8.5±27.9:5.3±24.4 
 
6.7±30.2:7.1±28.7 
 
NR 
 
p = 0.08 
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Table 2.3 (continued) 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
Cauza (2005) 
Austria [92] 
 
RT 
 
 
AT 
NR Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
8.3±8.0:7.1±1.7 
-1.2 Δ 
 
7.7±1.2:7.4±1.2 
-0.3Δ 
 
p = 0.001 RT; NS 
AT 
p = 0.009 
11.32±7.62:8.16±3.77 
-3.2 Δ 
 
8.88±2.06:8.83±2.31 
-0.05 Δ 
 
p < 0.001 RT; NS AT 
 
p = 0.002 
130.9±84.0:118.4±85.4  
-12.5 Δ 
 
105.1±77.5:125.6±96.1 
+20.46 Δ 
 
NS both grps 
 
p = 0.04 
HOMA-IR 9.1±7.0:7.2±5.6 
-2.0 Δ 
 
6.8±5.8:8.4±7.8 
+1.5 Δ 
 
p = 0.04 RT; NS AT 
 
p = 0.009 
Cauza (2005) 
Austria [93] 
RT 
 
AT 
NR Pre:Post 
 
 
 
Time effect 
 
Group*time 
7.5±1.4:7.0±2.1 
 
8.0±3.8:7.6±4.8 
 
NS both groups 
 
NR 
    
Dunstan (2005) 
Australia [89] 
RT  
 
 
Con 
48 hours Pre:post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
Returned toward 
baseline 
 
Returned toward 
baseline 
 
p < 0.05 
 
NR 
NR:NR 
+0.3±2.2 ∆ 
 
NR:NR 
-0.5±2.1 ∆ 
 
NS both grps 
 
NS  
NR:NR 
-0.1±46.8 ∆ 
 
NR:NR 
-19.3±50.1 ∆ 
 
p < 0.05 Con; NS RT 
 
NS 
HOMA-IR NR:NR 
+0.04±5.5 ∆ 
 
NR:NR 
+5.4±6.5 ∆ 
 
p < 0.05 Con; NS RT 
 
NS 
Baldi (2003) 
New Zealand [79] 
RT 
 
Con 
36-48 hours Pre:Post 
 
 
 
Time effect 
 
Group*time 
8.9±3.6:8.4±1.8 
 
8.5±2.4:8.4±1.8 
 
p = 0.057 RT; 0.64 
Con 
NR 
12.0±2.7:11.4±2.4 
 
11.1±3.3:11.0±3.0 
 
p < 0.05 RT 
 
NR 
268.1±106.3:146.5±85.4 
 
191.7±191.7:214.6±156.3 
 
p < 0.05 RT 
 
NR 
Insulin 
sensitivity index 
0,120 
20.3±3.9:22.6±3.9 
 
22.2±11.4:19.9±5.1 
 
NS 
 
NR 
Castaneda (2002) 
USA [81] 
PRT  
 
 
Con 
48 hours Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
8.7±1.7:7.6±1.1 
-12.6±11.1% Δ 
 
8.4±1.7:8.3±2.8 
+1.2±5.6% Δ 
 
NR 
 
p = 0.01 
8.8±2.8:7.9±2.2  
 
 
9.7±3.9:8.9±3.9 
 
 
NR 
 
p = 0.34 
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Table 2.3 (continued) 
Author (year) 
Country 
Group Time of 
follow up 
Type of 
change 
HbA1c  
(%) 
Glucose 
(mmol·L-1) 
Insulin 
(pmol·L-1) 
Insulin 
sensitivity 
method 
Insulin sensitivity 
.Dunstan (1998) 
Australia [80] 
CRT 
 
 
Con 
48 hours Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
8.2±1.9:8.0±1.9 
 
 
8.1±2.1:8.3±2.4 
 
 
NS both grps 
 
NS 
9.6±3.5:9.4±3.1  
 
 
9.9±4.2:9.8±4.5 
 
 
NS both grps 
 
NS 
64.3±49.1:63.1±48.8  
 
 
82.6±36.4:93.8±43.7 
 
 
NS both grps 
 
NS 
OGTT 
- Glucose AUC 
- Insulin AUC 
-22±240 Δ 
-2183±6053 Δ 
 
+191±291 Δ 
+3947±5352 Δ 
 
NR 
 
p < 0.05 glucose & insulin 
RT = resistance training; Flex = flexibility training; Vib = vibration training; Con = control; T2DM = type 2 diabetes mellitus; NR = not reported; AT = aerobic training; YC = young healthy controls; OC = age 
matched controls; grps = groups; NS = not significant; PRT = progressive resistance training; CRT = circuit resistance training; CT = combined aerobic & resistance training 
Castaneda [105] did not report any metabolic variables 
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2.4.5. Insulin Signalling 
Only three studies reported data on glucose transport and insulin signalling in individuals 
with diabetes [86, 100, 105, 109] with two of these being RCTs [100, 105]. Improved 
glucose disposal, as measured by incorporation into muscle glycogen, support findings 
using the euglycaemic-hyperinsulinaemic clamp [86, 105]. Changes in the glucose 
transporter-4 (GLUT4) are less clear with an earlier study [86] reporting a 40% increase 
(p < 0.05) in GLUT4 density compared to a more recent study [105] reporting no 
evidence of change in GLUT4 gene or protein expression. This could be due to 
population differences (males vs. females) or the different training protocols (whole-body 
vs. lower-limb). 
 
Eight weeks of moderate-high intensity resistance training resulted in increased protein 
content of the insulin receptor, protein kinase-B, and glycogen synthase to similar levels 
in individuals with diabetes and healthy control subjects [86]. However, no training 
effect was observed for protein content of insulin receptor substrate-1, the p85 subunit of 
phosphatidylinositol(PI)-3-kinase, or percent glycogen synthase activity [86]. This is in 
contrast to findings from 12 weeks of resistance training and combined aerobic and 
resistance training that produced increased expression of insulin receptor substrate-1 
[100]. Moderate-intensity resistance training resulted in similar changes to various AMP-
activated protein kinase (AMPK) subunit isoforms (α1:+16%, β2:+14%, γ1:+29%, γ3:-
48%) in patients with diabetes and healthy controls [109], while muscle glycogen levels 
significantly increased with resistance training [86, 105], when compared to controls (p = 
0.04) [105]. 
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2.4.6. Muscle Strength 
Fifteen papers from 12 RCTs reported muscle strength data (Table 2.4), with all but three 
studies [94, 98, 99] reporting statistically significant improvements after completing 
resistance training. One of these studies [94] actually reported a decrease (p < 0.05) in 
strength after resistance training, with small losses after 12 months of a home or leisure-
centre based maintenance program following on from a two-month supervised 
intervention period, although only lower body strength in the home-based group 
decreased below baseline, and was likely to be due to not being able to maintain the 
appropriate intensity. In most cases [81, 89, 91, 101, 102, 104, 105], these changes were 
significant when compared to sedentary controls, but not when compared to aerobic 
training [92, 93]. Eight non-RCTs [62, 86, 107, 108, 110, 113, 114, 116] also reported 
muscle strength improved, with similar improvements in muscle strength observed in 
individuals with diabetes compared to those without diabetes [86, 108]. One study also 
reported muscle power output improved over time [110]. Studies that reported greater 
improvements in muscular strength, utilised durations between 16 weeks [92, 93, 114, 
116] and six months [89] at moderate or moderate-high intensities. In contrast to other 
results, one study [62] reported highly significant (p < 0.01) increases in muscle strength 
after six weeks of moderate intensity resistance training and two studies reported 
significant changes in strength against control groups with 12 weeks of training with 
resistance bands [101, 102]. However, overall it appears that higher intensity resistance 
training is appropriate and more time efficient for muscle strength gains, although data 
evaluating lower intensity resistance training in patients with diabetes is limited (4/31 
studies). 
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Improved glycaemic control was observed in five [79, 81, 91, 92, 95] of the 13 papers 
from RCTs (3 studies) that reported significant improvements in strength, while four 
RCTs [80, 90-92, 95] that increased strength also improved insulin sensitivity, leaving 
five RCTs [79, 89, 101, 102, 104] that did not improve insulin sensitivity despite 
increasing strength. In non-RCTs, one study that improved strength reported improved 
glycaemic control [114], while four studies [86, 107, 113, 116] that improved strength 
reported improved insulin sensitivity and two [62, 108] did not improve insulin 
sensitivity.  
 
2.4.7. Body Composition 
2.4.7.1. Lean Body Mass 
Lean body mass was measured by dual energy x-ray absorptiometry (DXA) in eight 
studies [81, 89, 91, 99, 101, 102, 104, 107, 115] including six RCTs [81, 89, 91, 99, 101, 
102, 104], or estimated after accounting for fat mass in a further seven studies [62, 63, 
79, 88, 92, 94, 113, 114] including four RCTs [79, 88, 92, 94], with one study [93] not 
specifying the method used (Table 2.4). Results varied, with significant lean body mass 
increases of 1kg [102] and 3-6kg with resistance training [79, 92, 93] and 2kg with 
aerobic training [93]. Three studies reported significant (p < 0.05; p = 0.04) [81, 91, 102] 
or a trend (p < 0.08) [89] towards improvements for lean body mass when resistance 
training was compared with the non-exercising control group.  
 
2.4.7.2. Fat Mass 
Fat mass was typically determined through mathematical equations after measuring body 
mass and using various techniques to estimate percentage fat. Significant decreases in fat 
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mass of 1-4.5kg with resistance training [62, 89, 92, 93, 102, 114, 116] and 2kg with 
aerobic training [92, 93] occurred over the training duration (Table 2.4). One study [79] 
reported no changes in fat mass with resistance training, compared with a 3.5kg increase 
(p < 0.05) in controls over 10 weeks. With the exception of one study [62], interventions 
with durations less than 10 weeks did not report fat mass (Table 2.4). The current 
evidence suggests that moderate or high intensity training of greater than 10 weeks tends 
to reduce fat mass in individuals with type 2 diabetes.  
 
2.4.7.3. Percentage Body Fat 
One non-RCT [107] reported a decrease in percentage body fat as measured by DXA. 
With two RCTs [96, 104] and one non-RCT [115] reporting no change. Percentage body 
fat results were not reported in other studies despite utilising DXA [81, 89, 91, 99, 101, 
102]. Two further studies [79, 113] utilised hydrostatic weighing, and reported no 
evidence of change to percentage body fat (Table 2.4). Bioelectrical impedance was used 
in three studies [62, 88, 94, 103], with changes only reported when aerobic training was 
compared to controls (p = 0.008) [88] (Table 2.4). Four studies utilised the less sensitive 
measure of skin-fold measurements where decreases in body fat of up to 9.1% were 
reported (Table 2.4). One non-RCT [110] reported percentage body fat results, but not 
how it was measured. 
 
2.4.7.4. Body Mass 
Typically there was no change in body mass with any exercise regimen; however, one 
study [79] reported a 2kg increase (p < 0.05) after 10 weeks of moderate intensity 
resistance training (Table 2.4). After six months of home-based maintenance [89], body 
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mass significantly increased (p < 0.05), although final levels remained lower than 
baseline.  
 
2.4.7.5. Girth Measures 
Measures of waist circumference were not routinely completed (14/31 studies; Table 2.4) 
[62, 81, 88, 89, 91, 94, 95, 98, 99, 101-104, 115, 117, 121] with change occurring when 
comparing sedentary controls with resistance training [81], aerobic training [88, 103] and 
over time with resistance training [89, 102, 112, 115]. Waist circumference was reported 
to remain decreased after six months of home-based resistance training maintenance [89] 
. 
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Table 2.4: Body composition markers 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Jorge (2011) 
Brazil [100] 
CT 
 
RT 
 
AT 
 
C 
Pre:Post 
 
 
 
 
 
 
 
Time effect 
 31.2±3.9:31.1±3.5 
 
32.1±3.8:30.8±5.0 
 
29.3±2.2:29.1±2.4 
 
30.0±4.9:30.1±4.8 
 
NS 
      
Plotnikoff 
(2010) 
Canada [104] 
RT 
 
 
 
C 
Pre:Post 
 
 
 
 
 
Group effect 
97.2±27.1:97.8±27.3 
 
 
100.5±18.4:100.2±20.4 
 
 
p = 0.41 
35.3±8.5:35.6±9.0 
 
 
35.9±5.2:35.9±5.8 
 
 
p = 0.59 
110.0±16.6:108.6±16.8 
 
 
115.4±14.1:114.7±15.6 
 
 
p = 0.64 
46.2±21.8:55.5±26.3^ 
128.1±86.0:175.0±141.5∨ 
 
44.9±15.8:44.8±15.9 
99.5±61.5:93.8±63.4 
 
p = 0.003 
DXA 41.9±6.7:42.0±6.8 
 
 
41.5±7.4:41.4±7.2 
 
 
p = 0.71 
35.6±7.8:35.6±9.0 
 
 
38.5±8.5:37.8±7.9 
 
 
p = 0.31 
50.1±12.7:49.9±12.9 
 
 
55.0±12.7:54.3±12.6 
 
 
p= 0.59 
Church (2010) 
USA [99] 
CT 
 
 
AT 
 
 
RT 
 
 
C 
Pre:Post 
∆ 
 
 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
100.6±20.4:NR 
-1.5±NR ∆ 
 
97.5±18.6:NR 
-0.8±NR ∆ 
 
96.9±16.6:NR 
-0.3±NR ∆ 
 
97.0±20.0:NR 
+0.4±NR ∆ 
 
NR 
 
NR 
35.8±6.2:NR 
NR 
 
34.7±6.1:NR 
NR 
 
34.1±5.4:NR 
NR 
 
34.8±6.2:NR 
NR 
 
NR 
 
NR 
114.9±14.5:NR 
-2.8±NR ∆ 
 
111.3±14.2:NR 
-1.5±NR ∆ 
 
110.9±12.2:NR 
-1.9±NR ∆ 
 
110.6±14.4:NR 
+0.7±NR ∆ 
 
NR 
 
NR 
2.2±0.6:NR (Nm.kg-1) 
+0.2±NR ∆ 
 
2.3±0.6:NR 
-0.1±NR ∆ 
 
2.2±0.6:NR 
+0.2±NR ∆ 
 
2.1±0.5:NR 
0.00±NR ∆ 
 
NR 
 
NR 
DXA 38.8±6.8:NR 
NR 
 
37.1±7.7:NR 
NR 
 
37.0±7.6:NR 
NR 
 
38.5±7.0:NR 
NR 
 
NR 
 
NR 
39.0±11.3:NR 
-1.7±NR 
 
35.7±10.1:NR 
-0.6±NR 
 
36.1±10.1:NR 
-1.4±NR 
 
37.9±11.8:NR 
+0.1±NR 
 
NR 
 
NR 
57.9±11.3:NR 
0.0±NR 
 
57.3±10.7:NR 
-0.5±NR 
 
58.2±10.7:NR 
+0.8±NR 
 
56.9±11.8:NR 
+0.1±NR 
 
NR 
 
NR 
Ku (2010) 
Korea [101] 
RT 
 
 
 
 
AT 
 
 
 
 
C 
Pre:Post 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group effect 
66.1±4.4:65.0±4.7 
-1.1±1.3 ∆ 
 
 
 
66.3±6.0:64.4±5.4 
-1.9±1.2 ∆ 
 
 
 
67.6±7.5:67.0±7.4 
-0.6±1.7 ∆ 
 
 
 
p = 0.05 
27.1±2.3:26.7±2.3 
-0.4±0.5 ∆ 
 
 
 
27.1±2.4:26.3±2.1 
-0.8±0.5 ∆ 
  
 
 
27.4±2.8:27.1±2.8 
-0.3±0.7 ∆ 
 
 
 
p = 0.04 
90±5:88±6 
-2±3 ∆ 
 
 
 
89±5:86±5 
-3±3 ∆ 
 
 
 
90±12:90±6 
0±14 ∆ 
 
 
 
NS 
17±4:19±4^ 
+2±2 ∆ 
87±25:97±15∨ 
+10±16 ∆ 
 
17±3:15±3^ 
-2±3 ∆ 
89±23:82±25∨ 
-7±22 ∆ 
 
18±6:16±7^ 
-2±2 ∆ 
87±33:75±24∨ 
-12±21 ∆ 
 
P < 0.001^; = 0.004∨ 
DXA NR 
 
 
 
 
NR 
 
 
 
 
NR 
NR 
 
 
 
 
NR 
 
 
 
 
NR 
NR 
 
 
 
 
NR 
 
 
 
 
NR 
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Table 2.4 (continued) 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Kwon (2010) 
Korea [102] 
RT 
 
 
C 
Pre:Post 
 
 
 
 
 
Time effect 
 
Group*time 
66.1±4.4:65.0±4.7 
 
 
68.2±7.5:67.5±7.3 
 
 
p = 0.009 RT; NS C 
 
p = 0.42 
27.1±2.2:26.7±2.2 
 
 
27.6±2.8:27.3±2.8 
 
 
p = 0.008 RT; NS C 
 
p = 0.52 
90.2±5.0:87.9±5.6 
 
 
89.8±12.5:89.3±5.7 
 
 
p = 0.009 RT; NS C 
 
p = 0.49 
16.5±4.3:18.5±4.4^ 
86.8±24.8:96.9±15.1∨ 
 
18.1±6.6:17.0±6.7^ 
85.7±33.1:75.1±24.1∨ 
 
p < 0.05 All 
 
p < 0.001^; = 0.006 
DXA  23.1±4.5:21.3±4.6 
 
 
24.7±5.1:24.0±51.9 
 
 
p < 0.001 RT; = 0.02 C 
 
p = 0.04 
40.3±3.4:41.5±4.1 
 
 
41.2±5.0:41.1±4.8 
 
 
p = 0.003 RT; NS C 
 
p = 0.007 
Ng (2010) 
Singapore 
[103] 
RT 
 
 
AT 
Pre:Post 
∆ 
 
 
 
 
Group effect 
69.5±14.2:69.7±14.4 
+0.2±1.1 ∆ 
 
70.3±13.8:70.2±13.6 
0.0±1.4 ∆ 
 
NS 
27.4±4.7:27.5±4.7 
+0.1±0.4 ∆ 
 
27.8±5.2:27.8±5.2 
0.0±0.5 ∆ 
 
NS 
90.8±11.2:89.2±11.7 
-1.6±2.6 ∆ 
 
91.9±11.6:92.1±11.0 
+0.2±2.4 ∆ 
 
p < 0.05 
 Bio-
impedance 
33.1±6.2:31.6±6.1 
-1.4±2.4 ∆ 
 
33.9±5.2:32.8±5.3 
-1.1±2.2 ∆ 
 
NS 
  
Arora (2009) 
India [97] 
RT 
 
AT 
 
C 
Pre:Post 
 
 
 
 
 
Time effect 
 
Group effect 
 27.0±4.1:26.8±4.1 
 
26.2±3.2:25.8±3.8 
 
25.0±3.0:25.1±3.1 
 
NS 
 
NR 
      
Cheung (2009) 
Australia [98] 
RT 
 
 
 
 
C 
Pre:Post 
∆ 
 
 
 
 
 
 
 
 
Group effect 
 39.7±9.0:NR 
-0.2±1.2 ∆ 
 
 
 
37.7±9.2:NR 
+0.3±1.0 ∆ 
 
 
 
p = 0.22 
126.1±19.2:NR 
-3.3±6.7 ∆ 
 
 
 
121.4±20.5:NR 
-0.3±4.4 ∆ 
 
 
 
p = 0.12 
25.3±10.3:NR – Left 
+1.0±5.9 ∆ 
26.4±10.9:NR – Right 
+1.6±4.6 ∆ 
 
25.7±9.8:NR – Left 
-0.5±3.5 ∆ 
26.6±10.7:NR – Right 
+0.2±2.7 ∆ 
 
p = 0.40 – Left 
p = 0.26 - Right 
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Table 2.4 (continued) 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Winnick 
(2008) USA 
[96] 
Whites 
RT 
 
 
AT 
 
 
African 
RT 
 
 
AT 
Pre:Post 
∆ 
 
 
 
 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
 
98.1±20.1:NR 
 
 
99.1±23.6:NR 
 
 
 
109.5±39.5:NR 
 
 
99.5±17.2:NR 
 
 
NR 
 
NR 
 
35.1±5.7:NR 
+2.6% ∆ 
 
36.5±6.6:NR 
-1.18% ∆ 
 
 
33.6±5.9:NR 
-2.6% ∆ 
 
34.2±5.9:NR 
-0.7% ∆ 
 
NR 
 
p < 0.05 RT African v 
Whites 
  DXA  
40.2±12.5:NR 
+1.38% ∆ 
 
38.6±9.3:NR 
-0.22% ∆ 
 
 
38.5±11.4:NR 
-0.85% ∆ 
 
38.3±9.8:NR 
-0.40% ∆ 
 
NR 
 
NS 
  
Baum (2007) 
Germany [90] 
RT 
 
 
Vib 
 
 
Flex 
Pre:Post 
Δ 
 
 
 
 
 
 
 
Time effect 
 
Grp*time 
86.5±14.7:NR 
-1.30±2.36 ∆ 
 
83.3±13.4:NR 
- 0.86±1.77 ∆ 
 
88.6±24.1:NR 
-1.68±4.57 ∆ 
 
NS 
 
NR 
  NR:NR (Nm.kg-1) 
+14% Δ (left leg) 
 
NR:NR 
NR Δ 
 
NR:NR 
NR Δ 
 
NR 
 
NR 
    
Brooks (2007) 
USA [91] 
RT 
 
 
 
 
Con 
 
Pre:Post 
Δ 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
 30.9±6.13:NR 
NR Δ 
 
 
 
31.1±5.57:NR 
NR Δ 
 
 
 
NR 
 
NR 
99.7±12.81:NR 
NR Δ 
 
 
 
100.1±14.48:NR 
NR Δ 
 
 
 
NR 
 
NR 
66±22:90±33^  
+24±11 Δ 
338±150:568±189∨ 
+173±106 ∆ 
 
62±22:58±22^ 
-4±11 Δ 
300±156:285±150∨ 
-19±39 ∆ 
 
NR 
 
p < 0.001 
DXA  35.0±12.25:NR 
NR Δ 
 
 
 
33.7±13.36:NR 
NR Δ 
 
 
 
NR 
 
NR 
44.3±9.5:45.5±10.6 
+1.1±1.67 Δ 
 
 
 
44.9±10.6:44.8±9.5 
+0.4±1.11 Δ 
 
 
 
NR 
 
p = 0.04 
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Table 2.4 (continued) 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Sigal (2007) 
Canada [88] 
RT 
 
AT 
 
CT 
 
Con 
 
Pre:Post 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
99.1±30.4:98.0±30.4 
 
103.5±31.0:100.9±30.2 
 
101.9±30.4:99.3±30.4 
 
101.3±28.6:101.0±27.8 
 
NR 
 
p = 0.008 AT v Con 
34.1±9.6:33.7±9.6 
 
35.6±10.1:34.8±10.1 
 
35.0±9.6:34.2±9.6 
 
35.0±9.5:34.9±8.7 
 
NR 
 
p = 0.009 AT v Con 
110±24:107±24 
 
113±23:110±23 
 
112±24:108±24 
 
112±24:111±24 
 
NR 
 
p = 0.03 AT v Con 
 Bioelectric
al 
impedance 
35.9±9.6:35.0±9.6 
 
37.0±9.3:36.3±9.3 
 
36.0±9.6:35.0±9.6 
 
36.6±8.7:36.9±9.5 
 
NR 
 
NS 
36.5±19.2:35.2±19.2 
 
39.2±19.4:37.6±19.4 
 
37.6±19.2:35.7±19.2 
 
38.0±17.5:38.2±17.5 
 
NR 
 
p = 0.44 AT v Con 
62.3±13.6:62.5±13.6 
 
64.0±13.9:63.0±13.9 
 
63.9±13.6:63.2±13.6 
 
63.0±12.7:62.5±12.7 
 
NR 
 
NS 
Castaneda 
(2006) 
Germany [105] 
RT 
 
 
Con 
 
Pre:Post 
 
 
 
 
 
Time effect 
 
Group*time 
 32.1±6.8:NR 
NR Δ 
 
33.4±6.3:NR 
NR Δ 
 
NR 
 
NR 
 NR:NR 
+43±29% Δ* 
 
NR:NR 
+19±31% Δ* 
 
NR 
 
p = 0.01 
    
Dunstan (2006) 
Australia [94] 
Cent 
 
 
 
 
Home 
 
Pre:Post 
Δ 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
92.6±17.1:NR 
-2.1±3.4 ∆ 
 
 
 
91.2±13.6:NR 
-2.2±3.2 ∆ 
 
 
 
p < 0.05 both grps 
 
NS 
32.8±4.8:NR 
NR Δ 
 
 
 
32.4±4.4:NR 
NR Δ 
 
 
 
NR 
 
NR 
105.6±11.7:NR 
-1.3±5.3 ∆ 
 
 
 
107.4±10.8:NR 
-2.0±5.9 ∆ 
 
 
 
NS 
 
NS 
78.8±43.9:NR^  
-3.4±17.8 Δ 
29.9±10.1:NR∨ 
-7.2±10.5 ∆ 
 
78.3±49.1:NR^ 
-3.7±19.6 
30.3±12.0:NR∨ 
-0.3±6.3 ∆ 
 
p < 0.05 RT∨ 
 
p < 0.05 ∨ 
Bioelectric
al 
impedance 
 37.6±12.3:NR 
-0.8±3.2 ∆ 
 
 
 
35.8±10.0:NR 
-1.0±3.2 ∆ 
 
 
 
NS 
 
NS 
55.0±9.8:NR 
-1.3±1.6 ∆ 
 
 
 
55.4±10.5:NR 
-0.9±2.2 ∆ 
 
 
 
p < 0.05 both grps 
 
NS 
Gordon (2006) 
USA [95] 
RT 
 
Con 
 
Pre:Post 
 
 
 
Time effect 
 
Group*time 
80±19:NR 
 
88±15:NR 
 
NR 
 
NR 
30.7±6.2:31.3±6.2 
 
33.5±6.2:33.4±5.8 
 
NR 
 
p = 0.05 
100±13.4:101±10.8 
 
108±11.2:109±12.4 
 
NR 
 
p = 0.43 
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Table 2.4 (continued) 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Cauza (2005) 
Austria [92] 
 
RT 
 
 
 
 
AT 
 
Pre:Post 
Δ 
 
 
 
 
 
 
 
 
Time effect 
 
Group*time 
91.3±13.6:90.2±13.1 
-1.1% Δ 
 
 
 
96.7±18.6:95.4±18.6 
-1.1% Δ 
 
 
 
NS 
 
NR 
31.3±4.2:30.9±4.2 
-1.1% Δ 
 
 
 
33.9±5.4:33.5±5.4 
-1.1% Δ 
 
 
 
NS 
 
NR 
 54.6±16.0:68.6±18.8^  
+26% Δ 
114±36.6:168±45.5∨ 
+48% ∆ 
 
43.9±15.7:45.0±16.1^ 
+2.5% Δ 
93±35.9:107±42.1∨ 
+15% ∆ 
 
p < 0.001 RT^∨; ET∨ 
 
NR 
10 site 
skinfolds 
44.5±3.8:40.5±5.2 
-9.1% Δ 
 
 
 
46.3±3.3:44.5±3.3 
-3.4% Δ 
 
 
 
p < 0.001 both grps 
 
NR 
39.6±6.6:35.8±8.0 
-9.7% Δ 
 
 
 
44.8±9.5:42.5±8.7 
-5.3% Δ 
 
 
 
p < 0.001 both grps 
 
NR 
49.4±8.4:52.6±8.0 
+6.5% Δ 
 
 
 
51.9±10.3:52.9±11.1 
+2% Δ 
 
 
 
p < 0.001 RT 
 
NR 
Cauza (2005) 
Austria [93] 
RT 
 
AT 
 
Pre:Post 
 
 
 
Time effect 
 
Group*time 
 29.9±2.3:29.9±2.8 
 
36.3±12.4:36.3±6.9 
 
NS 
 
p = 0.03 
 47.4±15.0:59.7±18.4^ 
 
31.8±10.6:31.7±10.6^ 
 
p = 0.01 RT; NS AT 
 
NR 
NR  38.9±6.5:33.5±7.9 
 
46.9±10.6:44.4±10.3 
 
p < 0.01 both grps 
 
p = 0.04 
46.3±7.4:51.9±9.1 
 
56±10.3:58.2±11.1 
 
p < 0.01RT; = 0.03AT 
 
NR 
Dunstan (2005) 
Australia [89] 
RT  
 
 
 
Con 
 
Pre:Post 
Δ 
 
 
 
 
 
 
Time effect 
 
Group*time 
88.7±10.9:NR 
unspecified increase 
 
 
89.5±12.1:NR 
unspecified increase 
 
 
p < 0.05 RT 
 
NR 
 NR:NR 
-3.4±4.7 ∆ 
 
 
NR:NR 
-2.0±4.3 ∆ 
 
 
p < 0.05 RT 
 
NS 
NR:NR 
+26.4±22.8^ Δ 
+4.9±6.4∨ ∆ 
 
NR:NR 
-0.2±19.1^ Δ 
-0.1±5.4∨ ∆ 
 
p < 0.05 RT^∨ 
 
p < 0.05^∨ 
DXA  33.1±7.4:NR 
NR Δ 
 
 
35.6±6.8:NR 
NR Δ 
 
 
p < 0.01 both grps 
 
NR 
51.8±8.1:NR 
NR Δ 
 
 
49.7±9.5:NR 
NR Δ 
 
 
NS 
 
p < 0.08 
Baldi (2003) 
New Zealand 
[79] 
RT 
 
 
 
Con 
Pre:Post 
Δ 
 
 
 
 
 
Time effect 
 
Group*time 
112.3±12.0:114.0±12.3 
 
 
 
110.3±21.9:110.9±22.2 
 
 
p < 0.05 RT, NS Con 
 
NR 
34.3±9.6:NR 
 
 
 
36.4±9.3:NR 
 
 
NR 
 
NR 
 NR/NR:NR/NR(ext/flx) 
+32.0/+3.2%^ Δ 
+18.1%/+37.0%∨ ∆ 
 
NR/NR:NR/NR 
NR/NR Δ 
 
p < 0.05 RT^∨ 
 
NR 
Hydrostati
c weighing 
32.4±3.3:NR 
 
 
 
30.7±6.6:NR 
 
 
NR 
 
NR 
38.1±10.5:37.0±10.5 
 
 
 
37.7±17.1:40.3±18.9 
 
 
p < 0.05 Con 
 
NR 
74.3±3.6:76.9±3.3 
 
 
 
72.6±9.6:70.6±9.0 
 
 
p < 0.05 RT; NS Con 
 
NR 
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Table 2.4 (continued) 
Author(year) 
Country 
Group Type of 
change 
Mass (kg) BMI (kg.m-2) Waist Circumference 
(cm) 
Muscle Strength (kg) 
unless specified 
% fat 
method 
% fat Fat Mass (kg) 
Unless specified 
LBM (kg) 
Castaneda 
(2002) 
USA [81] 
PRT  
 
 
Con 
 
Pre:Post 
Δ 
 
 
 
 
Time effect 
 
Group*time 
79.3±17.8:79.5±18.4 
 
 
78.6±17.3:79.4±16.2 
 
 
NR 
 
p = 0.89 
 99.7±12.8:97.5±12.8 
 
 
100±14.5:102±12.3 
 
 
NR 
 
p = 0.07  
389±167:518±267* 
+33±7% Δ 
 
351±173:299±167* 
-15±3% Δ 
 
NR 
 
p = 0.0001 
DXA  35.0±12.3:34.0±12.8 
 
 
33.7±13.4:34.6±12.3 
 
 
NR 
 
p = 0.26 
44.3±9.5:45.5±10.6 
 
 
44.9±10.6:44.8±9.5 
 
 
NR 
 
p = 0.04  
Dunstan (1998) 
Australia [80] 
CRT 
 
 
 
Con 
 
Pre:Post 
∆ 
 
 
 
 
 
Time effect 
 
Group*time 
83.6±14.3:83.2±14.3 
 
 
 
82.7±12.8:83.7±13.2 
 
 
NR 
 
p < 0.05  
28.3±3.1:28.1±3.1 
 
 
 
30.1±3.8:30.4±3.8 
 
 
NR 
 
p < 0.05  
 NR:NR 
+15±6%^ Δ 
+43±12%∨ ∆ 
 
NR:NR 
NR^∨ Δ 
 
p < 0.05^∨ 
 
NR 
7 site 
skinfolds 
NR NR NR 
RT = resistance training; Flex = flexibility training; Vib = vibration training; Con = control; Cent = centre based training; T2DM = type 2 diabetes mellitus; AT = aerobic training; YC = young healthy controls; OC = 
age matched controls; grps = groups; NS = not significant; PRT = progressive resistance training; CRT = circuit resistance training; ^ = upper body; ∨ = lower body; * = whole-body; ext = extension; flx = flexion; CT 
= combined aerobic & resistance training; NR = not reported 
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2.4.8. Cardiac Risk Factors 
2.4.8.1. Lipid Profile 
Blood lipids were reported in 14 studies with general improvements in total cholesterol, 
high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides 
reported after resistance training (p < 0.001; p < 0.01; p < 0.05) [92, 97, 100, 111, 115].  
 
2.4.8.2. Blood Pressure 
Blood pressure was measured in 16 studies. Three studies reported positive changes in 
systolic blood pressure associated with all forms of training [81, 90, 92, 97, 100, 103, 
114]. Improvements to diastolic blood pressure were less frequently observed, but still 
occurred over time with resistance training, aerobic training and combined exercise [92, 
100, 114]. 
 
2.5. Discussion 
Individuals with T2D are able to complete resistance training with minimal risk of 
negative health outcomes or injury, while improving overall glycaemic control, insulin 
sensitivity and muscular strength. Overall, based on reporting the criteria outlined within 
the CONSORT statement [122], the quality of the study design was good with 21 papers 
reporting on 18 RCTs, of which 10 were published between 2005 and 2008 and eight 
were published between 2009 and 2011. The major findings from these studies are that 
completing resistance training, and aerobic training over extended durations will result in 
similar improvements to glycaemic control [88, 93, 97, 101, 103]. However, resistance 
training could potentially provide greater benefits in terms of glycaemic control than 
aerobic training with researchers and practitioners intimating that resistance training, 
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comprising short bouts with intermittent rest periods, provides an attractive alternative to 
aerobic training [77, 123, 124]. Further investigation into the ability to complete each 
exercise mode is required though as data reported from exercise interventions indicates 
little difference in adherence to the different exercise modes [88]. Whether this is the 
same in real life clinical scenario’s is currently unknown. To further improve the quality 
of studies and knowledge in this area and to enable comprehensive comparison between 
studies in the future, consideration needs to be given to quantifiable and replicable 
exercise prescriptions, specifying how missing data is treated and determining sample 
sizes by power calculations.  
 
A clinically relevant lowering of HbA1c, a key marker of improved long term glycaemic 
control, was reported in a number of resistance training studies whilst those reporting no 
effect were intervention studies with durations of 12 weeks or less. These changes appear 
to be of a similar or greater magnitude to aerobic training [88, 92, 93, 97, 101, 103], 
however the effect of combining resistance with aerobic training remains unclear with 
only three studies [88, 99, 100] making a direct comparison between combined training 
and isolated resistance or aerobic training interventions.  
 
Interestingly, insulin sensitivity was only evaluated using the euglycaemic-
hyperinsulinaemic clamp in non-RCTs [86, 107]. Both of these studies reported increased 
insulin sensitivity following resistance training, despite the time that the measure was 
performed varying from 16 to 48 hours following the final exercise session and the 
intensity and frequency of the training varying markedly. Other, less precise measures of 
insulin sensitivity, generally indicated improvements at times ranging from 24 to 72-96 
hours [90, 115] following the final resistance training session of a long-term training 
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program. However, the effect of a single session of resistance training on insulin 
sensitivity in previously untrained subjects has not been investigated beyond 12-24 hours 
after the session [62, 63]. This raises questions about the training frequency that should 
be prescribed, which appears to be currently based on improvements to HbA1c. Eleven 
RCTs included in this systematic review [79, 80, 89-92, 94-96, 100-102] present HbA1c 
and insulin sensitivity data, with only one [79] indicating that insulin sensitivity did not 
improve when HbA1c improved. Furthermore, two studies [80, 90] indicated that insulin 
sensitivity improved but was not reflected in HbA1c, which did not change. Additionally, 
insulin sensitivity improved after 12 months of gym-based maintenance despite 
glycaemic control becoming worse [94]. Therefore, further investigations as to whether 
resistance training should be prescribed based on insulin sensitivity should be 
undertaken. If resistance training should be prescribed based on insulin sensitivity, it may 
need to be prescribed every day in this population, at least initially, as the length of time 
insulin sensitivity remains improved following a single resistance training session has not 
been adequately evaluated. After 12-16 weeks of training, improved insulin sensitivity 
appears to be maintained for four to five days [90, 91, 95], therefore glucose control may 
potentially be improved or maintained with one or two resistance training sessions each 
week. Both of these possibilities vary considerably from current recommendations of 
two-three days·wk-1 [50-52]. It is possible that resistance training should be performed 
more regularly initially to improve insulin sensitivity and glycaemic control, before it can 
be performed less frequently to maintain the benefits; however this is yet to be 
thoroughly examined.  
 
The training environment and intensity of resistance training also need further 
investigation, as decreased compliance to the training protocol appears to be associated 
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with a decline in insulin sensitivity as demonstrated by the lower adherence level and 
increased insulin resistance reported with home-based training [89, 94]. While high 
adherence to resistance training protocols resulted in significant muscle strength 
improvements, changes in body mass were generally not observed. In contrast, lean body 
mass increased and percentage body fat decreased, confirming that body composition is 
improved with resistance training. Therefore resistance training may provide further 
benefits for individuals with diabetes attempting to lose weight as resistance training may 
counteract the loss of muscle mass typically associated with isolated hypocaloric diets 
[125]. However, changes to body composition are unlikely to account for any changes in 
insulin sensitivity, as this can be increased following a single exercise session [62, 63]. 
Although changes to body composition may not improve insulin sensitivity, individuals 
with diabetes are at an increased risk of cardiac co-morbidities for which improved body 
composition would reduce this risk. Additionally, resistance training has the ability to 
improve muscle quality (defined as a functional measure of strength per unit volume of 
muscle) and change the characteristics of a muscle fibre [91, 126], suggested to result in 
increased glucose transport. Although, limited data from individuals with diabetes 
suggest that muscle mass or body composition changes do not influence insulin 
sensitivity, local contraction-mediated responses from resistance training might [86], 
resulting in increased intracellular signalling [77] leading to increased membrane bound 
GLUT4 transporters and improved insulin sensitivity. Additional mechanisms of 
improved insulin sensitivity with exercise include increasing mithochondrial biogenesis, 
increased microvascular perfusion [127] along with modifying S-nitrosation levels [128]. 
Despite mechanisms for why resistance training improves insulin sensitivity not yet 
being fully elucidated, they are understood to have some common mechanisms to aerobic 
training as well as some unique adaptations attributable to resistance training alone [46, 
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113]. But improved insulin sensitivity from resistance training can be attributed to an 
increase in the amount of GLUT4 transporters that are available to promote glucose 
uptake and also by increasing insulin receptor stubtrate-1 associated PI-3K activity [129]. 
 
Although not reviewed in detail here, resistance training invokes many health benefits for 
individuals with diabetes in addition to improved glycaemic control. These include 
improvements in bone strength, minimisation of sarcopaenic losses or muscle weakness 
associated with aging, improved balance and reduced falls risk [130]. The beneficial 
effects of resistance training on lowering cardiovascular risk (ie. blood pressure and 
blood lipids) have been reviewed elsewhere [74]. Of the studies reviewed here, the 
impact of resistance training on lipid profiles is minimal in individuals who were normal 
or just above normal at baseline, but it is promising that positive blood pressure effects 
have been reported in hypertensive patients with T2D [81, 90, 92, 100, 114]. Decreasing 
body mass by dieting (energy restriction) has detrimental effects on muscle mass while 
aerobic training is only able to maintain the integrity of muscle [131] however, it is 
suggested that resistance training is able to counteract these detrimental effects in a way 
that aerobic training cannot by actually improving the amount and integrity of muscle 
mass [125]. 
 
2.6. Conclusion 
Compelling evidence from both RCTs and non-RCTs is that resistance training is safe for 
individuals with diabetes who are likely to have complex co-morbidities, although it 
needs to be noted that all studies to date have excluded patients with contraindications to 
resistance training [132]. Of the 501 individuals who participated in resistance training 
interventions associated with a RCT, a total of 11 hypoglycaemic events were reported 
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with only one requiring medical attention, 26 individuals required their programs to be 
modified because of musculoskeletal injury and three individuals experienced episodes 
of chest pain. Resistance training is effective in improving glycaemic control and 
increasing insulin sensitivity. Higher intensity and longer intervention duration of 
resistance training appears most beneficial, but this along with training frequency, are 
parameters that require further investigation as some low intensity resistance training 
programs have reported metabolic benefits [101, 102, 107]. It is likely that individualised 
programs, taking into account an individual’s current level of strength, severity of 
diabetes and also co-morbidities will optimise the adaptive response and enhance 
compliance. Determining the minimum effective dose of resistance training, or if 
appropriate in conjunction with aerobic training, would possibly improve ongoing 
compliance, and therefore lead to improved health outcomes. Resistance training has 
been shown to not only be equivalent to AT in ameliorating diabetes and its associated 
complications; it may also be the exercise of choice for individuals with diabetes or pre-
diabetes who find adherence to continuous moderate intensity aerobic training too 
physically challenging.  
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3. An investigation into the accuracy of cytometric bead assay for measuring 
adipose and inflammatory cytokines before and after exercise 
 
3.1. Preface 
The initial challenge was to identify the most accurate method of performing blood 
analysis for the hormones and adipocytokines that were going to be measured throughout 
this series of studies. Enzyme-linked immunosorbent assay (ELISA) has traditionally 
been the most cost effective way to measure large volumes of most of these hormones 
and adipocytokines, however the recent advancement of technology through multiplex 
bead array assays (MBAA), theoretically improved both the time and cost efficiency of 
these measurements. The main advantage of using MBAA as opposed to traditional 
ELISA, is the ability to measure multiple adipocytokines and markers from the one small 
sample of serum or plasma. If the same accuracy can be gleaned from a smaller volume 
of blood with an increased volume of information, then a sound scientific, ethical and 
financial argument can be formed for MBAA being the most efficient and effective 
means of analysing adipoctyokine concentrations. Further, the ability to measure multiple 
outcomes from the single sample has long-term benefits in reducing overall costs of 
buying multiple ELISA kits and also significantly reducing human laboratory analysis 
time, thereby providing substantial financial savings. Therefore, it is important to 
compare the accuracy and agreement between these techniques. 
 
3.2. Introduction 
Pro- and anti-inflammatory cytokines have been implicated in health conditions such as 
obesity and type 2 diabetes [133] along with hypertension and cardiovascular disease 
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[134]. Methods of analysis such as the bead based cytokine assays and MBAA, where 
multiple cytokines can be measured with a very small amount of blood, are more 
frequently being used for the analysis of adipokines, cytokines and hormones. Concerns 
regarding sensitivity and accuracy of bead based cytokine assays have seemingly been 
allayed through findings of high precision and low variability when compared to World 
Health Organisation recognised standards [135]. However, whilst MBBA have also been 
found to correlate strongly with the commonly used enzyme-linked immunosorbent assay 
(ELISA), the accuracy and reliability of the absolute values obtained from MBBA and 
ELISA may differ and be dependent upon the vendor and the exact methods followed 
[136]. 
 
For example, Tarnok and colleagues [137] reported that the evaluation of interleukin-6 
(IL-6), -8 (IL-8) and -10 (IL-10) by cytometric bead array (CBA) using a FACSCalibur 
flow cytometer and ELISA were very strongly correlated and identified similar very high 
concentrations in children who had undergone cardiovascular surgery. Likewise, positive 
correlations have been demonstrated between the data gained from CBA using a 
FACSCalibur flow cytometer and ELISA for tumour necrosis factor-alpha (TNF-α) and 
IL-6 in rodents with inflammatory lung disease [138]. However, while these results were 
positively correlated (r = 0.66 for TNF-α and r = 0.92 for IL-6), the TNF-α 
concentrations measured by CBA were approximately 1.8 fold higher than when 
measured by ELISA, indicating an issue with the accuracy of the method [138]. These 
discrepancies concur with findings by Jiménez et al. [139] who have highlighted poor 
accuracy of CBA, with plasma concentrations of IL-10 and TNF-α approximately 33% 
and 17% greater respectively, when derived by CBA using a FACSCalibur flow 
cytometer compared to ELISA in people with renal transplant rejection, despite the 
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values not being significantly different. The sensitivity of the CBA can be questioned 
from findings of higher concentrations of plasma IL-10 and TNF-α in patients with renal 
transplant rejection, while no concentration of TNF-α was reported in patients without 
renal transplant rejection [139]. 
 
As inflammatory cytokines such as IL-6, TNF-α and leptin appear to be affected by 
exercise [140, 141] and may be used as indicators of the acute and chronic adaptations to 
exercise, it is important to ascertain the validity and reproducibility of the CBA assay in 
the context of measurement of cytokines from blood, following exercise. Aspects of this 
have been undertaken by Timmons et al. [142] who investigated the effect of exercise in 
young healthy men and women on plasma IL-6 and TNF-α by CBA analysis performed 
using a FAC-Scan flow cytometer. Plasma IL-6 was detected in 73% of samples (63% 
pre-exercise and 84% post-exercise) and TNF-α was detected in 57% of samples by 
CBA, while ELISA detected IL-6 in 100% of plasma samples [142], indicating a 
potential problem with assay sensitivity. While there was strong statistical correlation 
between CBA and ELISA derived concentrations of IL-6, Bland-Altman plots revealed 
poor statistical agreement between the methods, with CBA derived concentrations 
typically being less than those derived through ELISA [142]. 
 
With this conflicting evidence in relation to the accuracy and sensitivity of CBA analysis 
using blood samples from a range of different health conditions and populations, the aim 
of this study was to investigate the sensitivity and reliability of CBA to measure cytokine 
concentrations in older individuals with and without type 2 diabetes (T2D). In this 
instance, we chose to compare three cytokines that are considered to play important roles 
in the pathophysiology of diabetes and typically are thought to respond to exercise [33] 
 
 
85 
 
using two analysis methods that are popular and regularly used and reported in the 
published literature. It was hypothesised that cytometric bead assay would be sensitive 
enough to accurately measure adipocytokines. 
 
3.3. Methods 
3.3.1. Subjects and study design 
Ten individuals (six males, four females) with T2D treated with either diet alone or diet 
with oral hypoglycaemic medications and 10 apparently healthy individuals (three males, 
seven females) were recruited to undertake a single session of resistance exercise. 
Participants were interviewed by an accredited exercise physiologist to ensure they were 
inactive (not meeting the current exercise guidelines) and had not participated in 
resistance training for at least six months, and were screened according to criteria from 
the American College of Sports Medicine [143]. Physical activity levels were determined 
through extensive interviewing regarding their current exercise and incidental activity 
habits, asking questions specifically about how much walking, jogging, cycling or any 
other aerobic based leisure activities (such as golf or lawn bowls) they completed on a 
weekly basis. Participants were also questioned about their formal and informal 
resistance training habits (such as lifting heavy objects as part of their employment. 
Additionally, participants completed the short-form version of the International Physical 
Activity Questionnaire (IPAQ) [144].  
 
Inclusion criteria for this study were: aged 40-69 years and were taking a stable dose of 
medications (if they were taking medications). Participants were excluded if they had: 
recent coronary event or established heart disease, uncontrolled hypertension (> 150/90 
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mmHg), neuropathy, orthopaedic disorder preventing them from completing resistance 
exercise, any medical condition that contraindicated resistance exercise, and being unable 
to understand English or follow instructions. Participants’ mean ± SD age was 56.7 ± 8.2 
years, with a mean ± SD height and body mass of 170.3 ± 7.7 cm and 80.7 ± 13.1 kg 
respectively. All participants provided written informed consent prior to any involvement 
and all aspects of the study were conducted in accordance with the Declaration of 
Helsinki and approved by the human research ethics committees of RMIT University and 
Austin Health.  
 
Participants completed one-repetition maximum (1RM) testing on the five exercises to be 
included in the exercise session following a set protocol as reported previously [63], at 
least seven days before completing the resistance exercise intervention. Following a 12-
hour overnight fast, participants travelled to the laboratory via a private vehicle where 
they had a fasting blood sample collected before consuming a standardised breakfast 
meal (toast and juice) and undertaking the resistance exercise session. The single session 
of progressive resistance exercise session consisted of three sets of 10 repetitions at loads 
consistent with 45%, 60% and 75% of their predetermined 1RM for five whole-body 
exercises (bench press, 45° leg press, shoulder press, 45˚ calf raises and lateral pull-
down). Participants attended the laboratory again 24 hours after completing the resistance 
exercise session to provide another fasting blood sample. Participants recorded and 
replicated their evening meals prior to each visit and regular medications were withheld 
only during the fasting period and consumed after the fasting blood test.  
 
Venous blood samples were collected using standard venepuncture techniques into a 
serum separating tube and allowed to clot on ice before being centrifuged at 5000g and 
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4°C for seven minutes, and the serum stored at -80°C for later analysis. Due to technical 
difficulties, the post exercise blood sample was unable to be collected from one 
individual with T2D and one apparently healthy individual was discovered to have 
extreme hyperinsulinaemia during baseline testing, resulting in these two individuals 
being excluded from the analysis. In total, 36 samples were analysed using both 
techniques. 
 
3.3.2. Cytometric bead array analysis 
Interleukin-6, TNF-α, leptin and resistin levels were determined by a commercially 
available FlowCytomix Assay (eBioscience, San Diego, USA) according to the 
manufacturer’s instructions using 25μL of serum. According to the manufacturer’s, the 
sensitivity of the respective assays were 1.2 pg·mL-1, 3.2 pg·mL-1, 0.05 ng·mL-1 and 1.7 
pg·mL-1 for IL-6, TNF-α, leptin and resistin, respectively. After completing the test 
protocol, samples were transferred to FACS tubes and analysed by BD FACSCanto™ II 
flow cytometer (BD Biosciences, San Jose, CA, USA, RMIT Flow Cytometry Facility, 
RMIT Bundoora, Australia). Data recorded from the flow cytometer were then analysed 
using the eBioscience FlowCytomix Pro 2.4 Software (eBioscience, San Diego, USA). 
Concentrations of resistin were able to be determined through the CBA and therefore, 
this analyte was included in the CBA but not analysed by ELISA for comparative 
purposes. Samples were measured in duplicate to determine the coefficient of variation 
(CV). However, CV’s could not be calculated for IL-6 and TNF-α due to the CBA assay 
failing to detect either of these cytokines in the samples. The CV’s for leptin and resistin 
were 11.5% and 3.6% respectively.  
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Additionally, a 5-parameter curve was created from the intensity of known standards 
using GraphPad Prism 5.01 for Windows (GraphPad Software, La Jolla, CA, USA) with 
the concentrations of the unknown samples extrapolated from this to determine if there 
were any differences in concentration derived from the manufacturer’s analysis software 
and an independent company’s graphing computer software. 
 
3.3.3. Enzyme-linked immunosorbent assay 
Commercially available Quantikine ELISA kits were used to measure IL-6, TNF-α (R & 
D Systems, Minneapolis, MN, USA) and leptin (Millipore Corporation, Billerica, MA, 
USA) following the manufacturers protocol. According to the manufacturers, the 
sensitivity of the respective assays were 0.7 pg·mL-1, 1.6 pg·mL-1 and 0.5 ng·mL-1 for IL-
6, TNF-α and leptin respectively. A 5-parameter curve was created from the known 
standards using GraphPad Prism 5.01 for Windows with the concentrations from the 
unknown samples extrapolated. Samples were measured in duplicate and the CV of each 
assay was 3.2%, 2.7% and 2.8% for IL-6, TNF-α and leptin, respectively.  
 
3.3.4. Statistical analysis 
All data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p = 0.05. Leptin concentrations derived through both 
ELISA and CBA were not normally distributed and therefore underwent log 
transformation before being subjected to statistical analysis. No concentrations of IL-6 or 
TNF-α were detected by CBA, meaning that no comparative analyses were able to be 
undertaken for these cytokines, therefore all further statistical analyses relate only to 
leptin concentrations. Two-way repeated measures ANOVA (diabetes status x time) 
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indicated there was no difference in the response to exercise for those with and without 
T2D using either CBA or ELISA (p > 0.05; data not shown), therefore the two 
populations were treated as one group for the remaining analyses. A mixed between-
within repeated measures ANOVA (assay x time) was then completed to assess the 
variation between CBA and ELISA. A Pearson correlation was used to assess the 
statistical correlation between CBA and ELISA derived results. A two-way ANOVA 
(CBA vs ELISA) with a Tukey post-hoc analysis was then undertaken to assess whether 
the two assays produced the same or different values. Statistical agreement between CBA 
and ELISA was assessed using a Bland-Altman plot performed with GraphPad Prism 
5.01 for Windows. Finally, a paired T-test (two-tailed) was conducted to assess the 
differences in leptin concentration generated using the manufacturers software 
(eBioscience) and the independent company’s graphing software (GraphPad). Data are 
presented as mean ± SD or 95% confidence intervals (CI), as specified. 
 
3.4. Results 
Concentrations of IL-6 and TNF-α were detected in 94% and 47% of samples 
respectively by ELISA however, the CBA failed to detect IL-6 or TNF-α in any of the 
samples. Both ELISA and CBA assays detected leptin in 100% of the samples; however 
the two assay methods produced significantly different values (p < 0.001; Table 3.1). 
There was no statistically significant change following exercise compared to the pre 
exercise value for any cytokine with either assay method (p > 0.05).  
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Table 3.1: Comparison of cytokine concentrations as determined by CBA and ELISA 
assays 
 CBA ELISA 
IL-6 (pg·mL-1; N=18)   
All Samples 0 ± 0.0 5.5 ± 2.5* 
TNF-α (pg·mL-1; N=18)   
All Samples 0 ± 0.0 1.4 ± 1.6* 
Leptin (ng·mL-1; N=18)#   
All Samples 46.8 ± 33.0 21.8 ± 18.0* 
All samples are participants both with and without diabetes as there was no significant difference between 
populations. Data are mean ± SD with analysis conducted using two-way ANOVA. *Significant difference 
when compared to CBA determined concentration (p < 0.001). #Leptin concentrations were log 
transformed prior to statistical analysis and have been reported as actual concentrations. CBA = cytometric 
bead array; ELISA = Enzyme-linked immunosorbent assay; IL-6 = Interleukin-6; TNF-α = Tumour 
necrosis factor-alpha 
 
 
There was no significant assay x time interaction (p = 0.96) and the significant difference 
(p < 0.001) in the concentrations of leptin found between assays, both prior to and 
following exercise are illustrated in Figure 3.1, with the CBA producing higher values 
than the ELISA. There was a strong statistical correlation between the CBA and ELISA 
derived leptin concentration (Pearson’s r = 0.93, p < 0.001; Figure 3.2). Overall, the 
statistical agreement between the assays for determining leptin concentrations was poor, 
with the CBA assay overestimating the ELISA determined values by an average of 25.05 
ng·mL-1 (115%; Figure 3.3). There was also a significant degree of heteroscedasity 
present as indicated by the significant negative correlation between the average values 
from both assays and the difference in the values between assays (r = -0.79, p < 0.001; 
Figure 3.3). There was no difference in CBA determined concentrations of leptin when 
analysed by the manufacturer’s software or when generated from the 5-parameter 
standard curve (p = 0.85). 
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Figure 3.1: Comparison of methods for measuring leptin concentration.  
Leptin concentrations measured by ELISA (open bars) and CBA (solid bars) assays in older sedentary 
humans with and without type 2 diabetes prior to and 24 hours following resistance exercise (RE). Values 
are mean ± SD. *Significant difference between assays, p < 0.001 
 
 
Figure 3.2: Pearson correlation of leptin concentrations measured by ELISA and CBA assays.  
Thirty-six pairs of data available for comparison.  
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Figure 3.3: Bland-Altman limits of agreement of leptin concentrations measured by ELISA and CBA 
assays.  
Bias = -25.05 ng·mL-1 (95% CI: -63.28 to 13.18). Thirty-six pairs of data available for comparison. 
 
3.5. Discussion 
This study compared the ability of a commercially available CBA assay with a 
commercially available ELISA assay to determine concentrations of IL-6, TNF-α and 
leptin in older individuals with and without T2D within a single laboratory. With the 
increasing amount of research being conducted on adipose derived cytokine markers of 
inflammation, particularly in conditions of obesity and T2D, it is important to confirm 
the accuracy and reliability of an increasingly popular method that allows simultaneous 
detection of multiple cytokines in a single, small sample of serum against another 
commonly used method that analyses only a single cytokine. We chose to compare the 
statistical relationship and agreement for IL-6, TNF-α and leptin that have been shown to 
be implicated in obesity and T2D and also respond to exercise. 
 
Although there was good reliability of the CBA for leptin with an intra-assay CV of 
11.5%, concentrations of IL-6 or TNF-α were not detected. This is despite IL-6 being 
detected in 94% of samples and TNF-α being detected in 47% of samples with ELISA 
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assays. This suggests that when following the manufacturer’s specifications, the CBA is 
not sensitive enough to measure IL-6 or TNF-α in these older individuals either with or 
without type 2 diabetes. Importantly, this does not seem to be a problem with the curve 
fitting software, as two different software packages resulted in the same concentration of 
leptin calculated from the CBA data.  
 
While leptin was detected in all samples using both CBA and ELISA assays, the 
statistical agreement between the assays was poor; despite a strong correlation. This 
concurs with results reported by Timmons and colleagues [142] in young healthy 
individuals, and along with data from Young and colleagues [138], continues to suggest 
that CBA derived concentrations of cytokines over-estimate the actual concentration 
when compared to the commonly used method of ELISA.  
 
While IL-6 or TNF-α was not detected by CBA in this study, others have also reported 
difficulties detecting these cytokines, with concentrations detected in 73% and 48% of 
samples, respectively by CBA [142]. The findings from this study in a population of 
older adults with and without a chronic medical condition are in contrast to results 
reported by Jiménez and colleagues [139] who found that IL-5 was detected by CBA but 
not by ELISA. This particular study though was conducted in patients who had 
undergone kidney transplantation with some suffering from renal rejection. These 
contrasting findings highlight the inflammatory nature of acute medical conditions along 
with the reduced sensitivity of the CBA assay when trying to determine concentrations of 
multiple cytokines from the one sample. Therefore, despite the attractiveness of the CBA 
from both a time and cost perspective to measure multiple cytokines, unless participants 
are acutely unwell, it is unlikely that CBA derived concentrations will be able to fully 
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reflect the level of these cytokines. This may be due to a sensitivity issue with the beads 
being unable to ‘capture’ the desired cytokine, although equally it may be due to the 
ability of the multiplexing device to detect the captured cytokine on the beads. Where 
general flow cytometry (such as the CBA) use a combination of different size 
microsphere’s and colour intensities to identify individual cytokines, Luminex 
technology uses a single size microsphere and a proprietary dying process to identify 
individual cytokines. However, while the Luminex technology may provide slightly more 
accurate values than CBA through advancing the techniques used for flow cytometry, 
issues still remain [145]. 
 
The lack of response of these cytokines to a session of resistance exercise is somewhat 
surprising given that others have reported exercise derived changes [33, 146], however 
there is evidence to suggest that the response to acute resistance exercise is variable 
[147]. The CBA and ELISA are two of the most common techniques reported for 
determining hormone and cytokine concentration in the published literature and based on 
our data, although the CBA may have an application in some circumstances, caution 
needs to be used when comparing data generated through CBA for numerous cytokines 
measured from a small sample of human blood compared to data generated for a single 
cytokine using ELISA. 
 
3.6. Conclusion 
When following the manufacturer’s instructions, the CBA assay conducted in our 
laboratory is not sensitive enough to detect all of the desired cytokines, as the CBA assay 
was unable to detect IL-6 or TNF-α despite these cytokines being detected by ELISA. It 
can also be concluded that when the CBA assay does detect cytokines, its accuracy is 
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questionable as it was found that leptin was over-estimated by 115% when compared to 
ELISA, thereby rejecting the hypothesis. While this investigation found the accuracy and 
sensitivity of the low-cost, time effective CBA assay to be questionable, further research 
and development is justified because of its strong correlation with ELISA for leptin. 
Further research using laboratory validated standards is also justified to confirm these 
results. Additionally, further research could investigate whether modifying the 
manufacturer assay protocol, specifically determining whether the volume of sample 
used can modulate results. Until these results are confirmed, based on these data, it is 
advisable that caution is used when comparing cytokine concentrations derived through 
CBA and ELISA methods and that researchers conduct their own internal testing to 
determine the most accurate methods for their laboratories. 
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4. An investigation of the reproducibility of multiple repeated oral glucose 
tolerance tests 
4.1. Preface 
Following the determination that blood samples analysed through cytometric bead array 
do not detect the same concentration of hormones and adipocytokines as an ELISA 
(Chapter 3), analysis was conducted using ELISA. The next requirement was to 
determine whether oral glucose tolerance tests completed on consecutive days provided a 
consistent estimate of insulin sensitivity to see if it is an appropriate method to use to 
measure change following exercise in people with type 2 diabetes. This chapter is based 
on a peer-reviewed paper published in Diabetes Research and Clinical Practice [148] 
(Appendix A). 
 
4.2. Introduction 
Insulin sensitivity is regularly estimated through the use of an oral glucose tolerance test 
(OGTT) with a number of equations showing good correlation with the gold standard 
method, the euglycaemic-hyperinsulinaemic clamp [149]. However, issues concerning 
glucose load (50 g to 100 g), reproducibility and diurnal variation of the OGTT have 
been reported [24], with reliability questioned [150, 151]. Reproducibility investigations 
have centred on variables around the testing conditions, including glucose load [58], time 
of day [59], and the fasting period prior to testing [57, 59]. And while many studies have 
reported variations in glucose response from multiple or repeated OGTTs [48, 59, 150, 
151], none have looked at the reproducibility of OGTTs repeated on consecutive days. So 
in light of this, it was important to analyse the glucose and insulin responses in 
apparently healthy individuals to determine whether OGTTs are reliable to estimate 
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insulin sensitivity on consecutive days. Therefore, the aim of this study was to investigate 
whether insulin sensitivity was affected by repeated daily OGTTs and it was 
hypothesised that oral glucose tolerance tests repeated on four consecutive days would 
produce similar estimates of insulin sensitivity. 
 
4.3. Methods 
4.3.1. Participants and study design 
Ten inactive, apparently healthy individuals with no diagnosed metabolic conditions took 
part in this trial. Inclusion criteria were: aged 40-69 years, taking no medications 
influencing metabolism, and not having participated in resistance training in the last six 
months or completing regular aerobic exercise. Exclusion criteria included: recent 
coronary event or established heart disease, uncontrolled hypertension (> 150/90 mmHg), 
neuropathy and being unable to understand English or follow instructions. They 
completed the self-report International Physical Activity Questionnaire [144] and were 
instructed not to complete any structured or specific exercise during the study, record all 
food consumed in a food diary and replicate their diet before each OGTT. Participant 
characteristics are presented in Table 4.1.  
 
The study protocol is presented schematically in Figure 4.1 and was approved by the 
RMIT University Human Research Ethics Committee with written informed consent 
obtained prior to participation. Participants arrived at the research facility between 0600 
and 0900 by private vehicle, following a 12-hour overnight fast. Anthropometric 
measurements and a fasting blood sample were collected before participants undertook 
an OGTT to obtain baseline glucose and insulin responses [10]. Participants then 
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returned to the research facility to undergo further OGTTs on the three subsequent 
mornings.  
 
 
Figure 4.1: Study protocol 
Waist = waist circumference; Hip = hip circumference; BP = blood pressure; Lipids = cholesterol profile; 
IPAQ = international physical activity questionnaire; OGTT = oral glucose tolerance test 
 
4.3.2. Blood sampling and analysis 
A cannula was inserted into an antecubital vein with blood samples obtained before 
consuming 75 g of glucose in 300 ml of water (Gluco Scan, BIOCORP Aust Pty. Ltd.). 
Further blood samples were collected at 30, 60, 90 and 120 minutes after consuming the 
glucose, with patency maintained by flushing with saline, and the first 2 ml of blood 
collected being discarded.  
 
Lipid profiles and glycaemic control (HbA1c) were measured in a commercial 
laboratory. Glucose and insulin were measured using the YSI 2300 Stat Plus analyser 
(Yellow Springs, USA) and Millipore human insulin ELISA kits respectively. Area under 
the curve (AUC) was calculated by a computer-based trapezoidal model and insulin 
sensitivity estimated by the oral glucose insulin sensitivity (OGIS) index [152] and the 
Stumvoll insulin sensitivity index [153].  
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Table 4.1: Participant demographics  
Outcome Measure (units) Mean ± SD 
Male / Female  3 / 7 
Age (years)  54.6 ± 6.5 
Body mass (kg)  93.4 ± 16.4 
Height (cm)  167.7 ± 6.8 
BMI (kg·m-2)  33.3 ± 6.3 
Waist Circumference (cm) 98.8 ± 12.6 
Waist:Hip  0.88 ± 0.08 
SBP (mmHg)  126 ± 14 
DBP (mmHg)  83 ± 10 
Cholesterol (mmol·L-1)  4.9 ± 1.2 
LDL-C (mmol·L-1)  2.8 ± 1.0 
HDL-C (mmol·L-1)  1.42  ± 0.24 
Triglycerides (mmol·L-1)  1.6 ± 0.5 
HbA1c (%)  5.5 ± 0.3 
Glucose (mmol·L-1)  5.3 ± 0.3 
Insulin (pmol·L-1)  130.1 ± 82.1 
Activity (MET-min·wk-1)  1428 ± 1365 
Sedentary Time (min)  435 ± 207 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; LDL-C = low-
density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol; HbA1c = glycated 
haemoglobin; MET = metabolic equivalents 
 
4.3.3. Statistical analysis 
All data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p = 0.05 and a Bonferroni correction made for 
multiple analyses. A repeated measures analysis of variance (ANOVA) was completed to 
determine change over time of the overall outcomes and to determine the reliability of 
the change scores from each independent time-point for each repeated measure. Change 
was calculated by subtracting the follow-up score from the initial score and to provide an 
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indication of repeatability, coefficient of variation was calculated for each individual by 
dividing the standard deviation of their results from their four tests by their mean result. 
Data are presented as means (95% confidence intervals (CI)) unless otherwise indicated. 
Approximately 4% of glucose and insulin data points were missing (due to occlusions 
within the cannula) and were substituted by bringing the last known value for that time 
point forward to ensure AUC was calculated from five time-points [154].  
 
4.4. Results 
We failed to detect any statistically significant change in glucose or insulin response or 
insulin sensitivity over the 4-days of repeated, daily OGTTs (Table 4.2; p = 0.20). There 
were also no significant differences in the change scores for glucose AUC (p = 0.37), 
insulin AUC (p = 0.22), OGIS (p = 0.41) or Stumvoll ISI (p = 0.12; Table 4.3). 
 
At baseline, two participants were considered to have extreme hyperinsulinaemia (insulin 
≥ 200 pmol·L-1). One individual with extreme hyperinsulinaemia was classified as having 
impaired glucose tolerance (2-hour glucose ≥ 7.8 mmol·L-1) using the World Health 
Organisation criteria [10] at baseline, 24-hour and 48-hour testing, before reverting to a 
classification of normal glucose tolerance at the final test. At baseline, all other 
individuals were considered to have normal glucose tolerance however, impaired glucose 
tolerance classifications were present for one individual at the second OGTT (2-hour 
glucose = 8.7 mmol·L-1) and a different individual at the final OGTT (2-hour glucose = 
8.0 mmol·L-1).  
 
The glucose, insulin and insulin sensitivity responses are presented in Figure 4.2 and 
clearly show that as a group, the response is similar from test to test. However, the 
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individuals with hyperinsulinaemia clearly responded differently and have marked 
variation in their response. When only those with normal fasting insulin levels at baseline 
were considered (N = 8), the change scores were generally smaller and were still similar 
for glucose AUC (p = 0.17), insulin AUC (p = 0.41), OGIS (p = 0.15) and the Stumvoll 
ISI (p = 0.34). Effect sizes (partial eta squared) of these changes were large [56], with 
values of 0.608, 0.410, 0.625 and 0.461 respectively. Excluding the individuals with 
extreme hyperinsulinaemia, the mean (range) coefficient of variation for individuals from 
day to day was 6.3% (1.1% - 13.4%), 20.6% (6.8% - 48.0%), 7.8% (4.2% - 14.2%) and 
14.4% (0.3% - 43.3%) for glucose AUC, insulin AUC, OGIS and Stumvoll ISI 
respectively.  
 
The clinically relevant change (calculated by the change from the first test to the second 
± the 95% CI) in the response to an OGTT in apparently healthy individuals for glucose 
and insulin response along with insulin sensitivity is presented in Table 4.3. From a 
practical perspective, if these confidence intervals were converted into unit values, they 
would infer that glucose AUC increases of greater than 63.5 mmol·L-1·120min-1 and 
decreases of greater than 80.9 mmol·L-1·120min-1 exceed the combined daily 
measurement and biological variation and can therefore be viewed with confidence as 
indicating real unfavourable and favourable changes respectively. The same can be 
applied to insulin AUC increases of greater than 7,061 pmol·L-1·120min-1 and decreases 
of greater than 7,237 pmol·L-1·120min-1 indicating real unfavourable and favourable 
changes respectively with real unfavourable and favourable changes for OGIS 
respectively being a decrease of greater than 1.2 ml·min-1·m-2 and an increase of greater 
than 52.7 ml·min-1·m-2. The real unfavourable and favourable changes for Stumvoll ISI 
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are a decrease of greater than 0.008 index units and an increase of greater than 0.010 
index units respectively. 
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Table 4.2: Glucose, insulin and insulin sensitivity response to consecutive OGTTs. Mean (95% confidence interval). 
Outcome Baseline (0 hours) 24 hours 48 hours 72 hours 
N = 10     
2-hr Glucose 
(mmol·L-1) 
6.2 (5.1 – 7.3) 5.8 (4.4 – 7.2) 5.9 (4.7 – 7.1) 5.9 (4.8 – 7.1) 
Glucose AUC 
(mmol·L-1·120min-1) 
855.7 (741.3 – 970.2) 839.6 (690.1 – 988.6) 882.7 (706.3 – 1059.1) 866.2 (674.6 – 1057.7) 
2-hr Insulin 
(pmol.L-1) 
743.1 (214.0 – 1272.2) 676.1 (150.7 – 1201.5) 729.5 (213.2 – 1245.9) 595.6 (184.1 – 1007.1) 
Insulin AUC 
(pmol·L-1·120min-1) 
91851 (43944 – 139759) 142206 (18470 – 265941) 122431 (40811 – 204051) 104306 (54934 - 153677) 
OGIS 
(ml·min-1·m-2) 
333.6 (282.2 – 385.0) 351.8 (275.2 – 428.4) 373.0 (309.7 – 436.3) 372.9 (299.7 – 446.1) 
Stumvoll ISI 
(arbitrary units) 
0.047 (0.003 – 0.091) 0.051 (0.007 – 0.095) 0.046 (0.002 – 0.089) 0.056 (0.020 – 0.092) 
N = 8     
2-hr Glucose 
(mmol·L-1) 
5.8 (4.9 – 6.7) 5.8 (4.3 – 7.3) 5.8 (4.7 – 6.8) 5.9 (4.6 – 7.3) 
Glucose AUC 
(mmol·L-1·120min-1) 
835.0 (720.3 – 949.8) 826.3 (675.5 – 977.1) 873.7 (703.5 – 1043.9) 870.0 (653.8 – 1086.2) 
2-hr Insulin 
(pmol·L-1) 
531.7 (71.4 – 992.0) 516.4 (96.1 – 936.7) 586.2 (119.4 – 1052.9) 486.6 (134.7 – 838.5) 
Insulin AUC 
(pmol·L-1·120min-1) 
62672 (40630 – 84714) 62584 (38235 -86933) 77443 (40909 – 113976) 85505 (34296 – 136713) 
OGIS 
(ml·min-1·m-2) 
354.0 (301.3 – 406.7) 379.8 (318.8 – 440.7) 363.8 (282.1 – 445.4) 377.5 (300.9 – 454.1) 
Stumvoll ISI 
(arbitrary units) 
0.067 (0.028 – 0.106) 0.068 (0.027 – 0.108) 0.061 (0.018 – 0.104) 0.069 (0.035 – 0.104) 
AUC = area under the curve, OGIS = oral glucose insulin sensitivity index, ISI = insulin sensitivity index. 
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Table 4.3: The observed change (variation) for each repeated measure for glucose and insulin AUC, OGIS and Stumvoll ISI. Mean (95% CI). 
Outcome Change 1 Change 2 Change 3 Change 4 Change 5 Change 6 
N = 10       
Glucose AUC 
(mmol·L-1·120min-1) 
-16.1 (-77.6 – 45.4) 27.0 (-56.5 – 110.4) 10.4 (-94.2 – 115.0) 43.1 (-1.4 – 87.5) 26.5 (-57.3 – 110.4) -16.6 (-75.1 – 42.0) 
Insulin AUC 
(pmol·L-1·120min-1) 
50354.3 (-32581.7 – 
133290.3) 
30579.4 (-7999.9 – 
69158.7) 
12454.3 (-18172.3 – 
43080.9) 
-19774.9 (-99968.1 – 
60418.3) 
-37900.0 (-139828.4 – 
64028.4) 
-18125.1 (-70054.3 – 
33804.1) 
OGIS 
(ml·min-1·m-2) 
18.2 (-22.8 – 59.2) 39.4 (-16.4 – 95.2) 39.3 (-7.7 – 86.3) 21.2 (-51.2 – 93.6) 21.1 (-19.4 – 61.6) -0.1 (-52.1 – 51.9) 
Stumvoll ISI 
(arbitrary units) 
0.004 (-0.008 – 0.016) 
-0.001 (-0.013 – 
0.011) 
0.009 (-0.004 – 0.022) 
-0.006 (-0.012 – 
0.001) 
0.005 (-0.006 – 0.016) 0.010 (0.001 – 0.020) 
N = 8       
Glucose AUC 
(mmol·L-1·120min-1) 
-8.7 (-80.9 – 63.5) 38.7 (-44.4 – 121.7) 35.0 (-87.3 – 157.3) 47.4 (0.4 – 94.4) 43.7 (-61.7 – 149.1) -3.7 (-72.0 – 64.7) 
Insulin AUC 
(pmol·L-1·120min-1) 
-88.1 (-7237.1 – 
7060.9) 
14770.6 (-3586.9 – 
33128.1) 
22832.9 (-11855.2 – 
57520.9) 
14858.8 (-1571.5 – 
31289.0) 
22921.0 (-12737.0 – 
58579.0) 
8062.3 (-23063.2 – 
39187.7) 
OGIS 
(ml·min-1·m-2) 
25.7 (-1.2 – 52.7) 9.8 (-33.5 – 53.0) 23.5 (-6.6 – 53.6) -16.0 (-43.6 – 11.6) -2.3 (-28.7 – 24.2) 13.8 (-19.1 – 46.6) 
Stumvoll ISI 
(arbitrary units) 
0.001 (-0.008 – 0.010) 
-0.006 (-0.016 – 
0.004) 
0.002 (-0.007 – 0.011) 
-0.007 (-0.014 – 
0.001) 
0.001 (-0.009 – 0.012) 0.008 (-0.002 – 0.019) 
AUC = area under the curve, OGIS = oral glucose insulin sensitivity index, ISI = insulin sensitivity index, Change 1 = 24 hours minus baseline, Change 2 = 48 hours minus 
baseline, Change 3 = 72 hours minus baseline, Change 4 = 48 hours minus 24 hours, Change 5 = 72 hours minus 24 hours, Change 6 = 72 hours minus 48 hours
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Figure 4.2: Glucose, insulin & insulin sensitivity response over four consecutive days. 
Mean (■) and 95% CI for Glucose AUC (A), Insulin AUC (B), OGIS (C) and Stumvoll ISI (D) with 
individual responses of participants (N = 2) with extreme hyperinsulinaemia plotted (●) to show the 
variation. 
 
4.5. Discussion 
The OGTT has previously been reported to have unsatisfactory reproducibility in 
apparently healthy individuals [151] and those with mild diabetes [150] when the tests 
were repeated within two and seven days. This study has shown that the glucose and 
insulin response in apparently healthy individuals without hyperinsulinaemia is quite 
consistent and produced reliable results for insulin sensitivity (OGIS CV = 7.8%, 
Stumvoll ISI CV = 14.4%) from consecutive, repeated OGTTs. However, in those 
individuals who exhibited hyperinsulinaemia, in order to maintain glucose homeostasis, 
the findings suggest that repeated OGTTs may not produce a reliable estimation of 
insulin sensitivity.  
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However, it is difficult to interpret why these results do not concur with those published 
previously who have undertaken repeated OGTTs between two and seven days apart 
[150, 151], as participant demographic data were not reported. In the study by Olefsky 
and Reaven [151], it is reported that the average response to the two tests are quite 
similar, but there appears to be large amounts of intra-individual variability with glucose 
response at two hours varying by greater than 10% in 17 out of 31 cases and 12 of these 
17 varied by greater than 20%. Similarly for insulin response at two hours, 21 out of 31 
cases varied by greater than 20% with 11 of these 21 cases varying by more than 50% 
[151]. This is compared to the range of variation observed in this study for glucose 
response of between 1% and 13% in the eight participants who were not 
hyperinsulinaemic. 
 
The data on the variation in glucose and insulin sensitivity response is an important 
finding and is something that has not been reported previously, especially given that 
numerous studies (including randomised controlled trials) involving resistance training in 
individuals’ with type 2 diabetes that have used the OGTT to estimate insulin sensitivity 
[62, 63, 80, 90, 113]. One of the randomised controlled trials that used the OGTT to 
measure glucose change after an eight week intervention, was the initial resistance 
training randomised controlled trial [80] which was heavily relied upon for the formation 
for the initial resistance training guidelines for individuals with type 2 diabetes [55]. 
While this suggests that the findings from these trials that have used the OGTT in people 
with type 2 diabetes need to be cautiously interpreted, the limitations of this study also 
need to be considered. Although the large effect sizes and small 95% confidence interval 
range supports the clinical relevance of these findings for glucose, insulin and insulin 
sensitivity response, the small sample size, and particularly small for individuals with 
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hyperinsulinaemia, may limit the ability for this finding to be generalised to the diabetic 
population. 
 
4.6. Conclusion 
Through this small study of apparently healthy individuals without hyperinsulinaemia it 
can be suggested that the OGTT appears to be an appropriate method to estimate and 
measure change in insulin sensitivity over time, proving the hypothesis to be correct. 
However, other methods might be more appropriate for individuals with impaired 
glucose metabolism such as individuals with pre-diabetes or T2D. 
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5. An investigation into the insulin sensitivity response to a single resistance 
exercise session in apparently healthy individuals  
5.1. Preface 
Following the conclusion that oral glucose tolerance tests were reliable to measure 
change in insulin sensitivity in apparently healthy individuals with good glucose 
homeostasis (Chapter 4), the oral glucose tolerance test was employed to determine the 
effect of a single session of resistance exercise on insulin sensitivity in apparently healthy 
individuals. This chapter is based on a peer-reviewed paper accepted for publication in 
Journal of Endocrinological Investigation [155] (Appendix A). 
 
5.2. Introduction 
Insulin resistance is a condition where the tissues (specifically skeletal muscle and the 
liver) are less responsive or sensitive to insulin, resulting in decreased glucose uptake. 
This results in increased insulin secretion and abnormally high levels of circulating 
insulin (hyperinsulinaemia) in an attempt to maintain glucose homeostasis [29]. Low 
grade inflammation has been associated with conditions of insulin resistance and obesity 
[35], while both conditions are independent risk factors for the development of 
hypertension and type 2 diabetes (T2D) [9, 36, 156]. This condition is distinct from overt 
T2D, where the pancreas is unable to adequately increase insulin secretion to account for 
the decreased insulin action [29].  
 
Chronic exercise training, in the form of moderate-intensity aerobic type activities, has 
been shown to reduce fasting glucose levels, improve glycated haemoglobin levels 
(HbA1c) and increase insulin sensitivity [75]. More recently, resistance training has been 
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identified as a modality that is also capable of improving glucose levels and insulin 
sensitivity, as well as being associated with other health benefits such as improved body 
composition, blood pressure, lipid profiles and bone strength [132]. In relation to 
metabolic health, it is accepted that higher intensity resistance training is of greater 
benefit than lower intensity training, however the required frequency to maintain or 
continue these improvements remains unclear [70].  
 
In the context of insulin sensitivity and glucose homeostasis, there have been few studies 
that have investigated the acute effects of resistance exercise in healthy individuals [65, 
66, 68] and/or those with T2D [62, 63]. In those studies that have been published, the 
results are equivocal, with increased insulin sensitivity 24 hours after a single session of 
resistance exercise [64], and increased insulin action approximately 36 hours after 
unaccustomed eccentric resistance exercise [67]. However, Howlett and colleagues [66] 
refute these findings, suggesting that a single bout of resistance exercise impairs insulin 
action.  
 
Furthermore, the ongoing effects of a single bout of resistance exercise are unknown, 
with no studies tracking the insulin or glucose response beyond 36 hours following the 
exercise bout. Without such knowledge it is difficult to determine the optimal rest 
interval between acute bouts of resistance exercise and hence, the optimal training 
frequency. This is an important consideration for middle-aged adults who are more 
commonly at risk of developing diabetes and often have the perception of having 
decreased time available to exercise between work and family commitments [157].  
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It was therefore the aim of this study to investigate the insulin sensitivity response using 
oral glucose tolerance tests administered on each of the four days following a single bout 
of moderate-high intensity resistance exercise, to determine the period of time that any 
changes were present. It was also hypothesised that a single session of resistance exercise 
would not modulate insulin sensitivity in apparently healthy individuals 
 
5.3. Methods 
5.3.1. Participants and study design 
Ten inactive (completing less than 20 minutes of aerobic exercise twice weekly), 
apparently healthy males (N = 3) and females (N = 7) with a mean ± SD age of 51.6 ± 
5.8 years with no diagnosed metabolic conditions were enrolled to participate. Ethical 
approval was granted from the RMIT University and Austin Health Human Research 
Ethics Committees, and all participants provided written informed consent. This study 
conformed to the principles of the Declaration of Helsinki. Inclusion criteria were: aged 
40-69 years, taking no medications influencing metabolism, and not having participated 
in resistance training in the last six months. Exclusion criteria included: recent coronary 
event or established heart disease, uncontrolled hypertension (> 150/90 mmHg), 
neuropathy, orthopaedic disorder preventing them from completing resistance training, 
any medical condition that contraindicated resistance training, and being unable to 
understand English or follow instructions.  
 
All participants arrived at the research facility between 0600 and 0900 hours by the use 
of private vehicles, following a 12-hour overnight fast and had height (QuickMedical 
stadiometer to the nearest 0.1 cm), body mass (Tanita, BWB-600, to the nearest 0.1 kg), 
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waist and hip circumference (using a standard non-elastic tape, to the nearest 0.1 cm) 
measured following recognised procedures [143]. They also had a fasting blood sample 
collected before undergoing an oral glucose tolerance test (OGTT) according to World 
Health Organisation protocols to obtain baseline glucose and insulin responses [10]. The 
OGTT was conducted by inserting a cannula into an antecubital vein with blood samples 
obtained before consuming 75 g of glucose mixed in 300 ml of water (Gluco Scan, 
BIOCORP Aust Pty. Ltd.). Further blood samples were collected at 30, 60, 90 and 120 
minutes after consuming the glucose, with patency maintained by flushing with saline 
every 15 minutes. The first 2 ml of blood collected was discarded to ensure there was no 
saline in the sample. The study protocol is presented schematically in Figure 5.1. 
 
 
Figure 5.1: Study protocol 
BMI = body mass index; Waist:Hip = waist to hip circumference ratio; BP = blood pressure; Lipids = 
cholesterol profile; IPAQ = international physical activity questionnaire; OGTT = oral glucose tolerance 
test; DXA = dual x-ray absorptiometry; 1RM = one repetition maximum; reps = repetitions 
 
Participants returned to the research facility three to four days after their initial OGTT 
and underwent dual x-ray absorptiometry (DXA) before being familiarised with the 
resistance exercise equipment. Participants then underwent one repetition maximum 
(1RM) testing on all five exercises to be included in the resistance exercise bout. One 
repetition maximum testing followed a set protocol as reported previously [63]. 
Following a 13-14 day wash-out period, participants returned to the research facility to 
undergo the resistance exercise bout consisting of three sets of 10 repetitions for five 
whole-body exercises (bench press, 45˚ leg press, shoulder press, 45˚ calf raises and 
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lateral pull-down) at 45%, 60% and 75% of 1RM. The resistance training protocol was 
based on protocols used in similar previous research [63, 65]. Participants returned to the 
research facility after a 12-hour overnight fast to complete an OGTT for each of the next 
four days following the exercise session.  
 
Participants completed the self-report International Physical Activity Questionnaire [144] 
prior to beginning the study to assess activity levels. Participants were asked to record all 
food consumed throughout the study period in a food diary (with an example provided) 
and were instructed to replicate their diet before each OGTT. Nutritional analysis was 
conducted by the same researcher on the FoodWorks 2007 (Xyris software (Australia) 
Pty Ltd., xyris.com.au) dietary analysis computer program version 5, service pack 1, to 
compare total energy consumed and the volume (grams) of protein, fat and carbohydrate 
each day. 
 
5.3.2. Blood sampling and analysis 
Baseline fasting blood samples were collected in serum separator tubes and an EDTA 
containing tube. These were sent to a commercial laboratory for analysis of lipid profiles 
(total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein 
cholesterol and triglycerides with coefficients of variation (CVs) of 2%, 9%, 12% & 
3.5% respectively) and glycated haemoglobin (HbA1c: CV = 3%). Additional samples 
were also collected into serum separating tubes and tubes containing fluoride oxalate, and 
allowed to clot on ice before being centrifuged for seven minutes at 5000g and 4˚C. 
Aliquots of serum and plasma were frozen at -80˚C for later analysis of insulin and 
glucose respectively. Fasting, 30, 60, 90 and 120 minute plasma samples were analysed 
for glucose using the YSI 2300 Stat Plus analyser (Yellow Springs, USA) in duplicate 
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with a CV of < 1%. Corresponding serum samples were analysed for insulin using 
Millipore human insulin ELISA kits in duplicate with a CV of 10%. Insulin sensitivity 
was determined using glucose and insulin area under the curve (AUC) calculated by a 
computer-based trapezoidal model using GraphPad Prism 5 for Windows (Version 5.01, 
La Jolla, CA) and calculated using the oral glucose insulin sensitivity (OGIS) index 
[152].  
 
5.3.3. Statistical analysis 
All data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p = 0.05. Change scores for glucose and insulin 
response along with OGIS were calculated by subtracting the follow-up value from the 
baseline value. The mean change scores at each time-point were then compared with the 
predetermined [148] [Chapter 4] clinically meaningful change to determine its relevance. 
A repeated measures analysis of variance (ANOVA) was completed for nutritional 
components to determine change over time. Simple regression models were constructed 
to assess whether body composition variables measured through DXA, contributed to the 
changes experienced for glucose AUC, insulin AUC and OGIS. Data are presented as 
means (95% confidence intervals [CI]) unless otherwise indicated. Approximately 3% of 
data points were missing (due to occlusions within the cannula) and were substituted by 
bringing the last known value for that time-point forward [154] for 30 minute glucose 
and insulin (two and one occasions respectively), 60 minute glucose and insulin (one 
occasion), 90 minute glucose and insulin (three occasions) and 120 minute glucose and 
insulin (one occasion), ensuring that AUC was calculated from five time-points. On one 
occasion, the 60 minute sample of the baseline test was unable to be collected, resulting 
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in the AUC for that individual at that time being calculated on four time-points instead of 
five. Post-hoc power analysis was conducted using G*power 3.1 software. 
 
5.4. Results 
While being categorised as having normal glucose tolerance by the baseline OGTT, one 
individual was identified as having hyperinsulinaemia (130 < insulin < 200 pmol·L-1) at 
baseline, with an additional participant identified as having extreme hyperinsulinaemia 
(insulin ≥ 200 pmol·L-1) at baseline. The individual with hyperinsulinaemia experienced 
a potentially unfavourable reduction (64 ml·min-1·m-2) to insulin sensitivity, according to 
OGIS, 24 hours after exercise before returning to baseline and showing no additional 
change, while the individual with extreme hyperinsulinaemia experienced a beneficial 
increase to insulin sensitivity through OGIS of between 66 ml·min-1·m-2 and 128 ml·min-
1·m-2 at all follow-up time-points. Based on the findings from Chapter 4, these two 
participants (one male and one female) were excluded from the analysis leaving all 
further results presented as N = 8.  
 
The remaining (N = 8) participants characteristics are presented in Table 5.1. Briefly, 
these participants did not meet the criteria for clinical hypertension or 
hypercholesterolaemia and glycaemic control (HbA1c) did not reach the criteria for a 
diagnosis of type 2 diabetes. Included male participants’ had a mean total body fat of 
27.9% with a mean of 21.5 kg of fat mass and 55.7 kg of fat free mass while female 
participants’ had a mean total body fat of 35.4%, a mean fat mass of 25.7 kg and a mean 
fat free mass of 44.7 kg, as determined through DXA. The mean glucose and insulin 
response (area under the curve) to the baseline OGTT and baseline insulin sensitivity 
estimated through OGIS index is presented in Table 5.1. 
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Based on the previously identified clinically important values by measuring the response 
to repeated, consecutive daily OGTTs [148] [Chapter 4], a potentially unfavourable and 
clinically meaningful increase in the insulin response was observed on each of the four 
days following the resistance exercise session (> 7,061 pmol·L-1·120min-1; Figure 5.2). 
The glucose response also increased by to a clinically meaningful degree on the third day 
following exercise (> 63.5 mmol·L-1·120min-1; Figure 5.3), resulting in a potentially 
unfavourable change. In regards to OGIS index, a potentially unfavourable and clinically 
meaningful decrease (> 1.2 ml·min-1·m-2; Figure 5.4) was observed on all four days 
following the resistance exercise session. Simple regression modelling indicated that 
body composition variables did not contribute to the change in glucose AUC (p = 0.905; 
R2 = 0.119), insulin AUC (p = 0.717; R2 = 0.262) and OGIS (p = 0.820; R2 = 0.187). 
 
Analysis of food diaries revealed that baseline mean (95% CI) values for intake of 
energy, protein, fat and carbohydrate were 8228 kJ (7349.5 to 9106.4), 83.2 g (67.6 to 
98.8), 72.0 g (57.5 to 86.5) and 218.7 g (183.9 to 253.4) respectively. Repeated measures 
ANOVA with a Bonferroni adjustment indicated no significant differences (p = 0.56) 
across the intervention days. 
 
5.5. Discussion 
The major finding from this study was insulin sensitivity may be adversely affected for 
up to four days following a single unaccustomed resistance exercise session and that this 
is independent of body composition. This is in contrast to previous findings of improved 
insulin sensitivity following a single bout of resistance exercise in young healthy 
untrained individuals [63, 64], young strength trained individuals [61], and older 
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individuals with T2D [62, 63]. Indeed, our results do concur with those that have shown 
no improvements to insulin sensitivity following an acute bout of resistance exercise [65, 
66, 68]. Although, studies that have reported beneficial changes have generally involved 
individuals with poor glycaemic control, which may highlight the inability to improve 
something that is already functioning adequately [158]. 
 
The findings from this study tend to suggest that a single session of unaccustomed 
resistance exercise may actually result in increased insulin production to maintain 
glucose homeostasis, or being in a previously theorised state of transient insulin 
resistance [159]. It is therefore important to look at mechanisms for why this may occur 
as a previous study of acute aerobic exercise in trained older individuals reported a 
beneficial increase to insulin sensitivity, for three but not five days [160] in comparison 
to the inactive individuals who completed resistance exercise in this study. Therefore it 
may be that the exercise mode is important, since unfamiliar resistance exercise induces 
muscle damage that has been linked to increased concentrations of circulating pro-
inflammatory cytokines such as tumour necrosis factor alpha [159]. Aerobic type 
exercise (consisting of mainly concentric muscle contractions) does not typically induce 
the same amount of muscle damage, nor the same increase in pro-inflammatory cytokines 
[161]. The glycaemic control and mechanisms for maintaining glucose homeostasis 
(hyperglycaemia) appears to also be important with the acute aerobic exercise data [160] 
suggesting that it may be necessary for people who already have good glycaemic control, 
to undertake a period of regular ongoing training to enable the working muscles to 
become responsive to the exercise stimulus and observe beneficial improvements to 
insulin sensitivity that have been shown following regular resistance training [162].  
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Table 5.1: Participant Demographics 
Outcome Measure Mean ± SD 
Male / Female 2 / 6 
Age (years) 51.5 ± 6.3 
Weight (kg) 74.1 ± 11.2 
Height (cm) 170.1 ± 4.5 
BMI (kg·m-2) 25.7 ± 4.2 
Waist:Hip 0.83 ± 0.07 
SBP (mm Hg) 122 ± 13 
DBP (mm Hg) 73 ± 10 
Cholesterol (mmol·L-1) 5.0 ± 1.0 
LDL (mmol·L-1) 2.9 ± 0.4 
HDL (mmol·L-1) 1.54 ± 0.53 
Triglycerides (mmol·L-1) 1.2 ± 1.0 
HbA1c (%) 5.5 ± 0.2 
Glucose (mmol·L-1) 4.9 ± 0.5 
Insulin (pmol·L-1) 73.3 ± 43.1 
Activity (MET-min·wk-1) 968 ± 1053 
Sedentary Time (min) 368 ± 126 
Bench Press 1RM (kg) 35.3 ± 13.1 
Leg Press 1RM (kg) 115.6 ± 27.2 
Shoulder Press 1RM (kg) 24.1 ± 9.2 
Calf Raise 1RM (kg) 225.6 ± 70.7 
Lat Pull-down 1RM (kg) 27.5 ± 10.0 
Glucose AUC (mmol·L-1·120min-1) 762.2 ± 185.9 
Insulin AUC (pmol·L-1·120min-1) 50,634.5 ± 26,128.7 
OGIS index (ml·min-1·m-2) 439.3 ± 82.7 
Data excludes that from the individuals with hyperinsulinaemia. BMI = body mass index; DBP = diastolic 
blood pressure; HbA1c = glycated haemoglobin; HDL-C = high-density lipoprotein cholesterol; LDL-C = 
low-density lipoprotein cholesterol; MET = metabolic equivalents; SBP = systolic blood pressure; AUC = 
area under the curve; OGIS = oral glucose insulin senstivity  
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Figure 5.2: Insulin response to a single session of resistance exercise over four days. 
Change from baseline of insulin response (AUC) following exercise. Mean and 95% CI for eight included 
participants. Broken lines represent the cut-points for a clinically meaningful change. Increase greater than 
7061 pmol·L-1·120min-1 and a decrease greater than 7237 pmol·L-1·120min-1 
 
 
 
Figure 5.3: Glucose response to a single session of resistance exercise over four days. 
Change from baseline of glucose response (AUC) following exercise. Mean and 95% CI for eight included 
participants. Broken lines represent the cut-points for a clinically meaningful change. Increase greater than 
63.5 mmol·L-1·120min-1 and a decrease greater than 80.9 mmol·L-1·120min-1 
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Figure 5.4: Insulin sensitivity response to a single session of resistance exercise over four days. 
Change from baseline of OGIS index following exercise. Mean and 95% CI for eight included participants. 
Broken lines represent the cut-points for a clinically meaningful change. Increase greater than 52.7 ml·min-
1·m-2 and a decrease greater than 1.2 ml·min-1·m-2 
 
 
While two individuals with hyperinsulinaemia were excluded from this analysis of 
healthy individuals, their individual results were noteworthy. The individual with 
extreme hyperinsulinaemia (insulin ≥ 200 pmol·L-1) appeared to experience large 
beneficial increases in insulin sensitivity while the individual with a lower level of 
hyperinsulinaemia (130 < insulin < 200 pmol·L-1) seemed to experience larger 
unfavourable reductions in insulin sensitivity. While individuals with hyperinsulinaemia 
have not specifically been referred to in the literature, it could be reasonably assumed 
that individuals with type 2 diabetes would have some degree of hyperinsulinaemia given 
this is a mechanism to control glucose levels. Therefore, when comparing the results 
from these two individuals and those with type 2 diabetes from the published literature 
[62, 63], it is possible to cautiously suggest that individuals with sub-optimal levels of 
metabolic health may display different responses and responses of greater magnitude 
compared to individuals with normal glucose metabolism. This however, requires further 
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research in this specific population to elucidate why these differences may occur when 
compared to those individuals with insulin levels within the desirable range. 
 
5.6. Conclusion 
While considering the limitations of this study design with a small sample size and the 
absence of a control group to directly compare the results to, it can be concluded that a 
single bout of resistance exercise does not improve insulin sensitivity in apparently 
healthy individuals with good glucose homeostasis and may indeed have a potentially 
short-term adverse effect, proving the hypothesis correct. Post-hoc power analysis 
calculated an effect size of 0.88; and for our sample of eight with an alpha value of 0.05, 
the study appeared appropriately powered at 99%. However, further research is suggested 
to confirm these results. Potential issues have been identified for novice resistance 
training individuals to be aware of in the days immediately following resistance exercise. 
Further investigations into the training duration and frequency required before being able 
to observe known improvements to insulin sensitivity that occur from ongoing resistance 
training [162] are warranted. In addition, investigating the effect of a single session of 
resistance exercise in individuals at risk of, or with T2D is pertinent. These results pose 
further questions relating to the ability of ongoing resistance training to diminish the 
potentially adverse effects of acute resistance exercise and if this is the case, the length of 
time that training needs to occur for this to happen. 
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An investigation into markers of insulin 
sensitivity and inflammation in response 
to a single session of resistance exercise in 
inactive individuals   
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6. An investigation into markers of insulin sensitivity and inflammation in 
response to a single session of resistance exercise in inactive individuals. 
 
6.1. Preface 
Following previous findings that a single session of resistance exercise may have a 
potentially adverse short-term effect on glucose tolerance and insulin sensitivity (Chapter 
5), the question remained as to whether individuals with type 2 diabetes (T2D) respond to 
a single session of resistance exercise in a similar way to people without diabetes. 
Making this investigation more challenging however, was the previous finding that 
repeated oral glucose tolerance tests may not be appropriate to estimate insulin sensitivity 
in people with T2D [Chapter 4]. This chapter is based on a manuscript that has been 
submitted for peer-reviewed publication. 
 
6.2. Introduction 
Type 2 diabetes is a condition of chronic insulin resistance where the pancreas is unable 
to adequately increase insulin secretion to account for the decreased insulin action [29]. It 
has been linked with overweight and obesity, which has also been associated low-grade 
inflammation [35]. With the prevalence of T2D rapidly rising [18, 19], it is vital that 
appropriate treatment and prevention programs are established. Exercise is a key 
component of treating [4] and preventing [163] T2D, however a large proportion of the 
population fail to meet the recommended exercise guidelines [69], due to a perceived 
lack of time [157] along with a fear of falling, physical ailments and inertia specifically 
in older adults [164]. 
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The effect of resistance training on diabetes has become a focus, through findings of 
improved glucose levels and insulin sensitivity [80, 91, 92]. Consequently, guidelines 
now strongly advise the completion of resistance training [51]. Additionally, higher 
intensity resistance training appears to provide greater benefit than lower intensity 
training, however the required frequency to maintain or continue these improvements 
remains unclear [70]. Responses to a single session of resistance exercise in apparently 
healthy individuals have produced equivocal findings, with reports of increased insulin 
sensitivity 24 hours after the session [64], and insulin action ~36 hours after 
unaccustomed eccentric resistance exercise [67], whilst others [66] suggest an 
impairment of insulin action and impaired insulin sensitivity that may last for up to four 
days [155] [Chapter 5]. In people with T2D, insulin sensitivity or glucose tolerance has 
been reported to be improved up to 24 hours following a single resistance exercise 
session [62, 63], but the number of studies is limited and further research is required.  
 
Markers of inflammation in response to exercise have been investigated mainly in 
relation to aerobic type activity. When the response to a single session of resistance 
exercise has been investigated, it has typically been in healthy but not resistance trained 
individuals [147]. Leptin, resistin, tumour necrosis factor-alpha (TNF-α), C-reactive 
protein (CRP) and interleukin (IL)-6 are reported to be pro-inflammatory adipocytokines 
that impair insulin sensitivity while adiponectin and IL-10 are anti-inflammatory and 
enhance insulin sensitivity [165]. Long-term exercise interventions appear to promote 
reductions in inflammation which, unsurprisingly is influenced by the type of exercise 
[166]. However, after a single session of resistance exercise, there appears to be no 
change to TNF-α or CRP, and reductions to IL-6 are only observed in the immediate 
hours following exercise [147]. 
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Therefore the aim of this study was to investigate the insulin sensitivity and 
inflammatory cytokine response over three days following a single session of moderate-
high intensity resistance exercise in middle-aged adults with and without T2D. It was 
hypothesised that a single session of resistance exercise would improve insulin sensitivity 
in people with type 2 diabetes when compared with apparently healthy individuals. 
 
6.3. Methods 
6.3.1. Participants and study design 
Ten inactive (not meeting aerobic physical activity guidelines), apparently healthy males 
(N = 3) and females (N = 7) and 10 inactive individuals with T2D (males N = 6, females 
N = 4) with a mean ± SD age of 56.7 ± 8.2 years, height of 170.3 ± 7.7 cm and body 
mass of 80.7 ± 13.1 kg were enrolled to participate. Ethical approval was granted from 
the Human Research Ethics Committees of RMIT University and Austin Health, and all 
participants provided written informed consent. This study conformed to the principles of 
the Declaration of Helsinki. Inclusion criteria were: aged 40-69 years, had not 
participated in resistance training in the last six months and were taking a stable dose of 
medications (if they were taking medications). Exclusion criteria included: recent 
coronary event or established heart disease, uncontrolled hypertension (> 150/90 mmHg), 
neuropathy, orthopaedic disorder preventing them from completing resistance exercise, 
any medical condition that contraindicated resistance exercise, and being unable to 
understand English or follow instructions. The 10 apparently healthy individuals reported 
in this study are the same 10 participants reported in Chapter 5, with the fasting samples 
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collected for each oral glucose tolerance test used for the analysis and insulin sensitivity 
calculated using homeostasis modelling assessment equations [120]. 
 
Following a 12-hour overnight fast, participants arrived at the research facility between 
0600 and 0900 hours by private vehicle. They underwent dual x-ray absorptiometry 
(DXA) scanning (Lunar® DPX-IQ, GE Healthcare) for assessment of body composition. 
Height (QuickMedical stadiometer, to the nearest 0.1cm), body mass (Tanita, BWB-600, 
to the nearest 0.1kg) and blood pressure (NISSEI, DS-105E, Japan Precision Instruments 
Inc., Japan) were measured, and a fasting blood sample collected. Participants were then 
given a standardised breakfast (toast and juice) and were familiarised with the resistance 
exercise equipment. Participants completed one repetition maximum (1RM) testing on all 
exercises included in the resistance exercise session. One repetition maximum testing 
followed a set protocol as reported previously [63].  
 
Following a minimum of a 7-day wash-out period, participants returned to the research 
facility following a 12-hour overnight fast and had a blood sample collected prior to 
consuming the standardised breakfast.  Participants completed the progressive resistance 
exercise session consisting of three sets of 10 repetitions for five whole-body exercises 
(bench press, 45˚ leg press, shoulder press, 45˚ calf raises and lateral pull-down) at a load 
equal to 45%, 60% and 75% of their 1RM. The resistance exercise protocol was based on 
protocols used in similar previous research [63, 65]. Participants returned to the research 
facility after a 12-hour overnight fast to provide a blood sample on each of the next three 
days following the exercise session. The study protocol is presented schematically in 
Figure 6.1. 
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Figure 6.1: Study protocol. 
DXA = dual x-ray absorptiometry; BMI = body mass index; BP = blood pressure; IPAQ = international 
physical activity questionnaire; reps = repetitions; 1RM = one repetition maximum 
 
Participants completed the self-report International Physical Activity Questionnaire [144] 
prior to beginning the study. Prior to undertaking the resistance exercise session, 
participants were given an accelerometer (Actigraph GT1M, Actigraph, Pensacola, 
Florida) with instructions on how to wear it on the hip for the next three days. These data 
were analysed using ActiLife analysis software (v3.4.0, Actigraph, Pensacola, Florida) 
and enabled the researchers to determine whether participants had undergone any 
changes to activity patterns over the duration of the study, which may have impacted on 
their insulin sensitivity.  Participants were also asked to record all food consumed 
throughout the study period in a food diary (with an example provided) and were 
instructed to replicate their diet before each visit. Nutritional analyses were conducted by 
the same researcher on the FoodWorks 2007 (Xyris software (Australia) Pty Ltd., 
xyris.com.au) dietary analysis computer program version 5, service pack 1, to compare 
total energy consumed and the intake (grams) of protein, fat and carbohydrate each day. 
 
6.3.2. Blood analysis 
Baseline fasting blood samples were collected in serum separator tubes and an EDTA 
containing tube. These were sent to a commercial laboratory for analysis of lipid profiles 
(total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein 
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cholesterol and triglycerides with coefficient of variation’s (CV) of 2%, 9%, 12% & 
3.5% respectively) and glycated haemoglobin (HbA1c; CV = 3%). Additional samples 
were collected into serum separating tubes and tubes containing fluoride oxalate, and 
allowed to clot on ice before being centrifuged for seven minutes at 5000g and 4˚C. 
Aliquots of serum and plasma were frozen at -80˚C for later analysis of glucose, insulin, 
adiponectin, leptin, IL-6 and TNF-α. Plasma samples were analysed for glucose using the 
YSI 2300 Stat Plus analyser (Yellow Springs, USA) in duplicate (CV < 1%). Serum 
samples were analysed for insulin, adiponectin and leptin using defined human ELISA 
kits (Millipore Corporation, Billerica, MA, USA) and IL-6 and TNF-α using Quantikine 
ELISA kits (R & D Systems, Minneapolis, MN, USA) in duplicate (CV = 13.5%; 2.9%; 
2.8%; 3.2% & 2.7% respectively). Insulin sensitivity (%S) and resistance (HOMA2-IR) 
were determined using the updated homeostasis modelling assessment (HOMA2) 
equations [120]. Insulin sensitivity was determined using HOMA2 equations as it is 
suggested that repeating oral glucose tolerance tests on multiple days may not be 
appropriate in people with T2D [148] [Chapter 4]. 
 
6.3.3. Statistical analysis 
All data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p = 0.05. Independent t-tests (two-tailed) were 
conducted to assess the difference between the two groups at baseline. The covariates of 
physical activity and nutritional content were assessed by a mixed between-within 
multivariate analysis of variance (MANOVA). Data for insulin sensitivity were not 
normally distributed and therefore, log transformed prior to statistical analysis. Repeated 
measures (group x time) analysis of variance (ANOVA) were conducted for fasting 
glucose, fasting insulin, insulin sensitivity and insulin resistance to track the response 
 
 
130 
 
over 72 hours following exercise. A modified Bonferonni adjustment using the Holm 
procedure [167] determined alpha values required for statistical significance were 
0.0125, 0.017, 0.025 and 0.05 for glucose, insulin, insulin sensitivity and insulin 
resistance respectively. When differences between groups were detected, two-way 
ANOVA’s were conducted to assess whether differences remained across all four days. 
Repeated measures (group x time) ANOVA were also conducted for adiponectin, leptin, 
IL-6 and TNF-α to assess the response 24 hours following exercise, and modified 
Bonferonni adjustments were applied resulting in alpha values of 0.0125, 0.017, 0.025 
and 0.05 for the above outcomes respectively. Data are presented as means ± standard 
deviation (SD) or means (95% confidence intervals [CI]) unless otherwise indicated. 
Post-hoc power was calculated for the primary outcome measure of insulin sensitivity 
using G*power 3.1 software with the repeated measures, within-between interaction test 
selected, with the within groups calculated as 30.3 units and the mean variance over time 
following the exercise intervention calculated at 2.5 units. This resulted in an effect size 
of 0.29 and for our sample of 20 individuals across two groups with four repetitions, 
using an alpha value of 0.025 and a correlation among the repeated measures of 0.5, 
overall power was calculated to be 77%. 
 
One blood sample was unable to be collected 24 hours after exercise, and on one 
occasion technical difficulties meant no serum was obtained from the 72-hour sample. 
These values were substituted by bringing the last known value for that time-point 
forward [154]. In the instance of the 24-hour post resistance exercise sample not being 
able to be collected, this individual was excluded from the secondary analyses 
investigating the response of inflammatory markers, resulting in the T2D group being N 
= 9 for these analyses. Additionally, IL-6 was not able to be analysed for one apparently 
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healthy individual due to a lack of available serum, resulting in N = 9 for that analysis. 
There was a malfunction in recording the accelerometer data in one individual with T2D, 
therefore activity data were analysed with N = 9 for the individuals with T2D. 
 
6.4. Results 
Individuals’ with T2D had been diagnosed for an average (range) of 7.5 (0.25 – 15.0) 
years.  At baseline the individuals’ with T2D were on average 10 years older (p = 0.003) 
had a body mass that was 12 kg greater (p = 0.04), and had a tendency to have a larger fat 
mass (p = 0.08) than those without diabetes (Table 6.1). Additionally, individuals with 
diabetes had lower amounts of total and low-density lipoprotein cholesterol and impaired 
glycaemic control (HbA1c), fasting glucose and insulin sensitivity (Table 6.1). Nine of 
the 10 individuals with diabetes were treated with oral hypoglycaemic medications with 
six treated with metformin alone, two treated with metformin in combination with a 
glicazide and one treated with metformin and a glitazone. Additionally, individuals with 
diabetes were being treated with statins (N = 9), aspirin (N = 4), anti-hypertensives (N = 
4), proton-pump inhibitors (N = 3), diuretic (N = 1), anti-depressants (N = 1) and anti-
uricaemic agents (N = 1). Six apparently healthy individuals were not using medications 
while the others were taking stable doses of anti-hypertensive (N = 2), statin (N = 1) and 
thyroid (N = 1) medications. None of the apparently healthy individuals were currently 
smoking; however one individual with diabetes was currently smoking, but refrained 
from smoking during the fasting period. 
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Table 6.1: Participant Demographics 
Outcome Measure Apparently Healthy Mean ± SD 
Type 2 Diabetes 
Mean ± SD p value 
Male / Female 3 / 7 6 / 4  
Age (years) 51.6 ± 5.8 61.8 ± 7.2 0.003 
Body Mass (kg) 74.7 ± 10.0 86.8 ± 13.4 0.04 
Height (cm) 170.8 ± 7.9 169.7 ± 7.7 0.75 
BMI (kg·m-2) 25.8 ± 4.5 29.6 ± 3.9 0.06 
Fat Mass (kg) 25.8 ± 9.3 33.5 ± 9.4 0.08 
Fat Free Mass (kg) 46.3 ± 6.6 49.9 ± 6.8 0.25 
Percentage Fat (%) 35.3 ± 8.7 39.7 ± 6.7 0.22 
SBP (mmHg) 120 ± 13 131 ± 20 0.17 
DBP (mmHg) 74 ± 9 74 ± 8 0.88 
Cholesterol (mmol·L-1) 5.1 ± 0.8 4.1 ± 0.6 0.01 
LDL-C (mmol·L-1) 3.0 ± 0.4 2.1 ± 0.4 < 0.001 
HDL-C (mmol·L-1) 1.53 ± 0.47 1.32 ± 0.22 0.22 
Triglycerides (mmol·L-1) 1.2 ± 0.9 1.6 ± 0.6 0.24 
HbA1c (%) 5.6 ± 0.3 6.8 ± 0.6 < 0.001 
Glucose (mmol·L-1) 4.9 ± 0.5 7.6 ± 1.6 < 0.001 
Insulin (pmol·L-1) 95.6 ± 84.9 137.9 ± 82.5 0.27 
Insulin resistance (HOMA2-IR) 1.74 ± 1.51 2.75 ± 1.52 0.16 
Insulin sensitivity (%S) 92.0 ± 67.9 45.5 ± 20.7 0.05 
Activity (MET-min·wk-1) 987 ± 931 423 ± 256 0.09 
Sedentary Time (min) 378 ± 142 468 ± 198 0.26 
Bench Press 1RM (kg) 34.9 ± 11.7 33.2 ± 9.2 0.71 
Leg Press 1RM (kg) 115.5 ± 24.2 97.8 ± 28.2 0.15 
Shoulder Press 1RM (kg) 23.9 ± 8.3 15.6 ± 4.9 0.01 
Calf Raise 1RM (kg) 214.5 ± 74.4 123.3 ± 39.8 0.004 
Lateral Pull-down 1RM (kg) 27.8 ± 9.0 19.8 ± 4.3 0.03 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HDL-C = high-
density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; HbA1c = glycated 
haemoglobin; MET = metabolic equivalents; 1RM = one repetition maximum. Independent t-tests were 
conducted to assess the difference between groups at baseline.  
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On the day prior to completing the resistance exercise session, the mean ± SD total 
energy consumption for those with and without diabetes was 8,084 ± 1466 kJ and 8,154 
± 1102 kJ respectively. The breakdown of this for those with and without diabetes 
respectively was: 91.9 ± 31.3 g and 83.7 ± 19.2 g of protein; 71.4 ± 27.2 g and 68.9 ± 
20.3 g of fat; and 213.4 ± 48.9 g and 221.6 ± 43.7 g of carbohydrate. Mixed between-
within MANOVA revealed no statistical group by time interaction (p = 0.33) with no 
difference between groups (p = 0.18) or over time (p = 0.70) for diet. Individuals’ with 
diabetes accrued an average ± SD of 123,719 ± 64,567 activity counts and recorded 8.2 ± 
7.8 minutes of activity at a moderate intensity on the day of the resistance exercise 
intervention compared to those without diabetes accruing an average ± SD of 284,887 ± 
109,509 activity counts and 29.2 ± 21.4 minutes of moderate intensity activity. There was 
no group by time interaction for variables of physical activity (p = 0.25) with no 
statistically significant change in activity over time (p = 0.65) and no statistical 
difference between groups (p = 0.10). 
 
For the primary analysis, repeated measures ANOVA did not detect a statistically 
significant group by time interaction for glucose (p = 0.27), insulin (p = 0.18), insulin 
sensitivity (p = 0.12) or insulin resistance (p = 0.15). There were no time effects detected 
for any variable and no difference between groups for fasting insulin (p = 0.10). 
However, there were differences between those with and without diabetes for fasting 
glucose (p < 0.001), insulin sensitivity (p = 0.018) and insulin resistance (p = 0.05). 
Further analyses using two-way ANOVA revealed the fasting glucose values for those 
with and without diabetes were significantly different (p < 0.001) at all time points, 
however for insulin sensitivity and insulin resistance the differences were maintained for 
 
 
134 
 
two days post exercise before these variables became no longer statistically different 
between groups (Figure 6.2). 
 
Figure 6.2: Metabolic response to a single session of resistance exercise in people with and without 
type 2 diabetes. 
Response of fasting glucose (A), fasting insulin (B), HOMA2 insulin sensitivity (C) and HOMA2 insulin 
resistance (D) to a single session of resistance exercise in apparently healthy individuals (□) and 
individuals with type 2 diabetes (■). Pre is immediately before resistance exercise and 24 hours, 48 hours 
and 72 hours are all following resistance exercise. Bars are means with the standard deviation. * p < 0.05 
between individuals with and without type 2 diabetes 
 
In relation to the adipocytokines measured, adiponectin was detected in 95% of samples, 
with no adiponectin detected in one individual with diabetes either pre- or post-exercise. 
Leptin was detected in 100% of samples. Interleukin-6 was detected in 100% of samples 
pre-exercise but only 89% of samples post-exercise, with IL-6 not detected in two 
individuals with diabetes. Tumour necrosis factor-alpha was detected in 53% and 42% of 
samples pre- and post-exercise respectively, with one individual with diabetes and two 
apparently healthy individuals having TNF-α detected pre-exercise but not post-exercise 
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and one individual with diabetes having TNF-α detected post-exercise but not pre-
exercise. For the secondary analysis, no group by time interaction was detected for the 
markers of inflammation: adiponectin (p = 0.91); leptin (p = 0.42); IL-6 (p = 0.29); and 
TNF-α (p = 0.79). There were also no time (p > 0.05) or group (p > 0.05) differences for 
any variable (Table 6.2). 
 
Table 6.2: Response of markers of inflammation to a single resistance exercise session. 
Mean ± SD 
 Pre-exercise 24 hours Post-exercise p valuea 
Adiponectin (ng·mL-1)    
T2D (N = 8) 6.1 ± 6.6 4.7 ± 2.9 0.50 
AH (N = 10) 12.1 ± 11.9 10.2 ± 14.7 0.51 
 p valueb 0.22 0.31  
Leptin (ng·mL-1)    
T2D (N = 9) 23.1 ± 16.8 25.2 ± 14.3 0.37 
AH (N = 10) 26.1 ± 26.9 24.6 ± 28.4 0.69 
 p valueb 0.78 0.96  
IL-6 (pg·mL-1)    
T2D (N = 7) 5.8 ± 1.8 5.9 ± 2.3 0.75 
AH (N = 9) 6.2 ± 2.2 5.6 ± 2.2 0.26 
 p valueb 0.69 0.84  
TNF-α (pg·mL-1)    
T2D (N = 3) 2.6 ± 0.7 2.8 ± 0.7 0.80 
AH (N = 4) 3.5 ± 1.3 3.4 ± 0.5 0.92 
 p valueb 0.48 0.09  
T2D = type 2 diabetes; AH = apparently healthy individuals; IL-6 = interleukin-6; TNF-α = tumour 
necrosis factor-alpha. Paired t-tests were conducted to determine the change from pre- to post-exercise (p 
valuea). Independent t-tests were conducted to compare groups both prior to and following resistance 
exercise (p valueb).  
 
 
6.5. Discussion 
This study tracked the insulin sensitivity response to a single session of resistance 
exercise over three days in middle-aged individuals with and without T2D, along with 
assessing the response of adipocytokine markers of inflammation. The finding of no 
change to insulin sensitivity at any time, from 24 hours to 72 hours following resistance 
exercise is in contrast to previous findings from studies, using a similar resistance 
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exercise protocol, that reported improved insulin sensitivity 18 hours [63] and glucose 
tolerance 12-24 hours [62] after a single session of resistance exercise in people with 
T2D. These conflicting findings might be due to different methods of estimating insulin 
sensitivity (OGTT vs. HOMA2), or they may just indicate that improvements to insulin 
sensitivity following a single session of resistance exercise are a very acute phenomenon 
and therefore not detected in this study at 24 hours post exercise, suggesting that perhaps 
resistance exercise needs to be performed frequently, perhaps in excess of 2–3 times a 
week, to obtain metabolic health benefits. The lack of change, both in this study, and in a 
previous study of apparently healthy individuals [155] [Chapter 5], support this 
hypothesis that resistance exercise may need to be performed on an ongoing basis to 
observe changes to insulin sensitivity and glucose tolerance. However, it is interesting to 
note the significant difference in insulin sensitivity between those with and without T2D 
disappeared at 72 hours following resistance exercise. This appears to be due to small, 
non-statistically significant impairments in apparently healthy individuals and 
improvements in those with T2D, however the reasons for this are currently unclear and 
daily biological variation cannot be ruled out. 
 
Impairments to insulin sensitivity following a session of resistance exercise have 
previously been considered to be due to transient insulin resistance caused by muscle 
damage increasing adipocytokines such as TNF-α [159]. There was no statistically 
significant impairment of insulin sensitivity or increase in insulin resistance in either of 
this study’s population groups, nor were any markers of inflammation increased at 24 
hours following the resistance exercise session. 
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Due to its insulin sensitising and anti-inflammatory effects [168], adiponectin has been 
reported to be an independent indicator of insulin sensitivity [169] with recent review 
articles indicating increases to adiponectin in most cases, following ongoing resistance 
training [165, 168]. Studies investigating a single session of aerobic exercise have 
provided equivocal results in terms of changes to adiponectin, however increased 
adiponectin concentrations have been reported immediately following a single session of 
resistance exercise only in people who had been regularly completing resistance training 
[170]. The findings in inactive and untrained individuals from the current study concur 
with the findings of others that no change to adiponectin concentration occurs in 
sedentary individuals and individuals who run but do not complete weight training [170]. 
 
No difference in leptin concentrations have been reported in trained and untrained 
individuals immediately following a single session of resistance exercise [170, 171]. 
Nindl and colleagues [172] also reported no change in the hours immediately after a 
resistance exercise session, however differences between the control and exercise 
interventions were found at nine, 10, 12 and 13 hours following the exercise protocol. 
This indicated that leptin responses to resistance exercise are delayed. However in the 
current study, in which leptin was assessed at a time point later than those of Nindl and 
colleagues [172], it was found that leptin was not changed at 24 hours after the resistance 
exercise session. This may be due to leptin not changing at any time in the current study 
or if it did, it returned to pre-exercise concentrations within 24 hours. 
 
The response of IL-6 and TNF-α following a single session of resistance exercise are 
varied with reports of increased IL-6 on some occasions and no change on others, while 
typically TNF-α has remained unchanged [147]. Where increases have been observed in 
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IL-6, they have typically returned to baseline within 24 hours, although in one study they 
remained elevated for up to 72 hours [173]. The current findings add to the literature that 
no ongoing (at 24 hours) increase in IL-6 or TNF-α concentrations are observed 
following a single session of resistance exercise in inactive middle-aged individuals with 
and without T2D, suggesting that a lack of improvement in insulin sensitivity at that 
point in time, is not due to an increase in inflammation or transient insulin resistance. 
 
6.6. Conclusion 
While the findings of this study are limited by a small sample size and estimating insulin 
sensitivity through indices from fasting glucose and insulin concentrations, it is 
strengthened by the inclusion of adipocytokine markers of inflammation thought to be 
indicative of insulin sensitivity [174] along with vascular function [175]. Given these 
limitations, it can be concluded that insulin sensitivity and inflammation are not modified 
from a single session of unfamiliar resistance exercise between 24 hours to 72 hours after 
the session and suggest that if insulin sensitivity is modified, the response appears to be 
very acute (i.e. < 24 hours), failing to prove the original hypothesis. Given that 
significant differences in insulin sensitivity between those with and without T2D appear 
to be abolished 72 hours after the resistance exercise session, further research using 
methodologies that measure, rather than estimate insulin sensitivity and glucose 
tolerance, and/or sample frequently or continuously during free living conditions are 
justified to investigate whether these changes are significant and to determine the 
mechanisms behind them. Never-the-less, these results suggest that a single session of 
resistance exercise is not detrimental to metabolic health and that a lack of improvement 
is not a consequence of increased inflammation. 
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7. An investigation into glucose control following single bouts of resistance and 
aerobic exercise  
 
7.1. Preface 
Following findings of no change to insulin sensitivity using an estimate from fasting 
glucose and insulin levels or markers of inflammation following a single session of 
resistance exercise [Chapter 6], a method that measured glucose levels continuously was 
sourced to more rigorously examine glucose levels over a 24-hour period rather than 
using an approach that only captures a snapshot of time. A robust study design 
(randomised cross-over) was employed and it was decided to compare the responses 
between acute resistance and aerobic exercise. This chapter is based on a manuscript that 
has been submitted for peer-reviewed publication, which was completed in collaboration 
with a clinician from Austin Health and was possible thanks to funding received from the 
Australian Technology Network’s Centre for Metabolic Fitness. 
 
7.2. Introduction 
It is generally accepted that adherence to guidelines for aerobic exercise by individuals 
with type 2 diabetes (T2D), is an appropriate and effective modality for improving their 
health status: and current guidelines recommend the completion of 150 min·wk-1 of 
moderate intensity aerobic exercise [4]. By comparison, there is a lack of consensus with 
regards to guidelines for undertaking resistance exercise to achieve optimal health in 
people with T2D [50, 52, 71]. And whilst previous research has indicated significant 
benefits associated with completing on-going resistance exercise, it appears that the 
current guidelines are based mainly on data obtained from apparently healthy 
populations, rather than individuals with T2D. It is therefore important that the acute 
impact as well as chronic effects of such exercise sessions are known, and the duration of 
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any changes to blood glucose levels established, so that specific guidelines can be 
defined and routinely prescribed to optimise health outcomes for people with T2D.  
 
The development and publication of effective resistance exercise guidelines are of 
particular importance, given that many individuals with T2D may not be capable of 
achieving the amount, volume and intensity of aerobic exercise required for improving 
health [77, 124] and a large proportion of individuals with T2D fail to meet the current 
aerobic exercise guidelines [69]. Additionally, if resistance exercise produces different 
metabolic responses and/or works via different pathways to aerobic exercise [77], the 
implications of these differences need to be understood by researchers and clinicians.  
 
Along with lifestyle modifications and the initiation of glucose lowering medications, 
current treatment recommendations for T2D advocate the early implementation of insulin 
therapy to achieve and maintain glycaemic control [4]. And given the increasing 
prevalence of T2D, it is likely that health professionals will need to care for more insulin 
treated people with T2D. It is therefore important to examine the effect of exercise on 
individuals with T2D being treated with insulin. Few studies to date [176, 177] 
investigating the effect of exercise on people with T2D have included those being treated 
with insulin. Consequently this investigation was performed in an attempt to provide 
more information regarding glucose response to exercise in this ever increasing sub-
population of people with T2D. 
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Whilst it is known that exercise training improves insulin sensitivity in the long-term 
[74], literature regarding the immediate acute effects of exercise on insulin sensitivity 
and glucose tolerance are not as well defined [70]. Some clinical studies using animal 
models have investigated the acute effects of aerobic exercise [178-180] while in 
humans, results have indicated that a single session of low intensity aerobic exercise can 
reduce the mean 24-hour glucose concentration compared to no exercise, but high 
intensity aerobic exercise did not [181]. There are even fewer human studies 
investigating acute resistance exercise [62-66] and only three have specifically addressed 
this issue in people with T2D [62, 63, 177]. Results following these studies have been 
equivocal and an important limitation of all studies is a failure to determine the duration 
of improved insulin sensitivity following an acute bout of either resistance or aerobic 
exercise. Findings from aerobic exercise suggest that acute improvements in insulin 
sensitivity are likely to be localised to the exercised muscles through mechanisms such as 
glycogen depletion, along with improved contraction and insulin induced GLUT-4 
(glucose transporters) translocation [182]. However, any mechanisms underlying an 
improvement in insulin sensitivity following an acute bout of resistance exercise have not 
been fully elucidated, although they are understood to have some common mechanisms 
to aerobic exercise along with some unique adaptations attributable to resistance exercise 
alone [70]. 
 
Individuals with T2D have been shown to have increased insulin sensitivity or glucose 
tolerance for 12-24 hours after a single bout of resistance exercise [62, 63], however our 
preliminary results suggest that no change to insulin sensitivity up to 72 hours following 
a single resistance exercise session is observed using the updated homeostasis modeling 
assessment equations. Limitations of small sample sizes and short follow-up periods are 
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apparent in studies of resistance exercise and similarly are also seen in studies evaluating 
acute aerobic exercise. All but two [177, 181] of these studies have used methods that 
provide a ‘snapshot’ approach to estimating insulin sensitivity or glucose tolerance. 
However, the relatively recent development and availability of continuous glucose 
monitoring (CGM) systems means that a more complete picture of the 24-hour response 
can be provided in comparison to the one-off ‘snapshot’ methods of fasting blood tests 
and oral glucose tolerance tests. Furthermore, whilst ‘snapshot’ methods have limitations 
in being able to detect and quantify the magnitude and duration of excursions into 
hyperglycaemia, these significant events can be easily identified and quantified through 
the use of CGM. 
 
Therefore, the aim of this randomised, cross-over trial was to compare the glucose 
response, measured via CGM, after resistance and aerobic exercise; and secondly, to 
determine for what length of time any change to glucose tolerance remains following a 
single session of either exercise modality in inactive males with insulin treated T2D. It 
was hypothesised that a single session of resistance exercise would improve glucose 
control to a similar extent as that experienced following a single session of aerobic 
exercise. 
 
7.3. Methods 
7.3.1. Participants and study design 
Ethical approval was granted from the Human Research Ethics Committees of RMIT 
University and Austin Health, and all participants provided written informed consent. 
This study conformed to the principles of the Declaration of Helsinki and was registered 
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with the Australia and New Zealand Clinical Trials Register (ACTRN12610000906055). 
Inclusion criteria were: aged 50-70 years, had not undertaken resistance training on two 
or more occasions per week over the last three months, were taking a stable dose of 
medications, were weight stable and had HbA1c values between 7.0% and 10.0%. 
Participants were excluded if they had been taking beta-blocking or oral hypoglycemic 
medications for less than six months, had impaired liver function, renal failure, severe 
retinopathy, recent coronary event or unstable cardiac disease, uncontrolled hypertension 
(> 180/90 mmHg), neuropathy or any medical condition that contraindicated resistance 
exercise. Participants were also required to be able to understand English or follow 
instructions. 
 
The study design was a randomised cross-over trial, in which computer-generated 
concealed randomisation was used to allocate eight inactive (not meeting aerobic 
physical activity guidelines [53]) males with insulin treated T2D to complete either the 
aerobic or resistance exercise first. Once all baseline variables had been assessed and the 
participant had met all of the inclusion criteria, randomisation to which exercise session 
they would complete first, was achieved using individual opaque envelopes and 
administered by a person independent of the investigators. Participants’ had a mean ± SD 
age of 61.0 ± 7.2 years, height of 173.9 ± 8.4 cm and body mass of 102.8 ± 35.4 kg 
(Table 7.1).  
 
Participants were given a standardised meal to be consumed for dinner that contained 
1,932 kJ of energy, 24.8 g of protein, 10.4 g of fat and 61.6 g of carbohydrate, the night 
before all visits. Participants arrived at the research facility each morning between 0600 
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and 0900 hours by the use of private vehicles, following a 12-hour overnight fast and had 
their height (stadiometer, QuickMedical®, USA; to the nearest 0.1 cm) and body mass 
(Tanita, BWB-600, Tanita Health Equipment H.K Limited, Hong Kong; to the nearest 
0.1 kg) measured. Blood pressure was assessed using an automated blood pressure 
monitor (OMRON IA1B, OMRON healthcare Co. Ltd., Japan) before a fasting blood 
sample was collected. Each variable was measured in duplicate and in triplicate if a set 
tolerance threshold was reached, with the mean of duplicate values or median of 
triplicate values utilised. The coefficients of variation were < 1%, < 1% and 3% 
respectively for height, body mass and blood pressure. Participants were given a 
standardised breakfast (toast and fruit juice) and completed the self-report International 
Physical Activity Questionnaire [144]. Cardio-respiratory fitness was determined using 
an incremental exhaustive cycle protocol as reported previously [181] where the initial 
workload (Watts) was one Watt per kilogram of body mass and increased by 25% of the 
initial workload each 2.5 minute stage. Participants were required to maintain a cadence 
of 60-70 rpm for the duration of the test and oxygen uptake (VO2) was measured 
throughout the test using an automated computerized breath-by-breath metabolic cart 
(ParvoMedics2400 Truemax, Parvomedics Inc., East Sandy, UT, USA). Peak oxygen 
uptake (VO2peak) was defined as the maximum VO2 measured on termination of the test 
without necessarily attaining the required parameters to be considered their physiological 
maximum. On two occasions, participants were unable to complete the initial workload, 
and therefore had the initial workload halved to enable them to complete the assessment. 
Participants were then familiarised with the resistance exercise equipment before 
undertaking one repetition maximum (1RM) testing on all six exercises to be included in 
the resistance exercise session. One repetition maximum testing followed a set protocol 
as reported previously [63].  
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Following a minimum of a 7-day wash-out period, participants returned to the research 
facility following a 12-hour overnight fast and had the CGM (Medtronics, iPro™2 
professional model) inserted. The CGM consists of a microdialysis fibre (glucose sensor) 
that was inserted into the sub-cutaneous tissue in the lumbar region of the participants 
back (away from insulin injection sites) using a standard inserter (Sen-serter™), before 
connecting it to the recorder that sat on the skin surface immediately beside the glucose 
sensor. Participants were given a glucometer (Optium Xceed) to measure blood glucose 
values prior to each meal and before going to bed to calibrate the CGM. After consuming 
a standardised breakfast meal, participants were allowed to leave the research facility and 
return (again fasted) two days later to undertake either the resistance exercise session or 
the aerobic exercise session. Participants had a fasting blood sample collected, were 
given the standardised breakfast, and were instructed to take half of their normal insulin 
dose immediately prior to completing the exercise session. Apart from this, all 
medications were taken as prescribed by their physician. Following the exercise session, 
participants resumed their normal lifestyle for three days, during which time the CGM 
continued to record their blood glucose. Additionally they recorded time of food 
consumption, medication usage and glucometer derived blood glucose values. They then 
returned to the facility to have the CGM removed. Participants then resumed their normal 
lifestyle for two days, before repeating the protocol with the other exercise intervention. 
The study protocol is described schematically in Figure 7.1. 
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7.3.2. Exercise interventions 
Both exercise interventions followed the exercise guidelines for people with type 2 
diabetes [53, 55]. The resistance exercise session consisted of three sets of 8-10 
repetitions for six whole-body exercises (bench press, 45˚ leg press, lateral pull-down, 
unilateral leg extension, seated row and unilateral leg curl) at 70% of 1RM with 60-90 
seconds recovery between each set. The aerobic exercise session consisted of 30 minutes 
of cycling at 60% of VO2peak, with breath-by-breath analysis conducted in three, five 
minute intervals throughout to ensure that the correct intensity was achieved and 
maintained. Activity levels throughout the study were assessed by accelerometer 
(Actigraph GT1M) with participants given instructions on how to wear it on the hip. 
These data were analysed using ActiLife analysis software (v4.4.1) and enabled the 
researchers to determine whether the participants had undergone any changes to their 
activity patterns within the duration of the study, which may have impacted their glucose 
tolerance.   
 
7.3.3. Blood analysis 
Baseline fasting blood samples were collected in a serum separator tube and an EDTA 
containing tube and sent to a commercial laboratory for analysis of lipid profiles (total 
cholesterol [TC], high-density lipoprotein cholesterol [HDL-C] and triglycerides [TG] 
with a coefficient of variation [CV] of 2.8%, 3.5% & 3.4% respectively, with low-density 
lipoprotein cholesterol [LDL-C] mathematically calculated from TC, HDL-C and TG), 
glycated haemoglobin (HbA1c; CV = 2.8%), glucose (CV = 2.8%), insulin (CV = 7.0%) 
and high-sensitivity C-reactive protein (hs-CRP; CV = 4.0%). Serum was allowed to clot 
at room temperature for 30-60 minutes before being centrifuged for 15 minutes at 3000g 
and 4˚C. Prior to each exercise session, a blood sample was collected in a serum 
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separator tube for analysis of glucose, insulin, and hs-CRP to ensure there were no 
lasting effects from the testing session or the previous exercise session. 
 
7.3.4. Statistical analysis 
 A priori power calculation was based on the primary outcome of time spent in a state of 
hyperglycaemia, using estimates from the literature [177] where the minimally important 
change in the outcomes was three hours with a standard deviation of 11.95, an effect size 
of 0.26 was calculated. For the given effect size, an alpha value of 0.05, two groups 
completing four repetitions and a correlation among the repeated measures of 0.7, 
G*power 3.1 software recommended a sample size of 14 was required to achieve 80% 
statistical power. Given the cross-over design and allowing for 10% dropout, a sample of 
eight was recruited. All data were analysed using SPSS version 18 for Windows (SPSS, 
Chicago, IL) with significance set at an alpha level of p = 0.05. One-way repeated 
measures analysis of variance (ANOVA) were completed to assess the change over time 
between, baseline and immediately prior to each exercise intervention for serum glucose, 
serum insulin and hs-CRP, with a Bonferonni adjustment, the value for significance was 
p = 0.017. A mixed between-within multivariate analysis of variance (MANOVA) was 
conducted to assess the physical activity variables of total counts and total steps in each 
24-hour period before exercise and up to three days after exercise. A mixed between-
within repeated measures (intervention x time) ANOVA was conducted for area under 
the 24-hour glucose curve and the percentage of each 24-hour time-period spent in a state 
of hyperglycaemia (glucose ≥ 10 mmol·L-1) to track the response over 72 hours following 
exercise. A Bonferonni adjustment was again used and this time the alpha value required 
for significance was 0.025. Due to a small sample size and for clinical application, the 
effect size was calculated for the change in amount of time spent in hyperglycaemia to 
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assess practical significance. Data are presented as means ± standard deviation (SD) or 
means (95% confidence intervals [CI]) unless otherwise indicated.  
 
7.4. Results 
Participant flow throughout the study is presented in Figure 7.1 with baseline 
demographics in Table 7.1. Briefly, participants’ were on average overweight, borderline 
hypertensive and spent large amounts of time sitting. Their fitness and upper body 
strength were poor, while lower body strength was average [143].  They also had poor 
glycaemic control and low levels of HDL-C. One participant was currently smoking, but 
refrained from smoking during each fasting period. Of the eight participants, six were 
taking mixed insulin (Humalog Mix® = 3; NovoMix® = 3), and two individuals were 
taking both a long acting (Lantus®) and a short acting (NovoRapid®) insulin. All but 
one individual were taking oral hypoglycaemic medication along with the insulin, with 
five participants prescribed metformin monotherapy, one treated with dual therapy of 
metformin and a glitazone, and one taking a combination metformin and sulfonylurea 
medication. Participants were additionally treated with aspirin (N = 3), statins (N = 4), 
ACE inhibitors (N = 4), beta-blockers (N = 3), HMG-CoA reductase inhibitors (N = 2), 
angiotensin II receptor agonists (N = 2), diuretic, proton-pump inhibitor, calcium channel 
blocker and combination HMG-CoA reductase inhibitor and statin (all N = 1). There 
were no significant adverse events from completing either exercise intervention, however 
two individuals were unable to complete the 30 minute cycling protocol without frequent 
rest periods. All participants were able to complete the resistance exercise session as 
prescribed.
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Figure 7.1: Participant flow through study (Consort diagram) (A) and study protocol (B). 
IPAQ = international physical activity questionnaire; VO2peak = peak oxygen uptake; 1RM = one repetition 
maximum; CGM = continuous glucose monitoring 
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Table 7.1: Participant Demographics 
Outcome Measure Mean ± SD 
Diabetes (years) 18.0 ± 8.5 
Age (years) 61.0 ± 7.2 
Body Mass (kg) 102.8 ± 35.4 
Height (cm) 173.9 ± 8.4 
BMI (kg·m-2) 33.6 ± 9.4 
SBP (mm Hg) 139 ± 19 
DBP (mm Hg) 82 ± 8 
Cholesterol (mmol·L-1) 3.9 ± 0.3 
LDL-C (mmol·L-1) 2.2 ± 0.4 
HDL-C (mmol·L-1) 1.00 ± 0.23 
Triglycerides (mmol·L-1) 1.5 ± 0.7 
HbA1c (%) 8.0 ± 0.3 
Glucose (mmol·L-1) 8.4 ± 2.1 
Insulin (pmol·L-1) 268.9 ± 528.2 
C-peptide (nmol·L-1) 0.59 ± 0.55 
hs-CRP (mg·L-1) 6.0 ± 8.0 
Activity (MET-min·wk-1) 1683 ± 2524 
Sedentary Time (min) 559 ± 311 
VO2peak (ml·kg-1·min-1) 19.8 ± 6.1 
Bench Press 1RM (kg) 46.4 (15.2) 
Leg Press 1RM (kg) 158.1 ± 49.8 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; LDL-C = low 
density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; HbA1c = glycated 
haemoglobin; hs-CRP = high sensitivity C-reactive protein; VO2peak = peak oxygen uptake; 1RM = one 
repetition maximum 
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One-way repeated measures ANOVA between baseline and immediately prior to each 
exercise intervention failed to identify any significant difference for fasting serum 
glucose (p = 0.05), insulin (p = 0.58) and hs-CRP (p = 0.34) values. In the 24-hours prior 
to completing the resistance and aerobic training interventions respectively, participants’ 
recorded an average of 186,428 ± 96,746 and 226,812 ± 104,531 counts and an average 
of 5,972 ± 3,154 and 7,499 ± 2,877 steps. Mixed between-within MANOVA revealed no 
difference between the interventions for the amount of physical activity completed (p = 
0.97) and this did not change throughout either intervention (p = 0.44). 
 
In the 24 hours immediately prior to completing resistance exercise and aerobic exercise, 
the mean (95% CI) glucose response (area under the curve [AUC]) was 187.4 (158.9 to 
215.8) mmol·L-1·24-hrs-1 and 186.7 (158.2 to 215.1) mmol·L-1·24-hrs-1 respectively. 
Mixed between-within ANOVA detected a significant time effect (p = 0.015) for glucose 
AUC but no intervention by time interaction (p = 0.29). Pair-wise comparisons revealed 
that glucose AUC significantly increased (p = 0.006) in the first 24 hours following the 
exercise interventions (Figure 7.2) with a significant decrease (p = 0.05) returning to pre-
exercise levels in the 48-72-hour time-period (Figure 7.2). 
 
In the 24 hours prior to completing each exercise intervention, participants’ spent an 
average (95% CI) of 23.0% (10.7% to 35.4%; 124 min to 533 min) and 27.0% (14.7% to 
39.4%; 203 min to 574 min) of the time in a state of hyperglycaemia (glucose ≥ 10.0 
mmol·L-1) before resistance and aerobic exercise respectively. Mixed between-within 
ANOVA failed to detect any time effect (p = 0.11) or intervention by time interaction (p 
= 0.25) for the amount of time spent in a state of hyperglycaemia (Figure 7.3). Despite no 
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statistically significant change being observed, there was a large practically significant 
change in the amount of time spent in a state of hyperglycaemia in the first 24 hours after 
each exercise intervention from the 24 hours before exercise with effect size (Cohen’s d) 
calculated to be 0.98. In the periods of 24-48-hours and 48-72-hours after the exercise 
interventions, the practical significance of the change had reduced to a moderate level of 
d = 0.52 and d = 0.49 respectively. 
 
7.5. Discussion 
The major finding from this study was that glucose levels are elevated in the initial 24 
hours following a single session of moderate intensity exercise in normally inactive 
individuals with insulin treated T2D. This finding is in contrast with previous research 
using CGM that has shown a single session of low intensity aerobic exercise reduced the 
24-hour glucose response [181]. Furthermore, previous data indicates the 24-hour 
glucose response was not altered by a single session of low intensity resistance exercise 
followed by four short bouts of high intensity aerobic exercise [177]. 
 
The glucose response to exercise in young men with type 1 diabetes has previously been 
investigated by having participants perform 20 minutes of low to moderate intensity 
(40% VO2peak) cycling and then either rest or complete a 10 second all-out sprint [183]. 
This exercise regimen showed that glucose levels continue to decline following moderate 
intensity cycling for participants that rested only, but remained stable in the group that 
completed the all-out sprint. 
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Figure 7.2: 24-hour glucose response to resistance and aerobic exercise. 
The mean ± SD area under the 24-h glucose curve prior to and following resistance [white bars] and 
aerobic exercise [black bars] (A); the 24-h glucose response prior to [black line] and following [gray line] 
resistance exercise (B); the 24-h glucose response prior to [black line] and following [gray line] aerobic 
exercise. * p < 0.05  
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Figure 7.3: Hyperglycaemia in response to resistance and aerobic exercise. 
The mean ± SD percentage of time within a 24-h period spent in a state of hyperglycaemia (blood glucose 
≥ 10.0 mmol·L-1) prior to and following resistance [white bars] and aerobic [black bars] exercise 
 
 
The above study [183] and other similar studies involving people with T2D [177, 181] 
suggests that low intensity exercise could be most effective at reducing blood glucose 
levels following exercise. However, this approach is not reflected in the current exercise 
guidelines for individuals with diabetes [50, 52, 71]. The data from this study in which 
exercise was performed in accordance with current exercise guidelines, adds to the body 
of evidence that the volume and intensity of exercise described in this study results in a 
short-term impairment of the glucose response, as indicated by increased area under the 
glucose curve. And this may suggest that the current exercise guidelines are inadequate 
in terms of providing clinicians with information to optimise advice about the best way to 
manipulate insulin usage around periods of exercise in those that are novice exercisers. 
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The exact way that exercise influences insulin sensitivity and insulin resistance in T2D is 
yet to be precisely determined and subsequent changes in blood glucose levels remain 
unclear. These data does not support previous findings of increased insulin sensitivity 
(when calculated from a frequently sampled intra-venous glucose tolerance test) with no 
change to glucose effectiveness immediately following a single 20 minute aerobic 
exercise session in poorly controlled individuals with T2D [184]. However, these data do 
support findings of an attenuated exercise response from a previous study [185] that 
reported reduced muscle glycogen content with no change in AMPK phosphorylation 
following 40 minutes of low and moderate intensity aerobic exercise in well controlled 
individuals with T2D.  
 
In those with T2D, insulin sensitivity and glucose tolerance, estimated through the use of 
an oral glucose tolerance test, has been reported to improve between 12 and 24 hours 
following a single session of moderate to high intensity resistance exercise [62, 63]. 
Further, a single session of low intensity resistance exercise followed by four 30 second 
bouts of high intensity cycling did not change the 24-hour glucose response, although the 
amount of time spent in a state of hyperglycaemia significantly reduced [177]. These 
findings could not be replicated with either resistance or aerobic exercise. By using CGM 
however, it was possible to identify that participants who undertook the exercise regimen 
according to current guidelines in this study, spent a prolonged period of time in a state 
of hyperglycaemia. This is information that cannot be identified using methods of 
‘snapshot’ analysis, however the clinical implications surrounding the timing of 
medications and food consumption around exercise can be further investigated using 
CGM. Potentially it may even see the time of day at which exercise is completed become 
important. 
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The lack of any statistically significant change within fasting glucose, insulin and hs-
CRP concentrations prior to either exercise intervention indicates that the washout period 
of seven days was appropriate and suggests that any changes to glucose or insulin from a 
single session of exercise have been abolished within this time frame. A cohort of 
working Australians has been reported to have completed an average of almost 9000 
steps per day, with only approximately half of this sample meeting the physical activity 
guidelines [186]. Interestingly though, those who met the guidelines averaged 
approximately 9500 steps per day compared to the 8000 steps per day averaged by those 
who did not meet the guidelines [186]. Therefore the recorded average steps per day of 
between 6000 and 7500 in this study support the likelihood that these participants were 
indeed insufficiently active and not meeting the current physical activity guidelines [53]. 
Although the data is not shown, almost all of the activity measured by accelerometry in 
this study were recorded as being completed at a low intensity. 
 
7.6. Conclusion 
This randomised cross-over trial provides evidence that resistance exercise acutely (~24 
hours) impairs glucose control; an outcome that was also observed following aerobic 
exercise in older male individuals with insulin treated T2D, proving the original 
hypothesis correct. While this study did not attempt to elucidate the mechanisms of how 
glucose tolerance is affected by exercise, the use of a device capable of monitoring 
glucose levels 24 hours a day, for several days and the study’s randomised cross-over 
design, provide information that can be used to modify glucose altering treatment 
regimens and form the basis for further research. Further investigations are required to 
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determine: (i) whether females respond in a similar way to males; (ii) whether a similar 
glucose response occurs after multiple exercise sessions, and (iii) whether the glucose 
response is similar in individuals who are well trained in comparison to those who are 
inactive. While other health factors such as the cardiovascular response need to be 
considered when prescribing exercise to this population of at-risk individuals, it appears 
at least for the primary diabetes outcome of glucose tolerance that the current exercise 
guidelines require further refinement for untrained individuals beginning an exercise 
regimen. 
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8. The effects of eight weeks of aerobic and resistance exercise training on insulin 
sensitivity and glucose tolerance in people with type 2 diabetes: A randomised 
controlled trial 
 
8.1. Preface 
Following the series of acute investigations surrounding the effects of a single session of 
resistance exercise on insulin sensitivity and glucose tolerance [Chapters 5, 6 & 7] that 
all showed no change or a short-term impairment, it became clear that insulin sensitivity 
and markers of inflammation need a longer time course in which to respond and therefore 
should be investigated in response to a short-term exercise intervention. A randomised 
controlled trial was undertaken to compare the effects of resistance or aerobic training 
and a control condition (flexibility training) on insulin sensitivity and markers of 
inflammation. Although the most current exercise guidelines for type 2 diabetes 
recommend the completion of both aerobic and resistance type exercise [50, 58] this 
study was designed and commenced before the release of these guidelines, hence the 
comparison of the two modes and the lack of a combined exercise group. However, the 
most recent recommendation is based on limited studies that have evaluated the effect of 
combined training on metabolic health in people with type 2 diabetes [88, 99, 100], so 
should be examined further. The study described in the following chapter was completed 
in collaboration with researchers and clinicians at the Baker IDI Heart and Diabetes 
Institute and was made possible thanks to funding received from a Diabetes Australia 
Research Trust (DART) grant. 
 
8.2. Introduction 
Regular exercise is an essential component of type 2 diabetes (T2D) management, 
however most previous studies have concentrated on aerobic exercise. Only recently has 
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the benefit of resistance exercise in T2D been appreciated [82, 88]. Exercise is one of the 
cornerstones in the management of people with T2D [124] and it is currently 
recommended that people with T2D perform at least 150 minutes of moderate intensity 
aerobic exercise per week and, in the absence of contraindications, people with T2D are 
encouraged to perform resistance exercise two to three times per week [4, 55]. Even 
more recently the guidelines suggest that both forms of exercise be completed [50-52] 
however, the optimal exercise prescription in terms of type and frequency of exercise for 
improving insulin senstitivity in people with T2D is unknown. 
 
Numerous studies have investigated the effects of aerobic type exercise on metabolic 
outcomes in people with T2D. Although this type of exercise has been reported to result 
in improved glycaemic control [75], recent studies of aerobic exercise have failed to 
show the same improvements [84, 99, 100, 187]. When aerobic and resistance exercise 
have been combined though, post-exercise blood glucose levels have been reported to 
continually reduce over a four-week program [122] and reductions in HbA1c have been 
observed when compared to a control group [84, 99]. The data are also equivocal in 
relation to insulin sensitivity with some studies showing increases in the rate of glucose 
disposal and the phosphorylation of glucose transporter-4 [187] and a 20%, but not 
statistically significant, increase in the glucose infusion rate [84], while insulin resistance 
estimated through the homeostasis modelling assessment (HOMA) has shown no change 
[100]. 
 
Resistance exercise has also been reported to result in improvements to insulin sensitivity 
and glucose tolerance 12-24 hours after a single session of resistance exercise in people 
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with T2D [62, 63] and following a period of chronic resistance exercise (6 weeks to 6 
months) for between 48 hours [80] and 72-96 hours [90] after the final exercise session. 
Recently, a 12-week resistance training intervention has reported reduced insulin 
resistance, estimated through HOMA, and increased concentrations of adiponectin [100], 
however these changes were not statistically significant. Through their effects on 
carbohydrate and fat metabolism, the adipocytokines of adiponectin and leptin are 
believed to be surrogate markers of insulin sensitivity [146]. 
 
Despite the depth of positive evidence in relation to exercise and metabolic health and 
the strong recommendations to complete exercise as part of the treatment program in 
individuals with T2D [4], a large proportion of individuals with T2D do not complete the 
recommended levels [69]. Investigations regarding the minimal, most effective dose of 
exercise are required given a recent investigation of individualised lifestyle exercise 
prescription failed to increase either activity levels or glycaemic control [188]. The other 
major limitation of research to date is that insulin sensitivity following resistance training 
or aerobic training has not been tracked in people with T2D to determine the length of 
time that insulin sensitivity remains improved. 
 
Given this, it was hypothesised that compared to a sham exercise (flexibility training) 
control group; there would be no difference in the change to insulin sensitivity after 
aerobic or resistance exercise training. Therefore, the primary aim of this study was to 
evaluate whether insulin sensitivity was improved following an 8-week period of 
resistance training or aerobic training with a secondary aim of evaluating the length of 
time that insulin sensitivity remained changed in people with T2D. 
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8.3. Methods 
8.3.1. Participants and study design 
Computer generated concealed randomisation was used to allocate participants to one of 
the three parallel arms (control vs. aerobic exercise vs. resistance exercise) in previously 
insufficiently active individuals with T2D by an independent, blinded investigator using 
opaque envelopes. It was not possible to blind participants to group assignment and due 
to resources, the same exercise physiologist who supervised the exercise training 
sessions, conducted the pre and post exercise assessments. Ethical approval for the study 
was obtained from the Human Research Ethics Committees of the Baker IDI Heart and 
Diabetes Institute and RMIT University and all participants gave written informed 
consent prior to any involvement in the study. This study conformed to the principles of 
the Declaration of Helsinki and was registered with the Australia and New Zealand 
Clinical Trials Register (ACTRN12609000799257). 
 
A telephone-screening questionnaire, was used to identify potential participants who 
were ‘insufficiently’ active (less than 150 minutes of moderate intensity aerobic activity 
each week and not completing resistance exercise regularly more than once a week [53]). 
Volunteers then attended a screening visit to identify those eligible to participate and 
gave written informed consent prior to any measures being recorded. This screening 
process followed the guidelines published by the American College of Sports Medicine 
(ACSM) [143] detailing medical conditions that are contraindications to exercise 
participation. A physician reviewed all information collected during the screening 
process and completed a detailed medical assessment before providing the final approval 
of the person’s suitability to participate. In addition, a letter with details about the 
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research project was sent to the participant’s supervising doctor, requesting that medical 
treatment was not altered during the study unless medically required and that if this 
occurred, the researchers were informed.  
 
Participants were included in the study if they met the following criteria: males or 
females aged 20-70 years with established T2D (longer than six months), treated with 
diet and/or oral hypoglycaemic medications, were stable in weight over the past three 
months (less than 5% change in body weight), had stable glycaemic control of at least 
eight weeks (no changes to medication) and HbA1c was between 6.5% and 9.9% at 
screening. Exclusion Criteria was: extremes of body mass index (< 18.0, > 40.0), seated 
resting blood pressure > 160 mmHg systolic or > 95 mmHg diastolic, pregnancy, 
anticipated requirement for medications affecting glucose tolerance during the trial, 
macroalbuminuria, proliferative retinopathy or severe neuropathy, renal disease or kidney 
failure, being a current smoker, taking medication to lower heart rate (beta blockers), 
unable to commit to completing the entire protocol, language other than English, known 
physical activity contraindications (following ACSM guidelines) and other illness/injury 
(acute or chronic) leading to physical or medical problems that may limit the ability to 
perform the necessary exercise. All data were collected at the Baker IDI heart and 
diabetes institute with the exception of the exercise testing which was completed at a 
public gymnasium, where the exercise interventions were also conducted. 
 
Baseline measures were completed prior to randomisation to one of three interventions to 
be completed on three days each week for eight weeks. On the final session of the eighth 
week, participants completed their follow-up exercise assessments before returning to the 
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gym on the first scheduled session of the ninth week to complete their final exercise 
session. Participants then returned to the research laboratory two days (48 hours), four 
days (96 hours) and seven days (168 hours) after the final exercise session to have further 
assessments and blood tests completed. The study protocol is presented schematically in 
Figure 8.1.  
 
Figure 8.1: Study protocol 
HRR = heart rate reserve; min = minutes; reps = repetitions; 1RM = one repetition maximum 
 
8.3.2. Testing procedures 
8.3.2.1. Anthropometrics 
Basic anthropometric variables were assessed on the participant’s initial visit. Height was 
measured using a wall mounted stadiometer (Surgical & Medical Products™, Model 
1013522) to the nearest 0.1 cm. Body mass was measured to the nearest 0.1 kg on digital 
scales (Tanita BF-680W, Tanita Health Equipment H.K. Limited). Waist and hip 
circumference measurements were taken with a standard, non-elastic tape measure to the 
nearest 0.1cm according to ACSM guidelines [143]. Blood pressure was measured using 
a mercury sphygmomanometer listening for the first and last korotkoff sound through the 
brachial artery with a stethoscope. Each variable was measured in duplicate and in 
triplicate if a set tolerance threshold was reached, with the mean of duplicate values or 
median of triplicate values utilised. The coefficients of variation (CV) were < 1%, < 1%, 
< 1%, < 1%, 1.6% and 1.6% respectively for height, body mass, waist circumference, hip 
circumference, systolic blood pressure and diastolic blood pressure. 
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8.3.2.2. Aerobic Capacity 
Aerobic capacity was measured via completion of a sub-maximal cycle test using the 
YMCA protocol [143] (up to four stages of three minutes). Participants were 
appropriately set up on the stationary cycle ergometer (Ergomedic 828E, Monark 
Exercise AB, Sweden) with a heart rate monitor (Polar F1™, Polar Electro Oy, Finland) 
applied around the chest for the continual measurement of pulse rate. Peak oxygen 
consumption (VO2peak) was estimated via the use of standardised equations [143]. The 
YMCA protocol progresses intensity of the test according to the achieved heart rate of 
the participant at the completion of the first stage [143]. 
 
8.3.2.3. One Repetition Maximum Testing 
Before completing the maximal strength testing, a familiarisation session was completed 
where participants were orientated to the exercise equipment to be used. All weights 
were removed to eliminate as much resistance as possible during this learning experience 
and participants completed 1-2 sets of 10 repetitions practising the lifting procedures and 
breathing techniques taught to them. On completing the familiarisation session, one 
repetition maximum (1RM) testing took place following a set protocol as reported 
previously [63]. The 1RM was used to establish the weight required to initiate the correct 
intensity for the resistance training program.  
 
8.3.3. Exercise Intervention  
The exercise interventions were matched as closely as possible for equivalent levels of 
energy expenditure through variations in the specific training session durations. To 
achieve this, it was identified that the metabolic equivalent (MET) intensity levels for 
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resistance training is three METs [189] and then the updated Compendium of Physical 
Activities [190] a universally accepted tool that lists specific physical activities by rate of 
energy expenditure (METs) was used to determine aerobic workloads. The proposed 
resistance training intervention consisting of 3.0 METs was estimated to take 
approximately 45 minutes to complete, equating in a total energy expenditure of 135 
MET minutes (3.0 x 45). Moderate intensity aerobic exercise results in an intensity of 3-6 
METs according to the Compendium [190]. In planning the aerobic exercise session, it 
was decided to use 15 minutes of cycling at 100 Watts (5.5 METs) and 15 minutes of 
walking on a treadmill at 4.8 km·h-1 (3.3 METs). This equated to a total energy 
expenditure for the aerobic exercise of 132 MET minutes ([3.3 x 15] + [5.5 X 15]). All 
participants were to attend three supervised exercise sessions per week at a public 
gymnasium with all exercise sessions (resistance, aerobic, flexibility) supervised by an 
accredited exercise physiologist. 
 
8.3.3.1. Aerobic Training  
Fifteen minutes of aerobic exercise using a stationary cycle followed by 15 minutes of 
walking on a treadmill at an intensity of 40-70% of heart rate reserve was completed, 
followed by 5-10 minutes of stretching as a cool down/recovery, for three sessions per 
week. This intensity is equivalent to the aerobic training guidelines provided by leading 
health agencies with regards to a moderate intensity walk [53]. Heart rate and rating of 
perceived exertion (RPE) using the Borg scale [191] were monitored every 7.5 minutes 
throughout the exercise session by the supervising exercise physiologist and used to 
guide the participant to achieve the prescribed intensity. Intensity was increased as 
needed to ensure that participants heart rates were in the desired range. 
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8.3.3.2. Resistance Training  
An individualised resistance training program consisting of 7 whole-body exercises 
(bench press, 45° leg press, lateral pull-down, leg curl, shoulder press, triceps extensions 
and abdominal crunches) were completed using pin-loaded weight machines and free-
weights. Three sessions per week were completed consisting of three sets of 8-10 
repetitions at 70% 1RM followed by 5-10 minutes of stretching as a cool down/recovery. 
The weight lifted was progressively increased for each muscle group as tolerated once 
the prescribed number of sets of 10 repetitions was successfully achieved with 
appropriate technique on two consecutive sessions. One-repetition maximum testing was 
repeated after four weeks to establish a new baseline and to guide the prescription of 
training intensity within the prescribed range. Exertion levels were monitored using 
Borg’s RPE scale [191]. The program was progressive in nature with only one set 
completed on the first session of training, two sets on the second session and three sets 
thereafter. 
 
8.3.3.3. Controls  
Participants were advised not to change their baseline activity level for the 8-week 
intervention and maintain all current medical intervention. To control for researcher 
interaction, control participants attended the gymnasium to complete 30 minutes of 
flexibility training three days per week. 
 
8.3.4. Blood Analysis 
Blood samples were collected following a 12-hour fast using a standard venepuncture 
procedure with samples collected at baseline and then again at two days (48 hours), four 
days (96 hours) and seven days (168 hours) following the final exercise session. Blood 
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samples were collected in a serum separating tube and allowed to clot at room 
temperature for 30 minutes before being centrifuged at 3000g for 15 minutes. Serum was 
separated then stored at -20°C before being transferred to -80°C until analysed for serum 
insulin, adiponectin, and leptin in duplicate using defined human ELISA kits (Millipore 
Corporation, Billerica, MA, USA) with a CV of 10%, 2% and 4% respectively. Samples 
were also sent to a commercial laboratory for the analysis of glycated haemoglobin 
(HbA1c), plasma glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C) 
and triglycerides, within the same analyser. The Friedewald equation was used to 
calculate low-density lipoprotein cholesterol (LDL-C). Fasting insulin and glucose values 
were used to determine glucose tolerance and insulin sensitivity levels using the updated 
homeostasis modelling equations (HOMA2) [120].  
 
8.3.5. Statistical Analyses 
As this study was conducted in collaboration with a group of researchers from the Baker 
IDI heart and diabetes institute, the sample size was calculated for a primary outcome of 
endothelial function, and was based on results from Maiorana et al. [192], where the 
absolute difference in means for flow mediated dilatation was 3.3%. Therefore, based on 
detection of a 2% absolute change in flow mediated dilatation and a standard deviation of 
the change of 1.5%, 80% power and alpha of 0.01 and with consideration of the three 
parallel arm study design, a minimum of 14 participants per arm were required. Power 
calculations based on the study outcome of insulin resistance based on previous data 
using similar methodology [89, 91] where the absolute mean difference in the means 8% 
and the standard deviation of the change 3%. Using this data, an effect size of 0.2 was 
calculated, with an alpha level of 0.05 and 80% power and with consideration for three 
groups and four repeated measures G*power 3.1 software indicated that a total sample 
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size of 45 participants was required. This study was not powered, nor designed, to detect 
a difference between genders. Allowing for drop-outs recruitment was aimed at 16 
participants per group. 
 
One-way analysis of variance (ANOVA) with a Tukey post-hoc analysis was conducted 
to assess baseline differences between groups. Repeated measures (intervention by time) 
multivariate analysis of variance (MANOVA) were conducted separately for blood 
pressure variables (systolic and diastolic), lipid profiles (TC, TG, HDL-C and LDL-C) 
and fitness variables (estimated VO2peak, bench press 1RM and leg press 1RM). Changes 
to glycaemic control (HbA1c), fasting glucose, fasting insulin, insulin sensitivity 
(HOMA%S), insulin resistance (HOMA2-IR), adiponectin and leptin were assessed 
using repeated measures (intervention by time) ANOVA. Further, simple and stepwise 
regression models were constructed to assess the relationships of change (post minus pre) 
in metabolic and adipocytokine variables that were found to have either significant group 
by time or time interactions with fitness variables of aerobic capacity and strength. All 
data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p = 0.05. Effect sizes to report practical significance 
were calculated as the change from the intervention subtracted from the change in the 
control divided by the standard deviation of the change from the control. Where the two 
interventions where compared, the aerobic training intervention was used as the control. 
Data are presented as means ± standard deviation (SD) or means (95% confidence 
intervals [CI]) unless otherwise indicated. The analysis was conducted as intention to 
treat with missing data points substituted by bringing the last known value for that 
outcome forward [154]. Data needed to be substituted due to participants being unable to 
attend the follow-up visit at two days (N = 1), four days (N = 3) and seven days (N = 1), 
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with a technical difficulty obtaining serum from the blood sample of one participant four 
days after the final exercise session. 
 
8.4. Results 
Participant flow through the study is presented in Figure 8.2. Briefly, 38 participants 
were randomised into one of the three study arms, however Kolmogorov-Smirnov 
normality tests revealed that baseline levels of glucose (p = 0.003), insulin (p = 0.028), 
HOMA%S (p < 0.001), HOMA2-IR (p = 0.012), leptin (p < 0.001) and adiponectin (p = 
0.017) were not normally distributed. These variables were log-transformed and further 
analysis identified one individual from the resistance training group to be an outlier 
(greater than two SD from the mean) for glucose and another individual from the 
resistance training group to be an outlier for fasting insulin along with insulin sensitivity 
and resistance. Therefore, these two individuals were excluded from the analysis and data 
from 36 individuals were analysed. All pre and post exercise values for the above 
metabolic variables were subjected to log transformation prior to statistical analysis. The 
participants’ had an average ± SD age, height and body mass of 59.4 ± 7.6 years, 1.69 ± 
3.85 m and 92.6 ± 16.1 kg respectively and they had been diagnosed with diabetes for an 
average ± SD of 6.4 ± 3.9 years (Table 8.1). Of the 36 individuals, 27 were taking 
metformin with six of these taking metformin along with a DPP-4 inhibitor. Three 
additional participants were taking a combined DPP-4 inhibitor and metformin 
medication. Four individuals were taking no medications for any medical conditions, 23 
participants were prescribed medications for blood pressure, with 23 also prescribed 
medications for cholesterol. Aspirin was prescribed for eight individuals. All data was 
collected between October 2009 and December 2010, with the trial ending due to funding 
running out to maintain staff to collect data. 
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One-way ANOVA revealed that baseline participant demographics were similar between 
groups with the exception of body mass (p = 0.05), where Tukey post-hoc analysis 
revealed that the flexibility group was significantly heavier than the aerobic exercise 
group (p = 0.04), (Table 8.1). One person completed all baseline testing and the first 
week of the control intervention before suffering the flu and extreme shortness of breath 
unrelated to the study, and was unable to complete any more of the intervention or the 
follow-up exercise tests. They did however, return for follow-up assessment at two and 
four days after their intervention was scheduled to be completed, but did not attend for 
the seven day follow-up testing. One individual from the resistance exercise group was 
not able to complete the follow-up leg press 1RM due to an injury sustained outside of 
the supervised exercise program. Overall, participants complied to the intervention with 
an average ± SD of 87% ± 20% of sessions completed with no difference in compliance 
rate between groups (p = 0.23). Average ± SD compliance rates for the resistance 
training group, aerobic training group and flexibility group were 88% ± 18%, 92% ± 9% 
and 79% ± 28% respectively. A total of four participants (3 completing flexibility 
training and 1 completing resistance training) completed less than 75% of the scheduled 
sessions. 
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Figure 8.2: Participant flow through study (Consort diagram) 
 
Repeated measures MANOVA for lipid profiles revealed no intervention by time 
interaction (p = 0.86) with no effect over time (p = 0.94) or between groups (p = 0.44). 
Repeated measures ANOVA also revealed no intervention by time interaction for HbA1c 
(p = 0.63), which also did not change significantly over time (p = 0.86). Repeated 
measures MANOVA for systolic and diastolic blood pressure revealed no intervention by 
time interaction (p = 0.11) but did identify a change over time (p = 0.03), which pair-wise 
analysis revealed was for a small (3 mmHg) increase in diastolic blood pressure (p = 
0.01). 
 
Mean RPE values throughout the aerobic exercise sessions were 12/20, while during the 
resistance exercise sessions they were reported as 16/20. Repeated measures MANOVA 
for variables of fitness, being estimated VO2peak and upper and lower body strength, 
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revealed a significant intervention by time interaction (p < 0.001). Univariate analysis 
confirmed these intervention by time interactions for strength (upper body, p = 0.001 and 
lower body, p < 0.001) but not for VO2peak (p = 0.22). Figure 8.3 shows the resistance 
training group experienced a 19% and 22% increase in bench press and leg press strength 
respectively compared to a 3% increase in bench press strength for both the aerobic 
training and flexibility groups along with a 4% increase and a 3% decrease in leg press 
strength for those in the aerobic training and flexibility groups respectively over the 8-
week intervention. Despite being no intervention by time interaction for VO2peak, there 
was a significant time effect (p = 0.005) where the aerobic training, resistance training 
and flexibility groups experienced a 16%, 6% and 5% increase respectively (Figure 8.3). 
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Table 8.1: Baseline participant demographics. Mean ± SD 
Outcome Resistance  Aerobic  Flexibility  
 Pre Post Pre Post Pre Post 
N (M/F) 10 (8/2)  14 (7/7)  12 (8/4)  
Age (years) 60.3±6.2  60.4±6.9  57.4±9.5  
Diabetes (years) 4.8±4.2  7.2±3.7  6.8±3.7  
Height (m) 1.69±0.09  1.67±0.09  1.72±0.11  
Weight (kg) 92.3±18.0 93.1±19.0 85.6±12.1 84.7±11.8 101.0±15.8* 100.0±15.9* 
BMI (kg·m-2) 32.1±5.2 32.4±5.4 30.9±4.1 30.6±4.0 34.4±6.7 34.0±6.2 
SBP (mmHg) 129±13 132±13 133±11 128±10 131±18 133±16 
DBP (mmHg) 78±10 83±9 78±8 79±8 81±6 81±8 
HbA1c (%) 7.2±0.7 7.4±0.7 7.7±0.9 7.7±1.1 7.3±0.7 7.2±0.5 
Total Cholesterol 
(mmol·L-1) 
4.6±1.4 4.3±1.1 4.5±0.6 4.4±0.8 4.5±1.1 4.6±1.0 
Triglycerides 
(mmol·L-1) 
1.6±1.1 1.4±0.9 1.6±1.0 1.5±0.5 1.8±0.7 1.9±0.7 
HDL-C (mmol·L-1) 1.28±0.26 1.30±0.20 1.26±0.21 1.26±0.19 1.25±0.29 1.24±0.22 
LDL-C (mmol·L-1) 2.6±1.3 2.4±1.0 2.5±0.7 2.4±0.7 2.4±1.1 2.5±0.9 
Glucose (mmol.L-1) 7.8±1.5 7.1±1.0 8.1±1.8 7.7±2.0 7.5±1.4 7.8±1.4 
Insulin (pmol·L-1) 107.8±59.4 110.0±50.0 92.7±51.4 89.9±49.4 121.6±57.6 126.6±67.2 
Insulin Sensitivity 
(HOMA%S) 
62.1±38.1 55.4±27.4 62.4±25.3 66.8±26.9 50.5±25.8 46.6±18.9 
Insulin Resistance 
(HOMA2-IR) 
2.2±1.2 2.2±0.9 1.9±1.1 1.9±1.1 2.4±1.1 2.5±1.2 
Estimated VO2max 
(ml·kg.-1·min-1) 
25.7±3.5 27.1±6.2 25.6±6.7 29.7±8.2 24.7±5.8 26.0±9.1 
Bench Press (kg) 50.3±16.9 59.8±21.9 39.4±17.4 40.7±16.4 42.1±22.7 43.3±21.9# 
Leg Press (kg) 172.5±67.1 211.3±81.5 148.0±50.6 153.6±52.2 152.1±54.9 148.3±51.4*# 
Leptin (ng·mL-1) 11.6±6.3 9.5±3.8 14.9±11.0 12.8±8.7 23.5±24.6 18.9±17.2 
Adiponectin (ng·mL-1) 14.3±11.0 9.9±7.5 14.6±7.5 14.4±7.9 10.8±7.7 14.0±7.9# 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HDL-C = high density 
lipoprotein-cholesterol; LDL-C = low density lipoprotein-cholesterol; VO2max = maximal oxygen uptake; * p < 0.05 
between groups, # p < 0.05 group x time interaction. Data for glucose, insulin, insulin sensitivity, insulin resistance, 
leptin and adiponectin was log transformed for statistical analysis but raw values are reported here for comparative 
purposes. 
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Figure 8.3: Change in fitness variables in response to 8 weeks of exercise. 
Change from pre to post eight week exercise intervention for fitness and strength outcomes. Mean change 
with 95% CI. * p < 0.005. 
 
Repeated measures ANOVA indicated no intervention by time interactions for fasting 
glucose (p = 0.23), fasting insulin (p = 0.75), insulin sensitivity (p = 0.80) or insulin 
resistance (p = 0.83). For fasting insulin, insulin sensitivity and insulin resistance there 
was also no statistically significant change over time (p > 0.05), however a time effect 
was found for fasting glucose (p = 0.04), where pair-wise analysis revealed a significant 
difference in glucose levels between two days after the final exercise session and seven 
days after the final exercise session (p = 0.05; Figure 8.4). While no statistical difference 
between the intervention and control groups for any of fasting glucose, fasting insulin, 
insulin sensitivity or insulin resistance were detected, there was a large practical change 
according to the effect size, between the resistance intervention and control (Cohen’s d = 
1.3) and the aerobic intervention and the control (Cohen’s d = 1.1) two days after the 
final exercise session. At seven days after the final exercise session, there was no 
practical difference between the aerobic and control interventions (Cohen’s d = 0.01), 
however a large difference remained between the resistance and control interventions 
(Cohen’s d = 0.9). Between the two exercise interventions there were trivial and small 
differences at two days (Cohen’s d = 0.14) and seven days (Cohen’s d = 0.36) after the 
final exercise session respectively. 
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In respect to fasting insulin concentrations, the only practical change of note was a 
moderate change (Cohen’s d = 0.63) between the aerobic intervention and the control 
seven days following the final exercise session, while interestingly, a similar change was 
observed between the two exercise interventions at the same time point (Cohen’s d = 
0.49). There was a small practical change noted between the aerobic intervention and the 
control (Cohen’s d = 0.42) for insulin sensitivity two days following the final exercise 
session, which increased to a large change (Cohen’s d = 1.03) seven days after the final 
exercise session, while a small change (Cohen’s d = 0.47) was observed between the 
resistance intervention and control only at seven days after the final session. There were 
small differences in the change between exercise interventions at both time points. For 
insulin resistance a moderate change was noted (Cohen’s d = 0.58) between the aerobic 
intervention and control only at seven days after the final exercise session. 
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Figure 8.4: Glucose, insulin, insulin sensitivity & insulin resistance in response to 8 weeks of exercise. 
Mean values for fasting plasma glucose (A), fasting serum insulin (B), insulin sensitivity (C) and insulin 
resistance (D) before exercise (baseline) and 2-d post (48 hours), 4-d post (96 hours) and 7-d post (168 
hours) after the final exercise session. # p = 0.004 for time effect between 2-d post and 7-d post. 
 
Repeated measures ANOVA revealed a significant intervention by time interaction for 
adiponectin (p = 0.04). Figure 8.5 shows the resistance training group experienced a 31% 
reduction in adiponectin concentration two days after the final exercise session before 
returning towards baseline, where as the flexibility group experienced a 29% increase 
two days after the final stretching session and then maintained that level while the 
aerobic training group essentially experienced no change at any time. The effect size 
suggested large changes between the resistance and control interventions (Cohen’s d = 
1.81) and aerobic and control interventions (Cohen’s d = 0.81) two days after the final 
exercise session that remained large seven days after the final exercise session for the 
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change between resistance and control interventions (Cohen’s d = 1.48) and the aerobic 
and control interventions (Cohen’s d = 1.02). Interestingly, there was also a large change 
between the two exercise interventions (Cohen’s d = 0.87) two days after the final 
exercise session, but only a small difference (Cohen’s d = 0.33) seven days after the final 
exercise session.  
 
Repeated measures ANOVA revealed no significant intervention by time interaction for 
leptin (p = 0.63), however a time effect was noted (p = 0.007). Pair-wise analysis 
identified a trend for a reduction (p = 0.08) from pre exercise to two days after the final 
exercise session and a significant increase (p = 0.007) between the values at two days 
after the final exercise session to seven days after the final exercise session (Figure 8.6). 
A small practical change was observed for leptin concentrations between the resistance 
and control interventions (Cohen’s d = 0.25) and aerobic and control interventions 
(Cohen’s d = 0.24) two days after the final exercise session, but no change seven days 
after the final session or at any time between the two exercise interventions. 
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Figure 8.5: Adiponectin response to 8 weeks of exercise. 
Mean values for adiponectin before exercise (baseline) and 2-d post (48 hours), 4-d post (96 hours) and 7-d 
post (168 hours) after the final exercise session. ** p = 0.04 for group by time interaction. 
 
 
Figure 8.6: Leptin response to 8 weeks of exercise. 
Mean values for leptin before exercise (baseline) and 2-d post (48 hours), 4-d post (96 hours) and 7-d post 
(168 hours) after the final exercise session. # p = 0.007 for time effect between 2-d post and 7-d post. 
 
Several regression models were constructed to determine whether any variables of fitness 
(relative aerobic capacity, absolute upper body strength & absolute lower body strength) 
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follow-up process at the end of the eight-week intervention period. Overall, fitness levels 
after the 8-week exercise intervention did not contribute to the change in glucose 
concentration at any time (p > 0.05). Post intervention fitness variables did contribute to 
the change in adiponectin (p = 0.05; R2 = 0.214) and leptin (p = 0.02; R2 = 0.259) at two 
days post exercise, however it did not contribute to the changes in adiponectin or leptin at 
any other time (p > 0.05). Stepwise regression identified the only contribution of the 
fitness variables to these changes was lower body strength for both adiponectin (p = 
0.005; R2 = 0.206) and leptin (p = 0.012; R2 = 0.171). When the changes in fitness 
variables (post minus pre) over the eight-week duration were considered, again there was 
no overall contribution to the change in glucose (p > 0.05). In addition, there was no 
contribution to leptin (p > 0.05) at all follow-up times. The change in fitness made a 
significant contribution to the change in adiponectin at two days post (p < 0.001; R2 = 
0.52) and at seven days post (p = 0.005; R2 = 0.322). Again, stepwise regression 
identified that only change in lower body strength was the major contributor to these 
changes in adiponectin at both two days (p < 0.001; R2 = 0.469) and seven days (p < 
0.001; R2 = 0.315) post exercise. With the exception of the change in leptin from two 
days post to seven days post exercise (p = 0.044; R2 = 0.221: stepwise lower body 
strength p = 0.006; R2 = 0.202), there was no difference in the contributions when 
strength was considered relative to body mass (Table 8.2). 
 
Additionally, the changes in body mass, BMI, and waist circumference were assessed to 
determine whether they contributed to the changes experienced in adiponectin and leptin 
concentrations. The change in anthropometric variables made a significant contribution 
to the change in adiponectin at two days post (p = 0.009; R2 = 0.302), with stepwise 
regression identifying change in body mass was the only major contributor to this (p = 
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0.001; R2 = 0.291). The change in anthropometrics did not contribute to the change in 
adiponectin at seven days post exercise (p = 0.547). The change in anthropometrics did 
however contribute to the change in leptin concentration at two days post exercise (p = 
0.010; R2 = 0.296) with stepwise regression indicating change in BMI (p = 0.009; R2 
0.186) along with change in BMI and body mass (p = 0.004; R2 = 0.290) were the major 
contributors. While the change in anthropometrics contributed to the change in leptin 
concentrations at seven days post exercise (p = 0.014; R2 = 0.280), no individual variable 
made a significant contribution to this change. 
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Table 8.2: Regression modelling analysis results 
Regression model – Relative aerobic capacity, absolute lower body strength & absolute upper body strength 
 Post intervention values  Intervention change values 
Dependent variable p value R2 value Stepwise factor p value R2 value  p value R2 value Stepwise factor p value R2 value 
Glucose pre - 2d change 0.633      0.951     
Glucose pre – 7d change 0.907      0.684     
Glucose 2d - 7d change 0.623      0.460     
Adiponectin pre - 2d change 0.050 0.214 Lower body strength 0.005 0.206  < 0.001 0.52 Lower body strength < 0.001 0.469 
Adiponectin pre - 7d change 0.148      0.005 0.322 Lower body strength < 0.001 0.315 
Adiponectin 2d – 7d change 0.761      0.814     
Leptin pre - 2d change 0.021 0.259 Lower body strength 0.012 0.171  0.725     
Leptin pre – 7d change 0.426      0.257     
Regression model – Relative aerobic capacity, relative lower body strength & relative upper body strength 
 Post intervention values  Intervention change values 
Dependent variable p value R2 value Stepwise factor p value R2 value  p value R2 value Stepwise factor p value R2 value 
Glucose pre - 2d change 0.575      0.922     
Glucose pre – 7d change 0.898      0.349     
Glucose 2d - 7d change 0.613      0.274     
Adiponectin pre - 2d change 0.020 0.261 Lower body strength 0.002 0.252  < 0.001 0.457 Lower body strength < 0.001 0.403 
Adiponectin pre - 7d change 0.105      0.017 0.271 Lower body strength < 0.001 0.264 
Adiponectin 2d – 7d change 0.786      0.886     
Leptin pre - 2d change 0.010 0.296 Lower body strength 0.002 0.241  0.729     
Leptin pre – 7d change 0.257      0.303     
Leptin 2d - 7d change 0.044 0.221 Lower body strength 0.006 0.202  0.861     
  
 
 
184 
 
8.5. Discussion 
This study investigated the insulin sensitivity response to eight weeks of resistance 
training or aerobic training in comparison to a sham exercise control group (flexibility 
training). The major finding from this study was that eight weeks of exercise following 
the exercise guidelines [53, 55] three times a week in individuals with diet or oral 
hypoglycaemic medication treated T2D, did not significantly impact insulin sensitivity or 
insulin resistance estimated using HOMA2 equations. Additionally, glycaemic control 
was not changed with either exercise intervention and this was despite the exercising 
groups experiencing significant increases in strength and fitness. These findings however 
are in agreement with results reported following 12 weeks of resistance, aerobic or 
combined exercise completed three days a week [100], resistance training performed 
three times a week at home for six months [89] and also following 12 weeks of low 
intensity resistance training when insulin sensitivity was estimated using an insulin 
tolerance test [102]. Conversely, others have reported improved insulin sensitivity 
estimated using fasting indices [91, 92], oral glucose tolerance tests [80, 90] and when 
resistance exercise was combined with a high protein diet [193]. Additionally, insulin 
resistance has also been reduced by completing 12 months of aerobic exercise and 
aerobic combined with resistance exercise [166]. 
 
The fasting glucose response to eight weeks of exercise is interesting in itself by 
suggesting that both resistance and aerobic exercise have the ability to reduce fasting 
glucose to the same degree at two days following the final exercise session which then 
appears to be better maintained by resistance training in comparison to glucose levels 
increasing beyond baseline at seven days after the final aerobic exercise session as 
indicated by the large practical change in comparison to the control for the resistance 
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exercise intervention against no change compared to the control for the aerobic 
intervention. Although the difference in response between the two exercise groups was 
not statistically different, this particular trend suggests that perhaps eight weeks of 
exercise is not long enough for a statistical difference to be observed. This trend and 
previous findings of differences between resistance and aerobic training [93] highlight 
the need for more studies that compare the prescription of both forms of exercise to find 
the optimal dose and time-course for modifying glucose tolerance and insulin sensitivity. 
In addition, studies investigating the exercise prescription that follows the most recent 
exercise guidelines, which contains both aerobic and resistance training, in comparison to  
isolated aerobic or resistance exercise are warranted. Cumulative improvements in blood 
glucose levels have been observed over four weeks of combined exercise [122], which 
suggests that a longer study duration may have been required before differences between  
interventions would have been observed and indicates the need for different training 
frequencies to be investigated over extended durations.  
 
A lack of change or an increase in insulin resistance has previously been theorised to be 
due to an increase in inflammatory profiles that results in a transient insulin resistance 
[159]. With this in mind, further research has been conducted to look at the metabolic 
profile of other markers of inflammation, such as adiponectin, an adipose derived 
cytokine that has been suggested to respond to exercise [33] and be an early marker of 
changes to insulin sensitivity [146]. The significant (and large practical) difference in the 
adiponectin response between the two exercise groups in this study potentially argues 
against this as although adiponectin decreased following resistance training, glucose 
levels were also reduced. This also highlights the potentially different mechanisms in 
which resistance and aerobic training alter blood glucose levels, as similar reductions in 
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fasting glucose were found despite different concentrations of adiponectin. Further, the 
identification that both absolute and relative lower body strength was the only 
independent fitness component contributing 21% to 52% of the change to adipocytokines 
from pre exercise to post exercise, supports such a hypothesis. Interestingly though, it 
appeared to be only the change from pre to post exercise and not the changes during the 
follow-up period from two days after the final session to seven days after the final 
session, that were contributed to by variables of fitness. 
 
Following 12 months of high intensity aerobic exercise and combined aerobic and 
resistance exercise twice a week, concentrations of adiponectin were significantly 
increased while concentrations of leptin were significantly decreased [166]. This was 
reported along with reductions in high sensitivity C-reactive protein with the aerobic and 
combined exercise groups, where the combined group tended to continually decrease 
compared to the initial decrease that was maintained with aerobic exercise and significant 
reductions in the concentration of tumour necrosis factor-alpha (TNF-α) when compared 
to the non-exercising control group [166]. These findings were unable to be totally 
replicated, with adiponectin concentrations reducing following resistance exercise, being 
maintained with aerobic exercise and increasing in the sham exercise control –two days 
after the final training session. A trend for a reduction in leptin concentration was 
observed in all groups two days after the final session that then increased significantly 
back to or beyond baseline at seven days after the final session. Findings from Jorge et al. 
[100] differ again by reporting that after 12 weeks of either aerobic, resistance or 
combined exercise, adiponectin and TNF-α did not change and all groups (including the 
non-exercising control) experienced significant reductions in high sensitivity C-reactive 
protein. Interestingly though, expression of insulin receptor substrate-1, which is part of 
 
 
187 
 
the insulin signalling cascade, increased only after resistance exercise or when resistance 
exercise was combined with aerobic training [100]. Again signifying that different 
mechanistic pathways may be utilised in modulating insulin sensitivity and glycaemic 
control. 
 
While the duration and intensity of training in this study is different to some of the 
previous studies, it has been able to replicate some data and provide a contrasting view to 
others. The main finding from this study is that while following the exercise guidelines 
for eight weeks, people with T2D experienced improved levels of cardio-respiratory 
fitness and muscle strength, however long-term glycaemic control (HbA1c) and insulin 
sensitivity were not affected at two, four or seven days after the final exercise session. It 
is likely that the short study duration of the intervention and low sample sizes affected 
the trend for the difference in fasting glucose response between the aerobic and resistance 
exercise groups and this justifies the need for further research into how each of the 
exercise modalities impact glucose tolerance over an extended duration, especially given 
reports that insulin receptor substrate-1 expression is increased with resistance exercise 
but not aerobic exercise [100]. Differences in the response to adiponectin concentration 
in this study further highlights the need for this area of research and particularly to clarify 
how adipose derived cytokines and markers of inflammation impact the clinical diabetes 
outcome of blood glucose levels. However, the low statistical power and lack of a direct 
measure of insulin sensitivity limits the generalisability of this study and must be 
considered in the interpretation of the findings. 
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8.6. Conclusion 
From this study, it can be concluded that completing exercise in accordance with the 
guidelines for people with T2D for eight weeks is not sufficient for manipulating clinical 
diabetes outcomes of glycaemic control or insulin sensitivity, failing to prove the original 
hypothesis. What is clear however, is that exercise needs to be performed on an ongoing 
basis, as concentrations of glucose and leptin had deteriorated to a point above baseline 
values within seven days of completing the exercise intervention. While this does not 
clarify the optimal frequency at which exercise should be completed, it does highlight the 
acute nature of the response to a period of ongoing exercise training and the need to 
perform exercise on a regular basis. Whether the frequency and/or intensity of exercise 
participation to experience and maintain metabolic benefits changes over time, is still 
unknown. 
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9. General Conclusions 
 
The studies in this thesis set out to investigate the impact of a single session of resistance 
exercise on insulin sensitivity and glucose tolerance and then whether undertaking a 
period of ongoing training modifies this impact. This was done specifically in relation to 
exercise prescription guidelines for people with type 2 diabetes (T2D). With all of the 
data and research indicating that the prevalence of T2D is set to continue to increase [19, 
20], the minimal effective exercise dose to achieve maximum adherence, for the primary 
prevention of T2D and the secondary prevention of diabetic complications and 
cardiovascular risk factors is required. Therefore this series of studies set out to explore 
the response of insulin sensitivity and glucose tolerance to resistance exercise and how 
long this response remained with the intention to better inform guidelines regarding 
training frequency. 
 
The numerous diabetes prevention programmes around the world have shown the 
effectiveness of exercise interventions and healthy nutrition choices as part of a general 
improvement to an individual’s lifestyle to reduce the incidence of T2D [163, 194-197], 
even in comparison to therapeutic medications [163]. These exercise interventions have 
mainly comprised aerobic type exercise though, which has been reflected in exercise 
guidelines for T2D. However, it seems clear that the exercise guidelines for individuals 
with T2D, especially in regards to resistance training, have been mainly based on data 
collected from individuals without T2D given that only two randomised controlled trials 
were cited in the initial population specific guidelines [55], and that only one randomised 
controlled trial involving resistance training in people with T2D [80] had been completed 
at the time the guideline was published. As the years progressed, more major health and 
diabetes organisations released exercise guidelines, yet even with the body of literature 
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surrounding resistance training in particular; there remains no consensus as to the most 
effective dose of resistance exercise for people with T2D.  
 
Overall, from this series of studies the following conclusions were drawn: 
i. A systematic review of the literature on resistance training interventions in 
people with T2D identified that diverse methods of measuring insulin 
sensitivity and glucose tolerance outcomes are commonly employed. 
Therefore only a general conclusion that a period of ongoing resistance 
training will result in an improvement to insulin sensitivity anywhere from 24 
hours after the final exercise session through to 72-96 hours after the final 
exercise session was able to be drawn. Both of these time frames vary 
considerably from the recommendations of undertaking resistance training 
every two to three days [50-52, 71]. An important limitation identified from 
these studies was a lack of tracking the change to insulin sensitivity and 
glucose tolerance, therefore the length of time that insulin sensitivity was 
improved following a session, or a period, of resistance exercise is not known. 
 
ii. Various investigators have used cytometric bead array analysis to measure 
multiple cytokines, adipokines and hormones in humans under a variety of 
conditions [137-139, 142]. While concerns around accuracy have seemingly 
been allayed [135], Timmons and colleagues [142] reported a lack of 
statistical agreement between values obtained through cytometric bead array 
analysis and the ELISA method. Therefore a preliminary methodological 
study was completed investigating the hypothesis that cytometric bead assay 
would be sensitive enough to accurately measure adipocytokines. In 
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agreement with Timmons and colleagues [142], statistical analysis of values 
obtained through both cytometric bead array and ELISA determined that 
hormone and adipocytokine concentrations were different, and that it was 
likely that the cytometric bead array was not sensitive enough to detect all of 
the required adipocytokines or accurate enough when they were detected, 
hence failing to prove our hypothesis correct.  
 
iii. Oral glucose tolerance tests (OGTT) have been used to estimate insulin 
sensitivity and the change in insulin sensitivity following an exercise program 
in people with type 2 diabetes for many years [62, 63, 80, 90, 160], however 
repeatability of the OGTT has only been assessed between two and seven 
days after the initial test [150, 151], but never on two consecutive days. An 
investigation was undertaken into the hypothesis that an OGTT repeated on 
four consecutive days would produce similar estimates of insulin sensitivity. 
Analysis of the intra-individual variation of insulin sensitivity found a mean 
coefficient of variation of 7.8% and no statistical difference between days, 
allowing the conclusion that OGTTs provide replicable estimates of insulin 
sensitivity when repeated four days in a row in apparently healthy individuals, 
proving the hypothesis correct. However, the OGTT may not be suitable to 
estimate insulin sensitivity in those people with a metabolic disturbance such 
as T2D. This is an important finding as numerous studies have collected data 
on individuals with T2D following a single session of resistance exercise [62, 
63] and ongoing resistance exercise [80, 90], using the OGTT. Therefore, 
caution is needed when interpreting this data. 
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iv. Findings regarding insulin sensitivity in response to a single session of 
resistance exercise in apparently healthy individuals are equivocal [64-68], 
although a time course study is yet to be completed. In a study investigating 
the insulin sensitivity response over four days to a single resistance exercise 
session, it was hypothesised that a single session of resistance exercise would 
not modulate insulin sensitivity in apparently healthy individuals. However, it 
was concluded that insulin sensitivity was impaired to a practically relevant 
level for at least four days in inactive apparently healthy individuals who were 
unaccustomed to resistance exercise, failing to prove the hypothesis. This 
however, concurred with findings from Howlett and colleagues who measured 
insulin sensitivity with a euglycaemic-hyperinsulinaemic clamp [66] and is 
likely due to an increase in levels of inflammation theorised to cause transient 
insulin resistance [159]. 
 
v. In contrast, in individuals with type 2 diabetes, a single session of resistance 
exercise appears to improve insulin sensitivity for up to 24 hours [62, 63], 
however each of these studies used OGTTs to estimate insulin sensitivity. 
With these and earlier findings from this thesis, it was hypothesised that a 
single session of resistance exercise would improve insulin sensitivity in 
people with type 2 diabetes when compared to apparently healthy individuals. 
In this case, estimates of insulin sensitivity were obtained using an index 
(HOMA2) from fasting glucose and insulin concentrations and identified no 
significant change to insulin sensitivity at 24 hours, 48 hours or 72 hours after 
a single session of resistance exercise, with no difference in the response in 
people with and without T2D, rejecting the hypothesis. This finding may be 
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different to previous findings using a similar exercise protocol in a similar 
population [62, 63] due to a different method of estimating insulin sensitivity 
being employed. This also provided information that resistance exercise 
following the broad exercise guidelines of 2-3 sets of 10 repetitions at a 
moderate-high intensity did not have a negative influence on metabolic health 
as theorised markers of transient insulin resistance [159] also did not change. 
However, given the reliance on fasting glucose and insulin concentrations that 
can only be obtained once a day, it was unclear whether any affect was so 
acute that it was being missed. 
 
vi. Technological improvements in continuous glucose monitoring devices have 
been utilised to improve treatment of individuals’ with type 1 diabetes [198] 
and others have recently reported the glucose response to a single session of 
exercise in individuals with type 2 diabetes to improve by decreasing [177, 
181]. Using continuous glucose monitors to assess glucose control to compare 
resistance and aerobic exercise of a volume and intensity prescribed according 
to the exercise guidelines, it was hypothesised that a single session of 
resistance exercise would improve glucose control to a similar extent as that 
experienced following a single session of aerobic exercise. The findings were 
in opposition to those from other investigators [177, 181] and indicated the 
glucose response to a single, session of unaccustomed exercise in normally 
inactive individuals with type 2 diabetes had a negative, short-term impact on 
24-hour glucose response and that this was independent of exercise mode. 
The key differences between the population of this study and other published 
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studies is the intensity of exercise had not followed the exercise guidelines 
previously and was much lower [177, 181] than that prescribed in this study. 
 
vii. Metabolic health (explained through estimates of insulin sensitivity and 
measures of glucose control) has been reported to improve [62-64, 177, 181], 
or not [61, 65-68], depending on the population and the exercise dose. The 
initial studies from this PhD thesis using different populations (apparently 
healthy individuals, people with type 2 diabetes either taking no medication or 
oral hypoglycaemic medications, and people with insulin requiring type 2 
diabetes) and different methods of estimating and measuring metabolic health 
using the same (or extremely similar) exercise dose, indicate metabolic health 
is impaired for a short period of time following such unaccustomed exercise. 
However, this does not appear to be due to transient insulin resistance 
associated with increased inflammation thought to accompany muscle damage 
[159] as adipocytokine markers of inflammation did not change. This 
highlights potential inadequacies of the methods for estimating insulin 
sensitivity and / or the intensity and volume of the recommended exercise 
prescription. 
 
viii. The general consensus from chronic resistance training interventions is that 
insulin sensitivity and glycaemic control are improved [70, 72, 74, 75, 78, 
165] however, the follow up period of each trial investigating these outcomes 
varied from 36-48 hours [79] to 72-96 hours after the final exercise session 
[90]. The hypothesis that compared to a sham exercise (flexibility training) 
control group; there would be no difference in the change to insulin sensitivity 
after aerobic or resistance exercise training was investigated using an eight 
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week intervention, exercising three days each week, prescribed according to 
the exercise guidelines. The results rejected the hypothesis and refuted 
findings reported previously [80, 90-92, 94] by finding that moderate to high 
intensity exercise was not sufficient to impact insulin sensitivity. However, 
while not being statistically significant, a moderate reduction in fasting 
glucose levels were observed two days after the final exercise session that 
appeared to be maintained for seven days after resistance training compared to 
reverting to baseline levels four days after the final session and deteriorating 
above baseline, seven days after the final exercise session in those 
undertaking aerobic exercise. Due to the follow-up period that was employed, 
this is a finding that has not been reported previously; although Cauza et al. 
[92] have reported that resistance training significantly reduces insulin 
resistance when compared to aerobic exercise in a small, RCT from which the 
results are limited by the lack of a non-exercise control group. While no solid 
conclusions can yet be drawn from this study, further investigation is 
warranted, as it would appear that resistance exercise may need to be 
undertaken less frequently than aerobic training to have the same glucose 
lowering effect. This however, might have important consequences of 
reducing the risk of renal disease, neuropathy, retinopathy and cardiovascular 
disease [4]. If this is proven to be the case, the positive implication for the 
prescription of exercise is increased adherence to exercise by individuals with 
T2D who may be more likely to complete exercise once or twice a week, 
compared to three, four or five days a week, given the common perception of 
not having enough time to exercise [157]. 
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9.1. Limitations and Delimitations 
 
Limitations and Delimitations of these studies include: 
i. Only two of the studies completed utilised randomised designs; however the 
preliminary methodological studies and the initial resistance exercise response 
study investigated only a single group of participants to initially confirm methods 
to be used in the later studies, and the other resistance exercise response study 
compared two distinct populations (apparently healthy vs T2D) meaning that 
randomised designs were not appropriate. 
 
ii. Participants were not recruited equally amongst genders, with the exception of the 
final acute resistance exercise study that investigated only males. However, all 
participant characteristics were extensively detailed allowing for the 
generalisation to other individuals with similar characteristics, additionally there 
is no clear evidence in the literature that suggests genders respond differently to 
exercise.  
 
iii. The gold standard measurement for insulin sensitivity of the euglycaemic-
hyperinsulinaemic clamp has not been used throughout this thesis. However, 
estimates from oral glucose tolerance tests and fasting indices correlate highly 
with the gold standard technique. Indeed, all of these methods only provide 
isolated ‘snapshots’ about glucose and therefore the final time course study of a 
single session of exercise was conducted using continuous glucose monitors. 
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iv. The durations of these investigations were short, investigating a single session of 
exercise and then eight weeks of exercising three days a week. The short nature of 
the eight week intervention did not allow for the assessment of the long-term 
adherence to the exercise program. However, assessing adherence was not the 
objective of this thesis but rather investigating the duration of any changes to 
resistance exercise to better inform, and provide guidance for training frequency. 
 
v. The attention given to each group was identical over each of the acute 
interventions and the eight-week intervention by using a sham exercise group to 
counteract differences in researcher time given to the control group. Therefore, 
adherence or non-adherence to the intervention was not the result of increased or 
decreased opportunity to access external motivation and support. 
 
vi. The follow-up of interventions investigating the time-course of change in 
response to exercise addresses limitations of previous interventions, and one 
study specifically used a technique that allowed for measurement continuously 
for 24 hours a day for a period of three days after the completion of the exercise 
session. 
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9.2. Recommendations 
 
At the conclusion of these studies, several directions for future research are 
recommended: 
 
i. Further investigations are required to determine (i) whether a similar 
glucose response occurs after single and multiple exercise sessions, and 
(ii) whether the glucose response is similar in individuals who are well 
trained in comparison to those who are inactive. This will help elucidate 
the frequency, intensity and timing of exercise prescription necessary in 
relation to initial and ongoing adaptations. 
 
ii. Initial research using low intensity exercise interventions have shown 
beneficial results following a single session [177, 181] and following four 
to six weeks of resistance exercise [107] in people with type 2 diabetes. 
This also has potential implications for exercise compliance as exercise 
interventions that are simple and convenient to complete are more likely 
to be complied with long-term than interventions that require large time 
investments, special equipment and organisation in terms of having 
appropriate clothing and amenities. Therefore, further research using 
continuous glucose monitors during low intensity resistance exercise in 
people with type 2 diabetes is warranted. 
 
iii. Therefore, finally, research should be completed with varied intensities of 
resistance exercise over extended durations to determine the intensity that 
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leads to the best compliance so that it can then be determined how best to 
implement exercise at that particular intensity. There is unequivocal 
evidence that exercise is the most powerful intervention to prevent and 
treat chronic disease such as type 2 diabetes, however ensuring people 
adhere to such interventions is the next challenge. 
 
In Summary, from this series of studies, it is possible to suggest that a single session of 
resistance exercise following the broad exercise guidelines currently available for people 
with type 2 diabetes, has either no impact, or a short-term impairment on insulin 
sensitivity and glucose control in both apparently healthy individuals and those with type 
2 diabetes. Interestingly this appears to be in contrast to data reported following exercise 
completed at a low intensity following a single exercise session or high intensity exercise 
after a period of chronic training. Without being able to accurately define the frequency 
of resistance training required to first improve and then maintain insulin sensitivity and 
glucose control, this dissertation has provided valuable information from which further 
studies can be designed to identify the minimum effective exercise prescription in people 
with type 2 diabetes. What can be concluded though is that for resistance exercise to be 
effective, it needs to be completed on a regular basis. The studies in this thesis have 
investigated resistance exercise prescribed in accordance with the current broad exercise 
guidelines and shown minimal effect on insulin sensitivity and other markers of 
metabolic health. Therefore, further research should be conducted using intensities 
different to those currently recommended, such as low intensity resistance training, to 
elucidate optimal gylcaemic control for both novice and trained people with type 2 
diabetes.  
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This paper systematically reviews the effect of resistance training (RT) on glycemic control
and insulin sensitivity in adults with type 2 diabetes.
Twenty studies were included, with the volume, frequency and intensity of RT varying
markedly. Supervised RT improved glycemic control and insulin sensitivity, however, when
supervision was removed compliance and glycemic control decreased. Evidence indicates
themechanisms behind the improvements to glucose tolerance require further elucidation.
Although research demonstrates apparent benefits of RT for individuals with diabetes,
further research is required to elucidate the minimum effective dose by describing fre-
quency, intensity and the duration of acute and chronic improvements.
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The world-wide incidence of type 2 diabetes continues to
increase [1] however, despite exercise being promoted as a
vital part of the treatment process, exercise prescription does
not vary between prevention and treatment. For individuals
with existing diabetes, specific benefits of exercise include
increased insulin sensitivity, improved glycemic control [2,3],
improved lipid profile and lower blood pressure [3]. Impor-
tantly, individuals with diabetes completing exercise training
using various exercise modes for between 8 weeks and 12
months have experienced decreased HbA1c by clinically
significant levels (0.6%), improved insulin sensitivity and
reduced serum triglycerides [4].
The American College of Sports Medicine (ACSM) endorses
exercise as a treatmentmethod for peoplewith type 2 diabetes
and currently recommends expending a minimum cumula-
tive total of 1000 kcal/wk of energy from aerobic activities [5].
The American Diabetes Association (ADA) has similar recom-
mendations for at least 150 min per week of moderate
intensity aerobic physical activity and/or 90 min per week of
vigorous aerobic exercise [6]. Accordingly, aerobic exercise has
been the major focus for exercise-training studies due to
consistent findings of improved glucose control [7,8], however
long-term compliance to these recommendations remains
low [9] necessitating the investigation of an effective strategy
to improve adherence rates.
More recently, resistance training has been the focus of
increased research and is suggested to improve glycemiccontrol and insulin sensitivity partially via similar mechan-
istic pathways to aerobic training [10], and partially through
discrete pathways providing additive insulin signalling
benefits. The focus on resistance training is in part due to
a recognition that individuals with type 2 diabetes, who are
also likely to be obese or suffering from other co-morbidities,
are likely to struggle to achieve the volume and intensity of
aerobic training that is required to be effective [10,11], and
therefore compliance to resistance training may be higher.
Both the ACSM and the ADA have now included resistance
training in their exercise prescription guidelines for younger
individuals with type 2 diabetes and for older individuals
with type 2 diabetes free of contraindications. The recom-
mendations are; one set of 10–15 repetitions for 8–10
exercises twice a week [5] and, progressing to three sets of
8–10 repetitions three times a week [6]. These recommenda-
tions have largely been based on information regarding
healthy individuals and the few [12–15] randomized con-
trolled trials of resistance training in individuals with type 2
diabetes completed at the time that they were published.
However, it should be noted that significant improvements
to insulin sensitivity in healthy individuals have been
reported only when resistance training was performed three
or more days a week [16] and the responses of individuals
with diabetes may differ. It is therefore the purpose of this
paper to systematically review the literature on the effects
of resistance training on the diabetes markers of glycemic
control and insulin sensitivity in individuals with type 2
diabetes.
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2.1. Search strategy
OvidMEDLINE (1950 to August week 3, 2008), OvidMEDLINE In-
Process (September 02, 2008), OLD MEDLINE (1950–1965),
CINAHL (1982 to August week 5, 2008) and EMBASE (1980 to
2008 week 35) electronic databases were searched on Septem-
ber 03, 2008. First, three keyword and categorical searcheswere
performed (i) ‘diabetes’,or ‘diabetesmellitus’, or ‘type2diabetes
mellitus’; (ii) ‘weight lifting’, or ‘resistance training’, or ‘strength
training’, or ‘weight training’, or ‘progressive resistance train-
ing’, or ‘circuit training’; (iii) ‘glucose intolerance’, or ‘blood
glucose’, or ‘glucose’, or ‘glucose metabolism disorders’, or
‘glucose tolerance test’, or ‘insulin’, or ‘insulin resistance’, or
‘diabetes complications’, or ‘haemoglobin A’, or ‘glycosylated
haemoglobin A’, or ‘HbA1c’. Second, categories i–iii were
combined using ‘and’, limited to humans and reported in the
English language with duplicates removed. In addition, refer-
ence lists of all publicationsmeeting the inclusion criteriawere
manually searched to identify any relevant studies not found
through electronic searching.
2.2. Inclusion and exclusion criteria
Studies that met the following criteria were included in this
review: (i) published in English (ii) cohorts were adults above
the age of 18 years with type 2 diabetes, (iii) a form of
resistance training was included as an isolated intervention
arm, (iv) it was an intervention study, (v) one diabetes markerFig. 1 – Sequence of searching and search results. RCT, randomi
UCT, uncontrolled trial; combined interventions, aerobic and re(HbA1c, fasting glucose or insulin, insulin sensitivity) or an
insulin signalling outcome were reported. Non-trial studies,
review or opinion/editorial papers were excluded along with
studies that did not report diabetes or insulin signalling
markers or studies that investigated only individuals without
diabetes. Interventions that combined resistance training
with another intervention (aerobic training or diet) or did not
involve ongoing training were also excluded.
2.3. Statistical analyses
To avoid misrepresentation of the presented data, a meta-
analysis has not been conducted due to the methodological
differences in terms of frequency and intensity of training,
along with the number and type of exercises completed.
Clinical significance has been interpreted as a 0.6% improve-
ment in HbA1c [4]. Effect sizeswere not calculated as only four
papers included in the review provided enough information to
enable effect size to be calculated.3. Results
3.1. Search results
Twenty-four papers from 20 studies met the criteria and are
included in this review. Search results are shown in Fig. 1. One
doctoral dissertation was excluded, but its related publication
identified and also excluded [17]. A paper reporting insulin
sensitivity data was excluded [18] as this data had beenzed controlled trial; NRCT, non-randomized controlled trial;
sistance training OR diet and resistance training.
Table 1 – Study quality.
Reference Design Subjects Intervention Compliance Outcome Measures
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Resistance Training
Winnick[28] 2008 RCT Y N N N Y Y Y Y N N N N N Y Y N Y N
Baum [21] 2007 RCT Y N N N Y N ? Y Y N N N N Y N N Y N
Brooks [22] 2007 RCT Y N Y N Y Y Y Y Y N N Y Y Y Y N Y Y
Sigal [27] 2007 RCT Y Y Y N Y Y Y Y Y Y Y Y N Y Y Y Y N
Castaneda [29] 2006 RCT Y N Y N N Y Y Y Y N N N N Y Y N Y Y
Dunstan [25] 2006 RCT Y N N N Y Y Y Y N Y Y Y Y Y Y N Y N
Gordon [26] 2006 RCT Y N N N Y Y Y Y Y N Y Y N Y Y N Y Y
Cauza [24] 2005 RCT Y N N N Y Y Y Y Y Y Y N N Y N N Y N
Cauza [23] 2005 RCT Y N N N Y Y N Y Y Y N N N Y Y N Y N
Dunstan [20] 2005 RCT Y N N N N Y Y Y Y Y Y Y N Y Y N Y Y
Baldi [12] 2003 RCT Y N N N N Y Y Y Y Y Y Y N Y Y N Y Y
Castaneda [13] 2002 RCT Y N Y N Y Y Y Y Y Y Y Y Y Y Y N Y Y
Dunstan [15] 1998 RCT Y N N N Y Y Y Y Y N Y N Y Y Y N Y Y
Ibanez [35] 2008 NRCT N N N N Y Y N Y Y N N Y N Y Y N Y Y
Colberg [31] 2006 NRCT N N N N Y Y N Y Y N N N N Y Y N Y N
Wojtaszewski [34] 2005 NRCT N N N N N Y N Y Y N N N Y N N N Y N
Fenicchia [32] 2004 NRCT N N N N Y Y N Y Y N N N N Y Y N Y N
Holten [19] 2004 NRCT N N N N N Y N Y Y N N N N Y Y N Y N
Ishii [30] 1998 NRCT N N N N N Y Y Y Y N N N N Y Y N Y N
Honkola [36] 1997 NRCT N N N N N N ? Y Y Y Y Y Y Y Y N N N
Smutok [37] 1994 NRCT N N N N Y Y Y Y Y N N N N Y Y N Y N
Misra [40] 2008 UCT N N/A N N Y N/A N/A Y Y N N Y N Y Y N N/A N
Ibanez [39] 2005 UCT N N/A N N Y N/A N/A Y Y Y Y Y N Y Y N N/A Y
Eriksson [38] 1997 UCT N N/A N N N N/A N/A Y Y Y N N N Y Y N N/A N
RCT, Randomized controlled trial; NRCT, non-randomized controlled trial; UCT, uncontrolled trial; ?, not specified; Y, yes; N, no; N/A, not
applicable; Adverse events reported, refers to whether the authors reported on adverse events, not that adverse events occurred; CV’s
provided, coefficient of variation of the measure reported within the methodology section, indicating reliability of the measure.
d i a b e t e s r e s e a r c h and c l i n i c a l p r a c t i c e 8 3 ( 2 0 0 9 ) 1 5 7 – 1 7 5160published previously [19]. A paper reporting phase one of a
study [14] was excluded due to having a weight loss diet added
to the resistance training, however a paper describing phase
two [20] was included as dietary modification was ceased at
the completion of phase one.
3.2. Study design/quality assessment
Most (10/13) of the papers based on randomized controlled
trials (RCT) [13,15,21–28] reported eligibility criteria (Table 1);
as did just more than half (6/11) of the trials that had no
randomization.
Assessors were reported to be blinded in only three papers
[13,27,29]. In all studies, previous medical intervention was
maintained with changes to drug regimes occurring only
where medically required. With one exception [30], all studies
were completed using an out-patient design with participants
under free-living conditions.
3.3. Baseline characteristics
Generally, there were no differences between intervention
and control groups except where studies were intentionally
designed to compare different cohorts [19,31–35] (Table 1).Baseline characteristics differed in one RCT [23] with the RT
group having higher fasting blood glucose levels and lower
body mass index and fat mass than untrained controls. Two
studies did not report any analysis between groups at baseline
[21,36], although there appears to be some differences in the
data presented in these [21,36].
3.4. Statistical analysis and power calculations
The purpose of the research was outlined in all studies except
two [21,24], however one paper [34] did not report the purpose
despite a previouspaper [19] from the samestudy reporting this
information. Additionally, few papers (6/21) reported how
missing data were treated (Table 1). With the exception of
one study [36], the intervention and control groups were
subjected to the sameresearchmethodology andanalysis.Only
one study [27] reported determining sample size by a priori
power calculation.4. Resistance training for type 2 diabetes
Within the included studies, RT was almost always
completed using machines, including pin-loaded machines
Table 2 – Exercise intervention characteristics.
Author (year) country N = Sample Control/Comparison
condition
Exercise mode and
intervention
F: Frequency Strength test Resistance
training
equipment
Duration Supervision
M/F I: Intensity
Age y D: Duration
Winnick et al.
(2008) USA [28]
n = 59
Whites = 23
RT = 8
AT = 15
African = 36
RT = 12
AT = 24
M = ?/F = ?
25–60 y
White subjects
Aerobic: 30–40 min
walking on motorized
treadmill, 3 week1 for
first 4 weeks
expending 600 kcal/wk,
then 5 week1 expending
1000 kcal/wk
Progressive resistance
training:
8 exercises: not specified,
modified after 4 weeks
in accordance with
performance outcomes
F: NR
I: NR
D: NR
10RM
All exercises
Machine
weights
8 weeks NR
Baum et al. (2007)
Germany [21]
n = 40
RT = 13
Flex = 13
Vib = 14
M = 24/F = 16
62.9  7.3 y
Flexibility: 8 exercises,
15 min
Vibration: 8 exercises,
20 min
Resistance training
8 whole-body exercises:
leg extension, seated leg
flexion, leg press, seated
calf raise, lat pulley,
horizontal chest press,
butterfly and rowing
Wk 1–6 70% 1RM
Wk 7–9 increase to
2 sets  12 reps, Wk
10–12, 3 sets  10 reps,
80% 1RM
F: 3 week1
I: 1 set 
12 reps
D: 45 min total
1RM
Max isometric
torque (quads)
Machine
weights
12 weeks All sessions:
unspecified
personnel
Brooks et al. (2007)
USA [22]
n = 62
RT = 31
C = 31
M = 40/F = 22
66  15.7 y
Standard type 2 DM
care
Resistance training and
standard care
5 whole-body exercises:
upper back, chest press,
leg press, knee extension
and flexion
Wk 1–8 60–80% 1RM
Wk 10–14 70–80% 1RM
F: 3 week1
I: 3 sets  8 reps
High intensity
D: 45 min total,
5 min warm-up
and cool down
1RM
- Upper and
lower body
Pneumatic
Machine
weights
16 weeks NR
Sigal et al. (2007)
Canada [27]
n = 251
RT = 64
AT = 60
CT = 64
C = 63
M = 160/F = 91
54.7  7.5 y
Aerobic: 3 week1
45 min @ 75% HRmax
Combined: Aerobic and
resistance 3 week1
Control: No exercise
intervention
Resistance training
7 whole-body exercises:
Abdominal crunches, seated
row, biceps curls, bench press,
leg press, shoulder press and
leg extension. Progressing
from 1 set of 15 reps
@ 15RM to 3 sets of 8 reps
@ 8RM
F: 3 week1
I: 2–3 sets
 7–9 reps
D: NR
2–3 min
between sets
8RM Machine
weights
26 weeks Weekly first
4 weeks, then
fortnightly:
Unspecified
personnel
d
ia
b
e
t
e
s
r
e
s
e
a
r
c
h
a
n
d
c
l
in
ic
a
l
p
r
a
c
t
ic
e
8
3
(2
0
0
9
)
1
5
7
–
1
7
5
1
6
1
Table 2 (Continued )
Author (year) country N = Sample Control/Comparison
condition
Exercise mode and
intervention
F: Frequency Strength test Resistance
training
equipment
Duration Supervision
M/F I: Intensity
Age y D: Duration
Castaneda et al.
(2006)
Germany [29]
n = 18
RT = 13
C = 5
M = 6/F = 12
66  8 y
Standard type 2 DM
care
Resistance training
5 whole-body progressive
exercises: 2 upper body,
3 lower body exercises
60–65% 1RM, increasing
to 75–80% 1RM by week 4
F: 3 week1
I: 3 sets  8 reps
Moderate-high
intensity
D: 45 min total,
5 min warm-up
and cool down
1RM
- 2 upper and
3 lower body
exercises
Pneumatic
Machine
weights
16 weeks All
sessions:
unspecified
personnel
Dunstan et al.
(2006)
Australia [25]
n = 60
Int = 28
C = 29
M = 33/F = 27
60.5  8.2 y
Home-based resistance
training: given 1
dumbbell and weight
plates. Monthly
telephone call
Community gym-based
resistance training
8 whole-body exercises: similar
to program undertaken in
a supervised setting previously
F: 2 week1
I: 3 sets  8 reps
Increase weight
when able to
perform 3 sets
 8 reps
D: NR
1RM
-Bench press
- Leg extension
Machine
and free
weights
12 months Yes,
YMCA staff
Gordon et al.
(2006) USA [26]
n = 30
RT = 15
C = 15
M = 15/F = 15
67  11 y
Standard type 2 DM care:
no exercise, fortnightly
telephone interview
Resistance training and
standard care
5 whole-body progressive
exercises: knee extension,
chest press, leg curl, upper
back and leg press
60–65% 1RM, increasing
to 75–80% 1RM by week 4
F: 3 week1
I: 3 sets  8 reps
D: 45 min total,
1–2 min rest
between sets,
5 min warm-up
1RM Pneumatic
Machine
weights
16 weeks Yes:
unspecified
personnel
Cauza et al.
(2005)
Austria [24]
n = 43
RT = 22
AT = 17
M = 22/F = 21
56  6.6 y
Aerobic training: cycle
3 week1, 15 min
progressing 5 min
per week to 90 min
@ 60% VO2max
Resistance training
10 min warm-up moderate
cycling
Minimal weight wk 1 and
2 to teach technique
Progressive resistance
from wk 3
10 whole-body exercises: bench
press, chest cross, shoulder press,
pull downs, biceps curls, triceps
extensions, situps, leg press, calf
raises, leg extensions,
increasing to 4, 5 and 6 sets/wk
F: 3 week1
I: 3 sets/wk
 10–15 reps
i.e. 1 set
 10–15 reps
each session
Weight
increase
when able
to complete
15 reps
D: NR
1RM
- bench press
- rowing
- leg press
All seated
Machine
and free
weights
4 months All sessions:
Professional
instructor,
Physician
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Cauza et al.
(2005)
Austria [23]
n = 15
RT = 8
AT = 7
M = 4/F = 11
55  7.8 y
Aerobic training: cycle
3 week1, 15 min
progressing 5 min per
week to 90 min
@ 60% VO2max
Resistance training
10 min warm-up moderate
cycling
Minimal weight wk 1 and
2 to teach technique
Progressive resistance from wk 3
10 whole-body exercises: bench
press, chest cross, shoulder press,
pull downs, biceps curls, triceps
extensions, sit-ups, leg press,
calf raises, leg
extensions, increasing to 4,
5 and 6 sets
F: 3 week1
I: 3 sets
 10–15 reps
Weight increase
when able
to complete
15 reps
D: NR
1RM
- seated bench
press
Machine
and free
weights
4 months All sessions:
Professional
instructor,
Physician
Dunstan et al.
(2005)
Australia [20]
n = 36
RT = 14
C = 12
M = 21/F = 15
60–80 y
Home-based flexibility
training, 3 week1,
telephoned fortnightly
Home-based resistance training
9 whole-body exercises: lying
dumbbell flies, seated single-leg
extension, dumbbell shoulder
press, dumbbell bent-over row,
standing leg curl, dumbbell
biceps curls, dumbbell triceps
kickback, abdominal curls.
60–80% 1RM
Additional weights provided
to facilitate progression
F: 3 week1
I: 3 sets  8–10
reps
D: NR
1RM Free
weights
6 months No, telephone
monitoring
weekly first
4 weeks, then
fortnightly
Baldi and Snowling
(2003)
New Zealand [12]
n = 18
RT = 9
Con = 9
M = 18/F = 0
47.9 y
No exercise completed Resistance training
10 whole-body progressive
exercises: not specified
1 set  12 reps in wk 1 then
2 sets  12 reps. Resistance
progressed by 5% when able
to successfully complete the
program
F: 3 week1
I: 2 sets
 12 reps
Max weight
for 10 reps for
upper body
and 15 reps
for lower
body exercises
Moderate
intensity
D: NR, 60 s rest
between sets
Max isokinetic
torque
- Leg and arm
flexion
NR 10 weeks All sessions:
Unspecified
personnel
Castaneda et al.
(2002) USA [13]
n = 62
RT = 31
C = 31
M = 22/F = 40
66  11.8 y
Standard type 2 DM
care: Telephone
call fortnightly
Resistance training
5 whole-body progressive
exercises: chest press, leg press,
upper back, knee extension and
flexion.
Wk 1–8 = 60–80% 1RM
Wk 10–14 = 70–80% 1RM
Wk 9 and 15 = 10% decrease
F: 3 week1
I: 3 sets  8 reps
High intensity
D: 45 min total,
5 min warm-up
and cool down
1RM
- 2 upper and
3 lower body
exercises
Pneumatic
Machine
weights
16 weeks All sessions:
Unspecified
personnel
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d i a b e t e s r e s e a r c h and c l i n i c a l p r a c t i c e 8 3 ( 2 0 0 9 ) 1 5 7 – 1 7 5164(20/24 papers), with some studies incorporating the use of
free-weights [15,23–25,30,32,37] (Table 2). Two studies varied
the delivery of RT using circuit-type training [15,36]. A
whole-body training protocol, mostly progressive in nature
where the weight lifted, or sets and repetitions completed
increased at varying stages was favoured by most resea-
rchers (19/20 studies; Table 2). However, one study [19,34]
used only three exercises and focused solely on the lower
limbs.
4.1. Frequency
Resistance training protocols were commonly performed on
three non-consecutive days/wk (Table 2), although one non-
randomized study [30] admitted their participants tohospital to
complete low intensity RT 5 days/wk. Four studies [25,36,38,39]
performed RT on 2 days/wk, with one study [25] prescribing 2
days/wk tomaintain benefits achieved frompreviously training
2 days/wk.
4.2. Intensity
The intensity of each RT protocol varied considerably, with
some studies giving precise information about initial
intensities and progression points, while other studies
provided vague details of increasing the weight (by an
unspecified amount) when participants were able to com-
plete a certain number of sets and repetitions (Table 2). Two
studies [35,39] specifically reported completing power exer-
cises using low weight and high velocity movement, in
addition to their normal RT program. Two studies prescribed
the training weight as percentage 1RM but measured
strength using 3RM [19,34] or KIN-COM [30], while another
study [33] prescribed RT based on percentage 10RM after
conducting 1RM testing. The precise intensities reported for
each RCT are shown in Table 2.
4.3. Duration
The duration of all studies varied from 4–6weeks to 12months
of training. One study [32] reported the acute effects of RT,
before also reporting 6-week follow-up data. An additional
study reported data at 6 weeks [19,34], while another study
reported a duration of 4–6 weeks [30]. Six studies had
durations of 6–16 weeks [12,15,28,31,35,40], and another study
examined changes over 6months [27]. Additionally, one paper
reported a 6-month follow-up period [20] after a 6-month RT
and weight loss intervention [14]. One study reported a 2-
month supervised introductory phase, followed by 12 months
of home-based maintenance [25].
4.4. Compliance
When the interventions were completed at a specific
exercise venue, eight papers reported compliance levels of
85% with most of the training completed under super-
vision (Table 2). When direct supervision was removed
during maintenance programs at home or at a leisure-
centre, adherence dropped to 67–72% [20,25] and 68% [25],
respectively.
d i a b e t e s r e s e a r ch and c l i n i c a l p r a c t i c e 8 3 ( 2 0 0 9 ) 1 5 7 – 1 7 5 1654.5. Adverse events
Although information regarding adverse events was not
reported in 6 of 13 papers reporting RCT’s [15,21,22,26,28,29]
and only 3 of 11 papers describing non-RCT’s reported
information on adverse events [36,38,39] (Table 1), the
interventions seemed to be well tolerated in these clinical
populations with co-morbidities. Cases of hypoglycemia were
reported in five RT studies, during training [25], immediately
following training [13], during the night after RT [23], or at
unspecified times, with medication decreased to counteract
this outcome [27,38]. Hypoglycemic events were also reported
with combined training (CT), AT and in the control group, with
medication adjusted for this [27]. Additionally, hypoglycemia
occurred frequently in one individual both before and after AT
[23], while seven hypoglycemic events were reported in a
control group [13]. In only one case, was hypoglycemia severe
enough to warrant medical attention [25]. One study reported
musculoskeletal conditions requiring the program to be
modified [27], episodes of chest pain were reported twice
[13,27] and one study reported a case of hypotension [38].5. Glycemic control
5.1. Glycosylated haemoglobin
Glycosylated haemoglobin (HbA1c) is considered the optimal
way of measuring long-term (120 days) glycemic control [41],
with HbA1c values of <7.0% accepted as representing good
glucose control [41]. Nine RCT’s reported HbA1c data (Table 3),
with two studies [13,22,24,26] reporting HbA1c reduced by 1.0–
1.2%, from above 8.0% prior to 16 weeks of moderate-high
intensity training. Baldi and Snowling [12] showed an
improvement over the intervention period which approached
significance (P = 0.057) after 10 weeks of RT with HbA1c levels
reducing from8.9% to 8.4%.Maintenance programs completed
at home [20,25], or at a community-gym [25] reported glycemic
control returned towards baseline after 6 months or became
worse after 12 months, which is likely to be a result of
decreased compliance to the prescribed training. Interest-
ingly, RT appears to be as effective as AT at improving HbA1c
when compared to control groups [27] and more effective
when compared to AT [24]. This finding requires further
validation though as the RT group appeared to spend a larger
volume of time training than the AT group. Sigal et al. [27]
however, concluded that CT was superior at improving
glycemic control to either RT or AT on their own.
Seven non-RCT’s reported HbA1c data with only the trials
reporting different subjects (diabetes vs. non-diabetes) indi-
cating significant differences. Two [38,40] reported an
improvement over time, although another [30] reported a
2% improvement in HbA1c which was not significant.
The greatest improvements to glycemic control occurred
when HbA1c was poor (>8.0%) at baseline however, based on
current literature [4], clinically relevant improvements of 0.6%
were generally seenwithmoderate-high intensity RT orwhere
the duration of training lasted 10 weeks or longer. The
exception to this was 4–6 weeks of low intensity RT 5 days/wk
resulting in a 2.0% improvement of HbA1c [30], although thisstudy was not randomized and participants were remarkably
light and had a low body mass index, reducing the general-
izability of this study.
5.2. Fasting blood glucose
Fasting blood glucose (FBG) is less frequently used as a
measure of glycemic control but can be a substitute when
HbA1c is not measured, for instance when the intervention
duration is less than that required for a change in glycemic
control to be fully reflected in HbA1c (<3months). Seven RCT’s
reported FBG levels (Table 3), with only one [24] reporting a
significant change when compared to the comparison group
(AT). This was quite a large improvement (3.2 mmol/L) and
included some subjects taking insulin, where no other study
included subjects taking insulin. This study however was not
identically matched in terms of volume, with the RT group
completing up to six sets of 10–15 repetitions per week for 10
exercises (estimated to be 120 min of exercise per week plus
120 min of rest/recovery during the sessions) and the AT group
completing up to 90 min per week. Again, only two [39,40] of
six [19,31,32,38–40] non-RCT’s reporting FBG indicated an
improvement over time.6. Insulin sensitivity
6.1. Euglycemic–hyperinsulinemic clamp
Although considered the gold-standard for determining
insulin sensitivity levels [42], only two studies used the
euglycemic–hyperinsulinemic clamp [19,30]. Holten et al. [19]
reported that despite individuals with diabetes having
significantly lower glucose disposal rates (GDRs) and therefore
greater insulin resistance than controls, leg glucose clearance
rates increased during the second stage of the euglycemic–
hyperinsulinemic clamp, showing that improvements are
achievable with RT despite being less sensitive to insulin. Ishii
et al. [30] also used an euglycemic–hyperinsulinemic clamp,
reporting a 48% (P < 0.05) increase in insulin sensitivity with
RT and no change in sedentary individuals with diabetes
acting as controls.
Comparing these studies is difficult due to one [19]
reporting GDR at varying levels of insulin infusion, and
another [30] reporting final GDR. However, it is likely that
RT for 4–6 weeks will result in increased insulin sensitivity.
6.2. Oral glucose tolerance test
Insulin sensitivity using area under the curve (AUC) equations
for glucose and insulin levels during an oral glucose tolerance
test (OGTT) has been validated against the euglycemic–
hyperinsulinemic clamp [42] with lower glucose values
indicating better glucose tolerance and lower insulin values
indicating increased insulin sensitivity. The OGTTwas used in
two RCT’s [15,21] (Table 3), with results indicating an
improvement in insulin sensitivity when compared to
sedentary controls [15] but not when compared to vibration
or flexibility training [21], although the method of performing
this analysis varied from other studies as blood was drawn
Table 3 – Metabolic outcomes.
Author (year) country Group Time of follow-upType of change HbA1c (%) Glucose (mmol/L) Insulin (pmol/L) Insulin sensitivity
method
Insulin sensitivity
Winnick et al.
(2008) USA [28]
Whites NR HOMA IR
RT
AT
African
RT
AT
Pre:Post
D
Time effect
Group  time
7.9  2.0:NR
7.8  1.2:NR
6.5  1.0:NR
7.6  1.5:NR
NR
NR
6.8  4.8:NR
+13.2%
10.6  8.5:NR
3.68%
5.8  2.4:NR
19.15%
8.6  7.4:NR
+3.79%
NR
P < 0.05 RT African
v Whites
P > 0.05 AT African
v Whites
Baum et al.
(2007) Germany [21]
RT
Vib
Flex
72–96 h Pre:Post
D
Time effect
Group  time
6.8%  0.17:NR
+0.2  0.15 D
7.3%  0.66:NR
0.3  0.22 D
6.7%  0.26:NR
+0.34  0.26 D
NR
NR
6.99  1.28: 6.66  1.22
7.38  3.16: 6.77  1.94
6.66  1.39: 6.38  1.22
NR
NR
OGTT – ear lobe
Glucose only
NR:NR
5.6% D
NR:NR
6.3% D
NR:NR
0.00% D
P < 0.05 RT and Vib
NR
Brooks et al.
(2007) USA [22]
RT
Con
72 h Pre:Post
D
Time effect
Group  time
8.7  10.0: 7.6  8.4
1.0  1.1 D
7.8  8.9: 8.3  7.2
+0.4  1.7 D
NR
P < 0.001
8.8  2.8:7.9  2.2
0.9  2.8 D
9.9  3.9:9.5  3.3
0.3  4.5 D
NR
P = 0.92
116 (124):105 (70)*
16 (69)* D
115 (131):133 (126)*
+6 (86)* D
NR
P = 0.27
HOMA-IR 7.1 (5.7):5.3 (5.5)*
0.7 (3.6)* D
6.7 (9.0):6.4 (6.8)*
+0.8 (3.8)* D
NR
P = 0.05
Sigal et al.
(2007) Canada [27]
RT Minimum 48 h Pre:Post
Time effect
Group  time
7.5  1.5: 7.2  1.5
AT 7.4  1.5: 7.0  1.5
CT 7.5  1.5: 6.6  1.6
Con 7.4  1.4: 7.5  1.5
P = 0.018 RT
P = 0.002 AT
P < 0.001 CT
P = 0.57 Con
P = 0.038 RT v Con
P = 0.007 AT v Con
P = 0.001 CT v RT
P = 0.014 CT v AT
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Dunstan et al.
(2006)
Australia [25]
Centre
Home
48 h Pre:Post
D
Time effect
Group  time
7.8  0.9:NR
+0.1  1.0 D
7.5  0.5:NR
+0.2  1.2 D
P < 0.05 both grps
NS
9.0  2.0:NR
0.3  1.8 D
8.4  1.9:NR
0.2  2.2 D
NS
NS
143.7  66.1:NR
21  47.6 D
126.6  55.1:NR
8.5  32.8 D
P < 0.05 centre
NS
HOMA 46.9  26.1:NR
+9.4  16.4 D
50.7  24.6:NR
+2.4  12.4 D
P < 0.05 centre
NS
Gordon et al.
(2006) USA [26]
RT
Con
72 h Pre:Post
Time effect
Group  time
8.7  1.9:7.7  1.6
8.0  1.6:8.3  1.6
NR
P < 0.01
173  108:132  54
157  101:168  139
NR
P < 0.05
HOMA-IR 8.5 (7.2):5.3 (6.3)*
6.7 (7.8):7.1 (7.4)*
NR
P = 0.08
Cauza et al.
(2005) Austria [24]
RT
AT
Pre:Post
D
Time effect
Group  time
8.3  8.0:7.1  1.7
1.2 D
7.7  1.2:7.4  1.2
0.3D
P = 0.001 RT, NS AT
P = 0.009
11.32  7.62:8.16  3.77
3.2 D
8.88  2.06:8.83  2.31
0.05 D
P < 0.001 RT, NS AT
P = 0.002
130.9  84.0:118.4  85.4
12.5 D
105.1  77.5:125.6  96.1
+20.46 D
NS both grps
P = 0.04
HOMA-IR 9.1  7.0:7.2  5.6
2.0 D
6.8  5.8:8.4  7.8
+1.5 D
P = 0.04 RT, NS AT
P = 0.009
Cauza et al.
(2005) Austria [23]
RT
AT
Pre:Post
Time effect
Group  time
7.5  1.4:7.0  2.1
8.0  3.8:7.6  4.8
NS both groups
NR
Dunstan et al.
(2005)
Australia [20]
RT
Con
48 h Pre:post
D
Time effect
Group  time
Returned towards
baseline
Returned towards
baseline
P < 0.05
NR
NR:NR
+0.3  2.2 D
NR:NR
0.5  2.1 D
NS both grps
NS
NR:NR
0.1  46.8 D
NR:NR
19.3  50.1 D
P < 0.05 Con, NS RT
NS
HOMA-IR NR:NR
+0.04  5.5 D
NR:NR
+5.4  6.5 D
P < 0.05 Con, NS RT
NS
Baldi and
Snowling (2003)
New Zealand [12]
RT
Con
36–48 h Pre:Post
Time effect
Group  time
8.9  3.6:8.4  1.8
8.5  2.4:8.4  1.8
P = 0.057 RT, 0.64 Con
NR
12.0  2.7:11.4  2.4
11.1  3.3:11.0  3.0
P < 0.05 RT
NR
268.1  35.4:146.5  28.5
191.7  63.9:214.6  52.1
P < 0.05 RT
NR
Insulin
sensitivity
index 0.120
20.3  3.9:22.6  3.9
22.2  11.4:19.9  5.1
NS
NR
Castaneda et al.
(2002) USA [13]
PRT
Con
48 h Pre:Post
D
Time effect
Group  time
8.7  1.7:7.6  1.1
12.6  11.1% D
8.4  1.7:8.3  2.8
+1.2  5.6% D
NR
P = 0.01
8.8  2.8:7.9  2.2
9.7  3.9:8.9  3.9
NR
P = 0.34
Dunstan et al.
(1998)
Australia [15]
CRT
Con
48 h Pre:Post
D
Time effect
Group  time
8.2  1.9:8.0  1.9
8.1  2.1:8.3  2.4
NS both grps
NS
9.6  3.5:9.4  3.1
9.9  4.2:9.8  4.5
NS both grps
NS
64.3  49.1:63.1  48.8
82.6  36.4:93.8  43.7
NS both grps
NS
OGTT
- Glucose AUC
- Insulin AUC
22  240D
2183  6053D
+191  291D
+3947  5352D
NR
P < 0.05 glucose
and insulin
RT, resistance training; Flex, flexibility training; Vib, vibration training; Con, control; NR, not reported; AT, aerobic training; NS, not significant; PRT, progressive resistance training; CRT, circuit
resistance training; CT, combined aerobic and resistance training; *, values are median (interquartile range). Castaneda [29] did not report any metabolic variables.
d
ia
b
e
t
e
s
r
e
s
e
a
r
c
h
a
n
d
c
l
in
ic
a
l
p
r
a
c
t
ic
e
8
3
(2
0
0
9
)
1
5
7
–
1
7
5
1
6
7
d i a b e t e s r e s e a r c h and c l i n i c a l p r a c t i c e 8 3 ( 2 0 0 9 ) 1 5 7 – 1 7 5168from the ear lobe, rather than the commonly used antecubital
vein and only glucose was measured, not insulin as well. Two
non-RCT’s [32,37] completed OGTT’s with AUC for glucose and
insulin improving over time with both RT and AT [37],
although Fenicchia et al. [32] showed no change after 6 weeks
of RT despite reporting an improvement 12–24 h after the first
RT session, however, the time of completing the OGTT post
training was later. The time utilized for each OGTT trial varied
considerably between 24 and 72–96 h post-training (Table 3).
This may be a factor in whether studies reported improve-
ments or not as it is still unclear precisely how long insulin
sensitivity remains increased following RT, and therefore
acute rather than chronic training effects could have been
reported. The training regimes may also have contributed to
the varied results as different protocols at different intensities
were employed by each study.
6.3. Homeostasis model assessment
The homeostasis model assessment (HOMA) is a mathema-
tical model of determining insulin resistance from fasting
glucose and insulin concentrations which has been validated
against the euglycemic–hyperinsulinemic clamp [42]. This
was the most common method of determining insulin
resistance and estimating insulin sensitivity, possibly because
of its ease and speed of completion as it requires only a fasting
blood sample, with six papers describing five RCT’s using this
method [20,22,24–26,28] (Table 3). HOMA was originally
developed in 1985 and updated in 1996 to estimate insulin
sensitivity [43] although it is unclear whether any of the
studies using HOMA modelling utilized the updated version.
A reduction in insulin resistance after 4 months of RT
(P = 0.04) was reported in a study with 22 participants [24],
while 12 months of centre-based maintenance following a 2-
month introductory period saw insulin sensitivity improve
(P < 0.05) [25]. Comparing RT with the control group signifi-
cantly improved (P < 0.05) [22] and tended to improve (P = 0.08)
[26] insulin resistance, while RT compared with AT also
showed a trend towards (P = 0.09) improvement of insulin
resistance [24]. Winnick et al. [28] reported a significant
improvement in insulin resistance for African Americans
completing RT when compared to Whites completing RT.
However, there was no difference between ethnicity when AT
was completed.
Insulin resistance improved by 3.2 when calculated using
HOMA 72 h after the final session [26], which is supported by a
9.4% improvement in insulin sensitivity when measured 48 h
after the final RT session [25]. Additionally one non-RCT [31]
reported HOMA, stating no change in insulin resistance 48–
72 h following the final RT session. The limited number of
studies and the variation in HOMA limit the ability to make
conclusions. However, insulin sensitivity seemed to at least
tend to improve compared to a comparison group [15,22,24,26],
though how long this improvement remains is unclear.
6.4. Insulin sensitivity index
The insulin sensitivity index is another validated mathema-
tical model for determining insulin sensitivity [42], but was
used by only one RCT [12] and one uncontrolled trial [39] witheach using a different model. Contrasting results were
reported, with Baldi and Snowling [12] finding no evidence
of change in either RT (10 weeks) or control groups, while
Ibanez et al. [39] observed a 46% improvement in insulin
sensitivity (P < 0.001) after 16 weeks of RT. This difference
could be time related as the improvement was measured 24 h
after the final session [39] compared to 36–48 h when no
improvement was seen [12], or this could be related to
intensity or duration of training.
6.5. Short insulin tolerance test
One non-RCT [40] used the short insulin tolerance test to
measure insulin sensitivity. This test was completed 72–96 h
after the final training session of a 12-week program
completed with free weights in a physiotherapy clinic, and
reported a significant improvement in insulin sensitivity.7. Insulin signalling
Only two studies reporteddataonglucose transport and insulin
signalling in individuals with diabetes [19,29,34] with one of
these being a RCT [29]. Improved glucose disposal, asmeasured
by incorporation into muscle glycogen, support findings using
theeuglycemic–hyperinsulinemicclamp [19,29]. Changes in the
glucose transporter-4 (GLUT4) are less clear with an earlier
study [19] reporting a 40% increase (P < 0.05) in GLUT4 density
compared to a more recent study [29] reporting no evidence of
change in GLUT4 gene or protein expression. This could be due
to population differences (males vs. females) or the different
training protocols (whole-body vs. lower-limb).
Eight weeks of moderate-high intensity RT resulted in
increased protein content of the insulin receptor, protein
kinase-B, and glycogen synthase (GS) to similar levels in
individuals with diabetes and healthy control subjects.
However, no training effect was observed for protein content
of insulin receptor substrate-1, the p85 subunit of phospha-
tidylinositol(PI)-3-kinase, or percent GS activity [19]. Moder-
ate-intensity RT resulted in similar changes to various AMP-
activated protein kinase (AMPK) subunit isoforms (a1: +16%,
b2: +14%, g1: +29%, g3: 48%) in patients with diabetes and
healthy controls [34], while muscle glycogen levels signifi-
cantly increased with RT [19,29], when compared to controls
(P = 0.04) [29].8. Muscle strength
Ten papers from seven RCT’s reported muscle strength data
(Table 4), with all but one study [25] reporting improvements of
at least 50% after completing RT. The study [25] reporting a
decrease (P < 0.05) in strength after RT, reported small losses
after 12 months of a home or leisure-centre based main-
tenance program following on from a 2-month supervised
intervention period, although only lower body strength in the
home-based group decreased belowbaseline, andwas likely to
be due to not being able to maintain the appropriate intensity.
In most cases [13,20,22,29] these changes were significant
when compared to sedentary controls, but not when
Table 4 – Body composition markers.
Author (year)
country
Group Type of
change
Mass (kg) BMI (kg m2) Waist
circumference
(cm)
Muscle strength
(kg) unless
specified
% Fat
method
% F Fat mass
(kg) unless
specified
LBM (kg)
Winnick et al.
(2008) USA [28]
Whites
RT
AT
African
RT
AT
Pre:Post
D
Time effect
Group  time
98.1  20.1:NR
99.1  23.6:NR
109.5  39.5:NR
99.5  17.2:NR
NR
NR
35.1  5.7:NR
+2.6%
36.5  6.6:NR
1.18%
33.6  5.9:NR
2.6%
34.2  5.9:NR
0.7%
NR
P < 0.05 RT
African v Whites
DXA 40.2  5:NR
+1.38%
38.6  :NR
0.22%
38.5  4:NR
0.85%
38.3  :NR
0.40%
NR
NS
Baum et al.
(2007)
Germany [21]
RT
Vib
Flex
Pre:Post
D
Time effect
Group  time
86.5  14.7:NR
1.30  2.36 D
83.3  13.4:NR
0.86  1.77 D
88.6  24.1:NR
1.68  4.57 D
NS
NR
NR:NR (Nm kg1)
+14% D (left leg)
NR:NR
NR D
NR:NR
NR D
NR
NR
Brooks (2007)
USA [22]
RT
Con
Pre:Post
D
Time effect
Group  time
30.9  6.13:NR
NR D
31.1  5.57:NR
NR D
NR
99.7  12.81:NR
NR D
100.1  14.48:NR
NR D
NR
NR
66  22:90  33^
+24  11 D
338  150:568
 189_
+173  106 D
62  22:58  22^
4  11 D
300  156:285
 150_
19  39 D
NR
P < 0.001
DXA 35.0  12.25:NR
NR D
33.7  13.36:NR
NR D
NR
NR
44.3  9.47:45.5  10.58
+1.1  1.67 D
44.9  10.58:44.8  9.47
+0.4  1.11 D
NR
P = 0.04
Sigal et al.
(2007)
Canada [27]
RT
AT
CT
Con
Pre:Post
Time effect
Group  time
99.1  30.4:98.0  30.4
103.5  31.0:100.9  30.2
101.9  30.4:99.3  30.4
101.3  28.6:101.0  27.8
NR
P = 0.008 AT v Con
34.1  9.6:33.7  9.6
35.6  10.1:34.8  10.1
35.0  9.6:34.2  9.6
35.0  9.5:34.9  8.7
NR
P = 0.009 AT v Con
110  24:107  24
113  23:110  23
112  24:108  24
112  24:111  24
NR
P = 0.03 AT v Con
Bioelectrical
impedance
35.9  :35.0
 9.6
37.0  :36.3
 9.3
36.0  :35.0
 9.6
36.6  :36.9
 9.5
NR
NS
36.5  19.2:35.2  19.2
39.2  19.4:37.6  19.4
37.6  19.2:35.7  19.2
38.0  17.5:38.2  17.5
NR
P = 0.44 AT v Con
62.3  13.6:62.5  13.6
64.0  13.9:63.0  13.9
63.9  13.6:63.2  13.6
63.0  12.7:62.5  12.7
NR
NS
Castaneda
et al. (2006)
Germany [29]
RT
Con
Pre:Post
D
Time effect
Group  time
32.1  6.8:NR
NR D
33.4  6.3:NR
NR D
NR
NR
NR:NR
+43  29% D*
NR:NR
+19  31% D*
NR
P = 0.01
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Table 4 (Continued )
Author (year)
country
Group Type of
change
Mass (kg) BMI (kg m2) Waist
circumference
(cm)
Muscle strength
(kg) unless
specified
% Fat
method
% Fat Fat mass
(kg) unless
specified
LBM (kg)
Dunstan et al.
(2006)
Australia [25]
Cent
Home
Pre:Post
D
Time effect
Group  time
92.6  17.1:NR
2.1  3.4 D
91.2  13.6:NR
2.2  3.2 D
P < 0.05 both grps
NS
32.8  4.8:NR
NR D
32.4  4.4:NR
NR D
NR
NR
105.6  11.7:NR
1.3  5.3 D
107.4  10.8:NR
2.0  5.9 D
NS
NS
78.8  43.9:NR^
3.4  17.8 D
29.9  10.1:NR_
7.2  10.5 D
78.3  49.1:NR^
3.7  19.6
30.3  12.0:NR_
0.3  6.3 D
P < 0.05 RT_
P < 0.05 _
Bioelectrical
impedance
37.6  12.3:NR
0.8  3.2 D
35.8  10.0:NR
1.0  3.2 D
NS
NS
55.0  9.8:NR
1.3  1.6 D
55.4  10.5:NR
0.9  2.2 D
P < 0.05 both grps
NS
Gordon et al.
(2006) USA [26]
RT
Con
Pre:Post
Time effect
Group  time
80  19:NR
88  15:NR
NR
NR
30.7  6.2:31.3  6.2
33.5  6.2:33.4  5.8
NR
P = 0.05
100  13.4:101
 10.8
108  11.2:109
 12.4
NR
P = 0.43
Cauza et al.
(2005)
Austria [24]
RT
AT
Pre:Post
D
Time effect
Group  time
91.3  13.6:90.2
 13.1
1.1% D
96.7  18.6:95.4
 18.6
1.1% D
NS
NR
31.3  4.2:30.9  4.2
1.1% D
33.9  5.4:33.5  5.4
1.1% D
NS
NR
54.6  16.0:68.6
 18.8^
+26% D
114  36.6:168
 45.5_
+48% D
43.9  15.7:45.0
 16.1^
+2.5% D
93  35.9:107
 42.1_
+15% D
P < 0.001 RT^
_, ET_
NR
10 site
skinfolds
44.5  3.8:40.5
 5.2
9.1% D
46.3  3.3:44.5
 3.3
3.4% D
P < 0.001 both
grps
NR
39.6  6.6:35.8  8.0
9.7% D
44.8  9.5:42.5  8.7
5.3% D
P < 0.001 both grps
NR
49.4  8.4:52.6  8.0
+6.5% D
51.9  10.3:52.9  11.1
+2% D
P < 0.001 RT
NR
Cauza et al.
(2005)
Austria [23]
RT
AT
Pre:Post
Time effect
Group  time
29.9  2.3:29.9  2.8
36.3  12.4:36.3  6.9
NS
P = 0.03
47.4  15.0:59.7
 18.4^
31.8  10.6:31.7
 10.6^
P = 0.01 RT, NS AT
NR
NR 38.9  6.5:33.5  7.9
46.9  10.6:44.4  10.3
P < 0.01 both grps
P = 0.04
46.3  7.4:51.9  9.1
56  10.3:58.2  11.1
P < 0.01 RT, P = 0.03 AT
NR
Dunstan et al.
(2005)
Australia [20]
RT
Con
Pre:Post
D
Time effect
Group  time
88.7  10.9:NR
Unspecified
increase
89.5  12.1:NR
Unspecified increase
P < 0.05 RT
NR
NR:NR
3.4  4.7 D
NR:NR
2.0  4.3 D
P < 0.05 RT
NS
NR:NR
+26.4  22.8^ D
+4.9  6.4_ D
NR:NR
0.2  19.1^ D
0.1  5.4_ D
P < 0.05 RT^_
P < 0.05^_
DXA 33.1  7.4:NR
NR D
35.6  6.8:NR
NR D
P < 0.01 both grps
NR
51.8  8.1:NR
NR D
49.7  9.5:NR
NR D
NS
P < 0.08
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also reported muscle strength improved, with similar
improvements in muscle strength observed in individuals
with diabetes compared to those without diabetes [19,31]. One
study also reported muscle power output improved over time
[35]. Studies that reported greater improvements in muscular
strength, utilized durations between 16 weeks [23,24,39] and 6
months [20] at moderate or moderate-high intensities. In
contrast to other results, one study [32] reported highly
significant (P < 0.01) increases in muscle strength after 6
weeks of moderate intensity RT. However, overall it appears
that higher intensity RT is appropriate andmore time efficient
for muscle strength gains, although data evaluating lower
intensity RT in patients with diabetes is limited (1/17 studies).
Improved glycemic control was observed in five
[12,13,22,24,26] of the 10 papers from RCT’s (3 studies) that
reported significant improvements in strength, while four
RCT’s [15,21,22,24,26] that increased strength also improved
insulin sensitivity, leaving two RCT’s [12,20] that did not
improve insulin sensitivity despite increasing strength. In
non-RCT’s, no studies that improved strength reported
improved glycemic control, yet four studies [19,30,37,39] that
improved strength reported improved insulin sensitivity and
two of six studies [31,32] did not improve insulin sensitivity.9. Body composition
9.1. Lean body mass
Lean body mass (LBM) was measured by dual energy X-ray
absorptiometry (DXA) in four studies [13,20,22,30,40] including
twoRCT’s [13,20,22], or estimated after accounting for fatmass
in a further six studies [12,24,25,27,32,33,37] including four
RCT’s [12,24,25,27], with one study [23] not specifying the
method used (Table 4). Results varied, with significant LBM
increases of 3–6 kg with RT [12,23,24] and 2 kg with AT [23].
Two studies reported significant (P < 0.05; P = 0.04) [13,22] or a
trend (P < 0.08) [20] towards improvements for LBM when RT
was compared with the non-exercising control group.
9.2. Fat mass
Fat mass was typically determined through mathematical
equations after measuring body mass and using various
techniques to estimate percentage fat. Significant decreases in
fat mass of 1–4.5 kg with RT [20,23,24,32,39] and 2 kg with AT
[23,24] occurred over the training duration (Table 4). One study
[12] reported no changes in fat mass with RT, comparedwith a
3.5 kg increase (P < 0.05) in controls over 10 weeks. With the
exception of one study [32], interventions with durations less
than 10 weeks did not report fat mass (Table 4). The current
evidence suggests that moderate or high intensity training of
greater than 10 weeks tends to reduce fat mass in individuals
with diabetes.
9.3. Percentage body fat
One non-RCT [30] reported a decrease in percentage body fat
as measured by DXA. With one RCT [28] and one non-RCT [40]
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reported in other studies despite utilizing DXA [13,20,22]. Two
further studies [12,37] utilized hydrostatic weighing, reporting
no evidence of change to percentage body fat (Table 4).
Bioelectrical impedance was used in three studies [25,27,32],
with changes only reported when AT was compared to
controls (P = 0.008) [27] (Table 4). Four studies utilized the less
sensitive measure of skin-fold measurements where
decreases in body fat of up to 9.1% were reported (Table 4).
One non-RCT [35] reported percentage body fat results, but not
how it was measured.
9.4. Body mass
Typically there was no change in bodymass with any exercise
regimen, however, one study [12] reported a 2 kg increase
(P < 0.05) after 10 weeks of moderate intensity RT (Table 4).
After 6 months of home-based maintenance [20], body mass
significantly increased (P < 0.05), although final levels
remained lower than baseline.
9.5. Girth measures
Measures of waist circumference were not routinely com-
pleted (7/20 studies; Table 4) [13,20,22,25–27,32,38,40] with
change occurringwhen comparing sedentary controls with RT
[13], AT [27] and over time with RT [20,40]. Waist circumfer-
ence was reported to remain decreased after 6 months of
home-based RT maintenance [20].10. Cardiac risk factors
10.1. Lipid profile
Blood lipids were reported in nine studies with general
improvements in total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol and triglycer-
ides reported after RT (P < 0.001; P < 0.01) [24,36,40].
10.2. Blood pressure
Blood pressure was measured in 10 studies. Three studies
reported beneficial changes in systolic blood pressure asso-
ciated with all forms of training [13,21,24]. Improvements to
diastolic bloodpressurewere less frequently observed, but still
occurred over time with RT and AT [24].11. Discussion
Individuals with diabetes are able to complete RT with
minimal risk of negative health outcomes or injury, while
improving overall glycemic control, insulin sensitivity and
muscular strength. Overall, the quality of study design was
good with 13 papers reporting on 10 RCT’s, of which all but
three were published since 2005. The major findings from
these studies are that completing RT, and AT over extended
durations will result in similar improvements to glycemic
control [23,27]. However, RT could potentially provide greaterbenefits in terms of glycemic control than ATwith researchers
and practitioners intimating that RT, comprising short bouts
with intermittent rest periods, is better tolerated than AT
[10,44,45]. To further improve the quality of studies and
knowledge in this area and to enable comprehensive
comparison between studies in the future, consideration
needs to be given to quantifiable and replicable exercise
prescriptions, specifying how missing data is treated and
determining sample sizes by power calculations.
A clinically relevant lowering of HbA1c, a key marker of
improved long-term glycemic control, was reported in a
number of RT studies while those reporting no effect were
intervention studies with durations of 10 weeks or less. These
changes appear to be of a similar or greater magnitude to
aerobic training [23,24,27], however the effect of combining RT
with AT remains unclear with only one study [27] making a
direct comparison between combined training and isolated RT
or AT interventions.
Interestingly, insulin sensitivity was only evaluated using
the euglycemic–hyperinsulinemic clamp in non-RCT’s [19,30].
These studies reported increased insulin sensitivity following
RT, despite the time that the measure was performed varying
from 16 to 48 h following the final exercise session and the
intensity and frequency of the training varying markedly.
Other, less precise measures of insulin sensitivity, generally
indicated improvements at times ranging from 24 to 72–96 h
[21,40] following the final RT session of a long-term training
program. However, the effect of a single session of RT on
insulin sensitivity in previously untrained subjects has not
been investigated beyond 12–24 h after the session [32,33].
This raises questions about the training frequency that should
be prescribed, which is currently based on improvements to
HbA1c. Eight RCT’s included in this systematic review
[12,15,20–22,24–26,28] present HbA1c and insulin sensitivity
data, with only one [12] indicating that insulin sensitivity did
not improvewhen HbA1c improved. Furthermore, two studies
[15,21] indicated that insulin sensitivity improved but was not
reflected inHbA1c, which did not change. Additionally, insulin
sensitivity improved after 12 months of gym-based main-
tenance despite glycemic control becoming worse [25]. There-
fore, further investigations as to whether RT should be
prescribed based on insulin sensitivity should be undertaken.
If RT should be prescribed based on insulin sensitivity, RTmay
need to be prescribed everyday in this population, at least
initially, as the length of time insulin sensitivity remains
improved following a single RT session has not been
adequately evaluated. After 12–16weeks of training, improved
insulin sensitivity appears to be maintained for 4–5 days
[21,22,26], therefore glucose control may potentially be
improved or maintained with one or two RT sessions each
week. Both of these possibilities vary considerably from
current RT recommendations of 3 days/wk [6]. It is possible
that RT should be performed more regularly initially to
improve insulin sensitivity and glycemic control, before it
can be performed less frequently to maintain the benefits;
however this is yet to be thoroughly examined.
The training environment and intensity of RT also need
further investigation, as decreased compliance to the training
protocol appears to be associated with a decline in insulin
sensitivity as demonstrated by the lower adherence level and
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ing [20,25]. While high adherence to RT protocols resulted in
significant muscle strength improvements, changes in body
mass were generally not observed. In contrast, LBM increased
and percentage body fat decreased, confirming that body
composition is improved with RT. Therefore, RT may provide
further benefits for individuals with diabetes attempting to
lose weight as RT may counteract the loss of muscle mass
typically associated with isolated hypocaloric diets [46].
However, changes to body composition are unlikely to account
for any changes in insulin sensitivity, as this can be increased
following a single exercise session [32,33]. Although changes
to body composition may not improve insulin sensitivity,
individualswith diabetes are at an increased risk of cardiac co-
morbidities for which improved body composition would
reduce this risk. Additionally, RT has the ability to improve
muscle quality (defined as a functional measure of strength
per unit volume of muscle) and change the characteristics of a
muscle fibre [22,47], suggested to result in increased glucose
transport. Although, limited data from individuals with
diabetes suggest that muscle mass or body composition
changes do not influence insulin sensitivity, local contrac-
tion-mediated responses from RT might [19], resulting in
increased intracellular signalling [10] leading to increased
membrane bound GLUT4 transporters and improved insulin
sensitivity. Despite mechanisms for why RT improves insulin
sensitivity not yet being fully elucidated, they are understood
to have some common mechanisms to AT as well as some
unique adaptations attributable to RT alone [7,37].
Although not reviewed in detail here, RT invokes many
health benefits for individuals with diabetes in addition to
improved glycemic control. These include improvements in
bone strength, minimization of sarcopenic losses or muscle
weakness associated with aging, improved balance and
reduced falls risk [48]. The beneficial effects of RT on lowering
cardiovascular risk (i.e. blood pressure and blood lipids) have
been reviewed elsewhere [4]. Of the studies reviewed here, the
impact of RT on lipid profiles is minimal in individuals who
were normal or just above normal at baseline, but it is
promising that beneficial blood pressure effects have been
reported in hypertensive patients with type 2 diabetes
[13,21,24]. Decreasing bodymass by dieting (energy restriction)
has detrimental effects on muscle mass and while AT is only
able tomaintain the integrity ofmuscle [49] it is suggested that
RT is able to counteract these detrimental effects in a way that
AT cannot by actually improving the amount and integrity of
muscle mass [46].
Compelling evidence fromboth RCT’s and non-RCT’s is that
RT is safe for individuals with diabetes who are likely to have
complex co-morbidities, although it needs to be noted that all
studies todatehaveexcludedpatientswithcontraindications to
RT [50]. Resistance training is effective in improving glycemic
control and increasing insulin sensitivity. Higher intensity and
longer intervention duration of RT appear most beneficial, but
this along with training frequency, are parameters that require
further investigation. It is likely that individualized programs,
taking into account an individual’s current level of strength,
severity of diabetes and also co-morbidities will optimise the
adaptive response and enhance compliance. Determining the
minimum effective dose of RT, or if appropriate in conjunctionwith AT, would possibly improve ongoing compliance, and
therefore lead to improved health outcomes. Resistance
training has been shown to not only be equivalent to AT in
ameliorating diabetes and its associated complications; it may
also be the exercise of choice for individuals with diabetes or
pre-diabetes who find adherence to continuous moderate
intensity aerobic training too physically challenging.Conflict of interest
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We assessed the oral glucose tolerance test’s (OGTT) ability to produce consistent results for
estimating insulin sensitivity over four consecutive days. Individual coefficients of variation
for OGIS and Stumvoll-ISI were 7.8% and 14.4% with no statistically significant difference
between days. Thereby, indicating repeated OGTT’s are reliable for estimating insulin
sensitivity.
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Insulin sensitivity is regularly estimated through the use of an
oral glucose tolerance test (OGTT) with a number of equations
showing good correlation with the gold standard method, the
euglycaemic hyperinsulinaemic clamp [1]. However, issues
concerning glucose load (50–100 g), reproducibility and diur-
nal variation of the OGTT have been reported [2], with
reliability questioned [3,4]. Reproducibility investigations
have centred on variables around the testing conditions,* Corresponding author at: School of Medical Sciences, RMIT University
fax: +61 3 9467 8181.
E-mail address: brett.gordon@rmit.edu.au (B.A. Gordon).
Abbreviations: OGTT, oral glucose tolerance test; AUC, Area under 
sensitivity index.
0168-8227/$ – see front matter # 2011 Elsevier Ireland Ltd. All rights 
doi:10.1016/j.diabres.2011.08.025including glucose load [5], time of day (6), and the fasting
period prior to testing [6,7]. And while many studies have
reported variations in glucose response from multiple or
repeated OGTT’s [3,4,6,8], none have looked at the reproduc-
ibility of OGTT’s repeated on consecutive days. So in light of
this, we believed it important to analyse the glucose and
insulin responses in apparently healthy individuals to
determine whether OGTT’s are reliable to estimate insulin
sensitivity on consecutive days. Therefore, the aim of this
study was to investigate whether insulin sensitivity was
affected by repeated daily OGTT’s., PO Box 71, Bundoora, Victoria 3083, Australia. Tel.: +61 3 9925 7037;
the curve; OGIS, oral glucose insulin sensitivity index; ISI, insulin
reserved.
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2.1. Participants and study design
Ten sedentary, apparently healthy individuals with no
diagnosed metabolic conditions took part in this trial.
Inclusion criteria were: aged 40–69 years, taking no medica-
tions influencing metabolism, and not having participated in
resistance training in the last six months or undertaking
regular aerobic exercise. Exclusion criteria included: recent
coronary event or established heart disease, uncontrolled
hypertension (>150/90 mm Hg), neuropathy and being unable
to understand English or follow instructions. Participants
completed the self-report International Physical Activity
Questionnaire [9] and were instructed not to complete any
structured or specific exercise during the study, record all food
consumed in a food diary and replicate their diet before each
OGTT. Participant characteristics are presented in Table 1.
Participants arrived at the research facility between 6 am
and 9 am by private vehicle, following a 12-h overnight fast.
Anthropometric measurements and a fasting blood sample
were collected before participants undertook an OGTT to
obtain baseline glucose and insulin responses [10]. Partici-
pants then returned to the research facility to undergo further
OGTT’s on the three subsequent mornings.
2.2. Blood sampling and analysis
A cannula was inserted into an antecubital vein with blood
samples obtained before consuming 75 g of glucose in 300 mL
of water (Gluco Scan, BIOCORP Aust Pty. Ltd.). Further blood
samples were collected at 30, 60, 90 and 120 min after
consuming the glucose, with patency maintained by flushing
with saline, and the first 2 mL of blood collected beingTable 1 – Participant demographics.
Outcome measure (units) Mean (SD)
Male/female 3/7
Age (years) 54.6 (6.5)
Weight (kg) 93.4 (16.4)
Height (cm) 167.7 (6.8)
BMI (kg m2) 33.3 (6.3)
Waist circumference (cm) 98.8 (12.6)
Waist:hip 0.88 (0.08)
SBP (mm Hg) 126 (14)
DBP (mm Hg) 83 (10)
Cholesterol (mmol L1) 4.9 (1.2)
LDL-C (mmol L1) 2.8 (1.0)
HDL-C (mmol L1) 1.42 (0.24)
Triglycerides (mmol L1) 1.6 (0.5)
HbA1c (%) 5.5 (0.3)
Glucose (mmol L1) 5.3 (0.3)
Insulin (pmol L1) 130.1 (82.1)
Activity (MET-min wk1) 1428 (1365)
Sedentary time (min) 435 (207)
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL,
high-density lipoprotein cholesterol; HbA1c, glycated haemoglo-
bin; MET, metabolic equivalents.discarded. The study protocol is presented schematically in
Fig. 1 and was approved by the RMIT University Human
Research Ethics Committee with written informed consent
obtained prior to participation. Lipid profiles and glycaemic
control (HbA1c) were measured in a commercial laboratory.
Glucose and insulin were measured using the YSI 2300 Stat
Plus analyser (Yellow Springs, USA) and Millipore human
insulin ELISA kits respectively. Area under the curve (AUC)
was calculated by a computer-based trapezoidal model and
insulin sensitivity estimated by the oral glucose insulin
sensitivity (OGIS) index [11] and the Stumvoll insulin sensitiv-
ity index (ISI) equation [12].
2.3. Statistical methods
All data were analysed using SPSS version 18 for Windows
(SPSS, Chicago, IL) with significance set at an alpha level of
p = 0.05 and a Bonferroni correction made for multiple
analyses. A repeated measures analysis of variance (ANOVA)
was completed to determine change over time of the overall
outcomes and to determine the reliability of the change scores
from each independent time-point for each repeated measure.
Change was calculated by subtracting the follow-up score
from the initial score and to provide an indication of
repeatability, coefficient of variation (CV) was calculated for
each individual by dividing the standard deviation of their
results from their four tests by their mean result. Data are
presented as means (95% confidence intervals (CI)) unless
otherwise indicated. Approximately 4% of glucose and insulin
data points were missing (due to occlusions within the
cannula) and were substituted by bringing the last known
value for that time point forward to ensure AUC was
calculated from five time-points [13].
3. Results
We failed to detect any statistically significant change in
glucose or insulin response or insulin sensitivity over the 4-
days of repeated, daily OGTT’s (Table 2; p = 0.20). There were
also no significant differences in the change scores for glucose
AUC ( p = 0.37), insulin AUC ( p = 0.22), OGIS ( p = 0.41) or
Stumvoll ISI ( p = 0.12; Table 3).
At baseline, two participants were considered to have
extreme hyperinsulinaemia (insulin 200 pmol L1). One indi-
vidual with extreme hyperinsulinaemia was classified as
having impaired glucose tolerance (2-h glucose 7.8 mmol L1)
1) using the World Health Organisation criteria [10] at baseline,
24-h and 48-h testing, before reverting to a classification of
normal glucose tolerance at the final test. At baseline, all other
Table 2 – Glucose, insulin and insulin sensitivity response to consecutive OGTT’s. Mean (95% confidence interval).
Outcome Baseline (0 h) 24 h 48 h 72 h
N = 10
2-h glucose (mmol L1) 6.2 (5.1–7.3) 5.8 (4.4–7.2) 5.9 (4.7–7.1) 5.9 (4.8–7.1)
Glucose AUC (mmol L1 120 min1) 855.7 (741.3–970.2) 839.6 (690.1–988.6) 882.7 (706.3–1059.1) 866.2 (674.6–1057.7)
2-h insulin (pmol L1) 743.1 (214.0–1272.2) 676.1 (150.7–1201.5) 729.5 (213.2–1245.9) 595.6 (184.1–1007.1)
Insulin AUC (pmol L1 120 min1) 91,851 (43,944–139,759) 142,206 (18,470–265,941) 122,431 (40,811–204,051) 104,306 (54,934–153,677)
OGIS (mL min1 m2) 333.6 (282.2–385.0) 351.8 (275.2–428.4) 373.0 (309.7–436.3) 372.9 (299.7–446.1)
Stumvoll ISI (arbitrary units) 0.047 (0.003–0.091) 0.051 (0.007–0.095) 0.046 (0.002–0.089) 0.056 (0.020–0.092)
N = 8
2-h glucose (mmol L1) 5.8 (4.9–6.7) 5.8 (4.3–7.3) 5.8 (4.7–6.8) 5.9 (4.6–7.3)
Glucose AUC (mmol L1 120 min1) 835.0 (720.3–949.8) 826.3 (675.5–977.1) 873.7 (703.5–1043.9) 870.0 (653.8–1086.2)
2-h insulin (pmol L1) 531.7 (71.4–992.0) 516.4 (96.1–936.7) 586.2 (119.4–1052.9) 486.6 (134.7–838.5)
Insulin AUC (pmol L1 120 min1) 62,672 (40,630–84,714) 62,584 (38,235–86,933) 77,443 (40,909–113,976) 85,505 (34,296–136,713)
OGIS (mL min1 m2) 354.0 (301.3–406.7) 379.8 (318.8–440.7) 363.8 (282.1–445.4) 377.5 (300.9–454.1)
Stumvoll ISI (arbitrary units) 0.067 (0.028–0.106) 0.068 (0.027–0.108) 0.061 (0.018–0.104) 0.069 (0.035–0.104)
AUC, area under the curve; OGIS, oral glucose insulin sensitivity index; ISI, insulin sensitivity index.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 9 4 ( 2 0 1 1 ) e 7 8 – e 8 2e80individuals were considered to have normal glucose tolerance
however, impaired glucose tolerance classifications were
present for one individual at the second OGTT (2-h
glucose = 8.7 mmol L1) and a different individual at the final
OGTT (2-h glucose = 8.0 mmol L1).
The glucose, insulin and insulin sensitivity responses are
presented in Fig. 2 and clearly show that as a group, the
response is similar from test to test. However, the individuals
with hyperinsulinaemia clearly respond differently and have
marked variation in their response. When only those with
normal fasting insulin levels at baseline were considered
(N = 8), the change scores were generally smaller and were still
similar for glucose AUC ( p = 0.17), insulin AUC ( p = 0.41), OGISA B
DC
Fig. 2 – Mean (&) and 95% CI for glucose AUC (A), insulin AUC (B
participants (n = 2) with extreme hyperinsulinaemia plotted (*( p = 0.15) and the Stumvoll ISI ( p = 0.34). Effect sizes (partial eta
squared) of these changes were large [14], with values of 0.608,
0.410, 0.625 and 0.461 respectively. Excluding the individuals
with extreme hyperinsulinaemia, the mean (range) coefficient
of variation for individuals from day to day was 6.3% (1.1–
13.4%), 20.6% (6.8–48.0%), 7.8% (4.2–14.2%) and 14.4% (0.3–
43.3%) for glucose AUC, insulin AUC, OGIS and Stumvoll ISI
respectively.
The clinically relevant change (calculated by the change
from the first test to the second  the 95% CI) in the response
to an OGTT in apparently healthy individuals for glucose
and insulin response along with insulin sensitivity is
presented in Table 3. From a practical perspective, if these), OGIS (C) and Stumvoll ISI (D) with individual responses of
) to show the variation.
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would infer that glucose AUC increases of greater than
63.5 mmol L1 120 min1 and decreases of greater than
80.9 mmol L1 120 min1 exceed the combined daily mea-
surement and biological variation and can therefore be
viewed with confidence as indicating real unfavourable
and favourable changes respectively. The same can be
applied to insulin AUC increases of greater than
7061 pmol L1 120 min1 and decreases of greater than
7237 pmol L1 120 min1 indicating real unfavourable and
favourable changes respectively, with real unfavourable and
favourable changes for OGIS respectively being a decrease of
greater than 1.2 mL min1 m2 and an increase of greater
than 52.7 mL min1 m2. The real unfavourable and favour-
able changes for Stumvoll ISI are a decrease of greater than
0.008 index units and an increase of greater than 0.010 index
units respectively.
4. Discussion
The OGTT has previously been reported to have unsatisfactory
reproducibility in apparently healthy individuals [4] and those
with mild diabetes [3] when the tests were repeated within two
and seven days. We have shown in this study that the glucose
and insulin response in apparently healthy individuals
without hyperinsulinaemia is quite consistent and produced
reliable results for insulin sensitivity (OGIS CV = 7.8%, Stum-
voll ISI CV = 14.4%) from consecutive, repeated OGTT’s.
However, our cases of individuals who exhibited hyperinsu-
linaemia in order to maintain glucose homeostasis, suggest
that repeated OGTT’s may not produce a reliable estimation of
insulin sensitivity for people with pre-diabetes and diabetes.
This is an important finding and to the best of our knowledge,
is something that has not been reported previously. We are
therefore able to suggest through our small study of
apparently healthy individuals without hyperinsulinaemia
that the OGTT appears to be an appropriate method to
estimate and measure change in insulin sensitivity over time,
but other methods might be more appropriate for individuals
with impaired glucose metabolism.
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Abstract 
 
Background: Regular resistance exercise completed for a number of weeks has been shown 
to increase insulin sensitivity and reduce the risk of diabetes related complications. However, 
the acute responses to resistance exercise have not been adequately investigated in relation to 
training frequency. 
Aim: To investigate the changes to insulin sensitivity in apparently healthy individuals 
following a single session of unaccustomed resistance exercise. 
Subjects and Methods:  Ten sedentary, apparently healthy individuals performed a baseline 
oral glucose tolerance test and maximal strength testing. Participants then performed a single 
session of moderate-high intensity resistance exercise which was followed by four 
consecutive days of oral glucose tolerance testing, for which participants replicated their 
initial diet. Mean estimated insulin sensitivity change scores from baseline values and their 
95% confidence intervals were compared to the previously determined values for a clinically 
meaningful change. 
Results: Two participants were identified as having hyperinsulinaemia and their data were 
therefore removed from the main analysis. There was a clinically meaningful increase in 
insulin response (mean >7,237 pmol.L-1.120mins-1) on all days following the exercise session 
and a clinically meaningful increase in glucose response (mean >81 mmol.L-1.120mins-1) on 
only the third day following exercise. These changes suggest a potentially adverse short-term 
effect. Additionally the two individuals with hyperinsulinaemia displayed more extreme 
results. 
Conclusion:  These results suggest that insulin sensitivity may be impaired following a single 
session of unaccustomed resistance exercise for approximately four days in healthy untrained, 
older individuals. Further research is required for individuals with hyperinsulinaemia. 
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Introduction 
 
Insulin resistance is a condition where the tissues (specifically skeletal muscle and the liver) 
are less responsive or sensitive to insulin, resulting in decreased glucose uptake. This results 
in increased insulin secretion and abnormally high levels of circulating insulin 
(hyperinsulinaemia) in an attempt to maintain glucose homeostasis (1). Insulin resistance has 
been associated with low grade inflammation that has been reported in obesity (2) and is a 
risk factor for hypertension and type 2 diabetes (3, 4). This condition is distinct from overt 
type 2 diabetes, where the pancreas is unable to adequately increase insulin secretion to 
account for the decreased insulin action (1). 
 
 
 
Chronic exercise training, in the form of moderate-intensity aerobic type activities is known to 
reduce fasting glucose levels, improve glycated haemoglobin levels (HbA1c) and increase 
insulin sensitivity (5). More recently, resistance training has been identified as a modality that 
is also capable of improving glucose levels and insulin sensitivity, as well as being associated 
with other health benefits such as improved body composition, blood pressure, lipid profiles 
and bone strength (6). In relation to metabolic health, it is accepted that higher intensity 
resistance training is of greater benefit than lower intensity training, however the required 
frequency to maintain or continue these improvements remains unclear (7). 
 
 
 
In the context of insulin sensitivity and glucose homeostasis, there have been few studies that 
have investigated the acute effects of resistance exercise in healthy individuals (8-10) and/or 
those with type 2 diabetes (11, 12). In those studies that have been published, the results are 
equivocal, with some reporting increased insulin sensitivity 24 hours after a single session of 
resistance exercise (13), and increased insulin action approximately 36 hours after 
unaccustomed eccentric resistance exercise (14). However, Howlett and colleagues (9) refute 
these findings, suggesting that a single bout of resistance exercise impairs insulin action. 
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Furthermore, the ongoing effects of a single bout of resistance exercise are unknown, with no 
studies tracking the insulin or glucose response beyond 36 hours following the exercise bout. 
Without such knowledge it is difficult to determine the optimal rest interval between acute 
bouts of resistance exercise and hence, the optimal training frequency. This is an important 
consideration for middle-aged adults who are more commonly at risk of developing diabetes 
and often have the perception of having decreased time available to exercise between work 
and family commitments (15). 
 
 
 
It was therefore the aim of this study to investigate the insulin sensitivity response using oral 
glucose tolerance tests administered on each of the four days following a single bout of 
moderate-high intensity resistance exercise, to determine the period of time that any changes 
were present. 
 
 
 
Methods 
 
Ten sedentary (completing less than 20 minutes of aerobic exercise twice weekly), apparently 
healthy males (n=3) and females (n=7) with a mean (SD) age of 51.6 (5.8) years with no 
diagnosed metabolic conditions were enrolled to participate. Ethical approval was granted 
from the RMIT University and Austin Health Human Research Ethics Committees, and all 
participants provided written informed consent. This study conformed to the principles of the 
Declaration of Helsinki. Inclusion criteria were: aged 40-69 years, taking no medications 
influencing metabolism, and not having participated in resistance training in the last six 
months. Exclusion criteria included: recent coronary event or established heart disease, 
uncontrolled hypertension (>150/90 mmHg), neuropathy, orthopaedic disorder preventing 
them from completing resistance training, any medical condition that contraindicated 
resistance training, and being unable to understand English or follow instructions. 
 
 
 
All participants arrived at the research facility between 0600 and 0900 hours by the use of 
private vehicles, following a 12-hour overnight fast and had height (QuickMedical 
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stadiometer to the nearest 0.1cm), weight (Tanita, BWB-600, to the nearest 0.1kg), waist and 
hip girth (using a standard non-elastic tape, to the nearest 0.5cm) measured. They also had a 
fasting blood sample collected before undergoing an oral glucose tolerance test (OGTT) 
according to world health organisation protocols to obtain baseline glucose and insulin 
responses (16). The OGTT was conducted by inserting a canulla into an antecubital vein with 
blood samples obtained before consuming 75g of glucose mixed in 300ml of water (Gluco 
Scan, BIOCORP Aust Pty. Ltd.). Further blood samples were collected at 30, 60, 90 and 120 
minutes after consuming the glucose, with patency maintained by flushing with saline every 
15 minutes. The first 2ml of blood collected was discarded to ensure there was no saline in 
the sample. The study protocol is presented schematically in Figure 1. 
 
 
 
Participants returned to the research facility three to four days after their initial OGTT and 
underwent dual x-ray absorptiometry (DXA) before being familiarised with the resistance 
exercise equipment. Participants then underwent one repetition maximum (1RM) testing on 
all five exercises to be included in the resistance exercise bout. One repetition maximum 
testing followed a set protocol as reported previously (12). Following a 13-14 day wash-out 
period, participants returned to the research facility to undergo the resistance exercise bout 
consisting of three sets of 10 repetitions for five whole-body exercises (bench press, 45˚ leg 
press, shoulder press, 45˚ calf raises and lateral pull-down) at 45%, 60% and 75% of 1RM. 
The resistance training protocol was based on protocols used in similar previous research (8, 
12). Participants returned to the research facility after a 12-hour overnight fast to complete an 
 
OGTT for each of the next four days following the exercise session. 
 
 
 
 
Participants completed the self-report International Physical Activity Questionnaire (IPAQ) 
(17) prior to beginning the study to assess activity levels. Participants were asked to record all 
food consumed throughout the study period in a food diary (with an example provided) and 
were instructed to replicate their diet before each OGTT. Nutritional analysis was conducted 
by the same researcher on the FoodWorks 2007 (Xyris software (Australia) Pty Ltd., 
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xyris.com.au) dietary analysis computer program version 5, service pack 1, to compare total 
energy consumed and the volume (grams) of protein, fat and carbohydrate each day. 
 
 
 
Baseline fasting blood samples were collected in serum separator tubes and an EDTA 
 
containing tube. These were sent to a commercial laboratory for analysis of lipid profiles 
 
(total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and 
triglycerides with laboratory variability levels of 2%, 9%, 12% & 3.5% respectively) and 
glycated haemoglobin (HbA1c – laboratory variability of 3%). Additional samples were also 
collected into serum separating tubes and tubes containing fluoride oxalate, and allowed to 
clot on ice before being centrifuged for seven minutes at 5000 rpm at 4˚C. Aliquots of serum 
and plasma were frozen at -80˚C for later analysis of insulin and glucose respectively. 
Fasting, 30, 60, 90 and 120 minute plasma samples were analysed for glucose using the YSI 
2300 Stat Plus analyser (Yellow Springs, USA) in duplicate with a coefficient of variation of 
 
<1%. Corresponding serum samples were analysed for insulin using Millipore human insulin 
ELISA kits in duplicate with a coefficient of variation of 10%. Insulin sensitivity was 
determined using glucose and insulin area under the curve (AUC) calculated by a computer- 
based trapezoidal model using GraphPad Prism 5 for Windows (Version 5.01, La Jolla, CA) 
and calculated using the oral glucose insulin sensitivity (OGIS) index (18). 
 
 
 
All data were analysed using SPSS version 18 for Windows (SPSS, Chicago, IL) with 
significance set at an alpha level of p=0.05. Change scores for glucose and insulin response 
along with OGIS were calculated by subtracting the follow-up value from the baseline value. 
The mean change scores at each time-point were then compared with the predetermined 
(Gordon, et al., unpublished data) clinically meaningful change to determine its relevance. A 
repeated measures analysis of variance (ANOVA) was completed for nutritional components 
to determine change over time. Data are presented as means (95% confidence intervals [CI]) 
unless otherwise indicated. Approximately 3% of data points were missing (due to occlusions 
within the canulla) and were substituted by bringing the last known value for that time-point 
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forward (19) for 30 minute glucose and insulin (two and one occasions respectively), 60 
minute glucose and insulin (one occasion), 90 minute glucose and insulin (three occasions) 
and 120 minute glucose and insulin (one occasion), ensuring that AUC was calculated from 
five time-points. On one occasion, the 60 minute sample of the baseline test was unable to be 
collected, resulting in the AUC for that individual at that time being calculated on four time- 
points instead of five. 
 
 
 
Results 
 
While being categorised as having normal glucose tolerance by the baseline OGTT, one 
individual was identified as having hyperinsulinaemia (130<insulin<200 pmol.L-1) at 
baseline, and another identified as having extreme hyperinsulinaemia (insulin ≥200 pmol.L-1) 
at baseline. The individual with hyperinsulinaemia experienced a potentially unfavourable 
reduction (64  ml.min-1.m-2) to insulin sensitivity, according to OGIS, 24 hours after exercise 
before returning to baseline and showing no additional change, while the individual with 
extreme hyperinsulinaemia experienced a beneficial increase to insulin sensitivity through 
OGIS of between 66 ml.min-1.m-2 and 128 ml.min-1.m-2 at all follow-up time-points. These 
two participants (one male and one female) were therefore excluded from the analysis leaving 
all further results presented as n=8. 
 
 
 
Analysis of food diaries revealed that baseline mean (95% CI) values for intake of energy, 
protein, fat and carbohydrate were 8228kj (7349.5 to 9106.4), 83.2g (67.6 to 98.8), 72.0g 
(57.5 to 86.5) and 218.7g (183.9 to 253.4) respectively. Repeated measures ANOVA with a 
Bonferroni adjustment indicated no significant differences (p=0.56) across the intervention 
days. 
 
 
 
The (n=8) participants characteristics are presented in Table 1. Briefly, these participants had 
mean blood pressures within the normal range, lipid profiles were normal and glycaemic 
control (HbA1c) was excellent. Included male participants had a mean total body fat of 27.9% 
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with a mean of 21.5kg of fat mass and 55.7kg of fat free mass while female participants had a 
mean total body fat of 35.4%, a mean fat mass of 25.7kg and a mean fat free mass of 44.7kg, 
as determined through DXA. The mean glucose and insulin response (area under the curve) to 
the baseline OGTT and baseline insulin sensitivity estimated through OGIS index is presented 
in Table 1. 
 
 
 
Based on our previously identified clinically important values which we determined by 
measuring the response to repeated, consecutive daily OGTT’s (Gordon, et al., unpublished 
data, values shown below), we observed a potentially unfavourable and clinically meaningful 
increase in the insulin response on each of the four days following the resistance exercise 
session (>7,237 pmol.L-1.120min-1; Figure 2). A potentially unfavourable and clinically 
meaningful increase in the glucose response was also observed on the third day following 
exercise (>81 mmol.L-1.120min-1; Figure 3). No clinically meaningful change to OGIS index 
(>52 ml.min-1.m-2; Figure 4) was observed. 
 
 
 
 
Discussion 
 
The major finding from this study was insulin sensitivity may be adversely affected for up to 
four days following a single unaccustomed resistance exercise session. This is in contrast to 
previous findings of improved insulin sensitivity following a single bout of resistance 
exercise in young healthy untrained individuals (12, 13), young strength trained individuals 
(20), and older individuals with type 2 diabetes (11, 12). However, our results do concur with 
those that have shown no improvements to insulin sensitivity following an acute bout of 
resistance exercise (8-10). However, studies that have reported beneficial changes have 
generally involved individuals with poor glycaemic control, which may highlight the inability 
to improve something that is already functioning adequately (21). 
 
 
 
Our current findings tend to suggest that a single session of unaccustomed resistance exercise 
may actually result in increased insulin production to maintain glucose homeostasis, or being 
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in a previously theorised state of transient insulin resistance (22). It is therefore important to 
look at mechanisms for why this may occur as a previous study of acute aerobic exercise in 
trained older individuals reported a beneficial increase to insulin sensitivity, for three but not 
five days (23) in comparison to our sedentary individuals who completed resistance exercise. 
This may suggest that it is necessary for people who already have good glycaemic control, to 
undertake a period of regular ongoing training to enable the working muscles to become 
responsive to the exercise stimulus and observe beneficial improvements to insulin sensitivity 
that have been shown following regular resistance training (24). 
 
 
 
While we have excluded two individuals with hyperinsulinaemia from our analysis of healthy 
individuals, their individual results were noteworthy. The individual with extreme 
hyperinsulinaemia (insulin≥200 pmol.L-1) appeared to experience large beneficial increases in 
insulin sensitivity while the individual with a lower level of hyperinsulinaemia 
(130<insulin<200 pmol.L-1) seemed to experience larger unfavourable reductions in insulin 
sensitivity. Therefore, we can cautiously suggest that these individuals with sub-optimal 
levels of metabolic health may respond differently and with greater magnitude. This however, 
requires further research in this specific population to elucidate why these differences may 
occur when compared to those individuals with insulin within the desirable range. 
 
 
 
While considering the limitations of our study design with a small sample size, we can 
conclude that a single bout of resistance exercise does not improve insulin sensitivity in 
apparently healthy individuals with good glucose homeostasis and may indeed have a 
potentially adverse short-term effect.  However, it may be that this study was underpowered 
and further research is required to confirm these results. We have identified potential issues 
for novice resistance training individuals to be aware of in the days immediately following 
resistance exercise. Further investigations into the training duration and frequency required 
before being able to observe known improvements to insulin sensitivity that occur from 
ongoing resistance training (24) are warranted. In addition, investigating the effect of a single 
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session of resistance exercise in individuals at risk of, or with type 2 diabetes is pertinent. Our 
current results pose further questions relating to the ability of ongoing resistance training to 
diminish the potentially adverse effects of acute resistance exercise and if this is the case, the 
length of time that training needs to occur for this to happen. 
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Table 1: Participant Demographics 
 
Outcome Measure  Mean (SD) 
 
Male / Female  2 / 6 
 
Age (years) 51.5 (6.3) 
 
Weight (kg)  74.1 (11.2) 
 
Height (cm)  170.1 (4.5) 
 
BMI (kg.m-2)  25.7 (4.2) 
 
Waist:Hip 0.83 (0.07) 
 
SBP (mm Hg)  122 (13) 
 
DBP (mm Hg)  73 (10) 
 
Cholesterol (mmol/L)  5.0 (1.0) 
 
LDL (mmol/L)  2.9 (0.4) 
 
HDL (mmol/L)  1.54 (0.53) 
 
Triglycerides (mmol/L)  1.2 (1.0) 
 
HbA1c (%)  5.5 (0.2) 
 
Glucose (mmol/L)  4.9 (0.5) 
 
Insulin (pmol/L)  73.3 (43.1) 
 
MET-mins.wk-1 968 (1053) 
 
Sedentary Time (mins)  368 (126) 
 
Bench Press 1RM (kg)  35.3 (13.1) 
 
Leg Press 1RM (kg)  115.6 (27.2) 
 
Shoulder Press 1RM (kg)  24.1 (9.2) 
 
Calf Raise 1RM (kg)  225.6 (70.7) 
 
Lat Pull-down 1RM (kg)  27.5 (10.0) 
 
Glucose AUC (mmol.L-1.120mins-1)  762.2 (185.9) 
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Insulin AUC (pmol.L-1.120mins-1)  50,634.5 (26,128.7) 
 
OGIS index (ml.min-1.m-2)  439.3 (82.7) 
 
Data excludes that from the individuals with hyperinsulinaemia. BMI = body mass index; 
DBP = diastolic blood pressure; HbA1c = glycated haemoglobin; HDL-C = high-density 
lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; MET = metabolic 
equivalents; SBP = systolic blood pressure; AUC = area under the curve. 
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Figure Legends: 
 
Figure 1: Study protocol. 
 
BP = blood pressure; IPAQ = international physical activity questionnaire; OGTT = oral 
glucose tolerance test; DXA = dual x-ray absorptiometry 
 
 
 
 
 
Figure 2: Change from baseline of insulin response (AUC) following exercise. Mean and 95% 
CI for eight included participants. Broken line represents the cut-point for a clinically 
meaningful change (>7237 pmol.L-1.120min-1). 
 
 
 
 
 
Figure 3: Change from baseline of glucose response (AUC) following exercise. Mean and 
 
95% CI for eight included participants. Broken line represents the cut-point for a clinically 
meaningful change (>81 mmol.L-1.120min-1). 
 
 
 
Figure 4: Change from baseline of OGIS index following exercise. Mean and 95% CI for 
eight included participants. Broken line represents the cut-point for a clinically meaningful 
change (>52 ml.min-1.m-2). 
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BP = blood pressure; IPAQ = international physical activity questionnaire; OGTT = oral glucose tolerance 
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Figure 2: Change from baseline of insulin response (AUC) following exercise. Mean and 95% CI for eight 
included participants. Broken line represents the cut-point for a clinically meaningful change (>7237 pmol.L- 
1.120min-1). 
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Figure 3: Change from baseline of glucose response (AUC) following exercise. Mean and 95% CI for eight 
included participants. Broken line represents the cut-point for a clinically meaningful change (>81 mmol.L- 
1.120min-1). 
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Figure 4: Change from baseline of OGIS index following exercise. Mean and 95% CI for eight included 
participants. Broken line represents the cut-point for a clinically meaningful change (>52 ml.min-1.m-2). 
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Abstract presented at RMIT University’s Higher Degree by Research student conference 
2010 
 
 
Presentation Title: Leptin and adiponectin responses to a single session of resistance exercise 
Name: Mr Brett Gordon 
School: Medical Sciences 
 
Introduction: Health conditions such as obesity, insulin resistance and type 2 diabetes are 
associated with low grade inflammation. As the prevalence of these conditions continues to 
rise, interventions that result in reductions of adipose derived hormones should therefore be 
investigated to try to prevent or delay the disease progression. 
Statement of Problem/Aim: Leptin and adiponectin are two adipocytokines that are used to 
measure inflammation and have been shown to respond to exercise. However, only one study 
to date has looked at the leptin response, and no studies have investigated the adiponectin 
response to a single resistance exercise session. Furthermore, research investigating the 
exercise response of these adipocytokines in people with type 2 diabetes is particularly 
lacking. Therefore the aim of this project was to investigate the responses of leptin and 
adiponectin in apparently healthy individuals and those with type 2 diabetes. 
Outcomes: Apparently healthy individuals (n=10) and people with type 2 diabetes (n=10) 
completed a single session of resistance exercise and fasting blood tests on the three days 
following the exercise. On average, the people with diabetes were older and weighed more 
(p<0.05) however, their total and low-density lipoprotein cholesterol was lower (p<0.05). As 
expected, fasting glucose and glycated haemoglobin were higher (p<0.05) in those with 
diabetes. Following the resistance exercise session, repeated measures ANOVA showed no 
statistically significant change from baseline in either leptin (16.7ng/ml 95% CI: -40.3 to 
73.6) or adiponectin (-0.7µg/ml 95% CI: -2.0 to 0.7) at any time from 24 to 72 hours after the 
exercise. This tends to indicate that in a previously sedentary population of people with and 
without type 2 diabetes, a single session of moderate to high intensity resistance exercise has 
no lasting effect on leptin or adiponectin and suggests that further research into the frequency 
of resistance exercise is required. 
 
Gordon BA, Fraser SF, Bird SR, Benson AC. (2010). Leptin and adiponectin responses to a 
single session of resistance exercise. Oral presentation at Higher Degree by Research Student 
Conference - Presenting Tomorrow's Knowledge, RMIT University, Melbourne, Australia, 
20 October 2010. 
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Abstract presented at RMIT University’s Higher Degree by Research student conference 
2011 
 
Presentation Title: A single session of resistance exercise does not modulate insulin 
sensitivity or adipocytokine markers of inflammation in  individuals with and without 
type 2 diabetes. 
Name: Mr Brett Gordon 
School: Medical Sciences 
 
Introduction: Type 2 diabetes (T2D) is a condition of chronic insulin resistance that is 
linked to conditions of overweight and obesity, which are associated with low-grade 
inflammation. Exercise is recommended to prevent and treat T2D and has also been shown to 
improve adipocytokine markers of inflammation. However, compliance to exercise 
recommendations is poor in both individuals with and without T2D, although resistance 
exercise has been theorised to be more achievable than aerobic based exercise. 
Statement of Problem/Aims: We sought to investigate the insulin sensitivity and 
inflammatory cytokine response in the three days following a single session of moderate-high 
intensity resistance exercise in middle-aged adults with and without T2D. 
Outcomes: Ten apparently healthy individuals (males=3; females=7) and 10 individuals with 
T2D (males=6; females=4) with a mean (SD) age of 51.6 (5.8) years and 61.8 (7.2) years 
respectively, consented to participate. The individuals with T2D were  older, weighed more, 
had impaired glycaemic control (higher HbA1c) and were less sensitive to insulin than the 
apparently healthy individuals (p<0.05). Repeated measures ANOVA failed to detect any 
group by time interactions for glucose, insulin, insulin sensitivity or insulin resistance 
(p=0.63), however a significant difference between groups for insulin sensitivity was 
abolished 48 hours after the resistance exercise session. There was no difference in 
adipocytokine markers of inflammation (adiponectin, leptin, interleukin-6, tumour necrosis 
factor alpha) prior to the resistance exercise session between groups (p>0.05), and we failed 
to detect any change 24 hours after the resistance exercise session (repeated measures 
ANOVA: p=0.44). These findings suggest that insulin sensitivity is not impacted by a single 
session of resistance exercise in middle-aged adults with and without T2D and that this is not 
caused by a change in adipocytokine markers of inflammation. 
 
Gordon BA, Fraser SF, Bird SR, Benson AC. (2011). A single session of resistance exercise 
does not modulate insulin sensitivity or adipocytokine markers of inflammation in individuals 
with and without type 2 diabetes. Oral presentation at Higher Degree by Research Student 
Conference – Vision to Reality, RMIT University, Melbourne, Australia, 21 October 2011.  
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Abstract presented at Exercise and Sports Science Australia bi-annual conference in 2012 
 
Continuous glucose response to resistance and aerobic exercise is similarly 
impaired in individuals with insulin requiring type 2 diabetes 
 
Gordon, Brett A1,2, Bird, Stephen R1, MacIsaac, Richard J3 and Benson, Amanda C1 
1Discipline of Exercise Sciences, School of Medical Sciences & Health Innovations Research Institute, 
RMIT University, Melbourne, Australia 
2Physiotherapy Department, Austin Health, Melbourne, Australia 
3Endocrinology and Diabetes, St. Vincent’s Hospital & Endocrine Centre, Austin Health & University of 
Melbourne, Melbourne, Australia 
 
Correspondence: brett.gordon@rmit.edu.au 
 
Introduction 
Long-term resistance and aerobic exercise is known to improve glycaemic control and metabolic 
health5. Low intensity aerobic exercise3 and combined resistance and aerobic exercise4 have been 
reported to reduce the amount of time spent in hyperglycaemia. However, the continuous glucose 
response to acute resistance exercise in untrained individuals with type 2 diabetes (T2D) treated with 
insulin is not known. Further, it is unclear whether the response to acute resistance exercise is similar 
to that experienced with aerobic exercise. 
 
Methods 
Eight males with insulin treated T2D had their anthropometric, health and exercise capacity 
measured. Glucose levels were then monitored using the Medtronic iPro™2 continuous glucose 
monitoring system throughout the 24hrs prior to a single session of whole-body resistance exercise (3 
sets, 10 repetitions at 70% one-repetition maximum) and 30 minutes of aerobic exercise (cycling at 
60% VO2peak), and for 3-days following each exercise session. The protocol was approved by the 
relevant Human Research Ethics Committees and participants provided informed consent prior to 
their involvement in this randomised cross-over trial where each individual completed each mode of 
exercise seven days apart. Regular insulin and medication doses were maintained except for 
immediately before exercise where half the prescribed insulin dose was administered. Data were 
analysed using repeated measures ANOVA. 
 
Results 
Participants mean (SD) age was 61.0 (7.2) years, were diagnosed with T2D 18.0 (8.5) years ago, 
weighed 102.8 (35.4) kg with HbA1c of 8.0% (0.3)%. During the 24hrs pre-exercise intervention, 
participants experienced blood glucose ≥10mmol.L-1 (hyperglycaemia) for 25.0% and 24.5% of the 
day prior to resistance and aerobic exercise respectively. We failed to detect a significant intervention 
by time interaction, however a trend for a time effect (p=0.06) was found with pair-wise comparison 
revealing a significant increase (p=0.05) in hyperglycaemia in the 24hrs after completing a single 
session of exercise. We also found a time effect (p=0.03) for continuous glucose response, with a 
significant increase (p=0.002) from the 24hrs pre-exercise to the immediate 24hrs post-exercise. 
 
Conclusion 
In novice exercisers, glycaemic control, when measured continuously, appears to be impaired to a 
similar extent following a single session of both resistance and aerobic exercise. These findings differ 
from those reported after a single session of aerobic exercise3, low-intensity resistance exercise 
combined with short high-intensity aerobic exercise4, or resistance exercise1 (measured by oral 
glucose tolerance testing) and may be due to a suggested transient insulin resistance2. Whilst chronic 
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exercise participation has been shown to improve glucose tolerance and control, regular sessions of 
exercise may be required to overcome the apparent transient impaired glycaemic control. 
 
References 
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2. Kirwan, JP. & del Aguila, LF. Biochemical Society Transactions 2003;31(Pt 6):1281-1285  
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Abstract presented at Australian Diabetes Society meeting in 2009 
 
A 4-day Time Course for Insulin Sensitivity in Response to a Single Bout of Resistance 
Exercise in Healthy 40-60 Year Olds 
 
Gordon, Brett1, Fraser, Steve2, Bird, Stephen1, Benson, Amanda1 
1 Exercise Metabolism Group, School of Medical Sciences, RMIT University, Melbourne, 
Victoria, Australia; 2 School of Exercise and Nutrition Sciences, Deakin University, 
Melbourne, Victoria, Australia 
 
Introduction 
Insulin sensitivity has been measured in response to a single acute bout of resistance exercise 
in previously healthy individuals[1-5], but the response has not been tracked for longer than 
36-hours[3]. Therefore, the purpose of this study was to track the effect of an acute bout of 
resistance exercise on insulin sensitivity over 96-hours, in the context of exercise prescription 
recommendations. 
Methods 
Ten sedentary (completing less than 20-minutes of aerobic exercise twice weekly), non-
diabetic males (N=3) and females (N=7) with a mean age of 51.6 (5.78) years consented to 
participate after ethical approval. Baseline testing consisted of height, weight, lipid profile, 
oral glucose tolerance test (OGTT) and one-repetition maximum strength testing. After a 2-
week wash-out, participants underwent a single resistance exercise session before returning 
on each of the subsequent 4-days to undergo OGTT’s. 
Results 
Sixty percent of participants were overweight (40%) or obese (20%) with mean BMI = 25.8 
(4.4) kg/m2. Participants had normal lipid profiles and good glycaemic control (HbA1c≤6.1); 
mean fasting glucose = 4.9 (0.5) mmol/l and insulin = 95.6 (84.9) pmol/l, although two 
individuals appeared to be hyperinsulinaemic (>167 pmol/l). Resistance exercise resulted in 
no statistically significant changes in insulin sensitivity. However, individual variances may 
explain this lack of change, with four participants more insulin sensitive 24-hours following 
exercise according to the oral glucose insulin sensitivity (OGIS) index, with two of these 
remaining increased at 96-hours. Two individuals also experienced increased insulin 
sensitivity at 96-hours despite some initial insulin resistance. Similar trends were observed 
for both OGIS and area under the insulin and glucose curves. 
Conclusion 
This data indicates variations in individual responses and that further investigation is 
warranted to determine the most effective exercise prescription for metabolic health. Whether 
a similar response is seen in individuals with type 2 diabetes is yet to be fully investigated. 
References 
1. Andersen, E. and A.T. Hostmark, Effect of a single bout of resistance exercise on 
postprandial glucose and insulin response the next day in healthy, strength-trained 
men. J Strength Cond Res, 2007. 21(2):487-91. 
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2. Chapman, J., et al., Unaltered insulin sensitivity after resistance exercise bout by 
postmenopausal women. Med Sci Sports Exerc, 2002. 34(6):936-41. 
3. King, D.S., et al., Effects of eccentric exercise on insulin secretion and action in 
humans. J Appl Physiol, 1993. 75(5):2151-6. 
4. Fluckey, J.D., et al., Effects of resistance exercise on glucose tolerance in normal and 
glucose-intolerant subjects. J Appl Physiol, 1994. 77(3):1087-92. 
5. Luebbers, P.E., et al., Glucose uptake after resistance training of different intensities 
but of equal work volume. J Strength Cond Res, 2008. 22(4):1094-100. 
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Results
Participant demographics can be seen in Table 1 and shows that participants
had normal lipid profiles and good glycaemic control, although two individuals
appeared to be hyperinsulinaemic (>167 pmol/l). Sixty percent of participants
were overweight (40%) or obese (20%) with mean BMI = 25.8 (4.4) kg/m2.
Participants non-diabetic status was endorsed during the baseline OGTT and 2-
hour plasma glucose measurement.
Table 1: Participant Demographics
A single bout of resistance exercise resulted in no statistically significant
changes in insulin sensitivity at any point in time (Figures 1a & 1b). It is
interesting to note though, that there was less variance for the area under the
insulin curve and also Oral Glucose Insulin Sensitivity (OGIS) index at 48
hours following the exercise bout, suggesting that some of the participants at
least experienced improved insulin sensitivity following resistance exercise.
A B
Figure 1: Area Under the Insulin Curve across days (A); OGIS across days (B);
Mean & 95% CI.
Individual variances may explain this lack of change, with four participants
more sensitive to insulin 24-hours following exercise according to the OGIS
index, with two of these remaining increased at 96-hours. Two individuals also
experienced increased insulin sensitivity at 96-hours despite some initial
insulin resistance. Similar trends were observed for both OGIS and area under
the insulin curves (Figures 2a & 2b).
Figure 2a: Individual Responses for Insulin AUC across days.
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A 4-day Time Course for Insulin Sensitivity in Response to a Single Bout of 
Resistance Exercise in Healthy 40-60 Year Olds
B. A. Gordon1, S. F. Fraser2, S. R. Bird1, A. C. Benson1
1Exercise Metabolism Group, School of Medical Sciences, RMIT University, Melbourne, Australia 
2School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
Introduction
Resistance training has been the recent focus of a number of diabetes
treatment and prevention studies, however there continues to be a lack of
agreement in terms of the most effective dose. Insulin sensitivity has been
measured in response to a single acute bout of resistance exercise in
previously healthy individuals [1-5], but the response has not been tracked
for longer than 36-hours [3]. Results from these studies are mixed, with
some reporting improvements in insulin sensitivity and others refuting this
effect. Therefore, the purpose of this study was to track the effect of an
acute bout of resistance exercise on insulin sensitivity over 96-hours, in the
context of exercise prescription recommendations [6-7].
Hypothesis
A single bout of moderate to high intensity resistance exercise will improve
insulin sensitivity for 48 hours following this bout.
Methodology
Study Design:
Ten sedentary (completing less than 20-minutes of aerobic exercise twice
weekly), non-diabetic males (N=3) and females (N=7) with a mean age of
51.6 (5.8) years consented to participate after ethical approval. Baseline
testing consisted of height, weight, lipid profile, oral glucose tolerance test
(OGTT) and one-repetition maximum strength testing on five exercises.
After a 2-week wash-out, participants underwent a single resistance exercise
session before returning on each of the subsequent 4-days to undergo
OGTT’s.
Measurements:
Body Mass & Height, (c.v.=0.03% & 0.10%)
Body Mass Index (BMI)  (Weight (kg) / Height2(m))
Waist Circumference (WC), (c.v.=0.19%)
Bloods (fasting lipids, HbA1c, glucose, insulin), (c.v.=
TC=2%, HDL-C=9%, LDL-C=12%, TG=3.5%,
HbA1c=3%, Glucose=1.1%, Insulin=12.1%)
Oral Glucose Insulin Sensitivity (OGIS) and Area
Under the Curve (AUC). OGIS and AUC are
mathematical modeling equations that are validated against
the hyperinsulinemic glucose clamp to predict insulin
sensitivity from an OGTT.
1RM testing:
A progressive protocol to failure on 2 consecutive
attempts on the following exercises – bench press, 45˚
leg press, shoulder press, calf raises & lateral-
pulldown.
Acute Resistance Exercise Bout:
The progressive exercise bout consisted of 3 sets of 10
repetitions for each exercise. Each set was completed at
45%, 60% & 75% of the participants 1RM for each exercise
with 60 seconds recovery between sets. Stretches were
completed as a cool-down. This exercise bout took
approximately 50 minutes to complete.
Statistical Analysis:
• All data were analysed using SPSS version 15 for Windows with
significance set at an alpha level of p<0.05.
• A one-way repeated measures analysis of variance (ANOVA) was
completed to assess the change over time for insulin sensitivity.
• Data are presented as means ± standard deviation (SD) unless otherwise
indicated.
Results cont. 
Figure 2b: Individual Responses for OGIS across days.
The results tend to suggest that individuals completing a bout of
unfamiliar resistance exercise may result in a period of transient
insulin resistance, a phenomenon that has been suggested previously
to be associated with a state of increased inflammation [8].
Therefore, future studies should also investigate markers of
inflammation to be able to further investigate this possibility.
Conclusions
• There is individual variation in the way that individuals respond to
a single bout of unfamiliar resistance exercise with improvements
in insulin sensitivity occurring at different time points.
• This study investigated apparently healthy individuals and it
remains to be seen if individuals with type 2 diabetes respond in the
same way over this time course after a single bout of resistance
exercise.
Where to From Here?
• Investigate the effect of an unfamiliar bout of resistance
exercise on markers of inflammation and transient insulin
resistance.
• Investigate whether individuals with type 2 diabetes
respond differently to apparently healthy individuals.
• Investigate whether this response changes in individuals
who regularly participate in resistance training exercise.
• The results of this study warrant further investigation to
determine the most effective exercise prescription for
metabolic health.
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Abstract presented at RMIT University’s Higher Degree by Research student conference 
2009 
 
The insulin response following a single bout of resistance exercise varies between 
healthy individuals and those with type 2 diabetes. 
1Brett A Gordon, 2Steve F Fraser, 1Stephen R Bird, 1Amanda C Benson 
1Discipline of Exercise Sciences, School of Medical Sciences, RMIT University, Melbourne, 
Victoria, Australia; 2School of Exercise and Nutrition Sciences, Deakin University, 
Melbourne, Victoria, Australia 
 
Type 2 diabetes is a major health epidemic, affecting between 7-10% of the Australian 
population. Lifestyle modifications, including exercise and healthy eating, are recommended 
as the first line of treatment, with clear guidelines developed for aerobic type exercise such as 
walking. However, due to the numerous co-morbidities generally associated with type 2 
diabetes, it can be difficult to attain these recommendations. Therefore, resistance training 
presents a viable and more tolerable option, however further development of current 
guidelines is needed for this cohort. 
 
The aim of this study was to determine the length of time that improvements to insulin 
sensitivity and glucose transport remained following a single acute bout of resistance 
exercise; to determine the most effective frequency of resistance training. Fasting blood 
samples were collected for this prior to undergoing the resistance training bout and for the 
following three days, with homeostasis modelling assessment (HOMA) equations used to 
determine insulin sensitivity and resistance. 
 
To our knowledge, this is the first study that has tracked the insulin response following a 
single resistance exercise bout for greater than 24-hours and 36–hours in people with and 
without type 2 diabetes respectively. The initial insulin sensitivity response (24-hours post 
training) appears relatively unchanged in individuals with type 2 diabetes, while tending to 
decrease in individuals without type 2 diabetes. At 48-hours, there is a similar response in 
both individuals with and without type 2 diabetes. However, the 72-hour response appears to 
track in opposite directions with a tendency for individuals with type 2 diabetes to increase 
their insulin sensitivity. This new information will be important in developing resistance 
training guidelines, as it shows that while the early response to acute resistance exercise is 
similar between individuals with and without type 2 diabetes, there are differences that 
should also be considered for exercise prescription. 
 
Gordon BA, Fraser SF, Bird SR, Benson AC. (2009). The insulin response following a 
single bout of resistance exercise varies between individuals with and without type 2 
diabetes. Poster presentation at A Step Ahead: Higher Degrees by Research Student 
Conference 2009, RMIT University, Melbourne, Australia, 23 October 2009.  
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Methodology
Study Design:
Ten sedentary (completing less than 20-minutes of aerobic exercise twice
weekly), individuals without type 2 diabetes and 10 sedentary individuals
with type 2 diabetes consented to participate after ethical approval.
Baseline testing consisted of height, weight, lipid profile, fasting glucose
and insulin, international physical activity questionnaire (IPAQ) and one-
repetition maximum (1RM) strength testing on five exercises. After a 7-14
day washout period, participants underwent a single resistance exercise
session before returning on each of the subsequent three days to undergo
fasting blood testing.
Measurements:
Body Mass & Height: (c.v.=0.3% & 0.10%)
Body Mass Index (BMI) – (Weight (kg) / Height2 (m))
Waist Circumference (WC): (c.v.=0.19%)
Bloods (fasting lipids, HbA1c, glucose, insulin: (c.v.= TC=2%,
HDL-C=9%, LDL-C=12%, TG=3.5%, HbA1c=3%, Glucose=1%,
Insulin=12.1%)
1RM Testing:
A progressive protocol to failure on two consecutive attempts on
the following exercise – bench press, 45° leg press, shoulder
press, calf raises & lateral-pulldown.
Acute Resistance Exercise Bout:
The progressive exercise bout consisted of 3 sets of 10 repetitions
for each exercise. Each set was completed at 45%, 60% and 75%
of the participants 1RM for each exercise with 60 seconds
recovery between sets. Stretches were completed as a cool-down.
This exercise bout took approximately 50 minutes to complete.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless otherwise
indicated.
• A two-way repeated measures (group x time) analysis of variance
(ANOVA) was completed to assess the change over time for insulin
sensitvity, with independent T tests comparing groups at individual time
points.
• All data were analysed using SPSS version 17 for Windows with
significance set at an alpha level of p<0.05.
The insulin response following a single bout of resistance exercise varies 
between individuals with and without type 2 diabetes
B. A. Gordon1, S. F. Fraser2, S. R. Bird1, A. C. Benson1
1Exercise Metabolism Group, School of Medical Sciences, RMIT University, Melbourne, Australia 
2School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
Introduction
Resistance training has been the recent focus of a number of diabetes
treatment and prevention studies, however there continues to be a lack of
agreement in terms of the most effective dose. Insulin sensitivity has been
measured in response to a single acute bout of resistance exercise in
previously healthy individuals [1-5] and people with type 2 diabetes [4, 6],
but the response has not been tracked for longer than 36-hours in people
without type 2 diabetes and 24 hours in those with type 2 diabetes. Results
from studies involving individuals without type 2 diabetes are mixed, with
some reporting improvements in insulin sensitivity and others refuting this
effect. However, the effect of resistance exercise appears to be more
definitive in people with type 2 diabetes with both [4, 6] studies reporting
improvements in insulin sensitivity. The aim of this study was to determine
the length of time that improvements to insulin sensitivity and glucose
transport remained following a single acute bout of resistance exercise; to
determine the most effective frequency of resistance training.
Hypothesis
A single bout of moderate to high intensity resistance exercise will improve
insulin sensitivity following this bout for 48 hours in people with type 2
diabetes compared with no change in people without type 2 diabetes.
Results
Participant demographics can be seen in Table 1 and shows that participants
had normal lipid profiles and good glycaemic control, although two individuals
without type 2 diabetes and four individuals with type 2 diabetes appeared to
be hyperinsulinaemic (>150 pmol/l). Sixty percent of the participants without
type 2 diabetes were overweight (40%) or obese (20%) with mean BMI = 25.8
(4.4) kg/m2 while 90% of people with type 2 diabetes were overweight (50%)
or obese (40%) with mean BMI = 29.6 (3.9) kg/m2.
Outcome Type 2 Diabetes No Diabetes 
N 10 10
Male / female 6/4 3 / 7
Age (years) 61.8 (7.2) 51.6 (5.8)
Height (cm) 169.7 (7.7) 170.8 (7.9)
Weight (kg) 86.8 (13.4) 74.7 (10.0)
Duration of Diabetes (years) 8.3 (5.1) N/A
SBP (mmHg) 131 (20) 118 (13)
DBP (mmHg) 74 (8) 73 (9)
TC (mmol/l) 4.1 (0.6) 5.1 (0.8)
LDL-C (mmol/l) 2.1 (0.4) 3.0 (0.4)
HDL-C (mmol/l) 1.32 (0.22) 1.53 (0.47)
TG (mmol/l) 1.6 (0.6) 1.2 (0.9)
HbA1c (%) 6.8 (0.6) 5.6 (0.3)
Fasting Glucose (mmol/l) 7.6 (1.6) 4.9 (0.5)
Fasting Insulin (pmol/l) 137.9 (82.5) 95 (84.9)
MET-mins/wk (IPAQ) 501 (273.4) 987 (931.1)
Sitting Time (mins/wk, IPAQ) 467 (209.5) 378 (141.5)
Table 1: Participant Demographics
Initial Visit & Informed Consent Height, Weight, BMI, Waist, BP, 
Insulin, Glucose, Lipids, IPAQ
Day 0 Day 1 Day 2 Day 3 Day 4
DEXA
Familiarisation
1RM testing
Insulin
Glucose
Insulin
Glucose
Insulin
Glucose
Insulin
Glucose
Acute Bout
Wash-out
7-14 days Results cont.
As might be expected, there was a significant difference for fasting glucose
levels between groups (p<0.01) and the mean insulin sensitivity was higher in
the individuals without type 2 diabetes at all time points, but only statistically
significant at time point zero (Figure 1). There were no within group
differences found over time for either group in regards to fasting glucose,
insulin or insulin sensitivity estimated using the Homeostasis Modelling
Assessment (HOMA) equation. Individual variation in insulin sensitivity in
response to a single resistance exercise bout is shown in figures 2 and 3 and
indicates that while many of the participants had a similar response to the
resistance exercise, some individuals responded differently and require further
investigation.
Figure 1: Mean insulin sensitivity (HOMA) before and after resistance exercise.
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Conclusion
• To our knowledge, this is the first study that has tracked the insulin
response following a single resistance exercise bout for greater than
24-hours and 36–hours in people with and without type 2 diabetes
respectively.
• There appears to be no change in insulin sensitivity following a single
bout of resistance exercise in previously sedentary individuals with
and without type 2 diabetes. This is in contrast to previous literature
in individuals with type 2 diabetes [4, 6] that suggest an improvement
to insulin sensitivity following a single bout of resistance exercise.
This suggests further research is required to examine the effect of
exercise intensity, type or the potential for change in each participant.
Where to Next?
• Investigate the effect of an unfamiliar bout of resistance exercise
on markers of inflammation and transient insulin resistance.
• Investigate whether participation in a regular resistance exercise
program changes this response.
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Figure 2: Individual variance in  insulin sensitivity (HOMA) in individuals with type 2 diabetes.
Figure 3: Individual variance in insulin sensitivity (HOMA) in individuals without type 2 diabetes.
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Consecutive oral glucose tolerance testing with or without prior resistance 
training does not affect insulin sensitivity in apparently healthy adults. 
 
Gordon, Brett A.1, Fraser, Steve F.2, Bird, Stephen R.1, Benson, Amanda C.1 
1RMIT University, Melbourne, Australia. 
2Deakin University, Melbourne, Australia. 
 
Introduction: Insulin sensitivity is a key component of type 2 diabetes (T2D) that 
decreases as the disease progresses. The oral glucose tolerance test (OGTT) is 
used to diagnose T2D and frequently to estimate insulin sensitivity; however, the 
effect of repeated, daily OGTT’s is unclear. Therefore, the purpose of this study was 
to track the insulin sensitivity response to four-consecutive OGTT’s and assess the 
impact of a prior single resistance exercise bout.  
 
Methods: RMIT University human research ethics committee approved the study 
and all participants gave informed consent. Twenty sedentary, apparently healthy 
individuals were recruited with ten (51.6±5.8 years) completing a single resistance 
exercise (RE) bout followed by four OGTTs on consecutive days and ten (54.6±6.5 
years) completing four OGTTs on consecutive days without a prior resistance 
exercise bout (No-RE).  
 
Results: At baseline, there was a significant difference in insulin sensitivity between 
groups according to the oral glucose insulin sensitivity index (418.8±95.1ml.min-1.m-
2, RE; 333.6±71.9ml.min-1.m-2, No-RE; p=0.04), however this difference was not 
present at any other time. There was no change in insulin sensitivity following 
repeated multiple OGTT’s, in either the RE or No-RE groups at any time point.  
 
Conclusion: Repeated OGTT’s provide a reliable estimate of insulin sensitivity in 
apparently healthy individuals that does not appear to be affected by administration 
on consecutive days.  Additionally, a single moderate-high intensity resistance 
exercise bout did not produce a discernable change in insulin sensitivity. The 
number of resistance exercise sessions required before changes to insulin sensitivity 
can be detected requires further investigation. 
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Consecutive oral glucose tolerance testing with or without prior resistance 
training does not affect insulin sensitivity in apparently healthy individuals
B. A. Gordon1, S. F. Fraser2, S. R. Bird1, A. C. Benson1
1School of Medical Sciences, RMIT University, Melbourne, Australia 
2School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
Methodology
Study Design:
Twenty sedentary (completing less than 20-minutes of aerobic
exercise twice weekly), apparently healthy individuals consented to
participate after ethical approval. Baseline testing consisted of
height, weight, lipid profile, fasting glucose and insulin, OGTT,
international physical activity questionnaire (IPAQ) and one-
repetition maximum (1RM) strength testing on five exercises in the
group undertaking the resistance exercise bout. The study protocol
is outlined in Figure 1.
Measurements:
Body Mass & Height: (c.v. = 0.3% & 0.10%)
Body Mass Index (BMI) – (Weight (kg) / Height2 (m))
Waist Circumference (WC): (c.v. = 0.19%)
Bloods (fasting lipids, HbA1c, glucose, insulin: (c.v. =
TC = 2%, HDL-C = 9%, LDL-C = 12%, TG = 3.5%,
HbA1c = 3%, Glucose < 1%, Insulin = 8.45%)
1RM Testing:
A progressive protocol to failure on two consecutive
attempts on the following exercises – bench press, 45° leg
press, shoulder press, calf raises & lateral-pulldown.
Acute Resistance Exercise Bout:
The progressive exercise bout consisted of 3 sets of 10
repetitions for each exercise. Each set was completed at
45%, 60% and 75% of the participant’s 1RM for each
exercise with 60 seconds recovery between sets.
Oral Glucose Insulin Sensitivity (OGIS) and Area
Under the Curve (AUC). OGIS and AUC are
mathematical modeling equations that are validated
against the euglycaemic hyperinsulinemic glucose clamp
to predict insulin sensitivity from an OGTT.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless
otherwise indicated.
• A two-way, mixed-between, repeated measures (group x time)
analysis of variance (ANOVA) was completed to assess the
change over time for insulin sensitivity.
• All data were analysed using SPSS version 17 for Windows
with significance set at an alpha level of p<0.05.
Introduction
• Insulin sensitivity is a key component of type 2 diabetes that
worsens as the disease progresses.
• The oral glucose tolerance test (OGTT) is used to diagnose type
2 diabetes and frequently to estimate insulin sensitivity;
however, the effect of repeated, daily OGTT’s is unclear.
• In apparently healthy individuals, insulin sensitivity has been
reported to increase 24 hours following a single session of
resistance exercise [1] and insulin action has been reported to
increase approximately 36 hours following unaccustomed
eccentric resistance exercise [2].
• Other studies however, have reported impaired insulin action
following a single bout of resistance training [3].
• The primary aim of this study was to assess the impact of
consecutive OGTT’s on insulin sensitivity. The secondary aim
was then to determine if a single, acute bout of resistance
exercise resulted in improved insulin sensitivity and glucose
transport and how long any changes remained; to determine the
most effective frequency of resistance training.
Hypothesis
• Repeated, daily OGTT’s will not affect insulin sensitivity.
• Insulin Sensitivity will improve for 48 hours following a single
bout of moderate to high intensity resistance exercise.
Results
Participant demographics can be seen in Table 1 and shows that
participants had normal lipid profiles, blood pressure and good
glycaemic control. The mean BMI for the resistance exercise group
was 25.8 (4.5) kg/m2 while it was 33.3 (6.3) kg/m2 for the no resistance
exercise group. One individual from the resistance exercise group and
two from the no resistance exercise group had an abnormal response to
the initial OGTT that would indicate they had impaired glucose
tolerance. Two individuals from the resistance exercise group and four
from the no resistance exercise group were hyperinsulinaemic (>130
pmol/L) at baseline.
Table 1: Participant Demographics
Results cont.
• There was no change over time for area under the insulin curve for 
either group (Figure 2).
• The OGIS showed good reproducibility as there was no change 
over time for insulin sensitivity for either group (Figures 3 & 4).
• There was no change over time for 120 minute glucose levels for 
either group and no significant difference between groups (Figure 
5).
Conclusion
• Repeated OGTT’s provide a reliable estimate of insulin
sensitivity in apparently healthy individuals that does not
appear to be affected by administration on consecutive days.
• A single bout of moderate to high intensity resistance exercise
did not produce a discernable change in insulin sensitivity.
• The OGTT produces moderately reproducible results in terms
of glucose levels.
Where to Next?
• Investigate the effect of an unfamiliar bout of resistance
exercise on markers of inflammation and transient insulin
resistance.
• Investigate the number of resistance exercise sessions
required before changes to insulin sensitivity can be
detected.
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Measure Resistance Exercise No Resistance Exercise
Male / Female 3 / 7 3 / 7
Age (years) 51.6 (5.8) 54.6 (6.5)
Weight (kg) 74.7 (10.0) 93.4 (16.4)*
Height (cm) 170.8 (7.9) 167.7 (6.8)
BMI (kg.m-2) 25.8 (4.5) 33.3 (6.3)*
Waist:Hip 0.83 (0.07) 0.88 (0.08)
BP (mmHg) 120 (13) / 74 (9) 126 (14) / 83 (10)*
Cholesterol (mmol/L) 5.1 (0.8) 4.9 (1.2)
LDL (mmol/L) 3.0 (0.4) 2.8 (1.0)
HDL (mmol/L) 1.53 (0.47) 1.42 (0.24)
Triglycerides (mmol/L) 1.2 (0.9) 1.6 (0.5)
HbA1c (%) 5.6 (0.3) 5.5 (0.3)
Glucose (mmol/L) 4.9 (0.5) 5.4 (0.4)
Insulin (pmol/L) 95.6 (84.9) 129 (82.7)
MET-mins.wk-1 (IPAQ) 987 (931) 1428 (1365)
Sedentary Time (mins) 378 (142) 435 (207)
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Figure 4: Variance in insulin sensitivity over time. Mean and 95% CI.
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Figure 5: Variance in 120 minute glucose from the OGTT over time.
Mean and 95% CI. Dotted line represents the cut off for a
normal response.
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Figure 2: Mean (SD) area under the insulin curve for each OGTT.
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Figure 3: Mean (SD) OGIS calculated from each OGTT.
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No change in insulin sensitivity following a single bout of resistance exercise in 
individuals with and without type 2 diabetes. 
Gordon, Brett A1, Fraser, Steve F2, Bird, Stephen R1, Benson, Amanda C1 
1RMIT University, Melbourne, Victoria, Australia  
2Deakin University, Melbourne, Victoria, Australia 
 
Introduction: Type 2 diabetes (T2D) is a major health epidemic, affecting between 7-10% of 
all Australians. Aerobic exercise is recommended for T2D, but is difficult for some 
individuals to attain the required volume and intensity. Therefore, resistance training has been 
proposed as a viable and more tolerable option. The aim of this study was to determine the 
time-course of changes to insulin sensitivity following a single bout of resistance exercise.  
Methods: RMIT University human research ethics committee approved this study and all 
participants gave written informed consent prior to participating. Ten apparently healthy 
(51.6±5.8 years) and 10 individuals with T2D (61.8±7.2 years) participated. Fasting blood 
samples were collected prior to undergoing a resistance exercise bout and on three 
subsequent days. Homeostasis modelling assessment (HOMA) equations were used to 
determine insulin sensitivity.  
Results: Mean insulin sensitivity was greater in individuals without T2D, although was only 
significantly different immediately prior to (86.2±45.5%, apparently healthy; 41.1±13.6%, 
diabetes; p=0.01) and after (p=0.03) the resistance exercise bout. Following the resistance 
exercise bout, no change in insulin sensitivity was detected in either cohort.  
Conclusion: A single resistance exercise bout produced no discernable change to insulin 
sensitivity in the majority of these participants. These findings are in contrast to previous 
literature1 concerning acute resistance exercise in T2D and suggest further research is 
required to examine participant health status on the potential for change in insulin sensitivity 
and the time-course for any changes.  
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Methodology
Study Design:
Ten sedentary (completing less than 20-minutes of aerobic exercise
twice weekly), individuals without type 2 diabetes and 10 sedentary
individuals with type 2 diabetes consented to participate after
ethical approval. Baseline testing consisted of height, weight, lipid
profile, fasting glucose and insulin, international physical activity
questionnaire (IPAQ) and one-repetition maximum (1RM) strength
testing on five exercises. After a 7-14 day washout period,
participants underwent a single resistance exercise session before
returning on each of the subsequent three days to undergo fasting
blood testing.
Measurements:
Body Mass & Height: (c.v. = 0.3% & 0.10%)
Body Mass Index (BMI) – (Weight (kg) / Height2 (m))
Waist Circumference (WC): (c.v. = 0.19%)
Bloods (fasting lipids, HbA1c, glucose, insulin: (c.v. =
TC = 2%, HDL-C = 9%, LDL-C = 12%, TG = 3.5%,
HbA1c = 3%, Glucose < 1%, Insulin = 13.6%)
1RM Testing:
A progressive protocol to failure on two consecutive
attempts on the following exercises – bench press, 45° leg
press, shoulder press, calf raises & lateral-pulldown.
Acute Resistance Exercise Bout:
The progressive exercise bout consisted of 3 sets of 10
repetitions for each exercise. Each set was completed at
45%, 60% and 75% of the participant’s 1RM for each
exercise with 60 seconds recovery between sets. Stretches
were completed as a cool-down. This exercise bout took
approximately 50 minutes to complete.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless
otherwise indicated.
• A two-way, mixed-between, repeated measures (group x time)
analysis of variance (ANOVA) was completed to assess the
change over time for insulin sensitivity, with independent t-tests
comparing groups at individual time points.
• All data were analysed using SPSS version 17 for Windows
with significance set at an alpha level of p<0.05.
No change in insulin sensitivity following a single bout of resistance 
exercise in individuals with and without type 2 diabetes
B. A. Gordon1, S. F. Fraser2, S. R. Bird1, A. C. Benson1
1School of Medical Sciences, RMIT University, Melbourne, Australia 
2School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
Introduction
• Insulin sensitivity has been measured in response to a single
acute bout of resistance exercise in previously healthy
individuals [1-5] and people with type 2 diabetes [4, 6], but only
for 36-hours in people without type 2 diabetes and 24 hours in
those with type 2 diabetes.
• Post resistance exercise improvements to insulin sensitivity
have been noted in individuals without type 2 diabetes [1, 7],
while others have refuted this effect [2, 5, 8].
• The effect of resistance exercise appears to be more definitive in
people with type 2 diabetes with both [4, 6] studies reporting
improvements in insulin sensitivity.
• The aim of this study was to determine the length of time that
improvements to insulin sensitivity and glucose transport
remained following a single acute bout of resistance exercise; to
determine the most effective frequency of resistance training.
Hypothesis
A single bout of moderate to high intensity resistance exercise will
improve insulin sensitivity following this bout for 48 hours in
people with type 2 diabetes compared with no change in people
without type 2 diabetes.
Results
Participant demographics can be seen in Table 1 and shows that
participants had normal lipid profiles and good glycaemic control,
although two individuals without type 2 diabetes and five individuals
with type 2 diabetes appeared to be hyperinsulinaemic (>130 pmol/l).
Sixty percent of the participants without type 2 diabetes were
overweight (40%) or obese (20%) with mean BMI = 25.8 (4.4) kg/m2
while 90% of people with type 2 diabetes were overweight (50%) or
obese (40%) with mean BMI = 29.6 (3.9) kg/m2.
Outcome Type 2 Diabetes No Diabetes 
N 10 10
Male / Female 6/4 3 / 7
Age (years) 61.8 (7.2) 51.6 (5.8)*
Height (cm) 169.7 (7.7) 170.8 (7.9)
Weight (kg) 86.8 (13.4) 74.7 (10.0)*
Duration of Diabetes (years) 8.3 (5.1) N/A
SBP (mmHg) 131 (20) 118 (13)
DBP (mmHg) 74 (8) 73 (9)
TC (mmol/l) 4.1 (0.6) 5.1 (0.8)*
LDL-C (mmol/l) 2.1 (0.4) 3.0 (0.4)*
HDL-C (mmol/l) 1.32 (0.22) 1.53 (0.47)
TG (mmol/l) 1.6 (0.6) 1.2 (0.9)
HbA1c (%) 6.8 (0.6) 5.6 (0.3)*
Fasting Glucose (mmol/l) 7.6 (1.6) 4.9 (0.5)*
Fasting Insulin (pmol/l) 137.9 (82.5) 95 (84.9)
MET-mins/wk (IPAQ) 423 (256) 987 (931)
Sitting Time (mins/wk, IPAQ) 468 (198) 378 (142)
Table 1: Participant Demographics
Initial Visit & Informed Consent Height, Weight, BMI, Waist, BP, 
Insulin, Glucose, Lipids, IPAQ
Day 0 Day 1 Day 2 Day 3 Day 4
Familiarisation
1RM testing
Insulin
Glucose
Insulin
Glucose
Insulin
GlucoseInsulinGlucose
Acute Bout
Wash-out
7-14 days
Results cont.
• There was a significant difference for fasting glucose levels 
between groups (p<0.01) at all time points.
• Mean insulin sensitivity was higher in the individuals without type 
2 diabetes at all time points, but only statistically significant 
immediately prior to and following the resistance exercise bout 
(Figure 1). 
• There were no within group differences found over time for either 
group in regards to fasting glucose, insulin or insulin sensitivity 
estimated using the Homeostasis Modelling Assessment (HOMA) 
equation. 
• Individual variation in insulin sensitivity in response to a single 
resistance exercise bout is shown in figures 2 and 3 and indicates 
that while many of the participants had a similar response to the 
resistance exercise, some individuals responded differently, a point 
that warrants further investigation.
Figure 1: Mean insulin sensitivity (HOMA) before and after resistance exercise.
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Conclusion
• To our knowledge, this is the first study that has tracked the
insulin response following a single resistance exercise bout
for greater than 24-hours and 36–hours in people with and
without type 2 diabetes respectively.
• There appears to be no change in insulin sensitivity following
a single bout of resistance exercise in previously sedentary
individuals with and without type 2 diabetes.
• This suggests further research is required to examine the effect
of exercise intensity, type or the potential for change in each
participant.
Where to Next?
• Investigate the effect of an unfamiliar bout of resistance
exercise on markers of inflammation and transient insulin
resistance.
• Investigate whether participation in a regular resistance
exercise program (chronic adaptation) changes this
response.
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Figure 2: Individual variance in  insulin sensitivity (HOMA) in individuals with type 2 
diabetes.
Figure 3: Individual variance in insulin sensitivity (HOMA) in individuals without type 2 
diabetes.
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* = significantly different between groups (p<0.05). 
 
 
286 
 
Abstract presented at RMIT University’s Higher Degree by Research student conference 
2010 
 
Presentation Title: Consecutive oral glucose tolerance testing with or without prior resistance 
exercise does not affect insulin sensitivity in apparently healthy adults. 
Name: Mr Brett Gordon 
School: Medical Sciences 
 
Introduction: Insulin sensitivity is a key component of type 2 diabetes (T2D) that decreases 
as the disease progresses. With the increasing prevalence of obesity and T2D, it is important 
to determine ways to improve insulin sensitivity and decrease the risk of future health 
conditions. Previous research has been unable to agree on the effects of a single session of 
resistance exercise and the length of time that these effects remain has not been fully 
investigated. 
Statement of Problem/Aim: The benefits of exercise are well understood, however having 
people adhere to exercise guidelines is challenging. Therefore, the purpose of this study was 
to track the insulin sensitivity response to four-consecutive oral glucose tolerance tests 
(OGTT’s) and assess the impact of a prior single resistance exercise bout to try to determine 
the optimum training frequency.  
Outcomes: Twenty sedentary, apparently healthy individuals were recruited with ten 
(51.6±5.8 years) completing a single resistance exercise (RE) bout followed by four OGTTs 
on consecutive days and ten (54.6±6.5 years) completing four OGTTs on consecutive days 
without a prior resistance exercise bout (No-RE). At baseline, there was a significant 
difference in insulin sensitivity between groups according to the oral glucose insulin 
sensitivity index (RE=418.8±95.1ml.min-1.m-2; No-RE=333.6±71.9ml.min-1.m-2; p=0.04), 
however this difference was not present at any other time. There was no change in insulin 
sensitivity following repeated OGTT’s, in either the RE or No-RE groups at any time point. It 
appears that repeated OGTT’s provide a reliable estimate of insulin sensitivity in apparently 
healthy individuals however; a single moderate-high intensity resistance exercise bout did not 
produce a discernable change in insulin sensitivity between 24 and 96 hours after the 
exercise. The optimum training frequency is yet to be determined and therefore, the number 
of resistance exercise sessions required before changes to insulin sensitivity can be detected 
requires further investigation. 
 
Gordon BA, Fraser SF, Bird SR, Benson AC. (2010) Consecutive oral glucose tolerance 
testing with or without prior resistance training does not affect insulin sensitivity in 
apparently healthy adults. Poster presentation at Higher Degree by Research Student 
Conference - Presenting Tomorrow's Knowledge, RMIT University, Melbourne, Australia, 
20 October 2010.  
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Consecutive oral glucose tolerance testing with or without prior resistance 
training does not affect insulin sensitivity in apparently healthy individuals
B. A. Gordon1, S. F. Fraser2, S. R. Bird1, A. C. Benson1
1School of Medical Sciences, RMIT University, Melbourne, Australia 
2School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
Methodology
Study Design:
Twenty sedentary (completing less than 20-minutes of aerobic
exercise twice weekly), apparently healthy individuals consented to
participate after ethical approval. Baseline testing consisted of
height, weight, lipid profile, fasting glucose and insulin, OGTT,
international physical activity questionnaire (IPAQ) and one-
repetition maximum (1RM) strength testing on five exercises in the
group undertaking the resistance exercise bout. The study protocol
is outlined in Figure 1.
Measurements:
Body Mass & Height: (c.v. = 0.3% & 0.10%)
Body Mass Index (BMI) – (Weight (kg) / Height2 (m))
Waist Circumference (WC): (c.v. = 0.19%)
Bloods (fasting lipids, HbA1c, glucose, insulin: (c.v. =
TC = 2%, HDL-C = 9%, LDL-C = 12%, TG = 3.5%,
HbA1c = 3%, Glucose < 1%, Insulin = 8.45%)
1RM Testing:
A progressive protocol to failure on two consecutive
attempts on the following exercises – bench press, 45° leg
press, shoulder press, calf raises & lateral-pulldown.
Acute Resistance Exercise Bout:
The progressive exercise bout consisted of 3 sets of 10
repetitions for each exercise. Each set was completed at
45%, 60% and 75% of the participant’s 1RM for each
exercise with 60 seconds recovery between sets.
Oral Glucose Insulin Sensitivity (OGIS) and Area
Under the Curve (AUC). OGIS and AUC are
mathematical modeling equations that are validated
against the euglycaemic hyperinsulinemic glucose clamp
to predict insulin sensitivity from an OGTT.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless
otherwise indicated.
• A two-way, mixed-between, repeated measures (group x time)
analysis of variance (ANOVA) was completed to assess the
change over time for insulin sensitivity.
• All data were analysed using SPSS version 17 for Windows
with significance set at an alpha level of p<0.05.
Introduction
• Insulin sensitivity is a key component of type 2 diabetes that
worsens as the disease progresses.
• The oral glucose tolerance test (OGTT) is used to diagnose type
2 diabetes and frequently to estimate insulin sensitivity;
however, the effect of repeated, daily OGTT’s is unclear.
• In apparently healthy individuals, insulin sensitivity has been
reported to increase 24 hours following a single session of
resistance exercise [1] and insulin action has been reported to
increase approximately 36 hours following unaccustomed
eccentric resistance exercise [2].
• Other studies however, have reported impaired insulin action
following a single bout of resistance training [3].
• The primary aim of this study was to assess the impact of
consecutive OGTT’s on insulin sensitivity. The secondary aim
was then to determine if a single, acute bout of resistance
exercise resulted in improved insulin sensitivity and glucose
transport and how long any changes remained; to determine the
most effective frequency of resistance training.
Hypothesis
• Repeated, daily OGTT’s will not affect insulin sensitivity.
• Insulin Sensitivity will improve for 48 hours following a single
bout of moderate to high intensity resistance exercise.
Results
Participant demographics can be seen in Table 1 and shows that
participants had normal lipid profiles, blood pressure and good
glycaemic control. The mean BMI for the resistance exercise group
was 25.8 (4.5) kg/m2 while it was 33.3 (6.3) kg/m2 for the no resistance
exercise group. One individual from the resistance exercise group and
two from the no resistance exercise group had an abnormal response to
the initial OGTT that would indicate they had impaired glucose
tolerance. Two individuals from the resistance exercise group and four
from the no resistance exercise group were hyperinsulinaemic (>130
pmol/L) at baseline.
Table 1: Participant Demographics
Results cont.
• There was no change over time for area under the insulin curve for 
either group (Figure 2).
• The OGIS showed good reproducibility as there was no change 
over time for insulin sensitivity for either group (Figures 3 & 4).
• There was no change over time for 120 minute glucose levels for 
either group and no significant difference between groups (Figure 
5).
Conclusion
• Repeated OGTT’s provide a reliable estimate of insulin
sensitivity in apparently healthy individuals that does not
appear to be affected by administration on consecutive days.
• A single bout of moderate to high intensity resistance exercise
did not produce a discernable change in insulin sensitivity.
• The OGTT produces moderately reproducible results in terms
of glucose levels.
Where to Next?
• Investigate the effect of an unfamiliar bout of resistance
exercise on markers of inflammation and transient insulin
resistance.
• Investigate the number of resistance exercise sessions
required before changes to insulin sensitivity can be
detected.
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Measure Resistance Exercise No Resistance Exercise
Male / Female 3 / 7 3 / 7
Age (years) 51.6 (5.8) 54.6 (6.5)
Weight (kg) 74.7 (10.0) 93.4 (16.4)*
Height (cm) 170.8 (7.9) 167.7 (6.8)
BMI (kg.m-2) 25.8 (4.5) 33.3 (6.3)*
Waist:Hip 0.83 (0.07) 0.88 (0.08)
BP (mmHg) 120 (13) / 74 (9) 126 (14) / 83 (10)*
Cholesterol (mmol/L) 5.1 (0.8) 4.9 (1.2)
LDL (mmol/L) 3.0 (0.4) 2.8 (1.0)
HDL (mmol/L) 1.53 (0.47) 1.42 (0.24)
Triglycerides (mmol/L) 1.2 (0.9) 1.6 (0.5)
HbA1c (%) 5.6 (0.3) 5.5 (0.3)
Glucose (mmol/L) 4.9 (0.5) 5.4 (0.4)
Insulin (pmol/L) 95.6 (84.9) 129 (82.7)
MET-mins.wk-1 (IPAQ) 987 (931) 1428 (1365)
Sedentary Time (mins) 378 (142) 435 (207)
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Figure 4: Variance in insulin sensitivity over time. Mean and 95% CI.
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Figure 5: Variance in 120 minute glucose from the OGTT over time.
Mean and 95% CI. Dotted line represents the cut off for a
normal response.
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Figure 2: Mean (SD) area under the insulin curve for each OGTT.
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Figure 3: Mean (SD) OGIS calculated from each OGTT.
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Introduction 
Long-term resistance exercise is known to improve glycaemic control.1 However, the 
continuous glucose response to acute resistance exercise in untrained individuals with type 2 
diabetes (T2D) treated with insulin are not known. 
 
Methods 
Seven individuals (males=4; females=3) with insulin treated T2D were recruited to 
participate, and their anthropometric, health and exercise capacity data recorded.  Blood 
glucose levels were then monitored using the Medtronic iPro™2 continuous glucose 
monitoring system throughout the 24hrs prior to a single session of whole-body resistance 
exercise (3 sets, 10 repetitions at 70% one-repetition maximum) and for 3-days following the 
exercise session.  Regular insulin and medication doses were maintained except for 
immediately before exercise where half the prescribed insulin dose was administered. 
 
Results 
Participants mean (SD) age was 56.0 (4.2) years, were diagnosed with T2D 15.3 (7.1) years 
ago, weighed 97.8 (40.1) kg with HbA1c of 8.2% (0.6)%. During the 24hrs pre-exercise 
intervention, participants experienced blood glucose ≥10mmol.L-1 (hyperglycaemia) for 
15.9% of the day. Post-intervention, time in hyperglycaemia increased from pre-exercise by 
22.0% (95%CI=-2.5 to 46.5), 20.6% (95%CI=4.1 to 37.1) and 24.3% (95%CI=1.8 to 46.8) 
between 0-24, 24-48 and 48-72 hours respectively. Whilst none of these differences reached 
statistical significance (probably due to the small sample size), a large effect size was noted 
(partial eta2=0.737). 
 
Conclusion 
In novice exercisers, a single session of resistance exercise appears to impair glycaemic 
control, when measured continuously, for up to 72 hours post-exercise. These findings differ 
from those reported after a single session of aerobic exercise,2 low-intensity resistance 
exercise combined with short high-intensity aerobic exercise,3 or resistance exercise4 
(measured by oral glucose tolerance testing) and may be due to a suggested transient insulin 
resistance.5 Our results suggest that resistance exercise may induce responses via a different 
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metabolic mechanism than aerobic or combined exercise. These mechanisms require further 
investigation. 
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Continuous glucose response to a single session of resistance 
exercise in individuals with insulin requiring type 2 diabetes
B. A. Gordon1,2, S. R. Bird1, R. J. MacIsaac3, A. C. Benson1
1School of Medical Sciences & Health Innovations Research Institute, RMIT University, Melbourne, Australia 
2Physiotherapy Department, Austin Health, Melbourne, Australia
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Methodology
Study Design:
Eleven individuals with insulin treated type 2 diabetes consented to
participate after ethical approval. The study protocol is outlined in
Figure 1. Participants consumed a standardised dinner meal on the
evening before each scheduled visit, while a standardised breakfast
meal was consumed at each visit. Regular insulin and medication
doses were maintained except for immediately before exercise,
where half the prescribed insulin dose was administered.
Baseline Testing:
Body Mass & Height: (c.v. = 0.3% & 0.10%)
Body Mass Index (BMI) = (Weight (kg) / Height2 (m))
Bloods (fasting lipids, HbA1c, glucose, insulin, hs-
CRP: (c.v.= TC=2.0%, HDL-C=9.0%, LDL-C=12.0%,
TG=3.5%, HbA1c=3.0%, Glucose=4.5%, Insulin=8.5%,
hsCRP=6.0%)
Physical Activity:
Activity volume and sedentary time were evaluated
using the short-form International Physical Activity
Questionnaire [6].
VO2peak Testing:
An incremental cycle protocol was performed on a Lode
(Excalibur Sport) cycle ergometer with initial workload
(Watts) related to participants body weight and
increased by 25% of the initial workload every 150
seconds.
1RM Testing:
A progressive protocol to failure on two consecutive
attempts for bench press, 45° leg press, lateral pulldown,
knee extension, seated row & knee flexion.
Resistance Exercise Intervention:
Acute Resistance Exercise Bout:
The resistance exercise bout consisted of 3 sets of 10
repetitions of each exercise. The load for each set was
70% of the participant’s 1RM with a recovery period of
60-90 seconds between sets.
Continuous Glucose Monitoring:
A Medtronics iPro™2 CGM was inserted two days
prior to and was removed three days after completing
the resistance exercise bout. Data was downloaded to a
computer for calculation of hyperglycaemia and area
under the curve (AUC).
Introduction
Current treatment recommendations for type 2 diabetes suggest that
metformin and lifestyle interventions be implemented immediately
and that early implementation of insulin therapy is employed to
achieve and maintain glycaemic control [1]. It has been reported that
individuals with type 2 diabetes experience hyperglycaemia (blood
glucose >10 mmol/L) for up to 40% of a single day [2].
Long-term resistance exercise is known to improve glycaemic
control in people with type 2 diabetes being treated with diet or oral
medications [3]. However, this has only been determined using a
one-off ‘snapshot’ method such as a blood test or oral glucose
tolerance test. Continuous glucose monitoring (CGM) has shown the
prevalence of hyperglycaemia can be reduced with single session of
aerobic exercise [4] or aerobic exercise combined with resistance
exercise [5]. The amount of time spent in hyperglycaemia is an
important aspect of diabetes control that can only be determined
through CGM.
Therefore, the purpose of this study was to investigate the effect of a
single session of resistance exercise, on glucose homeostasis using
CGM.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless
otherwise indicated.
• A repeated measures analysis of variance (ANOVA) was
completed to assess the change over time for area under the 24
hour glucose curve and percentage of time spent in
hyperglycaemia (blood glucose >10 mmol/L).
• All data were analysed using SPSS version 18 for Windows with
significance set at an alpha level of p=0.05.
Results
Participant demographics can be seen in Table 1 and shows that
participants had good lipid profiles, blood pressure and poor
glycaemic control. According to BMI, on average participants were
classified as obese. On average, participants completed a moderate
volume of physical activity and spent a large amount of time being
sedentary [6]. Participants also had a poor level of aerobic fitness
and muscular strength. In the 24 hours prior to completing the
resistance exercise, participants experienced hyperglycaemia on
average for 25% of the day. Whilst this did not change significantly
following exercise (p=0.53; Figure 2), a large effect size was found
(partial eta2=0.23). There was also no statistically significant change
to area under the 24-hour glucose curve (p=0.23) at any time
following the resistance exercise bout, although again a large effect
size was found (partial eta2=0.40; Figure 3).
Table 1: Participant Demographics
Conclusion
• In novice exercisers, a single session of resistance exercise
may impair glycaemic control when measured continuously
for up to 72 hours after resistance exercise.
This finding is in contrast to those reported after a single
session of aerobic exercise [4] or low-intensity resistance
exercise combined with short high-intensity aerobic exercise
[5]. It also differs to that reported following resistance
exercise of a similar intensity when insulin sensitivity was
estimated using oral glucose tolerance testing (OGTT) [7].
This may be due to the suggested transient insulin resistance
[8] or it may be that our results using CGM provide a more
complete picture of the response compared to a ‘snapshot’
view obtained from fasting blood samples or OGTT. Our
results however, suggest that resistance exercise induces
responses via different metabolic mechanisms to aerobic and
combined exercise.
• It is not known whether this level of variation is similar or
different to daily biological variation in 24-hour glucose
levels.
Where to Next?
• Investigate the daily variation of 24-hour glucose levels
under free living conditions without modifying
medication or activity levels.
• Investigate whether the response to a single session of
resistance exercise is similar in people who have regularly
completed resistance training for at least six months.
• Compare the mechanisms responsible for adaptation to
resistance and aerobic exercise.
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Measure Mean (SD)
Male / Female 6 / 5
Age (years) 58.9 (7.2)
Years of Diabetes 16.3 (8.5)
Weight (kg) 95.5 (37.0)
Height (cm) 167.1 (11.5)
BMI (kg.m-2) 33.6 (10.0)
BP (mmHg) 133(17) / 80 (9)
Cholesterol (mmol/L) 4.2 (0.7)
LDL (mmol/L) 2.3 (0.5)
HDL (mmol/L) 1.18 (0.37)
Triglycerides (mmol/L) 1.6 (0.8)
HbA1c (%) 8.0 (0.6)
Glucose (mmol/L) 8.1 (2.0)
Insulin (mIU/L) 33.1 (75.8)
hsCRP (mg/L) 4.7 (7.3)
Activity (MET-mins.wk-1) 1068 (2047)
Sedentary Time (mins) 455 (315)
VO2peak (ml.kg-1.min-1) 19.8 (6.9)
Bench Press 1RM (kg) 39.6 (17.2)
BMI = body mass index; BP = blood pressure; LDL = low-density lipoprotein;
HDL = high-density lipoproetin; HbA1c = glycated haemoglobin; hsCRP = high
sensitivity C-reactive protein; VO2peak = peak oxygen uptake; 1RM = one
repetition maximum
Figure 1: Study Protocol
Figure 2: Percentage of time spent in hyperglycaemia, Mean (SD).
RE = resistance exercise; 24-h = 24 hours; 48-h = 48 hours; 72-h = 72 hours
School of Medical Sciences, RMIT University
brett.gordon@rmit.edu.au
Figure 3: 24 hour glucose levels prior to and following resistance 
exercise. 
RE = Resistance Exercise
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Introduction: Long-term resistance exercise is known to improve glycaemic control 
however, less is known about the effects from a single session of resistance exercise. 
Reducing postprandial hyperglycaemic excursions is considered integral in treating type 2 
diabetes (T2D) with recent data suggesting individuals with T2D experienced 
hyperglycaemia for almost 40% of a single day.  
Statement of Problem/Aim: As prescription of exogenous insulin therapy is increasing in 
T2D, we sought to investigate the response to resistance exercise in untrained individuals 
with T2D treated with insulin using continuous glucose monitoring.  
Outcomes: Eleven individuals (males=6; females=5) with insulin treated T2D and a mean 
(SD) age of 58.9 (7.2) years consented to participate. Participants were diagnosed with T2D 
16.3 (8.5) years ago, weighed 95.5 (37.0) kg with HbA1c of 8.0% (0.6)%.  Blood glucose 
levels were monitored using the Medtronic iPro™2 continuous glucose monitoring system 
throughout the 24hrs prior to a single session of whole-body resistance exercise (3 sets, 10 
repetitions at 70% one-repetition maximum) and for 3-days following the exercise session.  
Regular insulin and medication doses were maintained except for when the insulin dose was 
halved immediately before exercise. During the 24hrs pre-exercise intervention, participants 
experienced blood glucose ≥10mmol.L-1 (hyperglycaemia) for 24.9% of the day. Post-
exercise, time in hyperglycaemia increased from pre-exercise by 14.1% (95%CI:-14.6 to 
42.8), 7.2% (95%CI:-20.6 to 35.0) and 9.5% (95%CI:-26.2 to 45.1) between 0-24, 24-48 and 
48-72 hours respectively. Whilst none of these differences reached statistical significance 
(probably due to the small sample size), a large effect size was noted (partial eta2=0.228).  
These findings differ from those reported after a single session of aerobic exercise or low-
intensity resistance exercise combined with short high-intensity aerobic exercise and suggests 
that in novice exercisers, a single session of resistance exercise appears to impair glycaemic 
control, when measured continuously, for up to 72 hours post-exercise. 
 
Gordon BA, Bird SR, MacIsaac RJ, Benson AC. (2011). Continuous glucose response to a 
single session of resistance exercise in individuals with insulin requiring type 2 diabetes. 
Poster presentation at Higher Degree by Research Student Conference – Vision to Reality, 
RMIT University, Melbourne, Australia, 21 October 2011.  
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Continuous glucose response to a single session of resistance 
exercise in individuals with insulin requiring type 2 diabetes
B. A. Gordon1,2, S. R. Bird1, R. J. MacIsaac3, A. C. Benson1
1School of Medical Sciences & Health Innovations Research Institute, RMIT University, Melbourne, Australia 
2Physiotherapy Department, Austin Health, Melbourne, Australia
3Endocrine Centre, Austin Health & University of Melbourne, Melbourne, VIC, Australia
Methodology
Study Design:
Eleven individuals with insulin treated type 2 diabetes consented to
participate after ethical approval. The study protocol is outlined in
Figure 1. Participants consumed a standardised dinner meal on the
evening before each scheduled visit, while a standardised breakfast
meal was consumed at each visit. Regular insulin and medication
doses were maintained except for immediately before exercise,
where half the prescribed insulin dose was administered.
Baseline Testing:
Body Mass & Height: (c.v. = 0.3% & 0.10%)
Body Mass Index (BMI) = (Weight (kg) / Height2 (m))
Bloods (fasting lipids, HbA1c, glucose, insulin, hs-
CRP: (c.v.= TC=2.0%, HDL-C=9.0%, LDL-C=12.0%,
TG=3.5%, HbA1c=3.0%, Glucose=4.5%, Insulin=8.5%,
hsCRP=6.0%)
Physical Activity:
Activity volume and sedentary time were evaluated
using the short-form International Physical Activity
Questionnaire [6].
VO2peak Testing:
An incremental cycle protocol was performed on a Lode
(Excalibur Sport) cycle ergometer with initial workload
(Watts) related to participants body weight and
increased by 25% of the initial workload every 150
seconds.
1RM Testing:
A progressive protocol to failure on two consecutive
attempts for bench press, 45° leg press, lateral pulldown,
knee extension, seated row & knee flexion.
Resistance Exercise Intervention:
Acute Resistance Exercise Bout:
The resistance exercise bout consisted of 3 sets of 10
repetitions of each exercise. The load for each set was
70% of the participant’s 1RM with a recovery period of
60-90 seconds between sets.
Continuous Glucose Monitoring:
A Medtronics iPro™2 CGM was inserted two days
prior to and was removed three days after completing
the resistance exercise bout. Data was downloaded to a
computer for calculation of hyperglycaemia and area
under the curve (AUC).
Introduction
Current treatment recommendations for type 2 diabetes suggest that
metformin and lifestyle interventions be implemented immediately
and that early implementation of insulin therapy is employed to
achieve and maintain glycaemic control [1]. It has been reported that
individuals with type 2 diabetes experience hyperglycaemia (blood
glucose >10 mmol/L) for up to 40% of a single day [2].
Long-term resistance exercise is known to improve glycaemic
control in people with type 2 diabetes being treated with diet or oral
medications [3]. However, this has only been determined using a
one-off ‘snapshot’ method such as a blood test or oral glucose
tolerance test. Continuous glucose monitoring (CGM) has shown the
prevalence of hyperglycaemia can be reduced with single session of
aerobic exercise [4] or aerobic exercise combined with resistance
exercise [5]. The amount of time spent in hyperglycaemia is an
important aspect of diabetes control that can only be determined
through CGM.
Therefore, the purpose of this study was to investigate the effect of a
single session of resistance exercise, on glucose homeostasis using
CGM.
Statistical Analysis:
• Data are presented as mean (standard deviation), unless
otherwise indicated.
• A repeated measures analysis of variance (ANOVA) was
completed to assess the change over time for area under the 24
hour glucose curve and percentage of time spent in
hyperglycaemia (blood glucose >10 mmol/L).
• All data were analysed using SPSS version 18 for Windows with
significance set at an alpha level of p=0.05.
Results
Participant demographics can be seen in Table 1 and shows that
participants had good lipid profiles, blood pressure and poor
glycaemic control. According to BMI, on average participants were
classified as obese. On average, participants completed a moderate
volume of physical activity and spent a large amount of time being
sedentary [6]. Participants also had a poor level of aerobic fitness
and muscular strength. In the 24 hours prior to completing the
resistance exercise, participants experienced hyperglycaemia on
average for 25% of the day. Whilst this did not change significantly
following exercise (p=0.53; Figure 2), a large effect size was found
(partial eta2=0.23). There was also no statistically significant change
to area under the 24-hour glucose curve (p=0.23) at any time
following the resistance exercise bout, although again a large effect
size was found (partial eta2=0.40; Figure 3).
Table 1: Participant Demographics
Conclusion
• In novice exercisers, a single session of resistance exercise
may impair glycaemic control when measured continuously
for up to 72 hours after resistance exercise.
This finding is in contrast to those reported after a single
session of aerobic exercise [4] or low-intensity resistance
exercise combined with short high-intensity aerobic exercise
[5]. It also differs to that reported following resistance
exercise of a similar intensity when insulin sensitivity was
estimated using oral glucose tolerance testing (OGTT) [7].
This may be due to the suggested transient insulin resistance
[8] or it may be that our results using CGM provide a more
complete picture of the response compared to a ‘snapshot’
view obtained from fasting blood samples or OGTT. Our
results however, suggest that resistance exercise induces
responses via different metabolic mechanisms to aerobic and
combined exercise.
• It is not known whether this level of variation is similar or
different to daily biological variation in 24-hour glucose
levels.
Where to Next?
• Investigate the daily variation of 24-hour glucose levels
under free living conditions without modifying
medication or activity levels.
• Investigate whether the response to a single session of
resistance exercise is similar in people who have regularly
completed resistance training for at least six months.
• Compare the mechanisms responsible for adaptation to
resistance and aerobic exercise.
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Measure Mean (SD)
Male / Female 6 / 5
Age (years) 58.9 (7.2)
Years of Diabetes 16.3 (8.5)
Weight (kg) 95.5 (37.0)
Height (cm) 167.1 (11.5)
BMI (kg.m-2) 33.6 (10.0)
BP (mmHg) 133(17) / 80 (9)
Cholesterol (mmol/L) 4.2 (0.7)
LDL (mmol/L) 2.3 (0.5)
HDL (mmol/L) 1.18 (0.37)
Triglycerides (mmol/L) 1.6 (0.8)
HbA1c (%) 8.0 (0.6)
Glucose (mmol/L) 8.1 (2.0)
Insulin (mIU/L) 33.1 (75.8)
hsCRP (mg/L) 4.7 (7.3)
Activity (MET-mins.wk-1) 1068 (2047)
Sedentary Time (mins) 455 (315)
VO2peak (ml.kg-1.min-1) 19.8 (6.9)
Bench Press 1RM (kg) 39.6 (17.2)
BMI = body mass index; BP = blood pressure; LDL = low-density lipoprotein;
HDL = high-density lipoproetin; HbA1c = glycated haemoglobin; hsCRP = high
sensitivity C-reactive protein; VO2peak = peak oxygen uptake; 1RM = one
repetition maximum
Figure 1: Study Protocol
Figure 2: Percentage of time spent in hyperglycaemia, Mean (SD).
RE = resistance exercise; 24-h = 24 hours; 48-h = 48 hours; 72-h = 72 hours
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Figure 3: 24 hour glucose levels prior to and following resistance 
exercise. 
RE = Resistance Exercise
